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UNIVERSITY OF SOUTHAMPTON 
 
ABSTRACT 
 
School of Medicine, Developmental Origins of Health and Disease, Institute of Human 
Nutrition, Public Health Nutrition 
Doctor of Philosophy 
 
THE IMPACT OF DIFFERENT DIETARY PATTERNS ON NUTRITIONAL STATUS AND 
METABOLIC INTEGRITY IN ASYMPTOMATIC PEOPLE LIVING WITH HIV INFECTION 
(PLWH) IN SOUTH AFRICA 
 
By 
Reginald A Annan 
 
Adequate nutritional status promotes optimal structure and function. In PLWH, few studies 
on the impact of dietary intake on nutritional and metabolic status have been undertaken. 
This  cross-sectional  secondary  data  analysis  examined  how  different  dietary  patterns 
influenced nutritional and metabolic integrity in asymptomatic PLWH in  the  North-West 
Province of South Africa. Dietary data were collected using validated QFFQ. Data analysis 
was by SPSS version 14. Dietary and nutrient patterns were generated using Principal 
Component  Analysis.  Though  asymptomatic,  marked  biochemical  differences  depicting 
altered metabolism and inflammation were observed in PLWH compared to the uninfected. 
PLWH also showed an anthropometric profile that depicted altered body composition and 
abnormal fat distribution. Four dietary patterns: animal-based, ‘recommended’, staple, and 
the Carbohydrate, Vegetable and Legumes (CVL) based were observed in both PLWH 
and the uninfected with slight differences. In PLWH, the animal-based similar to the CVL 
pattern was associated with better overall nutrient intake (r=0.5, p<0.001) and selected 
nutrients, including energy (r=0.3, p<0.001), protein (r=0.6, p<0.001), iron (r=0.5, p<0.001), 
zinc  (r=0.6,  p<0.001)  and  vitamin  A  (r=0.5,  p<0.001),  compared  to  the  other  dietary 
patterns.  The  animal  based  dietary  pattern  also  predicted  higher  BMI  (OR=2.2,  95% 
CI=0.9-5.0), LBM (3.6, 1.3-10.4), serum albumin (1.5, 0.9-2.4) and lower liver enzymes 
AST (0.5, 0.3-0.8) and ALT (0.6, 0.4-0.9). Using Graphical Chain Modelling, higher intake 
of the animal-based but lower staple-based dietary patterns were associated with better 
overall nutrient intake, serum vitamins A, E, lipid score, albumin, BMI and LBM suggesting 
that intake of this diet may provide better nutrient quality, enhancing nutritional status and 
metabolic proficiency, which may ultimately influence disease progression. The findings 
have implications for dietary guidelines for this population but further research is required. 
However,  if  these  findings  are  true,  then  a  predominantly  animal-based  diet  may  be 
‘recommended’  for  this  population.  Moreover,  the  longer  term  implications  of  high  fat 
intake associated with the animal based dietary pattern on obesity and associated risks 
should be considered. This poses a challenge to imperatively weigh up the longer term 
risks of the overall population profile crucial for public health. 
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CHAPTER ONE INTRODUCTION 
1.0   General Introduction  
The aim of this thesis was to explore the impact of different dietary patterns on nutritional 
status  and  metabolic  integrity  in  asymptomatic  HIV  infected  individuals.  The  term 
metabolic  integrity  used  in  this  thesis  refers  to  markers  which  depict  the  reliability, 
competence, capability and proficiency of the body to carry out its metabolic processes 
and functions. PLWHA is an abbreviation for People Living With HIV and AIDS but for this 
thesis, the abbreviation, PLWH was used instead of PLWH, to denote People Living With 
HIV. This was because the study population was asymptomatic. The use of PLWH in this 
thesis may sometimes include AIDS persons when referring to people living with HIV and 
AIDS in general. 
1.1   Layout of the thesis 
The  first  chapter  of  this  thesis  gives  an  overview  of  the  interrelationships  between 
infection, nutritional status and immune function and describes the conceptual framework 
used to explore how nutritional factors influence disease progression in people living with 
HIV/AIDS (PLWH). The aim, objectives, assumptions, hypothesis, exposure and variables 
are also outlined. Chapter Two presents a summary of findings from a systematic review 
of  evidence  regarding  the  impact  of  dietary  intake  and  nutritional  status  on  disease 
progression  in  PLWH.  It  also  explores  some  basic  facts  about  HIV/AIDS,  markers  of 
disease  progression,  strengths  and  weaknesses  of  available  methods  of  dietary  and 
nutritional status assessment and a review of current dietary and nutritional guidelines for 
PLWH. Chapter Three describes methods used for data collection including the discussion 
of the validity and reproducibility of the quantitative food frequency questionnaire used for 
the dietary assessment.  
 
Chapters Four, Five and Six are the results chapters. Chapter Four presents the basic 
descriptive  characteristics  (socio-demographic,  dietary  patterns,  basic  anthropometric 
analysis and biochemical status) and predictors of HIV infection in the study population. 
Chapter  Five  explores  the associations  between  different  dietary  patterns and  nutrient 
intakes, anthropometrics and biochemical markers of disease progression and markers of 
metabolic integrity. The last results chapter (Chapter Six) presents the interrelationships 
between  dietary  patterns,  nutrient  intake,  nutritional  biochemistry,  body  shape  and 
composition (such as BMI and lean body mass) and some markers of disease progression 
and  metabolic  integrity  (albumin,  total  bilirubin,  Aspartate  Aminotransferase)  using  a      
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graphical  chain  modelling  approach.  Chapter  Seven  presents  the  general  discussion, 
implications  of  the  findings  for  public  health  in general,  nutritional support  and current 
dietary  guidelines  for  PLWH  considering  the  ‘triple’  burden  of  disease  observed  in 
developing  countries  especially  in  sub-Saharan  Africa,  and  limitations  of  the  study. 
Chapter eight is the conclusion. 
1.2  Structure  of  the  framework  for  HIV  infection,  malnutrition  and  immune 
integrity  
This study sought to encapsulate the effect of different dietary patterns on nutritional and 
disease  state  of  HIV sero-positive  persons  with  the  research  question;  “was  a dietary 
pattern which followed the current South African dietary guidelines for PLWH associated 
with  more  optimal  nutrient  intake  and  serum  nutrient  status  leading  to  better 
anthropometrics (higher BMI and lean body mass), metabolic integrity and slower disease 
progression?”  
 
Long before the AIDS epidemic emerged in the early 1980s, the synergistic interaction 
between  infection,  nutritional  status,  and  immune  function  was  recognised.  Infectious 
diseases,  no  matter  how  mild,  influence  nutritional  status  and  conversely,  almost  any 
nutrient deficiency, if sufficiently severe impairs resistance to infection (Scrimshaw et al., 
1968, Scrimshaw et al., 1959). In the early 1940s little was known about the relationship 
between nutrition and infection (Jeliffe, 1950) but in the 1950s it was demonstrated that 
malnutrition  and  infection  in  humans  were  generally  synergistic  and  any  infection 
worsened nutritional status (Scrimshaw et al., 1961; Scrimshaw et al., 1957; Salomon et 
al., 1966). Further evidence supporting the relationship between nutrition and infection was 
confirmed by studies that showed reduction in infections, increased growth and reduced 
duration of recovery from infections following improved nutrition (Scrimshaw and Guzman, 
1995;  Chavez  et  al.,  1995;  Martorell,  1995).  Thus,  the  complex  interactions  between 
nutritional status, host immunity, and infectious diseases have been well documented in 
the literature (Scrimshaw and SanGiovanni, 1997; Calder and Jackson, 2000).  
 
The cyclical interrelationship between nutritional status, infection and immune integrity was 
described further by Jackson, emphasising the effect of infection and inadequate dietary 
intake  on  body  weight,  and  metabolic  integrity  (Figure  1.1).  Infection  could  lead  to 
unbalanced nutrient losses (e.g. zinc, vitamin A, vitamin B12 and folate losses as a result of 
diarrhoea and vomiting), which leads to the deficiencies of these specific nutrients. The 
specific nutrient deficiencies could influence appetite and consequently lead to low food 
intake (Jackson, 2007). Inadequate food intake, due to either a poor appetite or limited      
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availability of food, leads to wasting syndrome, best captured as a relative loss of weight 
and associated with a range of complex adaptive changes in all tissues and organs. Thus, 
reduced  weight  marks  this  process  of  reductive  adaptation  which  can  be  determined 
functionally at the molecular, cellular and tissue levels as a reduction in the capacity of 
many metabolic processes, impaired regulation and control, a loss of reserve capacity and 
a tissue of metabolic brittleness (Jackson, 2007). This implies that nutritional support or 
intervention and optimising nutritional status could play an important part in a person’s 
susceptibility to infections in general and HIV infection in particular as well as delaying 
disease progression, risk of morbidity and mortality from AIDS.  
 
Figure 1.1: Factors leading to wasting and tissue malfunction 
 
 
Source:  Factors  leading  to  wasting  and  tissue  malfunction  by  Jackson,  2007 
(Modified) 
 
The relationship between nutritional status and immune integrity in HIV infection follows a 
similar fashion and has been captured in a cyclic chain of events and described as the 
vicious cycle  of malnutrition and  HIV  disease progression  (Figure  1.2)  by  Semba  and 
Tang, (1999). Malnutrition and HIV have been shown to work in tandem, both affecting the 
immune  system.  HIV  compromises  nutritional  status  and  increases  susceptibility  to 
secondary infections. On the other hand, malnutrition exacerbates the effects of HIV by 
further weakening the immune system (Piwoz and Preble, 2001; Semba and Tang, 1999, 
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Calder and Jackson, 2000). Tang and colleague described the relationship between HIV 
infection,  immune  integrity  and malnutrition  as  cyclical  (Semba  and  Tang,  1999).  This 
implies that in the development of the HIV infection and progression to AIDS, the various 
factors are interrelated and one factor influences the other in a cyclical fashion. 
 
Figure 1.2: The vicious cycle of Malnutrition and HIV/AIDS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source:  The  vicious  cycle  of  malnutrition  and  HIV  by  Semba  and  Tang,  1999 
(modified) 
Poor nutrition which could be due to poor food intake, increased nutrient usage and loss of 
nutrients from the body due to diarrhoea for instance leads to malnutrition. This weakens 
the immune system as well as enhancing oxidative stress, decreasing the ability of the 
body to fight the infection. The weakened immune system results in repeated infection, 
increased HIV replication, increased morbidity and disease progression which in turn lead 
to poor dietary intake, nutrient losses and altered metabolism and so the cycle continues 
(Department of Health South Africa, 2001).  
 
Dramatic  decline  of  HIV  related  morbidity  and  mortality  has  been  recorded  with  the 
introduction of Highly Active Anti-Retroviral Therapy (HAART) and treatment of HIV/AIDS 
has  progressed  significantly  over  the  years  (Rousseau  et.  al  2000).  According  to  the 
Increased 
oxidative 
stress: immune 
suppression 
Insufficient dietary 
intake: malabsorption, 
diarrhoea, altered 
metabolism and 
nutrient storage 
 
NUTRITIONAL 
DEFICIENCIES 
 
Increased HIV 
replication, 
hastened disease 
progression and 
morbidity 
      
   
    5 
 
Association of Science of South Africa’s recent report on HIV/AIDS, TB and nutrition, the 
availability of highly effective drugs to control HIV/AIDS and cure tuberculosis has tended 
to downplay the potential benefits that may accompany appropriate supportive measures, 
designed to complement or precede pharmacotherapy, to arrest progression from infection 
to disease (TB), or to delay the rate of progression of the earlier phases of the illness, 
before specific medicinal interventions are indicated and nutritional support is one such 
potentially valuable measure (ASSAF, 2007).  
 
There  is  emerging  evidence  that  patients  who  begin  antiretroviral  therapy  without 
adequate  nutrition  have  lower survival  rates  and  patients starting  antiretroviral  therapy 
without adequate nutrition are six times more likely to die (Paton et al., 2006). Adequate 
dietary intake and absorption are essential for achieving the full benefits of antiretroviral 
treatment  (WHO, 2005)  and  ART  itself  may  increase  appetite  and  reduce  some side-
effects and promote adherence to the therapy if some of the medicines are taken with food 
(Hardon et al., 2007). Given the importance of adherence in delaying viral resistance to 
first-line  drugs,  nutritional  support becomes even  more  important  in  the  longer  run  for 
sustaining antiretroviral treatment (UNAIDS, 2008). Both earlier and recent studies show 
that immune deficiencies and wasting are prevalent in HIV infected persons on HAART 
(Drain et al., 2007; Mitsuyasu, 2000). Thus, ART alone may not be enough to tackle the 
HIV  epidemic  especially  in  developing countries  where  undernutrition  remains  a major 
problem and consequently food security and nutrition will be fundamental to HIV treatment 
(UNAIDS, 2008). 
 
The clinical picture of the HIV wasting syndrome (also known as the “slim disease”), a 
characteristic manifestation of AIDS in Africa, results in large part from undernutrition in 
the face of opportunistic illnesses, especially tuberculosis, which itself may be made more 
likely by inadequate food intake (Boelaert and Gordeuk, 2002; Lucas et al., 1994). Thus as 
donor funding expands in Africa, it is imperative to integrate nutrition into the treatment of 
HIV. Africa’s health needs extend beyond the treatment of HIV/AIDS because HIV-infected 
persons are at great risk from other threats as well, including malaria, tuberculosis, food 
insecurity and malnutrition on one hand and the rising trends of chronic diseases which 
could be caused by overnutrition on the other hand. 
 
Initial reports on nutritional status of PLWH indicated that, despite adequate or increase 
energy and nutrient intake, serum levels of a number of micronutrients were often low 
(Mantero-Atienza et al., 1991 and 1991; Baum et al., 1995). Vitamins A, E, B6, B12, β-     
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carotene, selenium, and zinc were of much concern (Beach et al., 1992; Coodley et al., 
1993; Tang et al., 1998) and intakes of vitamins A, C and E and iron during early infection 
were found to be positively associated with CD4+ cell count.  A low serum level of vitamin 
A was associated with more rapid disease progression and death (Semba et al., 1995; 
Semba  et  al.,  1993).  Tang  and  colleagues  also  reported  an  association  between  low 
serum levels of vitamin E and B12 and increased disease progression. Also, low serum 
selenium was found to be associated with faster disease progression (Baum et al., 1997). 
Smit and colleagues reported intake of vitamins A and E, calcium, and zinc below the 
recommended daily allowances for both HIV-1 sero-positives and sero-negative (Smit et 
al., 1996).  
 
On the basis of the above findings, studies that followed were mostly interventions and 
involved  micronutrient  supplementation  to  a  large  extent.  Available  literature  from 
observational  and  randomised  controlled  trials  have  revealed  that  nutritional  support 
(micronutrients, macronutrients, and  enteral/parenteral  nutritional support)  is associated 
with increased body weight (De Luis et al., 2001; Shabert et al., 1999; Melchior et al., 
1996), lean body mass (De Luis et al., 2001; Ireton Jones et al., 1998; Melchior et al., 
1996), CD4 cell count (Austin et al., 2006; Baum, 2003 and 1995; Bodgen et al., 2000), 
and  lower  hospitalisation  from  secondary  infections  and  disease  progression  to  AIDS 
(Baum, 2003 and 1995;  Tang et al., 1993).  Viral  load  (Van  Lettow  et  al.,  2004)  and 
mortality (Austin et al., 2006; Jiamton et al., 2003; Baum et al., 1997; Kupka et al., 2004) 
were  reduced  in  some  studies.  Supplementation  and  serum  status  of  specific 
micronutrients such as selenium (Kupka et al., 2007; Van Lettow et al., 2004), zinc (Baum, 
2003; Bodgen et al., 2000), vitamin A (Baum et al., 1995 and 1997; Van Lettow et al., 
2004)  and  multiple  micronutrients  (Austin  et  al.,  2006;  Tang  et  al.,  1993)  and  some 
macronutrients such as arginine, glutamine, whey proteins have led to improved disease 
outcomes (Rathmacher et al., 2004; Shabert et al., 1999; Clark et al., 2000; Schwenk et 
al., 1999) in PLWH. There is therefore some evidence supporting the role that adequate 
nutritional status plays in HIV infection.  
However,  there  are  several  studies  which  did  not  show  any  improvement  in  disease 
outcomes following nutritional support (Stephensen et al., 2007; Kupka et al., 2007; Kelly 
et al., 1999; Semba et al., 1998; Shor Posner et al., 2003) and it has been difficult to show 
causal associations between specific nutritional deficiencies and adverse clinical outcomes 
in  HIV-infected  persons.  Among  HIV-infected  women  from  Dar  es  Salaam,  Tanzania, 
selenium  supplements given  during  and  after  pregnancy  did  not  improve  HIV  disease      
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progression or pregnancy outcomes, but may improve child survival (Kupka et al., 2008). 
Moreover data linking replacement or supplementation of specific micronutrients with a 
clinical benefit have  been sparse and inconsistent (Marston and De Cock, 2004). The 
inconsistencies  in  findings  regarding  studies  on  specific  nutrients  and  HIV  infection 
coupled  with  studies  that  showed  enhanced  survival  of  better  nourished  HIV  infected 
persons  on  drug  treatment  present  a  dire  need  to  research  into  how  dietary  intake 
influence  disease  progression  in  PLWH.  No  study  has  conceptualised  the  pathway  of 
interrelationships  between  dietary  patterns,  nutrient  levels,  serum  nutrient  status,  and 
markers of disease progression (BMI, lean body mass, albumin, AST etc) in PLWH.  
 
From public health point of view however, dietary guidelines are better ways of providing 
nutritional support for the prevention of disease. Dietary guidelines which could incorporate 
locally  available  foods  might  be  more  beneficial,  feasible,  practical  and  sustainable  in 
resource poor settings such as in sub-Saharan Africa. The focus and approach of public 
health have shifted towards dietary guidelines rather than nutrients because people tend to 
consume patterns of food rather than nutrients (Williams et al., 2000). For instance, the 
nutritional  guidelines for the UK and the South African  nutritional guidelines  for  PLWH 
include ‘enjoy a variety of foods’ which could be advocating dietary patterns rather than 
nutrient. Foods are also usually consumed in a number of combinations providing a range 
of nutrients that interact with each other in a complex manner (Wirfaelt 2000). One of the 
reasons  why  studies  involving  specific  nutrients  have  not shown  the  required  benefits 
might  be  that  this  complex  interaction  between  various  nutrients  in  food  is  less 
acknowledged, hence this study.  
 
The synergistic relationship between malnutrition, infection and immune integrity however 
implies that adequate nutrition can promote and maintain immune and metabolic integrity 
in  HIV  infection,  suggesting  that  a  ‘healthy’  diet  for  PLWH  should  improve  clinical 
outcomes  by  reducing  HIV–related  morbidity,  delaying  disease  progression,  improving 
quality  of  life  and  thereby  reducing  AIDS  related  mortality.  Adults  living  with  HIV  are 
supposed to have 10−30% higher energy requirements than a healthy adult without HIV. 
Likewise,  children  living  with  HIV  have  50−100%  higher  than  normal  requirements 
(Seume-Fosso et al., 2004).  Good nutrition and food security are therefore very essential 
for keeping people living with HIV healthy (Friis et al., 2006). Just as was reported in the 
WHO/WFP/UNDAIDS (2008) policy brief; “A stronger, healthier body can better resist the 
opportunistic  infections  that  affect  people  living  with  HIV,  especially  in  resource-poor 
settings where preventive health care is not often available”.       
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The question worth asking then is whether the current dietary guidelines for PLWH could 
be  considered  ‘healthy’  for  this  population.  Obviously  the  nutritional  needs  for  HIV 
populations  are expected  to be different from the  general population  due to metabolic 
changes, inflammatory response to the infection, nutrient losses and increased nutrients 
usage among other factors. The South African national nutritional guidelines for PLWH 
recommends PLWH to choose from foods that are easily available and affordable, eat a 
variety  of  foods,  make  starchy  foods  the  basis  of  each  meal,  eat  lots  of  fruits  and 
vegetables,   meat  and dairy  foods may be eaten  daily, eat dried beans, peas,  lentils, 
peanuts or soya regularly, include sugars, fats and oils, use salt sparingly, be as active as 
you can, drink lots of clean, safe water and not to take alcoholic drinks (Department of 
Health, South Africa, 2001).  
 
A closer look at these and other national dietary guidelines for PLWH shows that these 
guidelines are quite similar to dietary guidelines for the general population. Moreover, no 
study  has  investigated  how  these  guidelines  influence  nutritional  status  and  disease 
progression and whether people following these guidelines have better nutritional status 
and  metabolic  integrity.  Moreover,  majority  of  the  studies  have  focused  on  specific 
nutrients. This study therefore sought to explore how different dietary patterns influenced 
nutrient  intakes,  serum  nutrients  status,  anthropometrics  and  markers  of  metabolic 
integrity PLWH in order to have some form of understanding of what optimal diet may 
imply for PLWH. 
 
1.3  Study Aim 
The study aim was to explore  the interrelationships  between different dietary patterns, 
dietary nutrient intake, serum nutrient status (serum vitamins A, E, lipids and proteins), 
body mass (BMI and lean body mass) and markers of metabolic integrity in PLWH. 
1.4  Specific Objectives 
1.  To describe the characteristics of the diet of the study population 
2.  To describe the association between different dietary patterns and dietary nutrient 
intake  
3.  To determine the association between different dietary patterns and serum nutrient 
status 
4.  To  identify  the  association  between  different  dietary  patterns  and  markers  of 
altered metabolism (serum albumin, AST, total bilirubin, lean body mass and BMI)      
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5.  To determine the pathway of interrelationships between dietary patterns, dietary 
nutrient intake, serum nutrient status, and markers of altered metabolism using the 
graphical chain modelling approach 
1.5  Hypothesis H 
HIV infected people who followed the current South African dietary guidelines for PLWH 
would have more optimal serum nutrient status, metabolic integrity and body composition 
than those who do not follow these guidelines. 
1.5.1  Exposures 
Dietary patterns and scores generated by principal component analysis 
1.5.2  Outcomes 
Dietary nutrient intake  
•  Specific nutrient intakes 
•  Nutrient patterns and score (first nutrient component of PCA) from nutrient intakes 
Serum nutrient status   
•  Vitamin A 
•  Vitamin E 
•  Serum lipid patterns and score (from first PCA of serum total cholesterol, HDL, LDL 
and triglycerides) 
•  Serum protein patterns and score (from first PCA of serum albumin, globulins and 
total proteins) 
Markers of metabolic integrity 
•  Serum albumin 
•  Liver enzymes (serum AST, ALT, ALP and GGT) 
•  Serum total bilirubin 
•  Serum lipids (total cholesterol, LDL, HDL and triglycerides) 
Body composition  
•  Body Mass Index (BMI) 
•  Lean body mass (LBM) 
1.6   The  conceptual  framework  for  the  thesis:  the  causal  pathway  of  dietary  
patterns, nutritional status and disease progression 
 
In HIV infection, there is a need for dietary changes to provide a solid nutrition foundation 
which may help to prevent some early problems of HIV such as weight loss (Ireton-Jones 
et al., 1998).  Wasting is included in the list of conditions that define AIDS and it is a major      
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feature of advanced HIV infection (Schwartlander et al., 1992). Malnutrition and wasting 
are serious complications of HIV and studies among hospitalised patients have shown that 
60% or more are underweight (loss of >10% of usual body weight) at the time of admission 
(Rabeneck et al., 1996). Inadequate oral intake has proved to be the most important factor 
among the causes of weight loss (Macallan et al., 1995) in PLHW. There are however 
many causes of poor nutrition and weight loss in HIV/AIDS such as increased needs for 
energy  and  protein  associated  with  altered  metabolism  as  the  body  mounts  an 
inflammatory and immune response to the infection. Repeated infections and fever, loss of 
appetite and reduced food intake due to eating problems also lead to weight loss. Weight 
loss is also associated with poor absorption of nutrients from foods, nutrient losses in urine 
and  stools,  medication,  depression  and  anxiety,  reduced  ability  to  care  for  oneself, 
tiredness, even in the early stages and poor access and availability of food (Department of 
Health, South Africa, 2001; Ott et al., 1993; Grunfeld et al., 1989; Grunfeld et al., 1992). 
 
HIV  infection  causes  the  activation  of  an  inflammatory  and  immune  response  which 
influences nutrient distribution (Calder and Jackson, 2001; Jackson, 2007). HIV infection is 
also associated with anorexia which is induced by the acute phase proteins released as a 
result of the chronic inflammatory state (Calder and Jackson, 2001; Kumar and Collins, 
1998).  There is also malabsorption, intestinal damage and diarrhoea especially in the 
symptomatic phase of the infection. Metabolic rate is also increased due to the immune 
and inflammatory response to the infection and the need to fight the invading virus and 
reduce replication of viral RNA.  
 
These together could lead to reduced dietary intake, reduced nutrient absorption, nutrient 
losses  and  increased  nutrient  requirements.  The  result  of  nutrient  losses,  increased 
requirements, reduced absorption and food intake is malnutrition and nutrient deficiencies. 
Reduced or altered food intake (dietary  patterns) could  lead to reduced and/or altered 
intake of dietary nutrients (for individual nutrients as well as lower overall nutrient score), 
and subsequently sub-optimal serum nutrient status.  
 
Sub-optimal or altered serum nutrient status would lead to altered body composition and 
metabolic  integrity.  Body composition  here  refers  to anthropometric  indicators  such  as 
body mass index and lean body mass and metabolic integrity for this thesis is measured 
by serum albumin, liver enzymes (AST, ALT, GGT and ALP), lipids (LDL and HDL), and 
total bilirubin. Ultimately there is increased immune suppression (low CD4 cell count, high 
viral load), increased incidence of secondary infections, reduced functionality and rapid      
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disease  progression  leading  eventually  to  mortality  from  AIDS.  However  markers  of 
immune  suppression,  secondary  infection  and  disease  progression  have  not  been 
assessed for this thesis. 
 
The  interrelationship  between  dietary  intake,  nutritional  status  and  metabolic  integrity 
described above implies that in HIV infection, dietary intake or different dietary patterns 
would influence the quality and quantity of nutrients in the diet and this would influence 
serum  status  of  nutrients  and  metabolites,  impacting  on  body  mass  and  metabolic 
integrity. This also implies that a desirable diet should improve nutrient intake leading to 
improved  nutritional  biochemistry  or  serum  nutrient  status  and  ultimately  better  body 
composition and  metabolic  integrity.    This was the basis  for  this  study  and  has been 
simplified into Figure 1.3.  
 
However  factors  such  as  HIV  infection  stage  (asymptomatic,  symptomatic  or  AIDS); 
physical activity and basal metabolic rate are also likely to influence the pathways outlined 
below.  For instance the stage of the disease can influence the degree of anorexia (lack of 
appetite) and anorexia is likely to be more severe in symptomatic HIV and AIDS due to 
secondary  infections  and  lead  to  reduced  and/or  altered  dietary  intake.  HIV  infected 
subjects with lower physical activity are also likely to consume less food and those with 
lower BMR are likely to have lower energy requirement and thus consume less food. This 
thesis did not assess the impact of these other factors. Reduction in food intake could also 
be  dependent  on  some  socio-economic  and  demographic  variables  such  as  food 
availability, education, residency and income (Enwonwu and Warren, 1995). Some of the 
factors described above (BMR, physical activity and lack of appetite)  were  outside the 
scope of this study. 
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Figure  1.3:  Causal  pathway  of  dietary  pattern,  nutritional  status  and  disease 
progression in HIV infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7  Assumptions 
The above  framework  required a longitudinal/progressive study design because causal 
relationships can only be explored with progressive study designs. However, data for this 
thesis  was  a  secondary  data  from  a  cross  sectional  study.  This  meant  that  causal 
relationship between these variables could not be concluded even if such associations 
existed. The effect of HIV infection on food intake can also be influenced by the stage of 
the HIV disease. In asymptomatic HIV infection loss of appetite, and unbalanced nutrient 
losses, which could be due to diarrhoea may not be major problems. Reduced dietary 
intake in HIV infection can also be due to low physical activity and reductive adaptation 
which together can reduce Basic Metabolic Rate and consequently energy expenditure. 
This study did not assess the influences of different levels of physical activity, BMR and 
Reduced or altered 
nutrient intake 
Altered body 
composition and 
metabolic integrity 
Reduced or altered 
serum nutrients 
Reduced or 
altered dietary 
intake 
Socio-demographic 
status 
HIV infection 
(stage of infection, 
BMR, physical 
activity)      
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assumed that the effects of these variables were similar within the HIV infected group and 
between the HIV infected and uninfected populations. 
 
It was also assumed that low dietary intake and for that matter reduced nutrient intake 
would lead to weight loss and reduction of lean body mass of the study participants. Again, 
low dietary intake, if associated with low physical activity and reduced BMR may result in a 
balance  between  energy  and  nutrient  intake  and  requirements.  If  this  balance  exists, 
changes in body weight and lean body mass may be absent. The final assumption was 
that altered metabolism and disease progression were marked by lowered BMI, lean body 
mass, serum albumin and higher liver enzymes and total bilirubin in the absence of more 
direct markers of disease progression such as CD4 cell count and viral load. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
   
    14 
 
CHAPTER TWO LITERATURE REVIEW 
2.1  Introduction 
This chapter of the thesis is in three sections. The first section describes the association 
between  diet  and  disease  in  general  as  well  as  a  systematic  review  of  the  available 
evidence surrounding the impact of nutritional status, nutritional supplementation and food 
intake on functional capacity (immune and metabolic integrity and disease progression) 
and structure (anthropometrics and body composition) in HIV infected populations. The 
second section describes  general issues regarding HIV  infection, including prevalence, 
markers and proxy markers of disease progression and differences in rates of disease 
progression between developing and developed countries. The third section explores the 
current nutritional and dietary guidelines for PLWH, discusses strengths and weaknesses 
of current nutritional and dietary assessment methods. 
2.2  The association between diet and disease  
One of the main risk factors for several chronic diseases including obesity, stroke, cancer 
and  type  2  diabetes  mellitus  is  unbalanced  diet  and  these  diseases  contribute  to 
preliminary  deaths,  restrict  life  quality  and  lead  to  enormous costs  for  health  systems 
(Thiele et al., 2004). Thus, monitoring the diet of populations and groups to help improve 
diet status as and when necessary by providing nutrition information and education should 
be very important to every health policy.  
 
Research has shown that certain dietary components, such as vegetables and saturated 
fat may reduce or increase the risk of chronic diseases, example coronary heart disease or 
cancer (Steinmetz & Potter, 1996; Gillman et al., 1995 and Hardman, 1996). Some studies 
also  investigated  the  protective  role  of specific nutrients  against  disease;  for  example, 
vitamin C intake against cancer risk was investigated by Block in 1991. Hu et al., 1997 and 
Ascherio et al., 1996 also described the role of fats in cardiovascular diseases. Though 
such an approach was potentially important in advancing understanding of the aetiology 
and pathogenesis of disease processes, it was criticised to be less valuable for policy 
formulation where some quantification of the overall health benefits of a dietary pattern is 
required  (Maynard  et  al.,  2004).  Therefore,  the  need  to complement  the  constituents–
disease  approach  by  describing  whole  dietary  patterns,  their  determinants  and  their 
relation to overall health was discussed (Maynard et al., 2004). This has led to series of 
studies on diet and disease outcomes conducted to show associations between dietary 
patterns and disease in several population based studies.   
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Keogh  and  colleagues  showed  a  clinically  significant  weight  loss  and  improvement  in 
cardiovascular  risk  factors  with  no  adverse  effects  among  subjects  on  a  high 
monounsaturated diet (Keogh et al., 2007). Carbohydrate-restricted diets were shown to 
be  effective  at  promoting  fat  loss  and  improving  blood  lipids  (Luscombe-Marsh  et  al., 
2005). Swain and colleagues (2008), in the Optimal Macronutrient Intake Trial to Prevent 
Heart  Disease  (OmniHeart)  reported  that  three  dietary  patterns  that  differed  in 
macronutrient composition offered substantial flexibility in macronutrient intake making it 
easier to eat a heart healthy diet and reduce cardiovascular disease risk. Schaefer et al., 
(1995) found that a low fat diet promoted weight loss and lowered LDL-C in middle aged 
and  elderly  men  and women with  moderate  hypercholesterolaemia.  In a  similar  study, 
Denke and  Grundy (1994) recommended  that  dietary  therapy should  remain the initial 
approach to the treatment of hypercholesterolemia because most of the subjects achieved 
LDL  cholesterol  levels  low  enough  to  remove  the  need  for  drug  therapy  in  primary 
prevention for coronary heart disease.  
 
Liu and colleagues showed that increased consumption of dietary fibre, whole grain foods 
and not refined grain foods was inversely associated with weight gain (Liu et al., 2003). In 
another study, increased fruits and vegetables consumption was associated with modest 
reduction  in the development of cardiovascular disease  (Hung et al., 2004). Protective 
relationship was also shown between fruits and vegetables- particularly cruciferous and 
green leafy vegetables and citrus fruit and juice and ischaemic stroke risk (Joshipura et al., 
1999).  Whole grain intake was inversely associated with the risk of type 2 diabetes (de 
Munter et al., 2007). In a randomised trial to investigate the effect of a plant based diet on 
plasma  lipids  in  hypercholesterolaemic  adults,  Gardner  et  al.,  (2005)  showed  that 
emphasizing a nutrient dense plant based foods increased the total and LDL cholesterol 
lowering effect of a low-fat diet.  
 
Regarding the effect of  dietary  intake  and cancer, Wirfalt et al.,  (2008) concluded that 
micronutrient dense, low fat, high fibre food patterns protected against colorectal cancer. 
Park  and  colleagues  also  reported  that  green  leafy  vegetables  and  not  fruits  were 
associated with a lower risk of colorectal cancer for men (Park et al., 2007). Liu et al., 
(2005)  prospectively  examining  the  association  between  dietary  intake  and  colorectal 
cancer found little evidence to support association between fruits and vegetables and fibre 
intakes and colorectal cancer risk but reported that legume fibre might reduce colorectal 
cancer. Schatzkin et al., (2007) on the contrary did not find an association between dietary 
fibre intake and colorectal cancer whereas whole-grain consumption was associated with a      
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modest  reduced  risk.  However  low  frequency  of  meat  and  potato  and  frequent 
consumption  of  fruits  and  vegetables  and  fat  reduced  foods  were  consistent  with  a 
decreased risk of colorectal cancer (Flood et al., 2008). 
 
The above discussion implies that the level of evidence regarding the role of dietary intake 
(foods and patterns) on risk of certain diseases is quite strong and dietary patterns can 
play an important role in the management and/or prevention of disease.  This provides a 
window of opportunity to explore the role of dietary patterns towards the maintenance of 
health  and  prevention  of  disease  in  HIV  infected  populations.    However  fewer studies 
among  PLHW  have  researched  the  association  between  food  or  dietary  patterns  in 
disease progression. Since nutritional status have been shown to influence infections and 
disease outcomes (such as cardiovascular diseases and colorectal cancer) and dietary 
patterns play a major role, it is expected that similarly in HIV infection an optimal nutritional 
status would influence disease progression and therefore a dietary pattern that promotes 
optimal nutritional status would most likely be ‘healthy’ for PLWH. 
2.3  Systematic review of the impact of nutritional status on disease progression 
in HIV infection 
Several studies have been conducted to show the impact of nutritional status on disease 
progression and immune function in HIV infection and some interesting reviews have been 
published (Coyne-Meyers, 2004; Fawzi et al., 2005; Piwoz and Preble, 2000; Kupka et al., 
2002; Kennedy et al., 2000). However electronic search of renowned databases (Pubmed, 
MEDLINE, COCHRANE, EMBASE, CINAHL and PsychInfo databases) showed very few 
studies  regarding  dietary  patterns.  Majority  of  the  studies  involved  specific  nutrient 
supplementation  (either  as  single  or  multiple  nutrients  or  combination  of  macro  and 
micronutrients). Summary of findings of these studies have been presented below but a 
great knowledge gap exists in terms of the influences of different dietary patterns on HIV 
disease progression. The Objective was to review the evidence regarding the impact of 
nutritional status on disease progression in people living with HIV/AIDS. Keywords were 
used for searching electronic databases on the topic. This was to ensure that all studies 
within the scope were captured. These keywords included HIV/AIDS, nutrition, nutritional 
status, disease progression, nutrients, anthropometrics, micronutrients, enteral nutrition, 
parenteral nutrition, macronutrients, food, and diet/dietary patterns.  
 
The hypothesis for the review was that adequate nutritional status (food and nutrient food 
intake,  and  biochemical  status  of  nutrients)  of  individuals  infected  with  HIV  delays  or      
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minimizes  the  rate  of  progression  of  HIV  to  AIDS  (CD4  cell  count,  viral  load,  body 
composition).  Exposures  in  this  case  were  defined  as  markers  of  nutritional  status 
including dietary and nutrient intakes, and biochemical assessment of nutrients. Outcome 
measures were defined as body weight, lean body mass, body cell mass,  HIV viral load, 
CD4+ and CD8+ T-lymphocytes cell count, opportunistic infections, indicators of quality of 
life such hospitalizations, diarrhoea incidences, AIDS related signs and symptoms and 
mortality from AIDS related disease. 
2.3.1  Search Strategy 
A  search  was  conducted  for  all  published  studies  from  1985  till  January  2008  which 
assessed  nutritional  status  and  disease  progression  in  HIV  infected  persons  and  this 
search was conducted systematically in order to identify all studies within the scope of the 
review. All relevant electronic databases, journals and books, internet and references of 
published  papers  were  searched  using  key  words  that  were  appropriate  to  capture 
nutritional  status,  disease  progression  and  HIV infection.  Using  the  EndNote software, 
separate searches were done in Pubmed for each keyword combined with HIV/AIDS or 
AIDS or HIV to obtain all publications in the selected electronic databases having those 
words.  The studies obtained for each of the keywords were combined and searched for 
duplicates  and  limited  to  studies  published  in  the  English  Language  and  in  human 
subjects. 
2.3.2  Inclusion and Exclusion Criteria 
The following inclusion criteria were used for the selection of studies: 
•  Study population: HIV infected only or a comparison of HIV infected and uninfected 
•  Population: Human population of any age group. 
•  Study  designs:  Both observational  and  intervention studies  (RCTs, prospective, 
cross-sectional and retrospective studies). 
•  Interventions:  Randomised  Controlled  Trials  (RCT)  involving  nutritional 
supplementation  or  observational  (longitudinal  and  cross-sectional)  studies 
involving nutritional status assessment. 
•  Outcomes: Outcomes measured should include any of the following: Body weight, 
lean body mass, body cell mass, CD4 cell counts, viral load, secondary infections, 
risk of dying or deaths and progression to AIDS defining illnesses. 
2.3.3  Main Sources of Papers for Review 
Research publications were selected from four main sources: 
1.  Electronic databases: A search was conducted between the 1
st February 2008 and      
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10
th February 2008 in Pubmed electronic data base using EndNote software. 
2.  Search of University of  Southampton Library  journals: The  journal database  for 
University  of  Southampton was searched using the  University’s A  to Z  journals 
available electronically. The key words discussed earlier were again used to search 
for papers. 
3.   Hand and Reference Search: References of the studies which were obtained, from 
the electronic databases and journals were also appraised and the abstracts of 
those studies which  seemed  to be appropriate for the review were  sought and 
checked and included if the inclusion criteria were met. 
4.   Books on nutrition and public health at the University's library were also searched 
for possible report of nutrition interventions among HIV seropositive individuals. 
2.3.4  Data Extraction 
A data extraction sheet was developed for extraction of important information from the 
studies. The usual method of data extraction requires that at least two people perform the 
extraction process independently and if possible blinded to enhance reliability. This was 
not feasible for this review but the extraction of data was however repeated for each study 
without consulting the first extraction. This was however unmasked. The data extracted for 
the repeated extraction was compared and rechecked where there were contradictions. 
This data extraction check list was used for studies which passed the stages one and two 
involving the key words in topic or abstract and reading of the actual abstract and were 
accepted for full text reading. Information extracted from the studies was: 
1.  Details of publication; this included the date (year and month), language, type of 
journal, volume and issue of journal as well as date the study was conducted, since 
this could be different from the publication date. 
2.  Rationale or aim of study. 
3.  Country of Study and year of publication. 
4.  Study  design  including  sample  selection  and  size,  and  data  collection  and 
description of the study population. 
5.  Stage  of HIV infection and whether subjects  were or  any form of anti-retroviral 
therapy. 
6.  Inclusion and exclusion criteria. 
7.  Type of nutritional intervention (exposures). 
8.  Main outcome measurements. 
9.  Main findings (findings in relation to the chosen outcomes).  
10. Conclusions made      
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2.3.5  Search Results 
A total of 534 references were available in Pubmed and were generated from the search of 
study  abstracts  which  had  the  various  keywords  using  the  EndNote  programme.  The 
number of studies obtained for each search is shown below. 
•  Diet and HIV and disease progression = 43 studies 
•  Food and HIV and Disease progression = 78 studies 
•  Enteral supplementation and HIV and disease progression = 88 studies 
•  Parenteral nutrition and HIV and disease progression = 111 studies 
•  Micronutrients and HIV and disease progression = 33 studies 
•  Nutrition and HIV and disease progression = 95 studies 
•  Nutritional status and HIV and disease progression = 83 studies 
•  Weight and HIV and disease progression = 0 studies 
•  BMI and HIV and disease progression = 0 studies 
•  Macronutrients and HIV and disease progression = 2 studies 
•  Anthropometrics and HIV and disease progression = 1 study 
 
These  references  were  combined  and  searched  for  duplicates.  After  removal  of  the 
duplicates  (165  references),  369  references  remained.  The  titles  of  each  of  the  369 
references were checked  in order  to eliminate any references which were single case 
studies, reviews, abstract publications, commentaries and titles that did not include any 
nutritional  indicators  at  all.  Studies  involving  mother-to-child  transmission  of  HIV  were 
excluded. This reduced the 369 references to 192 references. 
 
The next stage of the selection process was an assessment of the abstracts of 192 study 
references.  Each  abstract  was  assessed  in  terms  of  aim  of  the  study,  study  design, 
exposures and outcome measures, findings and conclusion. The aims/objectives of each 
study must be to show how nutritional status measured by any of the selected exposures 
impacted or was associated with disease progression (as shown by any of the disease 
progression indicators chosen for this review) in HIV infected adults. Any study design 
apart from reviews and single case studies were acceptable. This implied that the study 
could either be an observational or an intervention as long as the exposures and outcomes 
were measured. 
 
After  each  of  the  abstracts  had  been  scrutinized,  76  abstracts  were  accepted  for  the 
review  and  108  abstracts were  rejected.  Most  of  the  abstracts were  rejected  because      
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although the keywords were in the abstracts, either they were not studies carried out at all 
(such as nutritional guidelines, reviews and commentaries) or that the study did not relate 
any of the exposures and outcomes or the aims of these studies were outside the scope of 
this review. Some of the abstracts rejected were studies in HIV uninfected persons only, 
involved  vertical  transmission  of  HIV  infection  (without  associating  exposures  and 
outcomes in study subjects).  
 
A summary of the search history is shown in Figure 2.1. A further search of the references 
of these 76 studies yielded 5 other studies which met the requirement for inclusion in this 
review.  The  final  review  presented  in  this  document  included  8  studies,  which  were 
classified under 4 categories based on method or type of nutritional intervention. The four 
categories  were  studies  involving  micronutrients,  studies  involving  enteral  and/or 
parenteral nutritional support, oral macronutrients or diet and other studies (that is studies 
outside  the  first  three  categories).21 
 
Nutrition and 
HIV and DP           
 
       = 
95 references 
Weight or BMI or 
Anthropometrics and 
HIV and DP  
= 1 reference 
Nutritional 
status and 
HIV and DP         
        = 
83 references 
Micronutrients 
and HIV and 
DP 
         = 
33 references 
Diet and HIV 
and DP 
       = 
43 references 
Enteral or 
Parenteral 
nutrition and 
HIV and DP 
        =199 
references 
Food and HIV 
and DP 
       = 
78 references 
Macronutrient
s and HIV 
and DP 
       = 
2 references 
534 references in all 
combining all the references 
369 references remained 
after removal of duplicates 
165 references were 
duplicated when all the 
references were 
combined 
192 references remained 
after assessing titles of 
references 
84 references remained after abstracts 
and references of these abstracts were 
searched were assessed,  
177 references were 
rejected from the 369 
titles 
108 abstracts were 
rejected after 192 
abstracts were assessed 
Micronutrients Studies = 27 
studies 
Enteral and parenteral 
nutritional support studies = 23 
studies 
Oral macronutrient/diet studies 
= 19 studies 
Others: assessment of 
nutritional status in HIV infected 
populations = 12 
DP stands for disease progression 
Figure 2.1: Outline of search history for systematic review      
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2.4  Findings for studies involving micronutrient 
A  table  showing  summaries  of  data  obtained  from  studies  involving  micronutrients  is 
shown  in  Appendix VII.  In  all,  27  studies were  found  to  involve  micronutrients  in  HIV 
infection populations. Twenty-six of these studies were in adult population, usually from 18 
years (but two studies involved adolescents from 12-18 years) and above whereas 1 study 
involved  children.  Within  the  studies  involving  adult  participants,  nine  studies  involved 
micronutrient supplementation whereas 18 studies did not involve supplements. 
 
2.4.1  Study designs 
In this review the studies involving micronutrients were in two main categories based on 
the intervention or exposures measured. 
•  The  first  category  referred  to  the  group  of  studies  which  involved  micronutrient 
supplementation,  as  seen  in  prospective  study  designs  such  as  Randomised 
Controlled Trials, non-randomised trials or randomized placebo controlled studies.  
•  The  second  group  of  studies  was  described  as  observational  studies,  which  were 
either  prospective  studies  but  did  not  involved  supplementation  or  cross-sectional 
studies  (assessment  of  micronutrient  intake  and  serum  micronutrient  status  in 
observational studies). 
 
There were 9 studies involving supplementation and all 9 were randomized controlled trials 
(RCTs). Seven of these RCTs were double-blind studies whereas two were either not-
blinded  or  it  was  not  mentioned  in  the  article.  Nine  of  the  18  observational  (non-
supplemented)  studies  were  of  prospective  or  longitudinal  design  whereas  as  7  were 
cross-sectional studies. There were no retrospective studies among the adult study group. 
The single study involving children was a prospective (non-supplemented) study. 
 
2.4.2  Interventions  
Nine  (9)  studies  involved  micronutrient  supplementation  whereas  18  studies  were 
prospective observational studies. One study was among children and also a prospective 
observational  study.  The  supplements  given  ranged  from  single  micronutrient 
supplementations  to  multivitamin  supplementation.  Two  studies  involved  vitamin  A 
supplementation  only  either  as  vitamin  A  or  as  Beta-carotene  (Semba  et  al.,  1998; 
Coodley et al., 1996) and one study involved a single supplementation with selenium (Shor 
Posner  et  al.,  2003).  Fawzi  and  colleagues  also  assessed  a  single  vitamin  A 
supplementation  but  there  were  two  other  groups  receiving  either  multivitamins  or  a      
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combination  of  vitamin  A  and  multivitamins.  Five  of  the  studies  involved  a  multiple 
micronutrient supplementation and some included mineral elements.  
 
The  studies  which  did  not  involve  supplementation  were  either  assessment  of  dietary 
intake of micronutrients or plasma micronutrient status. There were 18 studies in all (17 
and 1 studies respectively involved adults and children participants). The study carried out 
in children participants was a biochemical assessment of micronutrients. Of the 17 adult 
studies, majority (11, 65%) was biochemical assessment of micronutrients status and 1 
(6%)  involved  dietary  assessment  of  micronutrients.  Five  (5,  29%)  studies  however, 
involved both dietary and biochemical assessment. 
  
2.4.3  Study population, setting and country 
The study populations for the studies involving micronutrients were quite diverse. There 
were  some  studies  whose  subjects  were  drug  abusers,  homosexual  or  bisexual  men, 
pregnant women, and studies whose subjects were part of larger cohorts or Multi-centre 
studies. Most of the study populations were HIV infected who were either outpatients (9 
studies), admitted and part of larger cohorts (4 studies). There were 5 studies that involved 
drug abusers  and  2  studies  involved  homosexual  and/or  bisexual  men.    Three  of  the 
studies in this category had pregnant study participants. 
In terms of country of study, majority of the studies took place in the USA (14, 53%), 
followed by Africa, where 7 (27%) studies were carried out (1 in Zambia, 4 in Tanzania, 1 
in South Africa and 1 in Malawi). One study each was carried out in England and Thailand. 
The  study  settings  were  either  outpatient  clinics  or  patients  admitted  in  hospitals, 
especially for AIDS patients. 
2.4.4  Main findings 
The main findings of studies in this category have been divided according to the type of 
study  (experimental  for  studies  which  involved  supplementation  and  observational  for 
studies which did not involve supplementation).  Summary of findings are presented in 
Tables 2.1 (outcome measured by studies) and 2.2 (main findings of studies).  
2.4.5  Findings  for  Experimental  (Intervention)  Studies  (Micronutrient 
supplementation) 
2.4.5.1  Impact of supplementation on serum micronutrient status 
In the randomized controlled trials, 4 studies reported changes in plasma micronutrients 
following supplementation and 3 studies (representing 75%) found statistically significant      
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improvement of plasma micronutrients following supplementation (Coodley et al., 1996; 
Semba et al., 1998; Shor Posner et al., 2003). Micronutrients (vitamin A) supplementation 
led to improved serum vitamin A levels for Semba et al., 1998 (p<0.05) and increased 
serum beta-carotenoids for Coodley et al., 1996 (p<0.05). Selenium supplementation led 
to increased serum selenium levels Shor Posner et al., (p<0.002). In the study by Kelly et 
al., (1999), improvements in plasma vitamin A following vitamin supplementation was not 
significant (p=0.52).   
2.4.5.2  Impact of supplementation on body weight 
There was just on study that assessed changes in body weight following glutamine and 
antioxidant micronutrients supplementation (Shabert et al., 1999). This study found that 
subjects who received the supplements gained an average weight of 2.2 kg compared to 
the controls who gained 0.3 kg and this difference was statistically significant (p=0.04). 
2.4.5.3  Impact of supplementation on Body Cell Mass (BCM) 
BCM was also measured in just one study (Shabert et al., 1999). Subjects who received 
micronutrients antioxidants and glutamine supplements gained 1.8 kg of BCM whereas the 
controls  gained  0.4  kg.  Again  the  improvements  in  the  supplemented  group  was 
significantly different from the controls (p=0.007). 
2.4.5.4  Impact of supplementation on CD4  and total lymphocyte cell counts 
Eight of the experimental (randomised trials) studies assessed changes in CD4 cell count 
following  micronutrient  supplementation.  Five  studies  did  not  find  significant  changes 
following supplementation (Kelly et al., 1999; Jiamton et al., 2003; Semba et al., 1998; 
Coodley et  al.,  1996 and  Shor Posner et al., 2003). Three studies  reported significant 
increase in CD4 cell count as follows: 
•  Fawzi et al., 2004 showed that multivitamins supplementation without vitamin A led 
to  higher  CD4  cell  counts  (p<0.05).  Overall,  the  mean  CD4+  cell  counts  were 
higher by 48 cells per
 cubic millimetre among women who received multivitamins 
than
 among those who received placebo (95% CI,
 10 to 85; p=0.01). 
•  Beta-carotene supplementation led to increased CD4 cell levels in Coodley et al., 
1993 (p=0.02) 
•  Austin et al., (2006) showed that subjects with higher baseline serum carotene had 
higher CD4 count (p=0.005) (Austin et al., 2006).  
The impact of micronutrient supplementation on total lymphocytes count was reported by 
one study which found no changes in total lymphocyte after selenium supplementation 
(Shor Posner et al., 2003).      
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2.4.5.5  Impact of supplementation on viral load 
Jiamton and colleagues in a randomised controlled trial did not find any changes in HIV 
viral load in subjects who received multiple micronutrients (containing both vitamins and 
minerals) supplementation. Fawzi et al., (2004) showed that viral load was significantly
 
lower  by  0.18  log  (95%CI,  –0.32
  to  –0.03;  p=0.02)  among  women  who  received 
multivitamins. 
2.4.5.6  Impact of supplementation on mortality  
Mortality  in  these studies  referred  to subjects  who  actually  died  during  follow-up  after 
supplementation. Risk of dying or survival was defined as the likelihood of subjects dying 
or surviving based on their micronutrients status and not on actual mortality rates. In the 
randomised  trials,  Jiamton  et  al.,  (2003),  Austin  et  al.,  (2006)  and  Fawzi  et  al.,  2004 
reported that micronutrient supplementation led to lower mortality in HIV infected subjects. 
In the study by Austin et al., (2006), mortality increased in subjects who did not receive 
mixed carotenoid supplementation (Hazard ratio= 3.15 95% CI 1.10-8.98, p=0.03). Fawzi 
also reported that 67 of 271 treatment group and 83 of 267placebos died (RR=0.71; 95% 
CI, 0.51 to 0.98; p=0.04). 
2.4.5.6  Impact of supplementation on disease progression 
Among the experimental studies, one study reported impact on risk of progression using 
the  WHO  stages  of  HIV  disease.  Fawzi  and  colleagues  showed  that  multivitamin 
supplementation led to reduced progression to WHO stage 4 of the disease (RR=0.50; 
95%  CI  0.28  to  0.90;  p=0.02).  Progression  to  WHO stage  3 was  also  reduced  in  the 
supplemented group (RR=0.72, 95% CI, 0.58-0.9, p=0.003). 
2.4.5.7  Summary of findings (Experimental studies) 
In summary the studies involving micronutrients have shown that: 
•  Micronutrients supplementation led to improved serum micronutrients status for the 
randomised controlled trials (3 out of 4 studies) 
•  Micronutrients supplementation was associated with increased CD4 cell count (5 
out of 8 studies, 42.8%).  
•  Viral load was significantly reduced in the study by Fawzi et al., 2004 and Jiamton 
et al., (2003) and not in Shor-Posner et al., 2003 (2 out of 3 studies). Specifically 
Fawzi et al., (2004) showed that viral load was significantly
 lower by 0.18 log (95% 
CI, –0.32
 to –0.03; p=0.02) among women who received multivitamins.      
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•  Progression to WHO stage 4 (RR=0.50; 95% CI 0.28 to 0.90; p=0.02) and stage 3 
(RR=0.72, 95% CI, 0.58-0.9, p=0.003) was also reduced in one study (Fawzi et al., 
2004). 
•  Mortality was reduced in 3 studies assessing it. For Austin et al., (2006), Hazard 
ratio= 3.15 95% CI 1.10-8.98, p=0.03 for controlled group and for Fawzi et al., 67 of 
271 treatment group and 83 of 267placebos died (RR=0.71; 95% CI, 0.51 to 0.98; 
p=0.04). 
2.4.6  Findings for observational studies 
2.4.6.1  Changes in serum nutrient status for observational studies 
The  longitudinal  studies  assessed  changes  in  plasma  micronutrients  status  over  time 
whereas  the  cross  sectional  studies  assessed  associations  between  either  dietary 
micronutrients  intake  and  plasma nutrients  status  or  the  associations  between plasma 
nutrients status and markers of disease progression. In the 10 observational studies (both 
longitudinal  and  cross  sectional)  that  assessed  either  plasma  micronutrients  status  or 
changes  in  plasma  micronutrient  levels  with  time,  seven  studies  (70%)  found  high 
prevalence  of micronutrient  deficiencies  in  the  study  participants  and  1 study  reported 
adequate levels of plasma status of these nutrients. One study reported different levels of 
plasma  micronutrients  but  did  not  mention  whether  these  levels  were  lower  than  the 
recommended and one other study showed that subjects who received supplements as 
part of dietary intake had higher serum vitamin B12.  
2.4.6.2   Effect of micronutrients on Body Mass Index (BMI) 
In three studies, findings on BMI were presented either as baseline characteristics of the 
study population or used in a univariate analysis to show associations with other markers 
of  disease  progression.  Van Lettow  et  al.,  (1998)  found  that close  to 60% of  the  HIV 
infected subjects had BMI <18.5 kg/m2 and 17% of the subjects were severely wasted 
(BMI <16  kg/m2). Low Body  Mass Index was found to  be significantly associated with 
plasma  HIV  load  (p<0.0001).  Van  Lettow  and  colleagues  also  found  that  the  odds  of 
having low BMI if a subject was vitamin A deficient was 2.86 (95% CI 2.11-3.89) and also, 
subjects who were wasted had a higher risk of being selenium deficient (OR 1.59 95% CI 
1.04-2.43). However in the study by Bodgen et al., (2000), HIV infection stage or status 
was not significantly associated with BMI or wasting. Stambullian et al., (2001) did not also 
find any significant differences in wasting or BMI between HIV infected and AIDS subjects.  
Thus in the 3 studies reporting findings on BMI or wasting, 1 (33%) study showed that 
wasting or low BMI was associated with faster disease progression in terms of HIV viral      
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replication and micronutrients (vitamin  A and selenium) deficiencies  and 2  reported no 
associations. 
2.4.6.3   The  impact  of  micronutrients  status  on  CD4  and  total  lymphocyte  cell 
counts 
The impact of micronutrients status (dietary intake, serum status or supplementation) on 
CD4+ cell count was assessed in 8 (%) of the 18 observational studies. Six studies (6 
studies, 42.8%) reported a significant positive association between plasma micronutrients 
status and CD4 cell count. One study reported a weak association between plasma zinc 
and CD4 cell count and 1 reported an inverse relationship between dietary iron intake and 
CD4 cell count. Among the 6 studies which found significant positive relationships between 
micronutrient status and CD4 cell levels:  
•  Two studies involved vitamin A (including carotenoids) only: 
Austin et al., (2006) and Baum et al., (1995) both found that subjects who had vitamin A 
deficiency or low plasma carotenoids had lower CD4 cell count (p=0.005 and p=0.025 in 
Austin et al., 2006 and Baum et al.,1995). 
•  Two studies involved zinc: 
Higher plasma  zinc was shown to be  associated with  CD4 cell  count by  Baum,  2003 
(correlation coefficient β=0.679, p=0.005) and Bodgen et al., (2000).  Bodgen et al., found 
that plasma zinc was an independent predictor of CD4 cell count. 
•  Two studies involved selenium: 
In the study by Baum et al., 1997, low plasma selenium was associated with low (<200 
cells/mm
3) CD4 cell count and Kupka et al., (2004), found a weak positive association 
between plasma selenium and CD4 cell count. 
•  One study each involved vitamin B12: 
Vitamin B12 deficiency was associated with lower CD4 cell count (p=0.037) (Baum et al., 
1995) 
•  One study involved magnesium: 
Bodgen et al., (2000) reported that plasma magnesium was an independent predictor of 
CD4 cell count. 
 
The effect of micronutrients status on total serum lymphocytes was assessed by one study 
which  found  that  over  time  plasma  zinc  levels  (β=0.35,  p=0.011)  were  significantly 
associated with higher total lymphocyte concentrations (Baum et al., 2003). 
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2.4.6.4   The impact of micronutrients status on HIV viral load 
Only one observational study assessed the impact of micronutrient status on viral load. 
Van Lettow et al., (2004), showed that plasma HIV viral load increased with decreasing 
plasma retinol (p<0.001), carotenoid (p<0.0001) and selenium (p<0.0001). 
2.4.6.5   The impact of micronutrient status on AIDS diagnosis   
For the observational studies, the impact of micronutrients on progression to AIDS or AIDS 
diagnosis was assessed by four studies as follows. 
•  Baum,  (2003)  showed  that  subjects  with  low  plasma  zinc  had  a  higher  risk  of 
developing AIDS (OR, 1.72, p=0.027).  
•  Low  baseline  vitamin  B12  significantly  predicted  disease  progression  and  AIDS 
index (p =0.005) in another study (Baum et al., 1995). 
•  Kupka et al., (2007) showed a marginal relationship between high serum ferritin 
and progression to HIV infection stage 4 (p=0.08).  
•  Plasma  selenium  was  not  associated  with  time  to  progression  in  the  study  by 
Kupka et al., (2004).  
•  High vitamin B1, C and niacin reduced rate of disease progression (relative hazard 
was  0.55  for  vitamin  C,  0.52  for  niacin  and  0.6  for  vitamin  B1);  all  significant 
(p<0.05). 
•  Very low and very high intakes of vitamin A enhanced disease progression (RH 
0.55 95% CI 1.16-3.64). Vitamin A and disease progression showed a U-shaped 
relationship. 
Thus the studies which reported on the relationship between micronutrients and disease 
progression showed a protective effect of zinc and vitamin B12, B1, C and niacin whereas 
one study showed no relationship with selenium. However, 1 study showed that higher 
biochemical markers of iron (serum ferritin) increased the risk of disease progression in 
HIV  infected  subjects  (p=0.01).  Moreover  very  high  and  very  low  intake  of  vitamin  A 
enhanced disease progression (RH 0.55 95% CI 1.16-3.64). 
2.4.6.6  The impact of micronutrients status on mortality, risk of dying or survival 
Mortality  in  these studies  referred  to subjects  who  actually  died  during  follow-up  after 
supplementation or an evaluation of plasma micronutrients status of subjects who later 
died in the observational longitudinal studies. Risk of dying or survival was defined as the 
likelihood of subjects dying or surviving based on their micronutrients status and not on 
actual  mortality  rates.  Two  observational  studies  in  the  micronutrient  group  assessed 
mortality  whereas  2  studies  assessed  survival  or  risk  of  dying.  Both  studies  found  a 
significant association between low plasma micronutrients status of subjects and mortality.      
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Baum et al., found in a longitudinal study that plasma vitamin A, B12, selenium and zinc 
deficiencies were  all significantly  related to mortality.    However  Kupka  and colleagues 
(Kupka et al., 2007) found that high serum ferritin was associated with end point AIDS 
related death (p=0.01). 
 
In the two studies which reported risks of dying or likelihood of surviving, Baum (2003) 
showed  a decreased risk  of dying by  1 mg/day  increase  of dietary  zinc  intake.  Lower 
serum selenium was shown to be associated with increased risk of dying  (p=0.01)  by 
Kupka et al., 2004. 
2.4.6.7  Summary of Findings for observational studies 
In  summary,  high  plasma  micronutrients  status  (vitamin  A,  B12,  zinc,  selenium  and 
magnesium) was  associated  with  increased  CD4 cell  count.  Progression  to  AIDS  was 
slower in subjects whose intakes and/or plasma status of zinc, vitamins B12, B1, C and 
niacin  were  high  (findings  from  3  (60%)  out  of  5  studies  which  assessed  disease 
progression). Low dietary iron intake and/or low plasma ferritin protected against declining 
CD4 cell count, disease progression and AIDS related death (2 studies assessed this and 
both found similar associations). High selenium, zinc, vitamins B12, vitamin A and multiple 
micronutrients status or supplementation, individually lowered mortality or risk of dying in 
HIV  infected  subjects  (findings  from  6  studies  which  reported  on  these  markers). 
Excessive vitamin A and zinc intake was associated with rapid disease progression and 
mortality (RH 0.55 95% CI 1.16-3.64).               30 
 
Table 2.1: Summary of Authors and outcomes measured for studies involving micronutrients and disease progression in HIV 
infected populations 
Body weight  BMI  Body cell 
mass 
Serum nutrient 
levels 
viral load  CD4 cell counts  Mortality  Diarrhoea  Anaemia  Disease progression  
or survival or risk of 
dying 
Experimental Studies 
Shabert et al., 
1999 
  Shabert et 
al., 1999 
Kelly et al., 1998  Shor Posner 
et al., 2003 
Kelly et al., 1999  Jiamton et 
al., 2003 
Kelly et al., 
1999 
Fawzi et 
al., 2007 
 
      Semba et al., 
1998 
Jiamton et 
al., 2003 
Jiamton et al., 
2003 
Austin et al., 
2006 
     
      Shor Posner et 
al., 2003 
Fawzi et al., 
2004 
Semba et al., 
1998 
Fawzi et al., 
2004 
     
      Austin et al., 
2006 
  Shor Posner et 
al., 2003 
       
          Austin et al., 
2006 
       
          Fawzi et al., 
2004 
       
Observational studies 
  Stambullian et 
al., 2007 
  Baum et al., 
2003 
 
Van Lettow 
et al., 1998 
Bodgen et al., 
2000 
    Kupka et 
al., 2007 
Kupka et al., 2004 
  Van Lettow et 
al., 1998 
  Baum et al., 
1997 
 
  Baum et al., 
2003 
      Tang et al., 1993 
  Bodgen et al., 
2000 
  Baum et al., 
1997 
 
  Baum et al., 
1997 
      Fawzi et al., 2004 
      Beach and 
Mantero-
Atienza, 1993 
  Baum et al., 
1995 
      Baum et al., 2003 
      Tang et al., 1993 
 
  Fawzi et al., 
2004 
   
 
  Baum et al., 1995 
      Kupka et al., 
2007 
  Baum et al., 
1997 
      Baum et al., 1997 
      Kupka et al., 
2004 
  Kruzich et al., 
2004 
      Kupka et al., 2007 
      Stambullian et 
al., 2007 
  Kupka et al., 
2004 
       
      Stephensen et 
al., 2007 
  Stephensen et 
al., 2007 
       
      Coodley et al., 
1996 
           
      Bodgen et al.,                           31 
 
2000 
      Woods et al., 
2003 
           
Table 2.2: Summary of the findings regarding the effects of micronutrients (supplementation, dietary intake or serum status) 
on CD4 cell count, total lymphocyte levels, viral load, AIDS or disease progression, survival or risk of dying and mortality 
in reviewed studies 
 
Authors  Study design  Nutrient assessed or 
supplemented 
CD4 cell count  Total 
lymphocyte 
levels 
Viral load  Disease 
progression or 
AIDS 
Survival or 
risk of dying 
Mortality 
Experimental (Randomised trials)  
Kelly et al., 1999  Experimental  Multiple-micronutrients 
(containing vitamin A, C, 
E, selenium and zinc) 
No changes           
Jiamton et al., 
2003 
Experimental 
 
Multiple micronutrients 
containing both vitamins 
and minerals 
No changes    No changes      Reduced in <200 
cells/mm
3 CD4 
group (p<0.003) 
Hazards ratio (0.2, 
95% CI 0.07-0.97) 
Semba et al., 
1998 
Experimental 
 
Vitamin A only  No changes           
Shor Posner. 
2003 
Experimental 
 
Selenium  No changes  No changes         
Austin et al., 2006  Experimental 
 
Mixed carotenoids  Subjects with high 
baseline serum 
carotene had higher 
CD4 count (p=0.005) 
        Increased in non 
supplemental 
group. Hazard ratio 
(3.15 95% CI 1.10-
8.98), P=0.03 
Fawzi et al., 2004  Experimental 
 
Vitamin A, multivitamins 
with or without vitamin A or 
placebo 
Multivitamins 
supplements without 
vitamin A led to 
higher CD4 cell 
counts (p=0.01) 
  Viral load 
was reduced 
in 
supplement
ed group 
(p=0.02) 
Progression to 
stage 4 reduced 
(RR=0.50; 95% CI 
0.28 to 0.90; 
p=0.02 
Death from 
AIDS  was 
reduced (0.73; 
95% CI, 0.51 
to 1.04; 
p=0.09) 
67 of 271 
treatment group 
and 83 of 
267placebos died 
(RR=0.71; 95% CI, 
0.51 to 0.98; 
p=0.04 
Coodley et al., 
1996 
Experimental  Beta carotene   No changes           
Coodley et al., 
1993 
Experimental  Beta carotene  CD4 increased 
significantly in 
treatment group 
(p=0.02) 
         
Observational (Longitudinal and cross sectional) 
 
Kruzich et al., 
2004 
Cross sectional  Dietary and plasma 
micronutrients 
Low dietary iron 
intake subjects had 
higher CD4 cell count 
(i.e. ≥500 cells/mm
3) 
         
Baum 2003  Observational 
 
Plasma zinc   Plasma zinc 
positively associated 
Plasma zinc 
positively 
  Low zinc 
associated with 
Decreased 
risk of dying 
               32 
 
with CD4 (β=0.679, 
p=0.005) 
associated 
(β=0.35, 
p=0.011) 
AIDS (OR, 1.72, 
P=0.027) 
by 1mg/day 
increase of 
dietary zinc 
intake 
Baum et al., 1997  Observational 
 
Plasma micronutrients            Vitamin A, B12 , zinc 
and selenium 
deficiencies were all 
significantly related 
to mortality 
 
 
Baum et al., 1995 
Observational    
 
Plasma micronutrients 
 
 
Vitamin A (p=0.025) 
and B12 (p=0.037) 
deficiencies were 
associated with low 
CD4 count 
     
 
Low baseline 
vitamin B12  
significantly 
predicted disease 
progression 
(p=0.041) and 
AIDS index 
(p=0.005) 
   
Baum et al., 1997  Observational 
 
Plasma prealbumin, 
selenium, Vitamins A and 
E 
Low selenium was 
associated with low 
(<200 cells/mm3) 
CD4 count 
         
Kupka et al., 2004  Observational 
 
Serum markers of 
anaemia (Hb, ferritin, 
transferrin receptor) 
      High serum ferritin 
was associated 
with disease 
progression to 
stage 4 (p=0.08)  
  High serum ferritin 
(>150  g/l) was 
associated with 
composite end point 
AIDS related death 
(p=0.01) 
Kupka et al., 2007  Observational 
 
Plasma selenium levels  Plasma zinc level 
was weakly 
associated with CD4 
cell count 
    Plasma selenium 
not associated 
with time to 
progression 
Lower 
serum 
selenium 
associated 
with 
increased 
risk of dying 
(p=0.01) 
 
Stephensen et al., 
2007 
Cross sectional  Plasma selenium, whole 
blood glutathione and 
GPX 
GPX was not 
associated with CD4 
cell count 
         
 
 
Bodgen et al., 
2000  
Cross sectional    
 
Dietary and plasma zinc, 
copper, magnesium, GSH 
 
 
Plasma haematocrit, 
magnesium, and zinc 
were independent 
predictors of CD4 cell 
count and was 
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statistically significant 
Van Lettow et al., 
2004 
Cross sectional   Dietary nutrient and serum 
micronutrients 
    Viral load 
increased 
with 
decrease 
plasma 
retinol 
(p<0.001), 
carotenoid 
(p<0.0001) 
and 
selenium 
(p<0.0001) 
     
Tang et al., 1993  Observational           High vitamin B1, C 
and niacin 
reduced rate of 
disease 
progression 
(relative hazard 
was 0.55 for 
vitamin C, 0.52 for 
niacin and 0.6 for 
vitamin B1), 
p<0.05 
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2.4.6.8  Discussions of findings for micronutrients studies 
Apart from wasting, micronutrient deficiencies have been shown to be very common during 
HIV infection (Kotler and Grunfield, 1995 and Liang et al., 1996) and as discussed earlier, 
there is a complex interaction between nutritional status, host immunity, and infectious 
diseases and several studies have documented these in the literature (Scrimshaw et al., 
1968;  Scrimshaw,  1997;  Gershwin  et  al.,  1985;  Chandra  and  Newberne,  1977  and 
Axelrod, 1971).  Micronutrients such  as vitamins  A,  B1,  B2,  B6,  B12,  C,  and  E,  and  the 
minerals (selenium, zinc and iron) have been shown to play essential roles in immune 
integrity and function in human populations, mainly because of the structural, catalytic and 
regulatory  roles  (Beisel  1982;  Dreizen,  1979  and  Kupka,  2004).  Many  micronutrients 
primarily serve as antioxidants thereby preventing oxidative stress. 
 
Vitamin A is an essential human nutrient that exists in several forms both in animal and 
plant foods.  Vitamin A chiefly exists in animal forms as retinol and can also exist in the 
form of retinal (an aldehyde) or as retinoic acid. In plant foods, vitamin A also exists as 
carotenoids, the precursors (provitamin) to the vitamin. Vitamin A is important for vision 
(especially night adaptation and vision), regulation of gene expression, immunity, growth 
and development, red blood cell production, and also nutrient interactions.   
 
Vitamin A in the form of retinoic acid and its isomers act as hormones to regulate gene 
expression via nuclear receptors known as retinoic acid receptors and retinoid X receptors 
(De luca, 1991) and the regulation of gene expression makes vitamin A very important in 
cellular  differentiation.  There  are  potent  effects  of  vitamin  A  on  immunity  and  other 
biological  functions  (Semba et  al.,,  1998),  because  vitamin A  and  retinoic  acid  play  a 
central  role  in  the  development  and  differentiation  of  white  blood  cells,  such  as 
lymphocytes, which play critical roles in immune response (Semba, 1998). The body’s first 
line of defence against infection is provided by the skin and mucosal cells (which line the 
airway, digestive tract and urinary tract) which serve as barrier against invading pathogens 
and retinol and its metabolites are required to maintain the integrity and function of these 
cells (McCullough et al., 1999). Vitamin A’s function in growth and development is shown 
by its regulation of expression of the gene for growth hormone and its function in foetal 
development  (Solomons,  2001).  In  red  blood  cell  production,  vitamin  A  is  important 
because stem cells that differentiate into red blood cells are dependent on vitamin A as 
well as the mobilisation of iron from storage sites to the developing cells for incorporation 
into haemoglobin (Ross, 1999).  
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Deficiency of vitamin A has been shown to be associated with increased morbidity and 
mortality in children (Sommer et al., 1983, 1984) and may predispose to different types of 
respiratory infections (Solon et al., 1978; Tielsch et al., 1986). However the interaction 
between vitamin A and infection is bidirectional such that infection (such as diarrhoea, 
chickenpox,  measles,  respiratory  infections  and  HIV  infection)  can  lead  to  vitamin  A 
deficiency (Rahman et al., 1996). Vitamin A has also been shown to reduce infectious 
diseases and morbidity (Coutsoudis et al., 1995) as well as increase circulating NK and 
CD4  cell  counts  (Hussey  et  al.,  1996).  Work  from  different  parts  of  the  world  has 
suggested the possible contribution of vitamin A and micronutrients in general to morbidity 
and mortality in HIV infected persons (Semba, 1993). 
 
Zinc has long been recognized to be an important factor in maintaining a healthy immune 
system (Baum et al., 2003). Zinc is required to stimulate enzymatic activities in cells and 
therefore very essential for biochemical reactions that promote growth and development, 
the  immune  response,  neurological  function  and  reproduction  in  the  human  body 
(Stanstead 1994). Zinc thus provides structural, regulatory as well as catalytic roles in the 
body. Zinc is needed for the maintenance of a healthy immune system, DNA synthesis, 
wound healing and normal growth and development at different physiologic stages such as 
pregnancy, childhood and adolescence (Solomons, 1998; Heyneman, 1996; Simmer and 
Thompson,  1985;  Black,  2003).  Adequate  zinc intake  would  thus  be  essential  to  help 
maintain  immune  integrity  and  prevent  infectious  diseases  during  HIV  infection.  Zinc 
deficiency has been shown to reduce the generation of T cells and depress humoral and 
cell-mediated  immunity  and  in  HIV  infected  persons  zinc  deficiency  can  influence 
intracellular  HIV-1  replication  (Edeas  et  al.,  199).  Hence  zinc  deficiency  can  hasten 
disease progression in HIV infected persons.  
 
Selenium is a trace element required for the antioxidant function of glutathione because it 
functions  as  a  co-factor  for  reduction  of  glutathione  peroxidases  and  certain  forms  of 
thioredoxin reductase found in animals and some plants. HIV infection increases oxidative 
stress which leads to oxidative damage (Stephensen et al., 2006) and thus the need for 
antioxidants to  prevent damages to cells  and tissues. Antioxidants enzymatic activities 
may however be dependent on intakes or status of nutrients needed for enzymatic activity 
and example of which is GPX which requires selenium for activity. Several studies have 
found low plasma selenium concentrations in subjects with HIV infection. This could be as 
a result of selenium deficiency or depression of selenium concentrations as a result of 
immune activation (Baum et al., 1997; Maehira et al., 2002; Nichol et al., 1998).      
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Selenium, vitamin B6, vitamin B12 and copper deficiencies have been reported in studies 
involving HIV infected patients  (Baum et al.,  1991; Beach et al., 1992;  Coodley  et al., 
1991). In a cross sectional study by Wellinghausen et al., 1999, involving HIV infected 
patients, zinc deficiency was observed among 23% of the subjects and in another study by 
Tang et al., (1993) a significant association between zinc, vitamin A, niacin, intakes and 
the progression to AIDS was observed. The above discussions imply that micronutrients 
perform very essential roles in the maintenance of the integrity of the immune system and 
thus in the prevention of infectious diseases.  
 
It is  therefore not surprising that the aims of the studies  involving micronutrients (both 
RCTs and observational studies) in this review were mainly to show whether micronutrient 
supplementation or status provided some clinical benefit such as maintenance of immune 
function  in  HIV  infected  populations. Thus  delaying  disease progression,  mortality  and 
promoting better quality of life in the midst of this chronic disease. 
 
The CD4 lymphocytes also known as the T4 lymphocytes are the main cells, which fight 
against infections in the body and prevent the body from falling sick. HIV on entering the 
human body attaches itself to the CD4 cells and injects its RNA into these cells. The viral 
RNA then attaches to the host’s DNA and becomes part of its genetic material. The virus 
thus uses the host division mechanism to replicate its own cells thereby producing more 
viral RNA. The resulting viruses invade other CD4 cells, destroying them and using them 
to make even more viral copies. This results in the decline of the CD4 cells levels whereas 
viral load increases. CD4 lymphocyte count is therefore an important marker of disease 
progression  in  HIV  infection  (Morgan  et  al.,  2002;  WHO,  2004).  Thus  majority  of  the 
studies  on  micronutrients  have  assessed  changes  in  CD4  cell  levels  as  indicative  of 
disease progression. 
 
In  summary,  the  key  findings  for  the  review  studies  were  that  Micronutrients 
supplementation improved serum micronutrients status in HIV subjects and high plasma 
micronutrients status (vitamin A, B12, zinc, selenium and magnesium) led to increased CD4 
cell count (reported in 6 studies, 42.8%). Disease progression to AIDS was reduced in 
subjects whose intakes or plasma status of zinc, vitamins B12, B1, C and niacin were high. 
Low  dietary iron  intake  and/or  low plasma  ferritin  protected against  declining CD4 cell 
count, disease progression and AIDS related death. Moreover, selenium, zinc, vitamins      
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B12,  vitamin  A  and  multiple  micronutrients  status,  individually  were  associated  with 
mortality and/or risk of dying in HIV infected studies.  
 
The  findings  from  the  review  studies  have  shown  that  disease  progression  could  be 
delayed  in HIV infected persons whose  intakes or status of micronutrients  are high or 
adequate.  This  confirms  the  important  role  vitamins  and  mineral  elements  play  in  the 
maintenance of immune function in the human body and during HIV infection which were 
discussed earlier in this section (Semba, 1998; Stanstead, 1994; Stephensen et al., 2006). 
There were however some general observations regarding the reviewed studies in this 
category. 
 
First of all, it was clear that many of the studies that involved supplementation did not find 
any  changes  in  CD4  cell  count  following  supplementation.  In  fact  among  the  8 
experimental studies only 2 showed that supplementation was significantly associated with 
CD4 cell count whereas as 6 out of the 7 observational studies assessing this account 
established  an  association  between  micronutrient  status  and  CD4  cell  count.  Five 
randomized controlled trials did not find any changes (Kelly et al., 1999; Jiamton et al., 
2003, Semba et al., 1998; Shor Posner et al., 2003; Coodley et al., 1996). The studies 
which found significant improvements or positive association between micronutrients and 
CD4  cell  levels  were  mostly  observational  (longitudinal  and  cross  sectional)  studies. 
Selenium (Baum et al., 1997), Zinc (Kupka et al., 2007; Bodgen et al., 2000), vitamin A 
(Austin et al., 2006; Baum et al., 1995), vitamin B12 (Baum et al., 1995) and magnesium 
(Bodgen et al., 2000) were the micronutrients which were shown to be associated with 
improved CD4 cell levels. Dietary iron was shown to be inversely associated with CD4 cell 
count by Kruzich et al., 2004 and this finding showed that HIV infected subjects whose 
dietary iron intakes were low had higher CD4 cell count.  
 
The reasons why the experimental studies did not find improvements in CD4 cell counts is 
not very clear but low sample sizes of the studies involving supplementation could be a 
factor.  It  is  also  possible  that  supplemented  subjects  were  taking  extra  nutritional 
supplements or had higher dietary micronutrients intake in addition to the supplements 
received. This could have affected the overall micronutrients intake by treatment groups 
and  controls.  It  was  also  not  shown  whether  supplements  were  given  based  on 
micronutrients status or not, because if supplements were given to those whose status 
were low whereas the controls had adequate status then effects of supplementation would 
be minimal. To address this problem, treatment and controls groups should have similar      
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baseline  micronutrients  status  before  supplementation.  Issues  surrounding  compliance 
could have also played a part in these observations. It was however not mentioned in 
some of the reviewed studies whether these issues were considered in the analysis of 
findings and whether adjustments were made to control for potential confounders. 
 
However,  for  the  prospective  observational  studies  micronutrients  status  was  mainly 
determined biochemically and changes in status over time were compared between the 
study populations and related to changes in CD4 cell counts and other markers of disease 
progression. Therefore, the issues of compliance, dietary intakes and extra supplement 
intakes were not likely to have affected or confounded the results and this could explain 
why the observational studies showed more significant findings with regards to CD4 cell 
count. 
 
With  regards  to  countries  where  studies  were  conducted,  the  micronutrient  studies 
generally had broad study setting and countries. These studies were conducted in Africa, 
America, Europe and Asia and thus the findings could be said to give a more global picture 
of the impact of micronutrients status on disease progression in HIV infection. 
 
Another major observation with regards to the studies in this category was that the study 
populations were quite different from between and even within studies. For some of the 
studies, the study population had AIDS, some were asymptomatic and for some studies 
the  participants  were  in  different  stages  of  the  disease.  With  regards  to  anti-retroviral 
treatment, some studies mentioned that some participants were on treatment and others 
were not. In other studies there was no mention of this at all. The impact of HIV infection 
stage and ART on the findings of studies in this review could not be ascertained but it is 
very possible that these factors influenced disease progression and thus influenced the 
impact of micronutrients status or supplementation.  
 
For instance in the study by Jiamton et al., (2003) which did not show significant changes 
in  level  of  mortality  when  all  subjects  and  controls  were  compared,  this  same  study 
recorded statistical significance among patients whose CD4 cell count at recruitment were 
lower than 200 cells/l. This finding was interpreted as follows ‘‘10 individuals with CD4 cell 
count <200/l and 4 individuals with CD4 cell count <100/l would need to be supplemented 
for  1  year  to  prevent  death  of  one  individual  over  this  time’’ This meant  that  multiple 
micronutrient supplementation could reduce mortality in AIDS patients with CD4 count less 
than 200/l that  is those who are very  ill.  Significantly, this study was  the first  to show      
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reduction in deaths and at the same time it confirms that the stage of infection influenced 
the impact of nutritional status or support. 
Some studies involving vitamin A supplementation (Semba et al., 1998 and Kelly et al., 
1999) showed low levels of serum vitamin A concentration after supplementation. This was 
attributed  to  possible  malabsorption,  owing  to  mucosal  damage  which  is  a  marker  of 
systemic inflammatory responses resulting from depression of circulating retinal binding 
protein or a marker of specific effect on epithelial cell and lymphocyte behaviour (Bates, 
1995).  Possible  auto  regulation  of  circulating  vitamin  A  in  people  with  adequate  liver 
vitamin A was also given as a possible explanation for the unchanged serum vitamin A. 
Semba et al., (1998) and Kelly et al., (1999), therefore suggested the possible increase of 
the dosage of vitamin A as an alternative option. The concern of other authors however 
was the fact that the toxic dose of serum retinol in AIDS was uncertain (Semba et al., 
1997) and this questioned the safety of an increased dose.  
Tang  and  colleagues  however  showed  that  HIV  infected  subjects  who  took  vitamin  A 
supplements above 4-5 times the RDA progressed faster and had higher risk of mortality 
that those whose intakes were 2-3 times the RDA. This finding could probably be the basis 
upon which experimental studies to assess the toxic doses of vitamin A supplementation in 
HIV infection can be examined with ethical considerations in mind. 
 
Also for zinc, it seems that the amount of supplementation is critical just as it is for vitamin 
A. This is because although zinc supplementation delayed HIV-1 disease progression and 
decreased the rate of opportunistic infections in a cohort of illicit drug users and a cohort of 
HIV-1 infected subjects who were receiving HAART (Mocchegiani et al., 1999; Baum et al., 
2003), excessive dietary intake of zinc has been linked with declining CD4 cell counts, and 
reduced survival, with faster disease progression and mortality (Tang et al., 1993; Tang et 
al.,  1996).  It  is  thought  that  excess  zinc  intake,  may  interfere  with  copper  and  iron 
utilization  and  affect  high-density  lipoprotein  cholesterol  concentrations  and  monocyte 
function (Schlesinger et al., 1993). This implies that unlike vitamin C, B1 and niacin, there 
is a threshold above which excess intakes of vitamin A and zinc is rather toxic and could 
hasten disease progression and mortality in HIV infected subjects. There is therefore the 
need to determine the levels of intake for Zinc and for vitamin A needed to maintain and 
delay  disease  progression  without  worsening  the  status  of  HIV  infected  subjects  with 
further research. 
      
   
    40 
 
In conclusion, the findings of micronutrients studies have supported the fact that single and 
multiple micronutrients status were beneficial in HIV infection. The cost effectiveness of 
such intervention compared with anti-retroviral drug treatment means that thousands of 
HIV  positive  people  living  in  developing  countries  could  be  supplemented.  However, 
further research needs to be conducted especially for the micronutrients in which very high 
levels of intakes were detrimental. 
2.5  Findings from studies involving enteral/parenteral nutrition 
2.5.1  Introduction 
A  table  showing  summaries  of  data  extracted  from  the  studies  in  enteral/parenteral 
supplementation  has  been  presented  in  Appendix  VIII.  In  all,  there  were  23  studies 
involving enteral or parenteral nutritional supplementation. Twenty of these studies were in 
adult population, usually from 18 years (but two studies involved adolescents from 12-18 
years) and above whereas 3 study involved children. Ten of these 23 studies involved 
parenteral supplementation  whereas  13  studies  involved  enteral  supplementation.  One 
study combined both enteral and parenteral supplementation. For 3 studies in children, 2 
studies  were  enteral  supplementation  and  one  was  both  enteral  and  parenteral 
supplementation. 
2.5.2  Study population, setting and country 
Majority of the studies (12, 52.2%) were carried out in the USA, and 5 were in Europe (2 
each in Germany and France and 1 in Spain). One study was in Australia. None of these 
studies was carried out in Africa or Asia. In terms of year of publication, only 3 of the 
studies  were  published  after  2000  and  majority  of  the  studies  were  conducted  and 
published more than 10 years ago. The study populations for this category were all HIV 
infected  subjects  who  were  suffering  from  AIDS  related  illnesses  and  mostly  were 
hospitalized  except  a  few  studies  which  involved  home  parenteral  supplementation. 
Recruitment of subjects took place in Hospitals and AIDS clinics.  
 
2.5.3  Main findings 
A summary of the study findings is shown in Table 2.3 and 2.4. The findings regarding 
body composition are presented in Table 2.3 whereas findings on immune function are 
presented  in  Table  2.4.  The  main  outcomes  for  which  findings  have  been  presented 
include body weight, lean body mass, body cell mass and the immune markers (CD4 cell 
count and viral load). Effects of supplementation on mortality have also been presented.       
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2.5.3.1   Impact of enteral/parenteral nutrition support on Body weight 
The impact of nutritional support on changes in body weight was assessed in all the 23 
studies in the enteral and parenteral category (Table 2.3). All 23 studies except 2 found an 
improvement  in  body  weight  following  supplementation.  For  all  the  studies  combined, 
Melchior et al., (1996) reported the highest weight gain for subjects who received Home 
Total Parenteral Nutrition (HTPN) support. Subjects in this study gained a mean weight of 
8.0 kg whereas controls lost 3.0 kg (p=0.0006). For the 21 studies which reported changes 
in body weight, majority (10, 47.6%) of them found significant increases in body weight. 
Some of the statistical significances were marginal significant whilst some were highly 
significant (p values ranging from <0.05 to <0.0006). Six (28.6%) studies did not find any 
statistical significance for improvement of body weight.  Four studies however did not state 
whether  the findings with  regards to body weight were significant or not. All the three 
studies  involving  children  found  significant  improvements  of  body  weight  following 
supplementation. 
  
When the studies were assessed separately as enteral or parenteral supplementation, the 
first two highest weight gains were both recorded in the parenteral supplementation (for 
Melchior et al., (1996), mean weight gain was 8 kg, p<0.0006 and for Bouletreau et al., 
(1995), mean weight gain was 7 kg, (significance not stated). Four (44.4%) of the 9 studies 
that involved TPN found statistical significance and 6 (54.5%) of the 11 studies on enteral 
supplementation found statistical significance of weight improvements. 
2.5.3.2   Impact of enteral/parenteral nutrition support on Lean Body Mass 
Four  (17.4%)  studies  in  the  enteral  and  parenteral  category  assessed  the  impact  of 
nutritional support on lean body mass. All four studies found improvements in lean body 
mass of subjects after supplementation. (Melchior et al., 1996) reported lean body mass 
gain of 9.0% and a loss of 3% for treatment group and controls respectively after subjects 
had received HTPN. De Luis et al., (2001) reported lean body mass gain of 0.5kg and loss 
of 0.7kg between subjects receiving enterotropic peptide based formula with omega-3 fatty 
acid against subjects who received standard enteral formula. Three of these studies found 
no  statistical  significance  in  changes  in  lean  body  mass  whereas  1  found  significant 
improvement in lean body mass.  
2.5.3.3   Impact of enteral/parenteral nutrition support on Body Cell Mass 
Changes in body cell mass were reported in only 3 studies within this category (Table 2.3). 
One  study  reported  no  change  at  all  whereas  two  studies  reported  significant 
improvements in body cell mass after enteral and parenteral supplementation. Melchior      
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and colleagues reported body cell mass gain of 15% and a loss of 12% between subjects 
who  received  HTPN  and  those  who  only  received  nutritional  counselling  respectively 
(Melchior et al., 1996). 
2.5.3.4  Impact of enteral/parenteral nutrition support on immune function (CD4 cell 
count, viral load and disease progression) and mortality 
For  this  category,  few  of  the  studies  assessed  changes  in  immune  function  following 
supplementation. The summary of findings in terms of immune function (Table 2.4), shows 
that 11 (47.8%) out of 23 studies in the enteral and parenteral nutritional support category 
assessed some markers of immune function. Moreover, 7 (54.5%) of these 11 studies 
assessed changes in CD4 cell counts only whilst 3 (27.2%) studies assessed the impact of 
supplementation on hospitalizations and/or length of hospital stay. Two (18.2%) studies 
assessed changes in mortality or survival whereas 1 (9.0%) study reported on the impact 
of supplementation on progression to AIDS. One study each assessed both CD4 cell count 
and hospitalizations, and mortality and hospitalizations. 
 
The impact of enteral and parenteral nutritional supplementation on immune function was 
generally low. Only 2 (28.6%) of the 7 studies that assessed changes in CD4 cell count 
found significant increases in CD4 levels and both found marginal statistical significances 
(p<0.05).  Three  (42.9%)  studies  reported  no  improvements  or  insignificant  increases 
whereas in the other two (28.6%) studies, CD4 cell levels rather reduced or were very low 
even  after  supplementation.  One  study  however  found  significant  increase  in  total 
lymphocytes (p<0.0001 by Kotler et al., 1991) though CD4 remained unchanged. 
 
Among the 3 studies that reported on the effect of enteral and parenteral supplementation 
on hospitalizations, 1 study found reduced hospitalizations in subjects that received and 
new  enteral  formula  compared  with  those  who  received  a  standard  enteral  formula 
(Chlebowski et al., 1993, p<0.02). For the two other studies, 1 found no improvements in 
hospitalization whereas  the  other study  found  increased  or  frequent hospitalizations  in 
AIDS  patients  who  received  an  all  in  one  nutritional  formula  containing  calories, 
electrolytes, vitamins and trace elements (Bouletreau et al., 1995). 
 
Ireton-Jones  et  al.,  (1998)  found  slight  reduction  in  progression  to  AIDS  among  HIV 
infected subjects who received HTPN but the reductions were not significant (p>0.05). For 
changes in mortality, the two studies that assessed this indicator both found unimpressive 
levels. Melchior et al., 1996 reported no improvements in mortality or survival following      
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HTPN support and in the study by Boultreau et al., 1995, 19 (76%) of the 25 AIDS subjects 
receiving parenteral nutrition supplementation died in the course of the treatment. 
2.5.3.5   Summary of key findings on enteral/parenteral nutrition support 
•  The effect of supplementation on changes in body weight was assessed in 23 studies 
in  the  enteral  and  parenteral  category  (Table  2.3)  and  all  23  studies  found  some 
improvement in body weight following supplementation. For all the studies combined, 
Melchior et al., 1996 reported the highest weight gain (8.0 kg, p<0.0006) for subjects 
who  received  HTPN  support.  For  the  21  studies  which  reported  changes  in  body 
weight, majority (10, 47.6%) of them found either marginal or significant increases in 
body weight.  
•  All four studies that assessed changes in lean body mass found some improvements 
but only 1 study recorded a statistical significance for the improvement. 
•  In terms of body cell mass, 2 of the 3 studies found significant improvements in body 
cell mass following supplementation.  
•  CD4  cell  counts  were  improved  in  2  out  of  7  studies  that  assessed  this  marker 
following supplementation. 
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Table 2.3: The impact of enteral and parenteral supplementation on body weight, body cell mass, and lean body mass in HIV 
infected subjects 
  Intervention  Subjects  Weight gain (kg)  Changes in body cells 
mass (BCM) (kg) 
Changes  in  lean 
body mass (kg) 
Statistical 
significance 
PARENTERAL SUPPLEMENTATION  T  C  T 
 
C  T  C  T  C   
Singer  et  al., 
1992 
HTPN for 2 months  8  100  5.0            p>.05 
Singer  et  al., 
1994 
910  kcal  Parenteral  Nutrition  including 
20%  lipid  emulsion  or  a  new  2%  lipid 
emulsion  with  high 
phospholipids/triglycerides  
25  25  1.6  1.0          p>.05 
Singer  et  al., 
1997 
Comparing  a  standard  PN  with  a 
phospholipids enriched formula 
50    Increased  Increased          p<0.05 
Kotler  et  al., 
1990 
HTPN  12    3    No change        No  controls, 
p>.05 
Ireton-Jones  et 
al., 
HTPN compared with oral diet  15  7  5.5  -5.0      3  -3.0  p>.05 
**p>0.05 
Melchior  et  al., 
1996 
HTPN or counselling  16  15  8  -3.0  15%  -12%  9.0%  -5.0%  p<.0006 
*p<002 
**p<.004 
Bouletreau  et 
al., 1995 
All in one nutritional formula (electrolytes, 
vitamins  and  trace  elements  with  2150 
kcal)  
25  0  7            Significance  not 
stated 
Suttmann et al., 
1993 
HTPN  14    Increased significantly  Increased significantly      p<0.005 
*p<0.05 
Edwards  et  al., 
1997 
Retrospective  assessment  of  medical 
records of TPN subjects 
80    2.2   -1.4          p<0.05 
                     
ENTERAL SUPPLEMENATION 
 
                 
Chlebowski  et 
al., 1993 
New  enteral  formula  verse  a  standard 
enteral formula 
25  31  1.8  -0.7          p>0.05 
De  Luis  et  al., 
2001 
Enterotropic  peptide  based  formula  with 
omega-3 fatty acid verse standard enteral 
formula 
38  36  2.0  1.9      0.5  -0.7  p<0.05 
**P>0.05 
Kotler  et  al., 
1991 
PEG tube nutritional support   8    3.0    increased        p>0.05 
*p<0.02 
Craig  et  al., 
1997 
Comparison  of  MCT  enriched  or  LCT 
enteral formula 
24  No 
controls 
No change             
Salomon  et  al., 
1999 
Nutritionally  complete  enteral  formula 
containing  hydrolysed  whey  protein  and 
23    but  (11 
completed) 
6  of  11 
gained 
          Significance  not 
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T denotes treatment groups, C denotes the controls. PEG stands for Percutaneous, Endoscopic Gastrostomy
medium chain triglycerides  weight 
Hoh et al., 1998  Comparison of a whole protein based or a 
peptide based enteral formula 
49    but  39 
completed) 
No significant change      No significant change   
Grovenor et al.,  2-3, 8 oz cans of new or standard enteral 
supplement 
80    Maintained 
weight 
better 
Maintain
ed 
weight 
poorer 
        P=0.04 
Branstma et al., 
1991 
PEG feeding                   
Cappell  and 
Godil, 2003 
PEG feeding  14  No 
controls 
Mean  weight  increased 
by 7.4% 
        Significance  not 
stated 
Crotty  et  al., 
1998 
PEG feeding  71  No 
controls 
5.8 gained by 51 and 10 
or  more  gained  by  9 
subjects 
        Significance  not 
stated 
Ockenga  et  al., 
1996 
PEG feeding  47  No 
controls 
3.3          P<0.001 
                     
Children studies                   
Guriano  et  al., 
2002 
TPN  62  No 
controls 
increase            P<0.05 
Henderson  et 
al., 1994 
Enteral feeding  18  No 
controls 
increased            P=0.04 
Miller  et  al., 
1995 
Enteral feeding  23  No 
controls 
increase            P<0.05               46 
 
T denotes treatment groups, C denotes the controls. PEG stands for Percutaneous, Endoscopic Gastrostomy
Table 2.4: Summary of changes in markers of immune function, hospitalisations, disease progression and mortality following 
enteral or parenteral supplementation 
  Intervention  Changes in CD4 
cell count 
Viral load  Hospitalisations  Mortality  or 
survival 
Progression 
to AIDS 
PARENTERAL SUPPLEMENTATION  T  C  T  C  T  C  T  C   
Singer  et  al., 
1992 
HTPN for 2 months  Low  levels  in 
both groups 
             
Singer  et  al., 
1994 
910  kcal  PN  including  20%  lipid 
emulsion or a new 2% lipid emulsion 
with high phospholipids/triglycerides  
Reduced  but  not 
significant 
             
Singer  et  al., 
1997 
Comparing  a  standard  PN  with  a 
phospholipids enriched formula 
No changes               
Ireton-Jones  et 
al., 
HTPN compared with oral diet                  Reduced 
slightly  in 
HTPN group 
Melchior  et  al., 
1996 
HTPN or counselling              No improvement   
Bouletreau  et 
al., 1995 
All  in  one  nutritional  formula 
(electrolytes,  vitamins  and  trace 
elements with 2150 kcal)  
        Frequent 
hospitalisations 
19 died during PN   
                     
ENTERAL SUPPLEMENATION                   
Chlebowski  et 
al., 1993 
New  enteral  formula  verse  a 
standard enteral formula 
        Reduced 
hospitalisations 
p<0.02 in NEF 
     
De  Luis  et  al., 
2001 
Enterotropic  peptide  based  formula 
with  omega-3  fatty  acid  verse 
standard enteral formula 
Increased 
significantly  in 
enriched  group 
p<0.05 
             
Kotler  et  al., 
1991 
PEG tube nutritional support   No  change  but 
increased  total 
lymphocytes 
p<0.0001 
             
Guarino  et  al., 
2002 
TPN  Increased  
p<0.05 
             
Miller  et  al., 
1995 
Enteral feeding  No improvement      No improvements            
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•  The  effect  of  enteral  and  parenteral  supplementation  on  CD4  cell  count, 
hospitalizations, progression to AIDS and mortality was poor across the whole group of 
studies in this category. Only 2 of 7 studies found significant improvements in CD4 cell 
counts  and  1  of  3  studies  found  improvements  in  hospitalisations.  Mortality  and 
disease progression were both not improved. 
Thus, among the reviewed studies enteral and/or parenteral supplementation was most 
effective against wasting and improved body weigh in HIV/AIDS. 
2.5.4  Discussions of enteral/parenteral nutrition support findings 
The  interventions  involving  enteral  and  parenteral  supplementation  in  this  review were 
aimed  at  overcoming  the  problem  of  wasting  and  weight  loss  in  HIV/AIDS  persons 
described  as  the  major  defining  characteristics  of  the  progression  of  HIV  infection 
(Macallan et al., 1993). Enteral supplementation was mainly used because for HIV/AIDS 
infected patients whose appetite were suppressed and had vomiting, enteral feeding was 
seen as the solution to ensure adequate intake of nutrients (Kotler et al., 1991). Enteral 
nutrition support could also help to restore body cell mass in malnourished AIDS patients 
(Kotler et  al.,  1991)  but this  is only successful when  the GIT  is capable of  absorbing 
nutrients.  
 
However, there is often severe malabsorption and GIT dysfunction in HIV/AIDS patients as 
observed in earlier studies involving AIDS subjects (Kotler et al., 1984 and Gillin et al., 
1985), and this raises the need for Total Parenteral Nutrition. TPN was administered in 
patients with conditions that caused the inability to tolerate nutrients enterally (Ireton-Jones 
et  al.,  1998).  This  referred  to  patients  whose  gastrointestinal  tract  could  not  support 
absorption of nutrients and was mostly observed in the advanced stages of AIDS (Kotler et 
al., 1990; Singer et al., 1991). 
 
In summary, the effect of supplementation on changes in body weight was assessed in all 
the  23  studies  in  the  enteral  and  parenteral  category  and  all  23  studies  found  some 
improvement  in  body  weight  following  supplementation.  The  highest  weight  gain  was 
however reported by Melchior et al., (1996), where subjects receiving HTPN gained (8.0 
kg,  p<0.0006).  In  all  about  10  studies  (47.6%)  found  either  marginally  statistical 
significance or highly significant increases in body weight. All four studies that assessed 
changes  in  lean  body  mass  found  some  improvements  but  only  1  study  recorded  a 
statistical significance for the improvement. In terms of body cell mass, 2 of the 3 studies 
found significant improvements in body cell mass.      
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The findings from the studies on enteral and parenteral supplementation have confirmed 
that  nutritional  support could  help  maintain  body  weight  or  enhance  repletion  of  body 
weight, lean body mass and body cell mass in HIV infected persons who cannot maintain 
adequate  food  intake  orally.  Maintaining  or  prevention  of  wasting  could  mean  that 
metabolic and functional integrity of tissues and organs could be established in advance 
HIV infection and disease progression and mortality could be delayed.  
 
The effect of enteral and parenteral supplementation on CD4 cell count, hospitalizations, 
progression to AIDS and mortality  was poor  across the whole group  of studies  in this 
category. The ability of nutritional supplementation in improving some aspects of immunity 
such as the number of CD8+ T-suppressor lymphocytes or intracellular lysosomal enzyme 
activities in phagocytic cells have been documented (Olomu et al., 1989 and Seth and 
Chandra, 1972). However, the studies in this review failed to confirm this. Further studies 
are however needed to test these possibilities. 
 
Only 2 of 7 studies found significant improvements in CD4 cell counts and 1 of 3 studies 
found improvements in hospitalisations. Mortality and disease progression were both not 
improved. The probable reason why this was the case was that majority of the studies in 
this category involved participants who were in advanced and probably terminal stages of 
HIV infection. About 78% of studies in this category involved AIDS patients and this meant 
that the CD4 cell counts of these subjects were likely to be <200 cells/l. Moreover the 
possibility of many systemic opportunistic infections and AIDS defining illnesses in these 
subjects were high. Some of the reasons which were mentioned to explain the lack of 
statistical  significance  of  findings  for  studies  in  the  enteral  and  parenteral  nutritional 
support category were short duration of supplementation and small sample size. Although 
these  reasons could be legitimate, the fact that  majority of the studies  on  enteral and 
parenteral nutritional support involved subjects with advanced HIV infection or who had 
AIDS diagnosis and probably terminally ill could have been the main reason for the lack of 
significance. Also the lack of findings could be associated with the composition of formulae 
giving as supplements.  
 
These findings however imply that improving food and nutrient intake in advanced HIV 
infection might not improve CD4 cell levels though nutrient intake, weight maintenance and 
other anthropometric and  body composition could  be  improved.  Secondly, most  of the 
studies in this category did not assess or report changes in immune markers and this      
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meant  that  there was  the  likelihood  that  CD4  cell  counts  and  levels  of other  immune 
markers could have been improved in some of the studies which did not assess these 
markers. 
 
It was also observed from the review that for AIDS patients receiving TPN repletion of 
body cell mass was possible but the pattern of repletion was related to the precise clinic 
circumstances (Kotler et al., 1990). This was because in the event of inadequate intake or 
absorption, simply increasing the number of calories reaching the systemic circulation by 
intravenous administration produced positive caloric balance and allowed repletion of body 
cell mass and body fat content.  However serious systemic illness, hypermetabolic and 
other derangements inhibited body cell mass repletion and shunted the extra calories to 
lipid.  
 
It was also realised from the review studies that fortified enteral and parenteral formulae 
were more  effective  in  improving nutritional status  of  HIV/AIDS patients than standard 
formulae (Chlebowski et al., 1993; de Luis Roman et al., 2001). This implies that other 
ways of improving enteral and parenteral formulae with specific nutrients that might have 
some  specific  effects  need  to  be  explored.  One  important  finding  from  these  studies 
however was that  both  enteral supplementation and total parenteral nutrition improved 
nutritional status to some extent and this should go a long way to improve the quality of life 
and survival for people living with HIV/AIDS. 
 
From  the  findings  on  enteral  and  parenteral  nutritional  support  studies,  it  could  be 
concluded that enteral and parenteral support is effective in promoting body weight, lean 
body mass and body cell mass in symptomatic HIV infection, which did not necessarily 
improve markers of immune function. 
2.6  Findings from studies involving oral macronutrient supplementation 
2.6.1  Introduction 
This section of the results was categorized as oral supplementation because the studies in 
this category differed in the form of intervention from the micronutrients studies and the 
enteral  and  parenteral  nutrition  studies.  The  studies  in  the  category  involved 
supplementation  with  nutritional  formula  containing  macronutrients  or  an  oral  mixture 
containing several macronutrients or even administering macronutrients capsules. Studies 
that  involved  supplementation  with  a  diet  or  a  meal  or  an  assessment  of  specific 
macronutrients intake were also part of this category. The difference between the studies      
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in this group and the micronutrient study group is that this group involved macronutrients 
only, diet or meals or combination of macronutrients and micronutrients whereas the latter 
involving only micronutrients. The difference between this group and the enteral/parenteral 
group  is  that  this  group  represented  oral  supplementation  whereas  the  latter  did  not 
involve oral supplementation. A summary of the characteristics of all the studies in this 
category is presented in a table in Appendix IX. There were 19 studies in this category.  
2.6.2  Study population, setting and country 
The  aims  of  studies  involving  oral  macronutrient  supplementation  was  to  test  the 
effectiveness of these dietary supplements against weight loss predominantly and immune 
integrity. The study populations for studies  in this category were all HIV  infected, with 
confirmed HIV infection who served sometimes as both controls and treatment groups in 
the randomized trials or non HIV infected controls. In the non-randomised trials, the study 
populations  were  all  HIV  infected  and  all  received  the  treatment.  The  majority  of  the 
studies  were  also  in  a  hospital  setting,  and  involved  HIV  infected  patients  in  hospital 
wards. A few studies however, had participants who were part of a bigger study or a multi-
centre trial. Another main characteristic of the study populations in this group of studies is 
that most of the participants were suffering from HIV related weight loss and had low CD4 
cell count.  In terms of country, 11 studies took place in the Americas (1 each in Brazil and 
Chile and 9 in the USA), and 7 took place in Europe (5 in Germany and 2 in Switzerland). 
None of these studies took place in Africa.   
2.6.3  Main findings 
Findings from the studies involving oral macronutrient supplementation were mainly based 
on anthropometrics and body composition parameters and markers of immune integrity. 
The main anthropometric markers were body weight, body cell mass and lean body mass 
and that of immune integrity were CD4 and CD8 cell counts and viral load. A summary of 
main findings is presented in Tables 2.5 and 2.6. 
2.6.3.1   Impact of oral nutrition support on Body weight 
Changes in body weight were analysed in 12 of the 19 studies belonging to this category 
(12, 66.8% of studies). Generally, most studies reported more weight gain in supplemental 
groups than controls (Table 2.5). The minimum weight gain for these studies was 0.3 kg in 
Topping et al., (2000) which involved two meals per day supplementation in HIV infected 
patients and the maximum mean weight gain was 3.0 kg reported by Clark et al., (2000). 
Between the supplemented groups and controls, difference in body weight was statistically 
significant (p<0.05) in 5 (41.7%) out of 12 studies.       
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2.6.3.2   Impact of oral nutrition support on Lean Body Mass (LBM) 
The impact of oral macronutrients/diet supplementation on lean body mass was assessed 
in 3  studies out  of the 19 studies  (Table 2.5)  in the category  and all 3 studies found 
significant gains of lean body mass in supplemented groups compared with controls. Clark 
et al., (2000) reported a higher gain of lean body mass in subjects receiving supplements 
compared with  the controls (2.6 and 0.7  kg gains respectively in  treatment group and 
controls, p<0.003). Berneis et al., (2000), also found that lean body mass assessed by 
bioelectrical  impedance  analysis  expressed  as  a  percentage  of  total  body  weight 
increased in the nutritional intervention group from 83.5 ± 1.8 to 86.2 ± 1.7% (p < 0.05 vs. 
baseline),  which  is  about  2.4kg,  while  in  the  controls,  lean  mass  did  not  change 
significantly. 
2.6.3.3   Impact of oral nutrition support on Body Cell Mass (BCM) 
Gains in body cell mass following supplementation were assessed in only 4 studies in this 
category  (Table  2.5).  The  gains  were  significantly  higher  between  supplemented  and 
controls in 1 study (1.8 kg and 0.4 kg in supplemented and control groups respectively). 
Two studies (Stechmiller et al., (2001) and Gibert et al., (1999)) did not find any statistical 
significance in body cell mass changes but Schwenk et al., (1999) reported a significant 
BCM  gain within  both  the supplemented  (2.2  kg,  p<0.05)  group  and  controls  (1.2  kg, 
p<0.05). 
2.6.3.4  Impact of oral nutrition support on immune function (CD4 cell count, viral  
load, disease progression) 
The impact of oral macronutrients/diet supplementation on markers of immune integrity 
and  function  indicated  by  changes  in  CD4  and  CD8  cell  counts  and  viral  load  was 
generally  poor  (Table  2.6).  In  the  first  place  only  few  of  the  studies  in  this  category 
assessed  changes  in  these  main  markers  although  other  markers  (plasma  total 
lymphocytes  and  cytokines)  were  assessed  apart  form  these.  The  impact  of 
supplementation on CD4 cell levels was assessed in 11 (57.9%) of the 19 studies in this 
category.  Gains  were  only  statistically  significant  in  1  (9%)  study  and  even  then  the 
statistical  significance  was  changes  in  plasma  total  lymphocytes.  For  the  rest  of  the 
studies,  either  there  were  no  changes  in  CD4  cell  counts  or  the  changes  were  not 
significant statistically. 
 
With regards to CD8 cell levels, 8 (42.1%) of the 19 studies assessed changes in this 
immune integrity indicator following supplementation. However these changes were only 
significantly high in supplemented group for only 1 (12.5%) study (table). The rest of the      
   
    52 
 
studies did  not find any changes or mostly likely,  the changes were too  little  to attain 
statistical significance. The impact of oral nutritional supplementation on viral load was 
only  assessed  in  3  (15.7%)  of  the  19  studies  in  this  category.  Viral  load  reduced 
significantly in 1 (33.3%) study (p=0.007 in Clark et al., 2000) and did not change in the 2 
other studies. 
2.6.3.5  Summary of findings on oral nutrition support 
For the studies involving oral macronutrients/diet supplementation: 
•  19 studies were reviewed and the range of supplements were diverse and mostly a 
mixture of macronutrients with few studies involving both macro and micronutrients 
or even meals. 
•  The outcome measures were basically body  weight, lean body mass, body cell 
mass, and markers of immune integrity and function (CD4 and CD8 cell counts, 
and viral load). 
•  Changes in body weight were assessed in 12 (63%) studies and minimum and 
maximum  gains  were  0.3  to  3.0  kg.  Weight  gain  was  statistically  significant 
(p<0.05) in 5 (41.7%) of 12 studies. 
•  Lean body mass gain was higher and statistically significant in all 3 studies which 
assessed this parameter where as BCM was only significantly higher in 1 out of 4 
studies that assessed changes in BCM. 
•  Markers of immune integrity (CD4, CD8 and viral load) were generally unchanged 
in the studies in this category. 
•  The findings from the studies involving oral macronutrients have also shown just 
like the studies on enteral/parenteral supplementation that supplementation led to 
gains in body weight, body cell mass and lean body mass rather than increases in 
immune markers. 
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P, *p and **p refers to statistical significance for changes in body weight, body cell mass and lean body mass. @ values of body weight and BCM refers to changes in the two different treatment 
groups. 
 
 
 
 
Table 2.5: Summary of the effect of oral macro and micronutrients, diet and/or food supplementation of body weight, body cell mass and lean body mass in HIV 
infected subjects 
 
  Intervention  Sample 
 
Changes in Body weight 
(kg) 
Changes in Body cell 
mass (kg) 
Changes in Lean body 
mass 
Remarks 
Authors  Intervention    Treatment  Control  Treatment  Control  Treatment  Control   
 
Swanson et al.,  19.6 g of arginine capsules  11 
 
             
Stechmiller et 
al., 
20 g, 10 g or 0 g of arginine per day for four weeks  19  1.1  -0.45  Slight changes         p>0.05 
  *p>0.05 
Micke et al.,  Whey proteins 
 
30               
Pichard et al.,  Oral supplement with vitamins and trace elements either enriched 
with arginine and omega fatty acid or not enriched 
64  2.2  1.9               p>0.05 
Shabert et al.,  40 g/d of Glutamine and selected antioxidants  21  2.2   0.3   1.8  0.4        p= 0.04 
*p= 0.007 
Rathmacher et 
al., 
A mixture of HMB, arginine and glutamine  68          3.25    p=0.003 
άClark et al.,  An amino acid mixture (HMB, glutamine and arginine) mixed in 
fruit juice 
68  3.0  0.4      2.6  0.7  p= 0.009 
**P=0.003 
Suttmann et 
al., 
Arginine, α-linoleic acid, RNA   10  2.9  -0.5          p<0.05 
Fogaca et al., 
 
Peptide based formula (909 kcal, 42.6 g protein, 16.2 g fat, 153.4 
g carbohydrate) with omega 3 fatty acid 
12  0.9 kg             p>0.05 
Schwenk et al., 
 
Fortified oral supplement  50  2.7 (p<0.05)   2.6 
(p<0.05)  
2.2 (p<0.05)  1.2 
(p<0.05) 
    p=0.87  
Charlin et al., 
 
A dietary supplement containing a regular food or a polymeric diet  46  3.7  0.5          p<0.05 
Winkler et al., 
 
1 l of fruit juice or 30 ml of fruit vegetable concentrate  41               
Arendt et al., 
 
1 l of fruit juice or 30 ml of fruit vegetable concentrate  41               
@ Gibert et al., 
 
A calorie supplement drink containing peptides and multivitamins 
or containing whole proteins 
684  0.8   0.7     0.6      p=0.74 
*p=0.63 
Pulse and 
Uhlig 
Essential fatty acid capsules, Aloe Vera juice and nutritional 
supplement powder 
31               
Rabeneck et 
al., 
Subjects received normal diet with oral supplements (specialised 
medium chain triglycerides) or normal diet only 
118  -0.1  -0.1      0.9  -0.3  p=0.97 
**p=.077 
Bell et al., 
 
Wrapped bars containing fish oil or safflower oil  21               
Berneis et al., 
 
Drink containing 2510 Kj, 26 g whey protein, 88 g carbohydrate  18  1.3  0.5       2.9  No change  p>0.05 
**p<0.05 
Topping et al., 
 
A two meal per day plan (2000 kcal, 100 g protein and 40% of 
energy from fat) for 7 d/week and snacks 
50  0.3             
Suttmann et 
al., 
Formula containing arginine, linoleic acid, lactose and RNA  10  2.9  -0.5          p<0.05               54 
 
 
 
Table 2.6: Summary of findings regarding oral macro and micronutrients, diet and/or food supplementation and markers of immune function in HIV 
infected populations 
 
Authors  Intervention 
 
CD4 cell count  CD8 cell count  Viral Load  
Swanson et al.,  19.6 g of arginine capsules 
 
Not changed  Not changed  Not changed  Not changed 
*Stechmiller et al.,  20 g, 10 g or 0 g of arginine per day for four weeks  Not significant    No sit significant   
Micke et al.,  Whey proteins 
 
No change  No change     
Pichard et al.,  Oral supplement with vitamins and trace elements either enriched 
with arginine and omega fatty acid or not enriched 
Not significant  Not significant     
Shabert et al.,  40 g/d of Glutamine and selected antioxidants 
 
No change       
Rathmacher et al.,  A mixture of HMB, arginine and glutamine 
 
       
Clark et al.,  An amino acid mixture (HMB, glutamine and arginine) mixed in 
fruit juice 
  Significant 
(p=0.02) 
Reduced 
(p=0.007) 
Increased  
Suttmann et al.,  Arginine, α-linoleic acid, RNA   Not significant       
Fogaca et al., 
 
Peptide based formula (909 kcal, 42.6 g protein, 16.2 g fat, 153.4 
g carbohydrate) with omega 3 fatty acid 
Not changed  Not changed     
Schwenk et al., 
 
Fortified oral supplement         
Charlin et al., 
 
A dietary supplement containing a regular food or a polymeric diet  Not changed  Not changed     
Winkler et al., 
 
1 l of fruit juice or 30 ml of fruit vegetable concentrate  Increased in total lymphocyte 
(p=0.0004) 
     
Arendt et al., 
 
1 l of fruit juice or 30 ml of fruit vegetable concentrate         
Gibert et al., 
 
A calorie supplement drink containing peptides and multivitamins 
or containing whole proteins 
       
Pulse and Uhlig  Essential fatty acid capsules, aloe Vera juice and nutritional 
supplement powder 
       
Bell et al., 
 
Drink containing 2510 Kj, 26 g whey protein, 88 g carbohydrate  No change  No change     
Berneis et al., 
 
A two meal per day plan (2000 kcal, 100 g protein and 40% of 
energy from fat) for 7 d/week and snacks 
No change  No change     
Topping et al., 
 
Formula containing arginine, linoleic acid, lactose and RNA         
Suttmann et al.,  Formula containing arginine, linoleic acid, lactose and RNA         55 
 
2.6.4  Discussions of findings on oral nutrition support 
Generally,  the  studies  in  this  category  were  aimed  at  assessing  the  effects  of  single 
macronutrients, a combination of macronutrients in the forms of different types of diets or 
formulae on immune function and body weight. The types of nutrients were based on the 
known  roles  these  nutrients  play  in  immune  activation  and  function,  weight  gain  and 
improvement of other parameters of body composition. In HIV/AIDS persons, the causes 
of malnutrition are multifactorial. Inadequate food intake, anorexia, dysphagia, diarrhoea, 
malabsorption,  opportunistic  infection  and  immulogical  and  intermediary  metabolism 
changes are the main disorders associated with the wasting syndrome (Kotler et al., 1991; 
Kotler  et  al.,  1992;  Raiten,  1991).  Loss  of  body  cell  mass  and  low  serum  albumin 
characterizes the clinical picture of protein-energy malnutrition in AIDS and is predictive for 
the mortality in advanced disease (Chlebowski et al., 1989; Kotler et al., 1989; Suttmann et 
al., 1995). 
 
The studies that involved fish oil supplementation were aimed at investigating the effects 
of fish oil on selected markers of immune function (Bell et al., 1996). The studies that 
supplemented with arginine and other amino acids or proteins were aimed at finding the 
impact of these nutrients on immune stimulation and HIV wasting (Swanson et al., 2000; 
Clark et al., 2000; Pichard et al., 1997). The studies on fruit juice supplementation were 
basically  investigating  the  effect  of  fruit  juice  on  improving  plasma  antioxidant 
concentration with the ultimate goal of improving immune function (Arendt et al., 2001; 
Winkler et al., 2004).  
 
The studies involving amino acids  in this  review were mostly focused on arginine and 
glutamine  and  beta-hydro-beta-methylbutyrate  (HMB)  either  singly  supplemented  or  in 
combination with other amino acids. This was basically so because there have been a lot 
of research which have shown the efficacy of these substrates on muscle wasting and 
immune  function  (Barbul  et  al.,  1980)  and  HIV/AIDS  syndrome  mostly  affect  body 
composition and immune function as mentioned earlier. Moreover, the studies involving 
different  macronutrients  such  as  omega  3  fatty  acids,  and  energy  were  trying  the 
investigate the effects of these nutrients on immune stimulation and weight loss in HIV 
infection  (Fogaca  et  al.,  2000;  Gibert  et  al.,  1999;  Pulse  and  Uhlig,  1990).  Thus  the 
ultimate goal for studies in this category was to delay disease progression in HIV infected 
subjects by providing oral nutritional support. 
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The mechanism of muscle wasting in AIDS is not well understood because most studies 
have limited scope but supplementation with arginine and glutamine have been shown to 
maintain lean tissue mass by sparing nitrogen, improve wound healing and support lean 
tissue gain. Nitric acid produced by arginine appears to be responsible for the beneficial 
effects of arginine in humans (Sitren and Fisher, 1977). Arginine has also been shown to 
function as a nutritional modulator of immune status. Literature has also shown that there 
are 3  nutritional substrates that can  impact muscle  proteolysis, arginine (Barbul et al., 
1990), glutamine (Lacey and Wilmore, 1990) and leucine metabolite HMB (Nissen et al., 
1996). All three have been shown to impact the loss of muscle or slow the turnover of 
muscle protein. Arginine plays a role in nitrogen sparing during trauma, wound healing and 
immune stimulation because it is precursor of nitric oxide (Kirk et al., 1993). Glutamine 
plays a major role in the nutrition of lymphocytes (Newsholme et al., 1985) whereas HMB 
protects muscle from proteolysis (Knitter et al., 1998).  
 
In  HIV infected subjects oxidative stress have  been  observed and has  been shown to 
impact on disease progression negatively by enhancing viral replication and apoptosis-
mediated CD4 cell depletion (Eck et al., 1989; Israel and Gougerot-Pocidalo, 1997; Allard 
et al., 1998; Sandtsrom et al., 1993; Baruchel and Wainberg, 1992). Oxidative stress is 
caused by increasing reactive oxygen species and could lead to increasing proliferation of 
defective CD4 T-lymphocytes (Dobmeyer et al., 1997; Cayota et al., 1996) and Cayota et 
al., was able to show that HIV infected subjects who received antioxidant supplementation 
were able to reverse impaired proliferation of these cells (Cayota et al., 1996). These were 
the reasons for the studies that involved fruit juice supplementation. Fruit juices are known 
to  be  rich  in  polyphenols  which  exert  strong  antioxidant  effects  and  could  therefore 
counteract oxidative stress, thereby improving immune function in HIV infected subjects 
(Rice-Evans et al., 1996). 
 
Dietary fish oil has been studied extensively for its effect on immune function in laboratory 
and clinical studies (Meydani et al., 1991; Chang et al., 1992; Kremer et al., 1987; Endres 
et al., 1989; Meydani et al., 1993; Kinsella et al., 1989). Fish oil can alter the biological 
response to an infection by creating a less inflammatory and immunosuppressive state 
(Endres  et al.,  1989;  Meydani  et al., 1993) which  may  desirable  for  patients  with  HIV 
infection  because  of  the  chronic  inflammation  and  immunosuppression  that  persist 
throughout the course of the disease (Aslan et al., 1992; Kremer et al., 1987). This benefit 57 
 
from fish oil is due to the presence of omega-3 fatty acids in fish oil (Kinsella et al., 1989). 
This formed the rationale for the studies that involved fish oil.  
 
In  the  oral  supplementation  category,  19  studies  were  reviewed  and  the  range  of 
supplements  were  diverse  and  mostly  a  mixture  of  macronutrients  with  few  studies 
involving  both macro  and micronutrients  or  even  meals. The  outcome measures were 
basically body weight, lean body mass, body cell mass, and markers of immune integrity 
and function (CD4 and CD8 cell counts, and viral load). Changes in body weight were 
assessed  in  12  (63%) studies  and  minimum  and  maximum gains  were  0.3  to  3.0  kg. 
Weight gain was statistically significant (p<0.05) in 5 (41.7%) of 12 studies. Lean body 
mass gain was higher  and  statistically  significant  in  all  3 studies  which assessed this 
parameter where as BCM was only significantly higher in 1 out of 4 studies that assessed 
changes in BCM. Markers of immune integrity (CD4, CD8 and viral load) were generally 
unchanged  in the studies  in this category. The findings from the studies  involving oral 
macronutrients  have  also  shown  just  like  the  studies  on  enteral/parenteral 
supplementation that supplementation enables repletion of loss of body weight, body cell 
mass and lean body mass rather than improving immune integrity and function. 
 
The findings from the studies involving fruit juice showed that ingestion of fruit juice might 
be favourable for HIV infected subjects because it led to proliferation of T cell lymphocytes.  
The findings did not therefore support the reversal of impairment of CD4 cell found by 
Cayota et al., (1996) but showed that fruit juice supplementation could lead to proliferation 
of T-cell lymphocytes. This could still have an impact on immune function ultimately in HIV 
infected subjects.  
 
Arginine and other amino acid supplementation were shown to improve body weight and 
body cell mass and thereby prevent HIV wasting. In the study by Clark et al., (2000), it was 
concluded that a combination of arginine, glutamine and HMB markedly altered the course 
of  lean  tissue  loss  in  patients  with  AIDS  associated  wasting.  This  was  confirmed  by 
Stechmiller et al., (2001) as well as in the study by Rathmacher et al., (2004). The studies 
involving  other  macronutrients  supplementation  have  also  supported  improvements  of 
body weight and body cell mass and thus, although immune function was not improved in 
most  of  these  studies,  arginine  and  other  macronutrients  supplements  could  be  very 
essential in the maintenance and prevention of HIV wasting. 
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The studies that fish oil and other fatty acids did not find improvements of CD4 cell levels 
in the populations. In fact, Bell et al., (1996) found a trend toward a decline in CD4 cell 
numbers  with  the  type  of  fish  oil  supplemented,  although  there  was  increased 
incorporation of the omega-3 fatty acid docosahexaenoic acid (DHA) into the phospholipid 
of  the  fatty  acids  of  the  plasma.  There  was  the  assumption  that  the  incorporation  of 
omega-3  fatty  acid  may  cause  displacement  of  arachidonic  acid  (AA)  due  to  the 
preferential competition with omega-6 fatty acid and thereby lead to favourable alterations 
in immune function (Kinsella et al., 1989).  
 
Also, Chlebowski et al., (1993) found in a study involving a novel enterotropic peptide-
based  enteral  formula  which  included  a  patented  polypeptide  plus  a  mixture  of 
carbohydrate  and  lipids  (including  sardine  oil),  that  body  weight,  triceps  skinfold 
measurement and blood urea nitrogen were all improved in HIV infected subjects who 
received this supplement. However in this study, no data was available on changes in 
immune parameters following supplementation. Thus the potential of fish oil and fatty acids 
for the improvement of immune function was suggested and much attention was given to 
the use of fish oil with subjects who were HIV infected. This was the basis on which the 
study  by  Bell  et  al.,  (1996)  and  other  studies  involving  fatty  acid  and  fish  oil 
supplementation were conducted but the findings did not support the expectations. It is 
however possible that the type of fish oil, dosage and mode of supplementation could have 
contributed to the findings.  
 
In conclusion, the studies involving oral supplementation of macronutrients and foods have 
shown  that  nutritional  support  could  improve  body  weight  and  other  markers  of 
anthropometrics without necessarily improving immune function and integrity. 
2.7  Findings from other studies 
2.7.1  Introduction 
The studies in this category were mainly studies that did not fall within the 3 categories 
described  in  the  earlier  section.  This  implies  that  they  were  not  micronutrients, 
enteral/parenteral supplementation or oral macronutrients related studies. This category of 
studies was best described as researches that involved a cross sectional assessment of 
the association between nutritional status (anthropometrics, dietary intake or biochemical 
assessment) and immune function in HIV infected population.  The main aim of studies in 
this category was to evaluate nutritional status of HIV infected populations and in some 59 
 
cases to compare HIV infected with non-infected populations in terms of nutritional status 
and immune function. There were 12 studies altogether for this category. 
2.7.2  Study population, setting and country 
The  populations  for  studies  in  this  category  were  mainly  asymptomatic  HIV  infected 
subjects who were either part of larger cohorts (5 out of the 12 studies), or were recruited 
at outpatient clinics (2 studies). It was just one study whose participants were in-patients at 
a hospital. Some of the studies had only male participants whereas some had just female 
subjects. Again the study populations in this category were mainly adults just like the other 
categories of studies described earlier. Yet again, majority (6, 50%) of the studies were 
conducted in the USA, followed by Europe where 3 studies (1 study each in France, Spain 
and the UK) were conducted. The other three studies were conducted in Ghana, South 
African and Sweden. 
2.7.3  Main findings 
The main findings for studies in this category were mainly presented as associations and 
description of the population  rather than the  impact of nutritional status on markers of 
disease progression. This is probably due to the fact that studies in this category were 
mainly of cross sectional designs.  
2.7.4  The key findings from the studies of this category are outline below: 
•  Significant reduction in body weight, BMI, fat mass, FFM were associated with an 
AIDS defining illness (Malvy et al., 2001: Sharpstone et al., 1999) 
•  Subjects with phase angle <8.2 had significantly higher body weight and BMI (de 
Luis et al., 2004) and even in the era of HAART, low phase angle remained an 
independent  adverse  prognostic  marker  of  clinical  progression  and  survival 
(Schwenk et al., 2000). 
•  HAART  treatment  was  associated  with  lipodystrophy  and  weight  loss  and 
lipodystrophy was associated with lower CD4 cell count (Karmon et al., 2005). 
•  HIV infection was associated with markers of altered metabolism such as lower 
serum HDL, total cholesterol, albumin and triglycerides and higher liver enzymes 
(serum ALT, AST, ALP and GGT) (Vorster et al., 2000). 
•  HIV infected subjects with weight loss had lowered BMI, MUAC, triceps skinfold 
and CD4 cell count compared with HIV infected subjects without weight loss (Luder 
et al., 1995). 
•  In  the  study  by  Chlebowski  et  al.,  (1995),  clinical  outcome  and  survival  were 
associated with CD4:CD8 ratio, weight and serum cholesterol and CD4:CD8 ratio, 60 
 
and  usual body weight  of HIV  infected  persons  were  independent predictors of 
event free survival.  
•  Bruce Williams et al., (2002), in a  study among 467 weight stable, HIV infected 
men with CD4 <200 cells/mm3 found that protein intake was positively associated 
with body cell mass (BCM) whereas carbohydrate intake was  inversely associated 
with BCM irrespective of muscle building activity (Bruce Williams et al., 2002). This 
study did not show any relationship between CD4+ cell count and protein intake. 
•  Malvy et al., (2001), also found that weight loss greater than 10% in HIV infection 
tripled the risk of progression to clinical AIDS and BMI <16.0 kg/m2 increased the 
relative risk of progression to AIDS to about 4.7. 
•  Weight loss was among the clinical conditions associated with disease progression 
in another study (Morgan et al., 2002). 
2.7.5  Discussion of findings of other studies 
In the earlier discussions, it was observed that inadequate food and nutrient intake in HIV 
infection due to several multifactorial reasons could lead to wasting and alterations in body 
weight and other markers of body composition. Loss of body cell mass and low serum 
albumin  characterizes  the clinical picture  of protein-energy  malnutrition  in AIDS  and is 
predictive for the mortality in advanced disease (Chlebowski et al., 1989; Kotler et al., 
1989; Suttmann et al., 1995). Loss of body cell mass is shown to be strongly associated 
with  disease  progression  and  mortality  in  HIV/AIDS  individuals  (Kotler  et  al.,  1985) 
although all body compartments are affected in HIV wasting (Mulligan et al., 1997; Paton 
et al., 1997). Initial reports of nutritional status in persons living with HIV infection showed 
strong associations between the loss of lean body mass and death (Gunfield & Feingold, 
1992). 
 
In some of the studies in this category associations were found between reduction in body 
weight, BMI, fat mass, FFM and AIDS defining illness (Malvy et al., 2001: Sharpstone et 
al., 1999). HIV infected subjects with weight loss had lowered BMI, MUAC, triceps skinfold 
and CD4 cell count compared with HIV infected subjects without weight loss (Luder et al., 
1995). Thus changes in body composition are indications of disease progression in HIV 
infection. Early in the HIV epidemic malnutrition was proposed to be an important factor of 
disease progression and several studies showed a relationship between weight loss and 
body cell mass loss as and rapid disease progression or shorter survival (Kotler et al., 
1989; Palenicek et al., 1995; Suttmann et al., 1995). 61 
 
However phase angle measured by BIA have been found to be a stronger correlate of 
disease progression and survival than the other body composition estimates (Ott et al., 
1995) and even when adjustments were made for CD4 cell count and viral load, phase 
angle  remained an  independent  predictive marker  of disease  progression and survival 
(Schwenk et al., 2000).  
 
The  phase  angle  is  defined  as  the  relation  between  the  2  vector  components  of 
impedance:  resistance  and  reactance.  It  may  be  interpreted  as  an  indicator  of  water 
distribution between the extra and intracellular spaces and angle can be easily obtained 
from bioelectric impedance analysis (BIA) (Schwenk et al., 2000; de Luis et al., 2004). In 
two observational studies, higher phase angles in HIV infection were associated with lower 
risk of mortality. De Luis et al., (2004) found that HIV infected subjects with a lower phase 
angle  (<8.2) had significantly  lower body  weight, and  BMI and Schwenk et al.,  (2000) 
found that even with the benefit of HAART treatment on nutritional status of HIV infected 
subjects, low phase angle remains an independent adverse prognostic marker of clinical 
progression and survival.  These studies have shown that phase angle is a better predictor 
of disease progression and survival even in the early stages HIV infection when wasting 
may not be very apparent. 
 
Notably among the findings in this category as well was the fact that HIV infection was 
associated with markers of altered metabolism such as lower serum HDL, total cholesterol, 
albumin  and triglycerides  and higher liver enzymes  (serum ALT, AST, ALP and GGT) 
(Vorster et al., 2000). The fact that this finding was in HIV infected subjects who were 
asymptomatic who had normal weights  and BMI suggests that alterations in  metabolic 
markers are probably earlier markers of disease progression in HIV infection. This implies 
that nutritional counselling and support should start in the early stages of HIV infection to 
maximize its impact. 
 
Weight loss and wasting thus continue to be a problem in HIV persons (Shevitz & Knox, 
2001).  However  on  the  other  end  of  the  spectrum  is  lipodystrophy,  which  has  been 
observed with greater frequency in persons living with HIV infection (Kotler et al., 1999; 
Hadigan et al., 1999; Wanke, 1999; Carr et al., 1998). Lipodystrophy is a syndrome and it 
includes changes in body composition, known as fat redistribution syndrome (FRS), and 
metabolic disorders (Kosmiski et al., 2001; Moyle et al., 2001; Wanke et al., 2002; Gerrior 
et al., 2001). Lipodystrophy is characterised by changes in body shape and metabolism 62 
 
and body shape changes may include accumulation and/or loss of fat, which can affect 
appearance and metabolic changes may include resistance to insulin and abnormally high 
levels of blood cholesterol and triglycerides. In HIV-associated lipodystrophy, fat atrophy 
occurs in the subcutaneous fat depot, especially in the face, buttocks and extremities. The 
metabolic abnormalities include dyslipidaemia, characterised by serum triacylglycerol and 
non-HDL-cholesterol concentrations below such norms, with or without insulin resistance 
(Hendricks et al., 2003). 
 
 
Abnormal  patterns  of  fat  distribution,  dyslipidaemia  and  insulin  resistance  have  been 
observed in HIV infected patients receiving HAART (Noor et al., 2001; Vigouroux et al., 
1999; Hadigan et al., 2001; Carr and Cooper, 1998; Walli et al., 1998). There is increasing 
evidence  that  antiretroviral  medications,  both  protease  and  nucleosides  reverse-
transcriptase inhibitors, may contribute directly to these abnormalities (Heath et al., 2001; 
Joly et al., 2001; Carr et al., 2001; Murata et al., 2000; Mulligan et al., 2000). This was the 
observation in the study Karmon et al., (2005) which found that about 7.4% of HIV infected 
subjects experienced changes in body composition consistent with lipodystrophy since the 
commencement of HAART. 
 
Whereas fat redistribution syndrome is likely multifactorial, some investigators believe that 
FRS occurs in response to the use of HAART.  The exact mechanism responsible for 
these changes is however not known (Hadigan et al., 2003) but dietary advice remains the 
first line approach to the management of these metabolic complications in HIV infected 
persons (Hadigan et al., 2003). Batterham et al., 2000, in a cross sectional study using 
food frequency questionnaires investigated energy, fat, and saturated fat intake between 
HIV-infected patients with fat redistribution and those without fat redistribution. There was 
no difference in total or saturated fat intake between the 2 groups, irrespective of use of 
antiretroviral therapy or Protease inhibitors use (Hadigan et al., 2003).  
 
 
However, the investigators identified an increased total energy intake among HIV-infected 
patients with  fat  redistribution. Hadigan  et al., (2001) assessed the  relationship among 
dietary intake, body composition and metabolic parameters in subgroups of HIV men with 
or  without  fat  redistribution  and  healthy  male  volunteers.    Similar  to  Batterham  and 
colleagues observation, this study also found that HIV-infected subjects reported a higher 
percentage of energy from fat (P<0.01), compared with controlled subjects. Moreover, HIV 
infected  patients  with  fat  redistribution  were  more  likely  to  have  a  cholesterol  intake 63 
 
>300mg/day compared with the controls. The results of this study indicates that there may 
be modifiable dietary habits that are associated with hyperinsulinaemia and dyslipidaemia, 
independent of PI use among patients with HIV and fat redistribution. 
 
In a study of HIV infected persons, Hendricks et al., (2003) observed that an overall high 
quality  diet,  rich  in  fibre  and  adequate  in  energy  and  protein,  may  be  beneficial  in 
preventing the development of fat deposition. This conclusion was based on the finding 
that  HIV-positive  patients  without  fat  deposition  had  greater  overall  energy  intakes 
(p=0.03), greater intakes of total protein (p=0.01) and total fibre (p=0.01) (Hendricks et al., 
2003). 
 
The studies in this category in summary have shown the interactions and interrelationships 
between markers of nutritional status especially body weight, body cell mass, lean body 
mass and phase angle on disease progression and survival during HIV infection. 
2.8  General discussion and overview of the review and conclusions 
In all the categories of studies within this review, some general issues were observed and 
it was thought  that these  issues could have affected the  findings of this  review, either 
negatively or positively. 
 
Majority of the studies had subjects who were in different stages of HIV infection. For a 
couple  of  studies,  analyses  were  done  controlling  or  taking  in  account  the  stages  of 
infected subjects were in. Most of the studies however combined all participants into one 
group for analysis. The question worth asking is whether the impact of nutritional support 
could be different at different stages of HIV infection and the answer is yes. Even for those 
studies were  separate  analyses  were  done  for different  HIV  stages,  there  were some 
interesting findings emerging. For instance in the study by Jiamton et al., (2003), mortality 
was significantly reduced in HIV infected subjects receiving micronutrient supplementation 
whose CD4 cell counts were <200 cells/l. This significance was lost when subjects were all 
combine and analysed. This showed that at different stages of HIV infection the gains from 
nutritional support could be different and it is worth investigating in order to provide a more 
effective support. 
 
Another observation was the lack of clarity in terms of which subjects were on antiretroviral 
therapy  and how this  might affect  the findings of studies in this review. Similar  to the 
stages of infection issue, it was observed that for some studies, all or a proportion of the 64 
 
subjects were receiving some form of anti-retroviral therapy. However, it was not shown 
the benefits from nutritional interventions were altered by either receiving or not-receiving 
ART.  The  effect  of  ART  on  changes  in  fat  deposition  (lipodystrophy)  have  been 
documented  and  it  has  been  shown  that  HIV  infected  patients  who  received  ART 
treatment  could  suffer  from  fat  redistribution  and  this  has  some  effects  on  body 
composition (Kotler et al., 1999; Hadigan et al., 1999; Wanke, 1999; Carr et al., 1998).  
 
One other limitation for the reviewed articles and therefore for this review is the fact that 
the interventions were very heterogeneous in nature. Even with studies belonging to the 
same  categories,  the  interventions  were  diverse  and  this  limited  the  extent  to  which 
comparisons could be made. Moreover, diversities in the study populations, settings, and 
designs  also  limited  the  strength  of  the  evidence  since  it  was  difficult  to  find  very 
homogenous studies.  
2.9   Current dietary and nutritional guidelines for PLWH, a review of 5 country 
guidelines 
2.9.1  South Africa 
The dietary guidelines for PLWH in South Africa summarily state that: 
1.  To start good nutrition as soon as one is aware of being HIV infected 
2.  To choose from foods that are easily available and affordable and to choose ones 
own food 
3.  Eat a variety of foods 
4.  Make starchy foods the basis of each meal 
5.  Eat lots of fruits and vegetables 
6.  Meat and dairy foods may be eaten daily 
7.  Eat dried beans, peas, lentils, peanuts or soya regularly 
8.  Include sugars, fats and oils 
9.  Use salt sparingly 
10. Be as active as you can 
11. Drink lots of clean, safe water 
12. Do not take alcoholic drinks 
A close look of these guidelines show that they are not different from guidelines for the 
general HIV uninfected population which generally encourages variety of foods, decrease 
fat intake, increased fruits and vegetables intake with moderate dairy, legumes, salt and 
sugar intake. 
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2.9.2  The Association of Nutrition Services Agencies (ANSA), USA 
 
Table  2.7  Association  of  nutrition  services  agencies  (ANSA)  recommended 
guidelines for energy and protein intake for PLWH 
 
 
 
 
 
 
 
 
 
 
.  
 
 
 
 
 
 
 
 
 
 
 
The  Association  of  Nutrition  Services  Agencies  (ANSA)  in  the  USA  also  developed 
guidelines for Agencies Providing Food to PLWH, published in 2002. ANSA provides two 
models for HIV infection. The first model focuses on specific nutrient recommendations for 
Stages  of  HIV  disease  whereas  the  second  model  gives  general  nutrient 
recommendations for HIV disease (ANSA, 2002). The general nutrient recommendation is 
based on determining BMR of the individual and adjusting it according to the 1.3 stress-
factor  for  HIV-infection.  The  ANSA  guidelines  also  provide  recommendations  for 
macronutrients intake including carbohydrates (50-55%), protein (15-20%) and fat intake 
(30%).  No  specific  guidelines  are  given  for  micronutrients  but  a  broad  spectrum 
Clinical Category A – Asymptomatic HIV, Persistent Generalized  
Lymphadenopathy (PGL), Acute HIV  
Clinical Category B – Symptomatic HIV, Complications by HIV 
Clinical Category C – CD4 cell count < 200, plus the presence of an AIDS  
defining condition and/or Opportunistic Infection (OI).  
1.  Calorie Recommendations (3) 
Clinical Category A – Estimated needs are 30-35kcals/kg.  
Clinical Category B – Estimated needs are 35-40kcals/kg.  
Clinical Category C – Estimated needs are 40-50kcals/kg.  
Clinical Category C (Severely Malnourished*) – Energy needs  
may be initially depressed if severely malnourished.  Estimated  
needs are 20kcals/kg to start, with gradual increases, as tolerated.  
2.  Protein Recommendations (3)  
Clinical Category A – Estimated needs are 1.1-1.5g/kg.  
Clinical Category B – Estimated needs are 1.5-2.0g/kg.  
Clinical Category C – Estimated needs are 2.0-2.5g/kg.  
Clinical Category C (Severely Malnourished*) – follow general recommendations for 
severely malnourished using caution to not overfeed. 
 
Source: Associations for Nutrition Service Agencies (ANSA), 2002 
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multivitamin-mineral once a day is mentioned. ANSA’s recommendations for energy and 
proteins are summarised in Table 2.1. 
 
Thus comparing  the  ANSA guidelines  with  the South  African Nutritional guidelines the 
main difference was that the ANSA guidelines is nutrient based whereas the South African 
guideline is food based. Though the ANSA guidelines seem more specific, the basis for 
these recommendations was likely to be criticised. Yet again, there does not seem to be a 
consensus regarding specific micronutrients requirement in spite of the numerous studies 
in this area 
2.9.3  Canadian dietary guidelines for PLWH 
A practical guide to nutrition for PLWH is also provided by the Canadian AIDS Treatment 
Information  Exchange  which  does  not  only  give  guidelines  to  adults  but  also  specific 
guidelines for children, pregnancy and breastfeeding, Hepatitis C Co-infection and for drug 
Addiction and Recovery (CATI, 2007). In summary HIV infected persons are advised to  
•  Eat carbohydrates with every meal 
•  Eat some fruits and vegetables every single day 
•  Choose whole grain breads and cereals 
•  Try to eat protein-rich foods at least 3 times a day 
•  Choose lower fat dairy products such as skim or 1% milk, low fat yoghurt, light 
cream cheese and lower fat cheese 
•  Cut back on greasy, fatty foods, such as fried foods and fatty red meat 
•  Get more fluids as water and less as sweet beverages (e.g. juice, drink crystal, soft 
drinks) and coffee 
Once again, these guidelines are food based just like the South African guidelines and 
give sources of the various food groups but may be more specific in terms of number of 
servings of various foods However, protein rich foods are highly recommended to promote 
lean body mass and provide building blocks for the immune system (CATI, 2007) unlike 
the South African guidelines. 
2.9.4  World Health Organisation guidelines 
The WHO guidelines for Living Well with HIV/AIDS recommend that PLWH should:  
•  Eat staple foods with every meal: These foods are relatively cheap and supply 
not only energy and protein but  also small  amounts of vitamins and minerals. Staples 
include cereals (such as rice, maize, millet, sorghum, wheat and barley), starchy roots 67 
 
(such  as  potatoes,  sweet  potatoes,  cassava  and  yams)  and  starchy  fruit  (such  as 
plantains). 
•  Eat legumes if possible  every  day:  These  foods include  beans, peas,  lentils, 
groundnuts  (including peanut  butter) and soybeans. When  eaten with staple  foods the 
quality of protein is increased.  
•  Eat animal and milk products regularly: Foods from animals and fish should be 
eaten  as  often  as  you  can  afford  them.  They  supply  good-quality  proteins,  vitamins, 
minerals and extra energy. All forms of meat, poultry (birds), fish, eggs and dairy products 
such as milk, sour milk, buttermilk, yoghurt and cheese should be included. If insects, such 
as caterpillars or grasshoppers, are part of your eating patterns, they also provide good 
nutrients. 
•  Eat vegetables and fruit every day: These foods are important for a person to 
grow well and fight infection.  
2.9.5   Zambian guidelines 
The  National  Food  and  Nutrition  Commission  of  Zambia  in  2004  published  Nutrition 
Guidelines  for  care  and  support  of  PLWH  (NFNC,  2004).  The  guidelines  provide  the 
nutrient needs and sources of foods to meet these needs. Moreover these guidelines were 
mostly based on the WHO  guidelines for  living well with  HIV/AIDS.  In summary these 
guidelines recommend: 
•  Energy needs will depend on whether there are symptoms or not and asymptomatic 
persons  are advised to  have 10% more energy  whereas symptomatic persons are 
advised to have 20-30% more energy above the recommended level. 
•  Protein need  for  the HIV  infected  is the as same  for  non-infected populations and 
should be 0.8 g/kg and 0.85 g/kg for females and males respectively. Protein needs 
should  increase  when  there  are  factors  which  increase  the  need  such  as  illness, 
surgery, infection, trauma and pressure ulcers.  
•  Fat  needs  are  not  increased  in  HIV  infection  and  should  be  similar  to  the  HIV-
uninfected people, which is 30-35% of total energy needs. 
•  Recommendations for micronutrients should be similar to the general population and 
should not exceed twice the Recommended Daily Allowance (RDA). 
 
The Nutrition guidelines for care and support of PLWH for Zambia states that WHO does 
not  recommend  increased  protein  and  micronutrient  but  the  WHO  Living  Well  With 
HIV/AIDS have stated that “When infected with the HIV virus the body’s defence system – 
the immune system – works harder to fight infection. This increases energy and nutrient 68 
 
requirements. Further infection and fever also increase the body’s demand for food. Once 
people  are  infected  with  HIV  they  have  to  eat  more  to  meet  these  extra  energy  and 
nutrient needs” It appears WHO recommends increased protein and micronutrients intakes 
for PLWH contrary to what have been recommended in the Zambian guidelines. 
2.9.6    Summary 
For all the guidelines there were very important areas discussed and explained, such as 
why good nutrition is important in HIV infection and effects of nutrition on the immune 
system  in  HIV  infection.  Further,  issues  of  monitoring,  evaluation,  assessment, 
counselling, food safety, hygiene and preparation, sources of nutrient rich foods and even 
HIV prevention were discussed and explained. These guidelines therefore provide PLWH 
with the right nutrition education and information as well as basis for good nutrition in HIV 
infection even though the actual dietary guidelines may not be appropriate.  
 
There were some discrepancies between some of the guidelines however. Some of the 
guidelines were food based whereas some were nutrient based. The different approaches 
and discrepancies observed could be confusing for HIV infected persons trying to find the 
best guidelines to follow.  However, the food based approaches may be easier to follow, 
practical  and  sustainable  especially  in  resource  poor  countries  where  availability  and 
accessibility to specific nutrient supplements coupled with illiteracy may create difficulties 
in  following  the  nutrient  based  guidelines.  Secondly,  the  Zambian  guidelines 
recommended that protein needs were similar between the HIV infected and uninfected 
although  the  Canadian  guidelines  recommended  increased  protein  rich  foods  to  help 
restore lean body mass and to serve as building blocks. 
 
However, most of  the  dietary advice given did not seem  to be very different from the 
information  given to normal healthy  populations and thus some of the guidelines were 
likely to lack the specificity needed for HIV infection. This probably might be due to the fact 
that evidence that would warrant such specific guidelines (for both foods and nutrients) are 
not  strong  enough,  thus  the  need  for  more  formal  research  into  these  especially  to 
investigate which dietary patterns are associated with better nutritional status and delayed 
disease progression. 
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2.10  The Human Acquired Immunodeficiency Virus 
2.10.1  The origin of HIV/AIDS (historical perspective) 
AIDS  was  first  observed  when  young  homosexual  men  began  to  show  symptoms  of 
unusual diseases such as Kaposi’s sarcoma and Pneumocystis carinii pneumonia in 1981 
in the USA (Adler, 2001) often seen in severely immune deficient individuals. What was 
unusual was the fact that these rare diseases were observed in previously healthy young 
men. Epidemiologists in those  early  stages thought  this syndrome was caused by the 
sharing of inhalant ‘‘poppers’’ – stimulant drug based on amyl nitrite, which was common 
in the gay community and for a short time the syndrome was called gay related immune 
deficiency or GRID in the USA. 
 
AIDS  was  soon  reported  in  other  populations  as  well,  such  as  haemophiliacs  and 
intravenous drug users and among men, women and children who had received blood 
transfusions. Although these groups were not necessarily exposed to amyl nitrite or to 
frequent  contamination  of  sperm,  scientists  argued  that  like  male  homosexuals,  these 
groups had been exposed to immune-stimulatory substances. Haemophiliacs used clotting 
factor  preparations,  which were  prepared  from  the pooled blood of  a huge  number  of 
donors and IV drug users often used needles contaminated with small amounts of blood 
from previous users thereby increasing their exposure to foreign tissues antigens. This 
emerging syndrome  began showing  in different categories of people; blood transfusion 
recipient adults from Central Africa and infants born to mothers who had AIDS or were IV 
users. Before long, these clusters of diseases had been observed in Europe, Australia and 
the rest of Africa.  The first photographs of HIV, the causative organism for AIDS were first 
taken with an electron microscope in February 1983 at the Pasteur Institute in Paris. 
2.10.2   Definition of HIV/AIDS 
HIV stands for Human Immunodeficiency Virus, and it is the virus that causes AIDS. HIV 
was discovered in 1983 and before the name HIV, it was known as lymphadenopathy-
associated virus (LAV), human T-cell lymphotropic virus type III (HTLV-III), or AIDS-related 
virus (ARV) (Devita et al., 1992).  HIV is a human retrovirus belonging to the lentivirus sub 
family (Cohen and Durham, 1993; Nye and Parkin, 1994). Retroviruses infect a cell and 
then integrate their own genetic material into the cell’s DNA, forever changing the DNA of 
the host cell (Anderson and Hope, 2005). After which these retroviruses use the cells RNA 
to build and spread their own cell types in the host. There are at least two subtypes of HIV; 
HIV1 and HIV2 and each of them have many strains. HIV1 was the first to be isolated from 
people  with  AIDS.  HIV2  was  isolated  in  the  mid  1980s  in  West  Africa  and  is  more 70 
 
prevalent in cases of HIV infections in West Africa (Cohen and Durham, 1993; Nye and 
Parkin, 1994; Adler, 2001). 
2.10.3   Transmission of HIV 
Till date, the commonest mode of HIV transmission is through sexual intercourse with an 
infected  person  (Adler,  1997  and  2001;  Cohen  and  Durham, 1993)  which  makes  HIV 
infection  basically  a  sexually  transmitted disease  (STD). Transfusion of  infected  blood 
products, sharing of contaminated drug injecting equipment, semen donation, tissue and 
organ  transplants  and  mother-to-child  transmission  are  all  ways  through  which  the 
infection is acquired (Batty, 1993; Adler, 2001 and Cohen and Durham, 1993). HIV has 
been  isolated  from  semen,  cervical  secretions,  lymphocytes,  cell-free  plasma, 
cerebrospinal fluid, tears, saliva, urine and breastmilk (Adler, 2001; WHO, 1994). HIV has 
also been found in retina, cornea, ear secretions, bronchial fluid, synovial fluid, amniotic 
cells and fluid and Langherhans cells of the skin and mucous membranes. This however 
does  not  imply  that  HIV  can  be  transmitted  through  all  these  modes  since  the 
concentration of the virus in the various secretions vary significantly.  
 
In1993,  sexual  intercourse  accounted  for  70-80%  of  all  HIV  transmissions,  where  as 
mother to children transmissions and needle sharing both contributed to between 5-10% of 
global transmissions. Casual or social contact does not spread HIV. HIV must penetrate 
the skin or come into direct contact with a mucous membrane for infection to take place. 
Doorknobs, toilet seats, crockery, swimming pools and drinking fountains do not cause 
transmission.  
2.10.4   HIV and the human immune system   
The  majority  of  the  clinical  features  of  HIV  infection  can  be  ascribed  to  the  profound 
immune deficit that develops in infected individuals. HIV is immunosuppressive because it 
infects cells of the immune system and ultimately destroys them (Adler, 2001). There are 
at least two life threatening direct effects of infection with HIV; depletion of the immune 
system and destruction of the central nervous system. The body cells that are the main 
targets of HIV are T-helper lymphocytes, and the scavenger cells known as monocytes, 
which turn into macrophages when they leave the blood stream and to enter a body organ. 
CD4 lymphocytes (T helper cells) play a central role in the immune response, and their 
destruction accounts at least in part for the immunosuppressive effect of the virus.  
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In a healthy immune system, the monocytes/macrophages defend the body by seeking out 
and eliminating foreign particles and dead or infected cells. The body also defends itself by 
manufacturing  special  proteins  called  antibodies  to  render  foreign  bodies  (antigens) 
harmless. HIV weakens the immune system gradually by  interfering with both of these 
processes  (WHO,  1994).  When  HIV  encounters  a  cell  with  a  specific  receptor  for  it, 
primarily the CD4 molecule, the virus enters the cells through fusion of the virus and the 
cell membranes. When HIV enters the cell, its RNA is transcribed by means of an enzyme 
into proviral DNA, which may accumulate in the cell cytoplasm or become integrated into 
the DNA of the host cell’s chromosomes (Cohen and Durham, 1993).  
 
HIV therefore uses the host cell’s machinery to reproduce rapidly and massively. The new 
virus that have been formed bud on the surface of the host cell before bursting into the 
blood stream to invade other cells (WHO 1994)  Preferentially infected cells are the T-
helper lymphocytes (T4 cells, CD4 lymphocytes), monocytes, macrophages, and antigen-
presenting dendritic cells (Haseltine, 1991).  
 
Destruction of these CD4 lymphocytes gradually leads to a very low number of CD4 in the 
blood which indicates an impaired immune system and means a person is unable to fight 
off  diseases  or  infections  that  would  normally  pose  little  threat.  In  the  case  of 
monocytes/macrophages, HIV is stored in them and is carried to different parts of the body 
such as the lungs, the brain and lymph nodes (WHO, 1994). An healthy person usually 
have more than 590 CD4 cells in each microlitre of blood but this can reduce to as low as 
200  in HIV  positive persons and a level less than 200  in an HIV-infected person is a 
definition of AIDS (WHO, 1994). 
2.10.5  Prevention of HIV transmission 
For  a  pandemic  which  has  no  cure  till  date  and  mostly  transmitted  through  sexual 
intercourse,  prevention  of  transmission  has  been  the  main  area  of  focus  for  a  global 
panacea  to  the  epidemic.  Prevention  strategies  that  have  been  advocated  since  the 
discovery  of  the  virus  are  abstinence  from  sex,  mutual  fidelity  (between  uninfected 
partners), and protective sex, that is, condom use for all forms of penetrative sex (Adler, 
2001).  Other  ways  by  which  the  spread  of  HIV  could  be  reduced  include  preventing 
transfusion of infected blood and blood products such as untreated factor VIII administered 
to people with haemophilia. Needle-sharing among drug users should be avoided and drug 
users  should  ensure  sterile  injection  equipments  as  well  as  cleaning  of  equipment 72 
 
adequately. Abstinence from drug use is however the main mode of prevention among 
drug users. 
 
However,  given the fact that many people are  infected with the virus  and the  growing 
incidence of the pandemic, there is the need to adequately manage or support people 
living  with  the  virus  to  ensure  that  secondary  infections  and  disease  progression  is 
delayed. Anti-retroviral therapy (ART) has done much to reduce morbidity and mortality 
(Patella, 1998; Rousseau et. al 2000) but obviously, the possible role of nutritional status 
to  either  delay  disease  progression  or  reduce  susceptibility  to  the  infection  has  been 
proposed  (Hsu  et  al.,  2005;  Friis,  2006).  Moreover,  as  anti-retroviral  (ARV)  treatment 
becomes readily available especially in resource poor settings, the associations between 
nutrition, HIV/AIDS and ARV treatment need special attention (Raiten et al., 2005). 
2.10.6  Prevalence of HIV/AIDS 
A status of HIV epidemic from the UNAIDS 2008 report on the global AIDS epidemic show 
that: 
•  The global percentage of adults living with HIV has levelled off since 2000 
•  In 2007 there were 2.7 million new HIV infections and 2 million HIV-related deaths 
•  The  rate  of  new  HIV  infections  has  fallen  in  several  countries,  but  globally  these 
favourable trends are at least partially offset by increases in new infections in other 
countries. 
•  In  14  of  17 African  countries with  adequate  survey  data, the percentage of  young 
pregnant women (ages 15–24) who are living with HIV has declined since 2000-2001. 
In 7 countries, the drop in infections has equalled or exceeded the 25% target decline 
for 2010 set out in the Declaration of Commitment 
•  As treatment access has increased over the last ten years the annual number of AIDS 
deaths has fallen 
•  Sub-Saharan Africa remains the region most heavily affected by HIV, accounting for 
67% of all people living with HIV and for 75% of AIDS deaths in 2007. However, some 
of  the  most  worrisome  increases  in  new  infections  are  now  occurring  in  populous 
countries in other regions, such as Indonesia, the Russian Federation, and various 
high-income countries 
•  Globally, the percentage of women among people living with HIV has remained stable 
(at  50%)  for  several  years,  although  women’s  share  of  infections  is  increasing  in 
several countries 73 
 
In virtually all regions outside sub-Saharan Africa, HIV disproportionately affects injecting 
drug users, men who have sex with men, and sex workers. 
•   (Source: 2008 report on the global AIDS epidemic, UNAIDS)APTER 2()() 
 
When the first cases of HIV was reported in 1981 in the USA and in 1985 in Africa, little 
was known that a global epidemic beyond the imagination of all humanity was on its way. 
HIV/AIDS is now responsible for more deaths globally than any other disease. The total 
number  of people  living with the human immunodeficiency  virus  (HIV) rose in  2004 to 
reach its highest level ever (Figure 2.2). UNAIDS estimated that 33 million (33-36 million) 
people are presently living with the virus (WHO/UNAIDS, 2008). 
 
Figure 2.2: A global view of HIV infection 
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Source: 2008 report on global AIDS epidemic, UNAIDS  
 
The  report  on  the  global  AIDS  epidemic  showed  disproportionate  distribution  of  HIV 
prevalence  globally  with  Africa,  especially  Sub-Sahara  Africa  still  bearing  the  greatest 
burden of this epidemic. Most of the countries in Sub Saharan Africa showed prevalence 
above 5% whereas majority of the countries in Europe recorded prevalence below 1%. On 
a global scale, the HIV epidemic had stabilized, although with unacceptably high levels of 
new HIV infections and AIDS deaths. Globally, there were an estimated 33 million [30.3 
million–36.1 million] people living with HIV in 2007 (Figure 2.1). The annual number of new 
HIV infections declined from 3.0 million [2.6 million–3.5 million] in 2001 to 2.7 million [2.2 
million–3.2 million] in 2007. Two million [1.8 million–2.3 million] people died due to AIDS in 
2007, compared with an estimated 1.7 million [1.5 million–2.3 million] in 2001. While the 74 
 
percentage  of people  living with  HIV  has stabilized  since  2000,  the overall number of 
people  living  with  HIV  has  steadily  increased as new  infections  occur  each  year,  HIV 
treatments extend life, and as new infections still outnumber AIDS deaths (Figure 2.2).  
 
Southern Africa continues to bear a disproportionate share of the global burden of HIV: 
35% of  HIV infections and  38% of AIDS deaths in 2007  occurred in  that Sub-Region. 
Altogether, sub-Saharan Africa is home to 67% of all people living with HIV. The figures 
(Figures 2.3) showing the estimated number of people  living  with  HIV/AIDS,  adult and 
children HIV prevalence since 1990 show a general rise in HIV prevalence from 1990 to 
2007. Although the global HIV prevalence has stabilized, in Sub-Saharan Africa on-going 
new infections and increasing availability of anti-retroviral therapy have caused the actual 
number of PLWH to increase (Figure 2.3).  
 
Figure  2.3:  Estimated  number  of  people  living  with  HIV/AIDS  and  adult  HIV 
prevalence globally and for sub-Saharan Africa, 1990-2007 
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Table 2.8: Global summary of the HIV and AIDS epidemic, 2002 to 2007 
 
 
Source: 2008 report on the global AIDS epidemic, UNAIDS 
 
 
Figure 2.4: Children Living with HIV globally, 1990-2007 
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    2003  2004  2006  2007 
Number  of 
people  living 
with HIV  
Total  (in 
millions) 
37.8(34.6-42.3  39.4 (35.9-44.3)  39.5  (34.1-
47.1) 
33 (30-36) 
Adults  35.7 (32.7-39.8)  37.2 (33.8-41.7)  37.2  (32.1-
44.5) 
 
Women  17 (15.8-18.8)  17.6 (16.3-19.5)  17.7  (15.1-
20.9) 
 
Children 
under  15 
years 
2.1 (1.9-2.5)  2.2 (2.0-2.5)  2.3 (1.7y-3.5)  2.0 (1.9-2.3) 
People  newly 
infected 
Total  4.8 (4.2-6.3)  4.9 (4.3-6.4)  4.3 (3.6-6.6)  2.7 (2.2-3.2) 
Adults  4.1 (3.6-5.6)  4.3 (3.7-5.7)  3.8 (3.2-5.7)   
Children 
under  15 
years 
0.63 (0.57-0.74)  0.64 (0.57-0.75)  0.53  (0.41-
0.66) 
0.37(0.33-
0.41) 
AIDS deaths in 
2004 
Total  2.9 (2.6-3.3)  3.1(2.8-3.5)  2.9 (2.5-3.5)  2.0 (1.8-2.3) 
Adults  2.4 (2.2-2.7)  2.6 (2.3-2.9)  2.6 (2.2-3.0)   
Children 
under  15 
years 
0.49 (0.44-0.58)  0.51 (0.46-0.60)  0.38 (0.29-0.5)   76 
 
 
Figure 2.5: Percentage of adults (15+) living with HIV who are female 1990-2007 
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Among children, HIV prevalence has increased since 1990 to 2007 on the global scale 
(Figure 2.4). Globally, about 2 million children were living with the virus in 2007. Likewise, 
prevalence of HIV infection in females continues to be high but has plateau over the past 
five years (Figure 2.5) but sub-Saharan African still bears a large proportion of the HIV 
infected females. 
 
The number of AIDS deaths reported in 2006 and 2003 were both 2.9 million. This data 
shows that the level of HIV mortality has not changed over the past 4 years. A total of 4.9 
million  new  infections  were  reported  in  2004  (an  increase  of  100  thousand  from  the 
previous year) and of this number, 640 000 were children below 15 years. In 2006, 4.3 
million  new  infections  were  recorded  globally  and  this  showed  a  slight  reduction  in 
estimated new  infections (Table  2.8). The prevalence  of HIV is growing steadily if not 
rapidly as shown by Table 2.8.  In 2006, alone about 4.3 million adults and children were 
infected with the virus globally. This showed an increase of about 400,000 from 2004. The 
majority of these new infections reported over the 4-year period occurred in Sub-Sahara 
Africa. Regionally, Sub-Saharan Africa recorded the highest prevalence (24.7 million) of 
adults and children living with the virus in 2006 compared to a prevalence of 23.6 million in 77 
 
2004  whereas  Oceania  Region  recorded  the  lowest  prevalence    of  81000  in  2006 
compared with 72000 in 2004 (Table 2.9). 
 
2.10.6.1 HIV infection situation in South Africa 
 
Table 2.9: HIV and AIDS estimates, South Africa 
 
  2007  2001 
Number of people living with HIV  5 700 000 [4 900 000 - 6 600 000] 
 
4 700 000 (4000000-5500000) 
Adults aged 15 to 49 prevalence 
rate 
18.1% [15.4% - 20.9%]   16.9% (14.3%-19.9%) 
Adults aged 15 and up living with 
HIV 
5 400 000 [4 700 000 - 6 200 000]  4 600 000 (3 900 000 -5 300 
000) 
Women aged 15 and up living 
with HIV 
3 200 000 [2 800 000 - 3 700 000]   2 700 000 (2 300 000 – 3 200 
000) 
Children aged 0 to 14 living with   280 000 [230 000 - 320 000]  
 
150 000 (120 000 – 190 000) 
HIV Deaths due to AIDS  350 000 [270 000 - 420 000]  180 000 (130 000 – 250 000) 
Orphans due to AIDS aged 0 to 
17 
1 400 000 [1 100 000 - 1 800 000]  400 000 (260 000 – 590 000) 
Source: Epidemiological Fact Sheet of HIV and AIDS, 2008 
 
Within  the  sub-Saharan  Africa,  prevalence  of  HIV  is  higher  in  the  Southern  African 
Countries especially in South Africa. Report of the 2008 global AIDS epidemic estimated 
5,700,000 South African adults and children living with HIV/AIDS. Prevalence of HIV for 
2007 was estimated as 18.1% compared to 16.9% in 2001. Adult (15 years and above) 
HIV infected population for 2007 was 5,400,000 and 300000 were children (Figure 2.7, 
Table 2.8). In 2001, the estimated adult and children HIV infected population for South 
Africa was 4,700,000, out of which 4,600,000 were adult. Thus between 2001 and 2007,  
the estimated number of people living with HIV and AIDS in South Africa increased by 
about 1,000,000. Total number of estimated children living with HIV/AIDS also rose from 
150 000 to 280 000 between 2001 and 2007, and increase of 130 000 (46.4%). Likewise, 
the estimated number of orphans due to AIDS aged 0-17 years between 2001 and 2007 
almost tripled from 400 000 to 1 400 000.  
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Figure 2.6: Estimated adult HIV (15-49) prevalence in South Africa, 1990-2007 
 
Source: Epidemiological Fact Sheet of HIV and AIDS, 2008 
 
Estimated number of deaths due to AIDS between 1990 to 2007 shows increases in AIDS 
mortality over this period (Figure 2.8). There was a steep increase between 1998 and 
2005, a slight decrease in 2006 and an increase again in 2007 as shown by Figure 2.8. 
However, trends of total HIV infected population as well as adults living with HIV infection 
in South Africa showed  rapid increase between  1993  and  2000  and since then levels 
remained similar (Figures 2.6 and 2.7). In terms of province, the South African Department 
of Health Survey in 2007 showed highest prevalence in Kwazulu-Natal (16.5%) and lowest 
in the Western (1.9%) with a National prevalence of 10.8%. HIV was higher in females 
than males according to gender and highest in Africans (13.3%) but least in the Whites 
(0.6%) according to race. 
 
Based on its sample of 33,488 women attending 1,415 antenatal clinics across all nine 
provinces, the South African Department of Health Study estimates that 28% of pregnant 
women were living with HIV in 2007. Prevalence of HIV infection was highest in Kwazulu-
Natal (39.1%) and least in the Western Cape (15.2) provinces in 2006 (Figure 2.9 and 
Table 2.10). In 2005, the highest and least prevalence were still recorded in these two 
provinces. Across the  provinces,  HIV  prevalence slightly  increased between  2005 and 
2006 in all provinces except in the Free State, which observed slight decrease (0.8%). 79 
 
Between 2006 and 2007, HIV prevalence slightly reduced in Kwazulu-Natal, Mpumalanga, 
Guateng, Eastern Cape, Limpopo and Western Cape. Prevalence however increased in 
Free State and Northern Cape and remained the same in the North West Province. The 
national average for antenatal attendees also reduced between 2006 and 2007 by (0.8%).  
 
Figure 2.7: Number of people living with HIV, 1990-2007 
 
Source: Epidemiological Fact Sheet of HIV and AIDS, 2008 
 
Figure 2.8: Estimated number of deaths due to AIDS in South Africa, 1990-2007 
 
Source: Epidemiological Fact Sheet of HIV and AIDS, 2008 
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Table 2.10: HIV prevalence by Province, Gender and Race  
Province  Number surveyed  Prevalence % 
KwaZulu-Natal  2,729  16.5 
Mpumalanga  1,224  15.2 
Free State  1,066  12.6 
North West  1,056  10.9 
Guateng  2,430  10.8 
Eastern Cape  2,428  8.9 
Limpopo  1,570  8 
Northern Cape  1,144  5.4 
Western Cape  2,204  1.9 
Male  6,342  8.2 
Female  9,509  13.3 
African  9,950  13.3 
White  1,173  0.6 
Coloured  3,382  1.9 
Indian  1,319  1.6 
National  15,851  10.8 
Source of data for Figure 2.9: South African Department of Health Survey, 2007 
 
 
Figure  2.9:  Estimated  HIV  prevalence among  antenatal  clinic  attendees  in  South 
Africa by Province 
 
Source of data for Figure 2.9: South African Department of Health Survey, 2007 
2.11  Stages of HIV disease progression 
The relationship between HIV/AIDS and poor nutrition has been postulated to be cyclical, 
which  means  that  in  the development of  the  disease, one  problem  worsens  the other 
(South African Department of Heath South Africa, 2001; Semba and Tang, 1999). The 
implication of this cyclical relationship between poor nutrition and HIV/AIDS is that unless 81 
 
the cycle is broken, the infected individual gets worse and worse until he/she dies. The 
aetiologic agent of acquired immunodeficiency syndrome (AIDS) is a retrovirus designated 
human immunodeficiency virus (HIV). The CD4+ T-lymphocyte is the primary target for 
HIV infection because of the affinity of the virus for the CD4 surface marker. The CD4+ T-
lymphocyte coordinates a number of important immunologic functions, and a loss of these 
functions results in progressive impairment of the immune response.  
 
HIV infection can generally be broken down into four distinct stages: primary infection, 
clinically asymptomatic stage, symptomatic  HIV infection,  and progression from HIV to 
AIDS also known as clinical disease progression (Morgan et al., 2002; WHO, 2006). The 
primary infection stage last for a few weeks and usually accompanied by flu-like illness 
and these symptoms are only serious enough to see a doctor in about 20% of people. 
There is also large amount of HIV in the peripheral blood and the immune system begins 
to respond to the virus by producing HIV antibodies and cytotoxic lymphocytes, a process 
called  sero-conversion.  HIV  anti-body  test  could  be  negative  if  sero-conversion  is  not 
complete. 
 
The  second  stage  (asymptomatic  stage),  as  the  name  suggests  is  free  from  major 
symptoms and last for averagely 3-10 years. There may be swollen glands and the level of 
HIV in the peripheral blood drops to very low levels although people remain infectious and 
antibodies  are  detectable  in  the  blood  (WHO,  2006).  Stage  three  of  the  infection  is 
characterised by failure of the immune system over time. The immune system loses the 
ability to contain HIV. This is because the lymph nodes and tissues become damaged 
because of years of activity. The body fails to keep up with replacing the T helper cells that 
are lost and also, HIV mutates and becomes more pathogenic, in other words stronger and 
more varied, leading to more T-helper cell destruction. Symptomatic HIV infection is mainly 
caused by the emergence of opportunistic infections and cancers that the immune system 
would normally prevent such as Tuberculosis, Pneumocystis Carinii Pneumonia (PCP), 
Candida, Kaposi’s Sarcoma, Herpes simplex, Varicella Zoster etc. 
 
Stage four of the infection is characterised by more damage to the immune system and the 
illnesses  that  present  become  more  and  more  severe  leading  eventually  to  an  AIDS 
diagnosis. In UK, the diagnosis of AIDS is confirmed with one or more of a specific number 
of severe opportunistic infections or cancers. 
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Considering how the disease develops and the stages of HIV infection, it is realised that 
good  nutrition  might  mean  differently  at  the  various  stages  of  the  infection  and  thus 
nutritional  needs  will  vary  according to  the  development  of  the  disease.  However,  the 
question  of  what exactly  is  needed  in the  different stages  of the  infection  in  terms of 
nutrition or dietary intake remains unanswered till date and the evidence is circumstantial 
(South African Department of Health, 2001; Macallan, 1999).  
2.12   Rates of disease progression between developing and developed countries 
Many of the earlier studies reported that progression of disease in HIV infected persons 
was more rapid in African populations especially in Sub-Saharan Africa than in rich and 
affluent  countries  (Colebunders  et  al.,  1991;  N’Galy  et  al.,  1988;  Whittle  et  al.,  1992; 
Anzala et al., 1995). The rate of disease progression varied between individuals following 
infection with the virus. In HIV infected persons, there is a usually a group known as rapid 
progressors because this group progresses to AIDS usually within 4 years (Anzala et al., 
1995). It was suggested that factors such as genetics and immune function, health care, 
and co-infections as well as viral genetic variability may affect the rate of progression to 
AIDS (Campbell et al., 2004; Matt and Roger, 2001; Fang et al., 2001; Morgan et al., 
2002).  
 
On the other hand is a group of individuals persistently infected with HIV-1 but show no 
signs of disease for over 12 years. Some of these individuals remain asymptomatic and it 
seems the infection has been halted with regards to disease progression (Buchbinder et 
al.,  1994;  Cao  et  al.,  1995;  Easterbrook,  1994)  but  it must  be  noted  that  progression 
towards AIDS can still occur after more that 15 years (Harrer et al., 1996). Hence the need 
to  know the extent at which other  factors such as dietary intake and nutritional status 
influenced disease progression in HIV infection. 
 
Rapid progression was originally thought to be continent specific as some studies reported 
that disease progression was more rapid in Africa (N’galy et al., 1988; Anzala et al., 1995; 
Whittle et al., 1992). This could be because  the other factors which influence  disease 
progression  (malnutrition  and  co-infection)  are  also  very  prevalent  in  Africa.  However, 
other studies have refuted the notion that disease progression is continent specific (French 
et al., 1999; Morgan et al., 2002) with the explanation that disease progression could be 
rapid irrespective of geographic location so far as the factors mentioned earlier prevail. 
Morgan and colleagues studied progression to symptomatic disease in people  infected 
with  HIV-1  in  rural  Uganda  in  a  prospective  cohort  study  and  concluded  that  disease 83 
 
progression was more rapid in rural Uganda and this was due to what could be taken as 
symptoms and signs of infection with HIV-1 (Morgan et al., 2002). 
 
Morgan et al., (2002) found that most of the population in rural Uganda lives in poverty; 
food is often in limited supply, there is no electricity and there is poor access to any; let 
alone clean water. This is coupled with high levels of Malaria and infections other than 
HIV, especially bacterial infections. They concluded that the shorter interval from sero-
conversion to symptomatic disease in African populations could probably be a reflection of 
the high background level of these conditions other than rapid disease progression. 
 
The  two  immediate  factors  that  lead  to  malnutrition  according  to  the  1990  UNICEF's 
conceptual framework are inadequate dietary intake and disease. However malnutrition 
and infection/disease have been shown to be interlinked and to work synergistically in a 
cyclic faction. Malnutrition predisposes to infection and infection could lead to malnutrition 
and  these together worsen the status  of the  individual.  It is therefore expected that in 
populations  were  malnutrition  and  other  infections  are  endemic,  people  could  be 
predisposed to a higher risk  of HIV  infection. Moreover PLWH could also have  higher 
likelihoods for progressing to symptomatic HIV infection and AIDS due to these underlying 
issues. 
2.13    Markers and proxy markers of HIV disease progression 
The traditional and widely accepted markers and most powerful prognostic indicators for 
disease progression in HIV infection are the CD4 cell count and HIV-1 RNA. The World 
Health Organisation and Centre for Disease Control have even categorised the stages of 
disease progression based on certain levels for these markers (CDC, 1992; WHO, 2006). 
However, these markers may not be regularly obtained in developing countries because of 
the cost and technology and may not explain all the variability in HIV disease progression 
(Mehta et al., 2006). Some discrepancies remain with the use of these markers and some 
patients with high CD4 counts or low HIV-1 RNA concentrations can develop AIDS or die 
from HIV-1-related infections. Thus other proxy markers of disease state such as albumin, 
bilirubin, wasting and weight loss, are being investigated.  
Some markers have been proposed for routine use but may not be acceptable due to 
inconsistency in findings and low feasibility. For some of the proposed markers also the 
underlying biological mechanisms are not fully understood (Sabin et al., 2002). Studies of 
these  proposed  markers  have  shown  that  high  concentrations  of  IgA  and  β−2 84 
 
microglobulin (Phillips et al., 1993 and Sabin et al., 1994) high CD8 counts (Phillips et al., 
1993; Kvale et al., 1999) and low platelet counts (Eyster et al., 1987; Levy et al., 1997) are 
associated with more rapid progression of HIV-1 disease.  
In  the  present study, CD4 cell count and viral  load  (the traditional markers of disease 
progression) were not among the parameters analysed because the original study did not 
set out to address these objectives and thus other markers or proxy markers of disease 
progression  which  were  mostly  biochemical  markers  had  to  be  used  as  outcome 
measures. Serum albumin, total bilirubin, Aspartate Aminotransferase (AST), Lean Body 
Mass  (LBM)  and  BMI  were  the  markers  used  to  depict  disease  progression  and  the 
purpose of  this section was to  review how  these markers are  associated with  disease 
progression from available literature. 
2.13.1  Albumin 
Proteins  are  the  most  abundant  compounds  in  serum  made  up  of  two  major  groups, 
albumin and globulins. Plasma contains 60-80 g/L of protein mainly in the form of albumin 
globulin and fibrinogen (Kumar and Clark, 1999). Albumin is principally synthesised in the 
liver  and  its  main  functions  are  to  maintain  the  intravascular  oncotic  (colloid)  osmotic 
pressure and to transport water-insoluble substances such as bilirubin, hormones, fatty 
acids  and  drugs.  Serum  albumin  levels could  decrease  in  liver  disease,  inflammation, 
nephrotic syndrome, burns, protein-losing  enteropathy, malabsorption,  malnutrition, late 
pregnancy, artefact, posture, genetic variations and malignancy (Kumar and Clark, 1999). 
Prolonged  reduced  synthesis  of  albumin  leads  to  hypoalbuminaemia  and  is  seen  in 
chronic liver disease and malnutrition. Elevated levels of albumin are caused by relative 
loss of water which could happen in dehydration or prolonged use of tourniquet.  
 
Low serum albumin levels have been associated with high mortality in different populations 
with different conditions (Phillips et al., 1989; Goldwasser et al., 1997; Goldwasser and 
Feldman,  1997;  Zimmermann  et  al.,  1999)  but  few  studies  have  investigated  the 
association between levels of serum albumin and HIV disease progression (Feldman et 
al., 2000; Graham et al., 2007; Mehta et al., 2006). Low serum albumin concentration have 
been associated with more rapid progression to AIDS and all cause mortality, independent 
of CD4 cell count, HIV – 1 load and highly active anti-retroviral therapy (HAART) (Feldman 
et al., 2000). In a study by Sabin et al., 2002, albumin concentrations measured shortly 
after HIV-1 sero-conversion were associated with risk of AIDS (relative hazard 0.91 [95% 85 
 
CI  0.84-1.00],  p=0.04)  and  death  (0.89  [0.82-0.96],  p=0.004)  over  a  15-year  period 
independent of the CD4 count and HIV-1 RNA concentration. 
 
Among 453 HIV-infected individuals, Mehta et al., (2006) found that albumin <35 g/litre 
was associated with faster progression to AIDS [adjusted relative hazard (ARH), 1.8; 95% 
confidence interval (CI), 1.2–2.8], AIDS mortality (ARH, 2.2; 95% CI, 1.3–3.8), and all-
cause mortality (ARH, 2.4; 95% CI, 1.6–3.5). Analyses restricted to HIV seroconverters 
were similar. Preseroconversion levels of albumin did not predict outcomes, but HIV sero-
conversion  appeared  to  lower  albumin  levels  suggesting  that  low  albumin  levels  are 
probably a consequence of HIV infection rather than merely reflective of some individuals 
inherently  having low albumin levels.  Feldman and colleagues (Feldman et  al., 2000) 
reported that serum concentrations of albumin were a strong predictor of death in women 
infected with HIV-1, independent of their CD4 count and HIV-1 RNA concentration over 3 
years' follow-up.  
 
In  more  recent  studies  Graham  et  al.,  (2007)  showed  that  each  1g/litre  decrease  in 
albumin with HIV-1 acquisition was associated with 13% increases (p=0.01) in the risk of 
progression to a CD4 cell count <200 cells/µl, after adjustment for set point plasma viral 
load. Moreover a decrease in albumin over 10% was associated with a 3.5 fold increase in 
the risk of progression to a CD4 cell count <200 cells/µl. Trends for an increase risk in 
mortality were seen as well (Graham et al., 2007) and thus the researchers concluded that 
decrease  in  albumin  concentration  may  be  a  marker  for  changes  in  early  infection 
associated with more rapid disease progression. Thus albumin levels could be good proxy 
marker of disease progression in PLWH. 
2.13.2  Changes  in  liver  enzymes  as  possible  markers  of  metabolic  alteration, 
inflammation and progression 
Aspartate  Aminotransferase  (AST)  and  Alanine Aminotransferase  (ALT) are  present  in 
hepatocytes and leak into the blood with liver damage (Kumar and Clark. 1999). ALT is the 
enzyme produced within the cells of the liver. The level of ALT abnormality is increased in 
conditions where cells of the liver have been inflamed or undergone cell death. As the cells 
are damaged, ALT leaks into the bloodstream leading to a rise in the serum levels. Any 
form of hepatic cell damage can result in an elevation in the ALT (Wikipedia, 2008; Kumar 
and Clark, 1999). Alanine transaminase (ALT), also called serum glutamic pyruvate.  86 
 
Aspartate  transaminase  (AST), also called serum glutamic oxaloacetic transaminase is 
another enzyme found in the liver, but is also present in red cells and cardiac and skeletal 
muscle and is therefore not specific to the liver. Therefore, the ratio of AST to ALT is 
sometimes useful in differentiating between causes of liver damage (Kumar and Clark, 
1999; Wikipedia, 2008). Alkaline Phosphatase and Gamma Glutamic Transpeptidase are 
also enzymes that could be associated with liver function. ALP is present in the canalicular 
and sinusoidal membranes of the liver, but is also present in many other tissues such as 
bone, intestine and placenta (Kumar and Clark, 1999; Wikipedia, 2008).  These are not 
very specific to the liver. Alkaline phosphatase is an enzyme, which is associated with the 
biliary tract. It is not specific to the biliary tract.  GGT enzyme is also produced by the bile 
ducts and it is present in many tissues apart from the liver. It is used often times to confirm 
that the alkaline phosphatase is of hepatic aetiology (Kumar and Clark, 1999; Wikipedia, 
2008). 
Many studies have shown elevated liver enzymes in PLWH associated with liver damage 
(Sterling et al., 2008; Livry et al., 2003; Ejilemele et al., 2007; Ofotokun et al., 2007). This 
could be indicative of altered metabolism, inflammatory stress, damage to liver tissues and 
probably disease progression. For some the studies, these increases were associated with 
anti-retroviral therapy (Maida et al., 2006; Bonacini, 2004) 
 2.13.3  Bilirubin 
Bilirubin is a major breakdown product of haemoglobin. Bilirubin is a breakdown product of 
haeme (a part of haemoglobin in red blood cells). Biliverdin is formed from the haeme and 
this is reduced to form bilirubin. The liver is responsible for clearing the blood of bilirubin 
and this is done by conjugating the bilirubin to make it water soluble. Bilirubin in the liver 
dissociates from albumin and is taken up by the hepatic cell membrane and transported to 
the endoplasmic reticulum by cytoplasmic proteins, where it is conjugated with glucuronic 
acid and excreted into bile (Kumar and Clark, 1999). The presence of bilirubin in urine 
gives it the yellow colour.  
Increased total bilirubin causes jaundice and could be a result of haemolytic anaemia and 
internal haemorrhage in which case the liver may not be involved. However, if the direct 
bilirubin is low, while the total bilirubin is high, this reflects liver cell damage or bile duct 
damage within the liver itself. Thus increased total bilirubin involving the liver could be due 
to reduced metabolism, impaired conjugation of bilirubin, damage of liver tissue as well as 87 
 
the  liver’s  response  to  inflammation  in  HIV  infection  and  is  suggestive  of  altered 
metabolism. 
2.13.4  LBM and BMI 
Weight loss and wasting are very common in HIV infection (Mulligan et al., 2005; Tang, 
2003; Summerbell, 1994; Kotler et al., 1989; Kotler, 1989) despite major advances in the 
treatment and survival of patients infected with human immunodeficiency virus (HIV). In 
the HIV-infected population, weight loss and wasting are associated with lower CD4+ cell 
counts, being independent predictors of mortality (Mangili et al., 2006) and are prognostic 
of disease progression and AIDS (Mulligan et al., 2005; Tang, 2003). Wasting and weight 
loss as low as 5% could significantly increase morbidity or mortality (Villarmor et al., 2005; 
Steinhart, 2001) in HIV infected persons. Hence HIV related wasting remains a significant 
concern in HIV infection. (Villarmor et al., 2005; Steinhart, 2001; Mangili et al., 2006) 
 
HIV-associated wasting is defined as > or = 10% involuntary weight loss and includes 
declines in both lean and fat mass (Moyle et al., 2004). Weight loss and wasting are used 
as markers for WHO/CDC stages of HIV infection. Moderate unexplained weight loss of 
<10% of presumed or measured body weight is used as one of the indicators for clinical 
stage 2 of HIV infection and severe weight loss of >10% of presumed or measured weight 
is an indicator in the third stage of HIV infection (WHO, 2006 and CDC, 1993).  
2.14  Nutritional Status  
Nutritional  status  is  a  measurement  of  the  extent  to  which  an  individual's  needs  for 
nutrients  is  being  met.  A  balance  between  nutrient  intake  and  nutrient  requirement  is 
needed to ensure an optimal nutritional status (Mahan and Scott-Stump, 2000). Nutritional 
health is maintained by a state of equilibrium in which nutrient intake and requirements 
balance  (Barker,  2002;  Jeejeebhoy,  2000).  Malnutrition  occurs  when  the  net  nutrient 
intakes  is  less  than  requirements and  malnutrition  leads  to a succession  of  metabolic 
abnormalities, physiologic changes, reduced organ and tissue function and loss of body 
mass. Nutritional status is therefore the state of health produced by the balance between 
requirement and intake of nutrients (Barker, 2002). 
Malnutrition and weight loss have been recognized as common and major complications of 
HIV infection (Summerbell, 1994; Kotler et al., 1989; Kotler, 1989), which may occur from 
the onset (Ott et al., 1993) or more frequently in the later stages of the disease (Ysseldyke, 
1991).  The impact of malnutrition, even if mild, has been shown to be clearly adverse on 
the outcome of HIV infection (Süttmann, 1996). Thus, malnutrition must be prevented or 88 
 
treated  in  order  to  enhance  the  survival  and  well  being  of  the  infected.  Opportunistic 
infections can cause symptoms such as diarrhoea, nausea, vomiting and pain (Kalrsson & 
Nordstrom, 2001) and can cause loss of more than 5% of normal weight in less than 28 
days (Nerad &  Gorbach 1994). Patients can however maintain a normal  weight  in the 
absence of opportunistic infections. 
 
Nutritional status, which has  always  been a strong predictor  of survival and  functional 
status in HIV infection (Kotler et al., 1989; Grinspoon et al., 1996; Wheeler et al., 1998), 
has been used variously to identify individuals at risk or to provide justification or a basis 
for evaluating nutritional interventions. However, because of the inter relationship between 
nutrition  and  HIV,  the  nutrition-associated  complications  and  disease  outcomes  are 
multifactorial.    This  means  that  any  influences  of  malnutrition  on  outcome  that  are 
formulated based on a single parameter or a simple model of nutritional assessment are 
most likely to be spurious because it would have failed to consider the many interacting 
factors (Jeejeebhoy, 2000).   
 
To  understand  the  relationship  between  nutrition  and  HIV/AIDS,  there  is  the  need  to 
consider the effect of the disease on body size and composition (weight, lean body mass, 
body cell mass) as well as the effect on the functioning of the immune system (Piwoz and 
Preble, 2000). Body size and composition are used as indicators of protein-energy status 
and these are most commonly expressed in terms of body weight and height or BMI. 
2.14.1   Factors which influence nutritional status 
The  nutritional  status  of  an  individual  is  an  outcome  of  complex  biological  and  social 
processes as summarized in  the conceptual  framework. The conceptual framework  for 
causes of malnutrition was  developed by  UNICEF (1990) to describe the multifactorial 
nature of nutritional status and the factors that influence it (Figure 2.10).  
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Figure 2.10: The Conceptual Framework on Causes of Malnutrition 
 
 
Source: UNICEF 1990 
 
Several factors affect nutritional status, and these tend to vary depending on a person's 
living  situation,  available  food  supply,  and  health  (Williams,  1999).  Nutrient  intake  is 
dependent on actual food/diet consumption, which is, in turn, influenced by many factors; 
including socioeconomic, eating behaviour, emotional climate, cultural influences and the 
effects  of  various  disease  states  on  appetite  and  the  ability  to  consume  and  absorb 
adequate amounts of nutrients.  Inadequate dietary intake and disease are the immediate 
causes, which may include energy, protein, and micronutrients deficits. Inadequate dietary 
intake itself could be a form of malnutrition and can lead to other forms of malnutrition 
(underweight, stunting etc). Inadequate dietary intake also increases susceptibility to and 
severity  of  infection;  many  infectious  diseases  also  reduce  dietary  intake  and  nutrient 
utilization through loss of appetite and reduced absorption. 90 
 
 
Possible underlying causes of malnutrition seem endless and their relationships complex 
but can be grouped under: 
•  Adequate access to food (household food security) 
•  Adequate care of children 
•  Adequate access to preventive health services with a healthy environment 
Some of the basic causes of malnutrition include: 
•  Ecological/technical conditions of production, including the environment (soil and 
climate), the population-resource ratio, the level of technology used and level of 
people’s skills. 
•  Social conditions and political factors  including policies on employment, prices, 
incomes, subsidies, health, education and agriculture as well as the legal system 
as a whole 
•  Ideological factors, including habits (food habits), beliefs, cultural preferences etc 
 
All  these  factors  are  interrelated  in a  complex  fashion and  determine nutritional state. 
Factors at one level influence the other levels and even factors of the same level are also 
interrelated.  Nutrient  requirements  are  also  influenced  by  many  factors  including 
physiological stress processes, fever and/or trauma, normal anabolic state of growth and 
pregnancy, body maintenance and well being. When adequate nutrients are consumed to 
support daily body needs, along with any increased metabolic demands, then a state of 
optimal  nutritional  status  is  achieved  (Mahan  and  Escott-Stump,  2000).  Conversely, 
malnutrition occurs when the net nutrient intake is less than requirement.  
 
Fundamentally, nutrition has been an intimate component of care for people living with HIV 
because  of  the  specific  roles  of  key  nutrients  in  maintaining  the  body's  immune 
competence. It is again a vital component of care for the involuntary weight loss and body 
tissue wasting caused by the disease effects on metabolism often reflected in severe state 
of malnutrition. Furthermore, for many of  the associated diseases, individual nutritional 
status influences the impact on morbidity and mortality irrespective of the disease process 
(Williams, 1999; Sarker et al., 2005).  
2.14.2   Methods of nutritional status assessment 
Traditionally,  nutritional  status  has  been  defined  by  body  composition,  plasma-protein 
concentrations, immune competence and multivariate analysis (Blackburn et al., 1977). 
Nutritional  status  of  individuals  or  groups  can  be  assessed  by  dietary  consumption, 91 
 
anthropometrics,  biochemical  examination  and  clinical  assessment  or  functionality. 
Several methods now exist for dietary assessment both in populations and individuals and 
the decision on which method to use depend to a large extent on the type of data needed 
(that is, qualitative or quantitative) as well as the purpose for which the data is needed 
(Wrieden, 2003). For instance in choosing a dietary assessment method, it is important to 
know if the research is intended to document intake of foods or of nutrients or whether the 
research is aimed at assessing dietary pattern of a population (Margetts and Nelson, 1997; 
Wrieden et al., 2003). The aim of this study was to assess the influence of dietary intake 
on nutritional status and markers of disease and metabolic state in HIV. Hence, detailed 
description  of  available  dietary  assessment  methods  as  well  as  other  methods  of 
nutritional assessment has been discussed below.  
2.14.2.1     Anthropometric Measurements 
The  use  of  weight  alone  to  assess  nutritional  status  should  be  limited  to  monitoring 
purposes  because  it  is  confounded  by  height.  However  weight  is  appropriate  for 
monitoring the progress  of patients suffering  from  long-term morbidity, recovering from 
disease or surgery, or during nutritional rehabilitation within a therapeutic feeding centre 
(Gerrior  and  Neff,  2005).  Weight  is  usually  measured  with  the  patient  wearing  light 
clothing. Height is measured with the individual in a standing straight and leaning against a 
flat surface. For individuals who cannot stand such as children, a measuring board is used 
with children in a lying posture. Height should be directly measured whenever possible, as 
this is likely to be more accurate than reported height for some patients, such as those 
with osteoporosis (Gerrior and Neff, 2005). 
 
Body Mass Index is the ratio of weight (kilograms) and height squared (in metres). A BMI 
of less than 18.5 is categorised as underweight whereas a BMI of 25 or more is indicative 
of increased adiposity in healthy adults. Between 18.5 and 24.99, BMI is said to be in the 
normal range. Degrees of underweight have been defined as chronic energy deficiency 
(CED) according to levels of BMI, and cut-offs of 18.5, 17 and 16 have been put forward 
as defining mild, moderate and severe chronic energy deficiency, respectively (James et 
al., 1988 & Ferro-Luzzi et al., 1992). The cut-offs for BMI were determined based on the 
clinical significance for the various levels of BMI. For instance, BMI of 25 and more have 
been shown to be linked with morbidity in normal populations. In HIV positive individuals it 
is  not  established  which  BMI  cut-offs  are  associated  with  rapid  or  delayed  disease 
progression. 
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Even in healthy adults, the relationships between the recommended cut-offs and aspects 
of  function  such  as  physical  work  capacity  and  morbidity  are  at  an  early  stage  of 
evaluation and results are not clear-cut (Margetts & Nelson, 1997). For example, the BMI 
below  cut-off  of  18.5  is  associated  with  higher  morbidity  in  Pakistan,  but  not  in  the 
Philippines and Ghana (Garcia and Kenney, 1994). Regional body shape can be assessed 
using circumferential measurements of the chest, waist, hip, mid-upper arm and mid-thigh. 
These  measurements  are  easy  to  perform  and  can  help  identify  patients  with  fat 
redistribution  syndrome,  metabolic  syndrome  or  abdominal  obesity  (Gerrior  and  Neff, 
2005). Waist circumference is probably the single most useful measurement among the lot 
and waist circumferences which are greater than 35 inches and 40 inches in women and 
men respectively are indicative of an increased risk of obesity-related comorbid diseases, 
such as diabetes, dyslipidaemia, hypertension and cardiovascular diseases. 
 
Skin fold thickness is another important anthropometric measurement used to identify HIV 
patients  who  have  developed  fat  atrophy  and  to  monitor  the  effects  of  specific 
interventions. Commonly measured in HIV-infected patients include triceps, subscapular, 
suprailiac and mid-thigh regions. However, the usefulness of skin-fold thickness is limited 
due to the need for trained personnel and special interpretive equations and tables. 
 
Bioelectric  impedance  (BIA)  is  another  method  of  performing  anthropometric 
measurements in HIV positive persons. BIA measures the opposition of bodily tissues to 
the flow of mild (less than one MilliAmp) alternating current. Impedance is a function of two 
components  (vectors):  the  resistance  of  the  tissues  themselves  and  the  additional 
opposition due  to the  capacitant  effect of membranes, tissue interfaces, and non-ionic 
tissues. Electrodes are typically placed on wrist and an ankle (in the tetrapolar method, on 
the dorsal surfaces of the right hand and foot as well as the wrist and ankle) and change in 
voltage between electrodes is measured. Impedance measures vary with the frequency of 
the current used. At low frequencies, current flows primarily through extracellular fluids, 
while  at  high  frequencies  it  penetrates  the  body  tissues.  Applications  of  the  BIA  use 
multiple frequency measurements, or a frequency spectrum, to show differences in body 
composition due to clinical and nutritional status as well as to age, ethnicity, sex and other 
variables. Equations are used to estimate total body water (TBW) and fat free mass (FFM) 
as a function of impedance, weight, height, gender and age. BIA has been used to predict 
mortality in some studies among HIV/AIDS patients. The main limitation of BIA however, is 
that patients must be adequately hydrated for accurate assessment. 93 
 
2.14.2.2    Biochemical Evaluation 
Many biochemical parameters could be investigated in patients with HIV/AIDS. Specific 
micronutrients markers could be assessed. These range from vitamins A, the B vitamins, 
C, D, E, and the like. In addition minerals like iron, selenium and zinc are also examined in 
HIV persons. Assessment of these nutrients should be done if deficiencies are suspected. 
Serum  lipid  and  albumin  concentrations  can  also  be  assessed  in  HIV  patients  and 
associations between lipid abnormalities and use of protease inhibitors have been well 
established  (Carr  et  al., 1998).  Serum electrolyte concentrations,  haematologic studies 
and  liver  function  studies  are  other  biochemical  measurements  relevant  to  nutritional 
status in HIV infected patients.  
2.14.2.3    Clinical and Physical examination 
Physical  signs  of  HIV-associated  malnutrition  may  include  signs  of  macronutrient 
deficiency (protein energy malnutrition) or excess (overweight and obesity), signs of fat 
redistribution and signs of micronutrient deficiency (Blackburn et al., 1977; Gerrior et al., 
2001; Kotler et al., 1989). PEM can present a combined energy and protein deficiency, as 
protein deficiency or as a combination of the two conditions where as fat redistribution is 
often associated with other physical findings, such as fat accumulation in the breasts, a 
dorsocervical fat pad, increased waist circumference and loss of fat in the extremities and 
buttocks  (Dube  et  al.,  2000).  Physical  and  clinical  examinations  for  any  of  the  signs 
mentioned could form part of nutritional status assessment of HIV infected persons 
2.14.2.4    Dietary Assessment 
Nutritional status is the balance between the intake of nutrients by an organism and the 
expenditure of these in the processes of growth, reproduction, and health maintenance. 
The  process  of  nutritional  status  assessment  is  highly  complex  and  because  of  that 
nutritional status assessment can be directed at a wide variety of aspects of nutriture, 
ranging from nutrient levels in the body, to the products of their metabolism, and to the 
functional processes they regulate. A major challenge facing the nutritional epidemiologist 
is the correct measurement of dietary exposure (Nelson and Bingham, 1997). 
 
There has been several attempts to obtain reliable estimates of food and nutrient intakes 
in order to relate them to the health of individuals and groups over the years (Marr, 1971; 
Block; 1982, Trulson and McCann, 1959; Abramson et al., 1963) and all these methods fall 
under  two  distinct  groups  or  categories;  quantitative  and  qualitative.  The  quantitative 
methods are concerned with the amount of foods consumed and level of nutrients in them 
whereas qualitative researches provide information on the kind of foods consumed, food 94 
 
preparation procedures, food preferences, cultural influences and attitudes towards foods. 
Researches that are intended to know the general eating habits and behaviour of a group 
of people or a population or what people consider as ‘prudent diet’ or a healthy diet without 
necessarily finding the nutrient levels of the foods could look at the eating patterns of the 
population or differences in consumption by sex, age, ethnicity etc. Such methods could 
also use scores to categorise individuals into good and bad consumption pattern based on 
specific foods consumed. On the other hand, if the aim is to measure nutrient intakes then 
the methods would be different. 
2.14.2.4.1    Food Frequency Questionnaire (FFQ) 
The  Food Frequency Questionnaire  (FFQ) is one of the most commonly  used tools in 
epidemiological studies to assess long-term nutritional exposure (Dehghan et al., 2005) 
and to assess diet in relation to chronic disease (Larsson et al., 2008; Hu et al., 2008). The 
food frequency questionnaire consists of a list of foods and a selection of options relating 
to the frequency of consumption of each of the foods listed, such as times per day, daily, 
weekly, monthly etc (Togo et al., 2003). FFQs are normally self-administered because they 
are designed to collect dietary information from large numbers of people (100 individuals 
or more). However it is possible for an interviewer to administer the questionnaire or for 
the FFQs to be administered through telephone interview (Haraldsdottir et al., 2001). 
 
It  is  usually  not  possible  to  measure  nutrient  intake  from  these  questionnaires  and 
depending on the foods and frequencies specified it may be difficult to look at adherence 
to specific dietary targets (Togo et al., 2003). FFQs normally aim to capture habitual intake 
or dietary behaviour pattern and for that matter ask about intake within a given time frame 
which could be in the past few months to a year or longer. The number of foods on the 
FFQ depends on the foods or nutrients of interest and the list could be as few as 11 items 
to as many as 150 food items. FFQs are referred to as semi-quantitative FFQS when an 
attempt is being made to collect information about portion size as well as frequency of 
consumption.  FFQs  have  been  shown  to  have  several  strengths.  These  include  low 
respondent burden, suitable for large scale surveys, being able to be self completed and 
also to be sent by post.  Some of the weaknesses which have been reported are problems 
regarding estimation of portion sizes especially when the semi-quantitative FFQ is used 
and possible over-reporting of healthy foods as well as its requirements to be validated in 
relation to reference method (Togo et al., 2003).  
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2.14.2.4.2    Weighed food Record 
The weighed food record or duplicate-food collection method is often regarded as the most 
precise method for estimating food and/or nutrient intakes of individuals.  This involves an 
individual or an investigator weighing each item of food and drink prior to consumption 
(Wrieden et al., 2003). A diary or a specific prepared booklet is used to record all weighed 
foods  and  describe  all  food  and  drink  consumed  as  well  as  weight  of  leftovers.  The 
weighed food records are kept for a period of 3 to 7 days (Wrieden et al., 2003) but the 7-
day weighed record has been taken as the ‘gold standard’ against which less detailed and 
demanding methods can be compared. The strengths of this method are that it is widely 
used and it also ensures precision of portion sizes. However this method has been found 
to be very expensive and causes high respondent burden and misreporting.  
2.14.2.4.3     Seven day food diary 
The seven day food diary is similar to the weighed food method in that participants are 
required to record in as much detail as possible, all foods, drinks and snacks consumed in 
a diary over a 7-day period. The food diary usually includes different colour photographs of 
portion sizes for participants to choose from the photographs those foods that represent 
the portion they eat. Participants are also allowed to mention if all portions were consumed 
and  record  leftovers  by  comparing  the photographs.  In  some cases,  portion  sizes are 
determined  using  other  measures  when  appropriate,  such  as  weights,  household 
measures  etc.  The  household  measures  could  be  spoons,  cups,  bowls  etc  and  food 
models could be used to determine portion sizes. This method is also referred to as the 
estimated  food  records  because  for  this  method,  portion  sizes  of  food  consumed  are 
estimated rather than weighed. The researcher after collecting diaries and estimates can 
convert the estimates into weights of foods and use those weights to calculate nutrient 
intake by comparing them with food composition tables. This method is widely used and 
poses  less  respondent burden compared  with the weighed  food  records.  It is however 
more expensive and time consuming compared with the FFQ and multiple pass recalls 
and  could  introduce  misreporting  as  the  weighed  food  records.  Its  most  important 
weakness is that portion sizes are estimates and could be under or over-estimated. 
2.14.2.4.4      Repeated 24-hour dietary recall (Multiple Pass Recall) 
The multiple pass recall method was developed in the USA to assess diet and nutrition in 
large groups or population studies. The diet is assessed over a period of 3 to 5 days 
during which the individual is asked to record all foods and drinks eaten over the past 24-
hour period. This method is called multiple pass because it allows the investigator to revisit 
and  cross-check  information  that  has  been  given  as well  as  prompt  for  any  forgotten 96 
 
information  during  the  revisits.  In  the  first  pass,  the  respondent  is  asked  to  list  foods 
consumed in the past 24-hours. In the second pass or visit, information about snacks and 
drinks are collected and in the final visit, the investigator prompts for foods that may have 
been forgotten. Then finally a review of the record and further details of foods consumed 
and portion sizes are completed. This method has been modified over the past five years 
to minimise under-reporting and burden on respondents. Multiple Pass Recall can be done 
by both face to face interviews and telephone interviews.  
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CHAPTER THREE METHODOLOGY 
3.1   Introduction   
This thesis is a secondary analysis of data from the THUSA study. The THUSA study was 
conducted to assess the impact of urbanisation on health outcomes of South Africans. As 
part of this study dietary intake, anthropometric and body composition, serum nutrients 
status  and  other  metabolic  parameters  were  determined  among  a  large  cohort  of 
volunteers some of which were HIV infected. The objective of the present study was to 
determine  the  associations  between  dietary  and  nutrient  intake  patterns,  nutritional 
anthropometric, serum nutrient status and metabolic markers of disease progression in the 
HIV infected subjects.  
 
This  chapter  describes  the  design, objectives,  sampling, data collection strategies  and 
validity of the data and also explains how the variables chosen for the present analysis 
were explored and the methods by which the selected variables were analysed to address 
the study  hypothesis. These  include assessment of  normality of the variables  and the 
description of various statistical analyses (principal component analysis, multivariate and 
logistic regression analyses and modelling) performed on the data. 
3.2   Design, population, sampling and data collection of the THUSA study 
The Transition, Health and Urbanisation in South Africa (THUSA) study was carried out 
from 1996 to 1998 in the North West Province of South Africa to identify the impact of 
urbanisation on the health and nutritional status of the study population (Vorster et al., 
2005; Maclntyre et al., 2000). THUSA is a Setswana word meaning ‘HELP’ and it is also 
an acronym for Transition and Health during Urbanisation of South Africans. The main 
objective  of  the  THUSA  study  was  to  explore  the  impact  of  urbanisation  on  health 
outcomes of South Africans so that appropriate health interventions could be undertaken. 
3.2.1    Study design 
The study was a cross-sectional comparative design in which a research team comprising 
of  both  Scientists  from  the  Natural  and  Social  Sciences  and  Setswana speaking  field 
workers  collected  information  qualitatively  and  quantitatively  through  interviews.  The 
chosen study design was based on the fact that the study did not intend to measure the 
prevalence  and  risk  factors  of  diseases  and  also  due  to  the  available  resources  and 
urgency  for  information,  a  prospective  randomised  controlled  trial  was  not  deemed 
necessary (Vorster et al., 2005). Prior to the study, a conceptual framework for the study 
was developed by looking from available literature potential exposures and outcomes that 98 
 
should be measured in order to describe the impact on health or changes in health during 
urbanisation (Vorster et al., 2005).   
3.2.2    Study population 
The study sample was men and women living in the North West Province of South Africa 
who were apparently healthy and were above 15 years or more. Pregnant and lactating, 
women below 15 years old and subjects who were diagnosed with any diseases as well as 
subjects taking any chronic medications were excluded. Other exclusion criteria included 
inebriated subjects and those with temperature above 37
0c.  Subjects were categorised 
into five groups which also described five levels or stages of urbanisation. The criteria for 
categorising subjects into these groups (levels or stages of urbanisation) were based on 
the jobs they had and where they lived. 
3.2.3    Sampling 
The sample was 1854 apparently healthy men and women recruited from 37 randomly 
selected sites representing all the health districts in the North West Province of South 
Africa. A model for sampling  and subject recruitment was developed  by  the Statistical 
consultative  Services  of  North  West  Province  based  on  available  data  on  population 
density of the Province and all subjects had equal chances of being selected. Subjects 
were stratified into 5 groups based on levels or stages of urbanisation.   
 
The first group consisted of rural people living in a traditional rural African village with a 
tribal head. Group 2 comprised farm dwellers living and working in commercial farms and 
Group 3 were made up of people  living in  informal housing  areas or  ‘squatter camps’ 
adjacent to all major towns and cities. These subjects moved into the informal housing 
areas recently from mainly rural areas and represent subjects in the most rapid transition 
phase. Group 4 were  volunteers from the old  established African  townships  with brick 
houses,  running  water  and  electricity  available  who  worked  as  labourers  in  various 
institutions and industries and the final group (Group 5) was represented by upper class 
urban  subjects  consisting  mainly  of  professional  people  (teachers  and  nurses), 
government employees, politicians and from businesses/corporate industrial environment. 
Group 1 and 2 can be described as rural and group 3, transitional. Group 4 and 5 could be 
regarded as urban (Vorster et al., 2005). 
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Figure 3.1: Map of South Africa showing North West Province 
 
 
Figure 3.2: Map of North West Province of South Africa, the study area 
 
3.2. 4     Data collection 
Most of the data were collected using appropriate questionnaires, designed and adapted 
for  the  study  as  well  as  validated  for  suitability.  Data  on  housing,  electricity,  water, 
education, income etc was collected with a demographic questionnaire. Dietary data was 
collected using a quantitative food frequency questionnaire (QFFQ). Anthropometric data 
was collected by trained personnel in  triplicate and  blood samples were collected and 
stored and analysed for biochemical markers. 100 
 
3.2.5    Assessment of dietary intake 
Dietary  intake  of  the  subjects  was  collected  using  a  quantitative  food  frequency 
questionnaire (QFFQ) which was developed and tested for reproducibility and validity by 
Maclntyre  et  al.,  (Maclntyre  et  al.,  2000;  Venter  et  al.,  2000;  Maclntyre  et  al.,  2000). 
Nutrients  intakes  were  calculated  from  food  data  using  a  programme  from  the  South 
African Food Composition tables (Langenhoven et al., 1991) and underreporting of energy 
intake was adjusted for (Willet et al., 1997).  
3.2.6    Anthropometric assessment 
Anthropometric  measurements  such  as  body  weight,  height  and  skinfolds  (triceps, 
subscapular, iliac crest and supraspinal) were measured in triplicate by trained personnel 
(postgraduate  biokinetics  students).  Measurements  were  standardised  by  a  level  III 
anthropologist. All the measurement scales were calibrated before use. 
 
3.2.6.1  Body weight, height and BMI 
Body weight was measured using the uniscale with subjects wearing light clothing. The 
measurement scale was placed on a  flat surface and zeroed.  Subjects were asked to 
stand on the scale and the readings were called out by the interviewers to the recorders. 
For each subject, the measurements were taken three times. Height measurements were 
taken using the microtoise. The measuring instrument was tied to a height (a wall) and 
subjects were asked to stand in erect position against the wall. The measurer then pulled 
the microtoise until it touched the head of the subject, making sure that the scale was as 
close to the scalp as possible. The scale reading was then called out for recording. This 
was  repeated three  times without  the  measurer  knowing what  the previous recordings 
were.  Subject’s  heights  were  measured  in  centimetres.  Subjects  BMI  (Quatelet)  were 
computed from the weight and height using the formula, BMI = weight (kg)/height (m) 
2. 
The other anthropometric measurements (skinfolds) were all measured using the skinfold 
calliper and recorded to the nearest millimetres. These were also measured three times 
independently. 
 
3.2.6.2  Waist circumference 
Waist circumference was measured at the narrowest area below the rib cage and above 
the umbilicus as viewed from the front while the subjects was standing in the anatomical 
position. An inelastic but flexible standard tape was used to measure the area at the end of 
a normal expiration. 
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3.2.6.3  Hip circumference 
The hip circumference was measured at the point of greatest circumference around the 
buttocks with  the subject  standing  in  the  anatomical  position.  The same  inelastic,  but 
flexible standard tape was used. 
 
3.2.6.4  Skinfold measurement 
The following skinfolds were measured in triplicate and the mean values were calculated 
and reported: 
•  Triceps 
•  Subscapular 
•  Abdominal 
•  Thigh 
•  Calf  
•  Iliac-crest 
Standardised skinfold callipers were used (John Bull, British indicators, Ltd). 
 
3.2.6.5  Girth measurements 
An elastic, but flexible standard tape was used to measure relaxed upper arm, tensed 
upper arm, forearm, thigh – 1 cm below gluteal fold, calf and wrist girths. 
 
3.2.6.6  Waist-to-hip ratio 
Waist-to-hip ratio was calculated from the measured waist circumference (cm) divided by 
the measured hip circumference (cm). This index provided knowledge on regional body fat 
distribution which is a valuable guide in assessing health risk for CHD and DM (Kaplan, 
1989).  
 
3.2.6.7  Body density 
Body density (BD) was calculated using the following formula: 
BD of women = 1.0992921 – (0.0009929 x sum of skinfolds: triceps, thigh, supra-iliac) + 
(0.0000022 x [sum of skinfolds: triceps, thigh, supra-iliac]
2) – (0.0001392 x age) (Jackson 
et al., 1980). 
 
BD of  men  = 1.1043 –  (0.001327  x thigh skinfold) –  (0.00131 x subscapular skinfold) 
(Sloan, 1967). 
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3.2.6.8  Fat percentage 
% fat for women = (5.03 / BD) – 4.59 
% fat for men = (4.95 / BD) – 4.5 
 
3.2.6.9  Fat mass and lean body mass 
Fat mass = (% fat /100) x Body mass 
(Mc Ardle et al., 1994) 
 
Lean body mass = body mass – fat mass 
(Mc Ardle et al., 1994) 
 
Percent body fat from girths (% fat) 
Women: 
% fat = (abdominal x 0.53) + (thigh measured 1cm below gluteal fold x 0.82) – (forearm x 
1.7). 
 
Men: 
% fat = (upper arm relaxed x 1.46) + (abdominal x 0.52) – (forearm x 2.14) 
(Mc Ardle et al., 1994) 
3.2.7     Biochemical evaluation  
Fasting blood samples were drawn from the vena cephalic using a sterile butterfly infusion 
set (Johnson & Johnson; 21G, 19 mm) and sterile syringes, after which a 2-hour glucose 
tolerance  test  was  performed.  Serum,  citrated  and  EDTA  (Ethylenediaminetetraacetic 
Acid)  plasma  were  prepared  immediately  in  the  field  using  a  Universal  16Re  Hettich 
centrifuge  (Tuttlingen,  Germany)  with  cooling  facilities.  Haematocrit  and  haemoglobin 
concentrations were determined in the field on EDTA blood. Serum proteins, minerals, 
electrolytes, glucose, lipids and enzymes were determined with the DAX system (discrete 
analyser, Technicon DAX48; Miles Inc. Diagnostic Division, Tarrytown, NY, USA). Serum 
insulin, vitamins A, B6, B12 and E, iron, ferritin, transferrin and iron-binding capacity as well 
as  erythrocyte  folate  and  urinary  sodium  and  potassium  were  determined  with  high-
performance liquid chromatography, immunological and colorimetric methods.  
 
Plasma  fibrinogen  was  measured  with  the  Clauss  method  using  the  ACL  200 
(Instrumentation  Laboratory,  Milan,  Italy)  system.  HIV  status  was  determined  with  an 
enzymeimmunological method (Enzymum-Test, anti-HIV 1 þ 2 þ subtype, catalogue no. 103 
 
1557319; Boehringer Mannheim, Mannheim, Germany). Appropriate standards were used 
in all instances (Vorster et al., 2005). 
3.3  Development of the QFFQ 
One of the aims of the THUSA study was to identify differences in dietary intakes and 
health  status  of  the  study  population  who  were  at  various  states  of  urbanisation. 
Maclyntyre  et  al.,  2000,  have  published  the  full  report  on  the  development  and 
reproducibility of the QFFQ. Prior to the study, the need to develop a culturally sensitive 
dietary assessment tool, suitable to the study population that has also been observed by 
different authors was taken into account (Buzzard and Sievert, 1994; Coates and Monteilh, 
1997). This is because food intake forms part of a complex behaviour of individuals and 
groups (Pelto 1981; Ritenbaugh, 1981) and thus a particular dietary assessment tool for 
one population may not necessarily be appropriate for another population. For this reason, 
a culture sensitive quantitative food frequency questionnaire was developed and tested for 
reproducibility and validated. 
 
The first stage to the development of the questionnaire was a preliminary study using a 
combination of  individual  interviews  and focus  group discussions.  This  was  done  both 
quantitatively  and  qualitatively  to  understand  the  food  habits  of  the  study  population. 
Thirty-two  female  subjects  from  all  the  urbanisation  categories  were  recruited  by 
convenient sampling and snowball sampling. Subjects for the focus group and individual 
interviews were categorised into five strata based on levels of urbanisation. The groups 
were  rural  dwellers,  farm  workers,  informal  settlement  dwellers,  middle  class  urban 
dwellers and upper class urban dwellers (Maclyntyre et al., 2000). 
 
The development of the quantitative food frequency questionnaire formed the first phase of 
the study. In the first phase, semi-structured interviews were conducted in the participant’s 
homes  in  Tswana  (the  most  common  language  of  the  North  West  Province  of  South 
Africa).  The  interviewers  collected  information  on  food  procurement,  preparation  and 
serving  methods,  and  frequency  of  consumption.  The  information  collected  was  then 
coded and most frequently used foods were identified. This was confirmed by presenting 
the identified frequently used foods and recipes to focus groups of the participants. These 
focus  groups  discussions  were  facilitated  by  the  same  interviewer  who  facilitated  the 
preliminary ones to ensure uniformity. Participants discussed the appearance, taste, and 
other  characteristics  of  the  dishes,  came  to  an  agreement  on  the  ingredients  and 104 
 
preparation methods and identified the most commonly consumed foods and drinks in their 
area (Maclyntyre et al., 2000).  
 
The participants also agreed portion sizes and the agreed portion sizes were weighed on a 
scale (EKS, France) and averages were used to determine the portion sizes of the QFFQ. 
The  QFFQ  was  developed  using  the  results  of  the  preliminary  study  and  existing 
information on dietary intakes of similar population groups (Quin, 1964; Greese, 1991). 
Nutritionists familiar with the dietary behaviour of the target population then scrutinized the 
QFFQ developed and modifications were made as appropriate. The improved QFFQ was 
then  translated  into  the  local  language  (Tswana)  and  pre-tested  for  completeness, 
appropriateness and whether they were understandable. 
 
The final QFFQ consisted of 145 food items grouped together from the most frequently 
consumed staple foods to those consumed in small amounts and/or infrequently.  Four 
columns  representing  frequency  of  consumption  were  also  provided  and  these  were 
number of times per day, per week, per month and seldom. A photographic representation 
of 37 foods in  three or four portion sizes was also developed  to aid  the  estimation of 
portion  sizes  (Venter  et  al.,  2000).  Dietary  patterns  of  the  study  population  were 
determined from the information obtained from the QFFQ, which was types of foods and 
quantitative estimation of intakes. 
 3.3.1    Reproducibility and validity of dietary assessment methods 
Reproducibility  indicates  the  extent  to  which  a  tool  is  capable  of  producing  the  same 
results when used repeatedly in the same circumstances. Repeatability and reliability are 
often used synonymously  with  the term  reproducibility but these  imply slightly  different 
aspects  of  measurements.  Repeatability  is  part  of  the  process  of  establishing 
reproducibility  whereas  reliability  is  the  quality  of  the  measure  that  has  reproducibility 
(Margetts and Nelson, 1997).  
 
Validity is the ability of a tool to actually measure what it purports to measure. A measure 
can have good reproducibility but poor validity but a measure that has good validity cannot 
have poor reproducibility. Concerning dietary assessment it is quite difficult to achieve the 
same circumstance, which is an important requirement for a tool to be reproducible and 
this is because dietary intake of people vary (example  daily, weekly,  and on seasonal 
basis). Most dietary studies normally seek to measure usual intakes and for that matter 
observed variations of intakes could be due to a genuine variability of the diet as well as 105 
 
biases associated with the method. There is the need to separate the variability associated 
with  reproducibility  from  variability  associated  with  genuine  biological  variation  during 
dietary assessment (Margetts and Nelson, 1997). 
 
Since  validity  is  the  expression  of  the  degree  to  which  a measurement  is  a  true  and 
accurate measure of what it purports to measure, establishing validity of an instrument 
requires  a  true  external  reference  measure  (an  absolute  measure)  against  which  the 
measurement  can  be  compared  (Margetts  and  Nelson,  1997)  also  known  as  a  gold 
‘standard’. In the past, weighed food intakes have been used as a gold standard against 
which other methods have been measured but this method has its errors. Some of the 
biases associated with the weighed intake are that subjects might change their habitual 
diet to increase compliance. Some subjects could skip meals or eat less outside to avoid 
carrying weighing scales, which could be what they usually do. For this reason, biomarkers 
such  as  urinary  nitrogen  excretion  and  energy  expenditure  have  been  used  as 
independent markers of dietary intakes (Katsouyanni et al., 1997). 
 
The decision on what validation method to use depends largely on the purpose of the 
dietary assessment because the stated purpose and its frame of reference will determine 
the techniques suitable for validation (Margetts and Nelson, 1997). If the purpose of the 
assessment is to identify the relationship between current dietary intake and disease, then 
a comparison of the test method and a more rigorous assessment of current diet could be 
appropriate. However if  the purpose of  the  assessment is to establish  the  relationship 
between past diet and disease, then the validation method should require a reference 
method which could measure the diet at the time to which the assessment relates. This is 
difficult to do because such references are unavailable. 
 
Sometimes the purpose of validation is to measure food consumption or nutrient intake. 
Abramson et al., in a study of the effect of diet on anaemia in pregnancy validated a food 
frequency list by comparing the results with a frequency data from a 30-minute interview 
(Abramson  et al.,  1963). This could  be  appropriate  because  both  methods used were 
assessing the frequency of diet, which was the purpose of this study. The limitation of this 
validation  method  however  was  biases  that  could  be  associated  with  the  interviewing 
process. In another study, Mojonnier and Hall were interested in assessing the adherence 
to prescribed diets in the National Diet-Heart Study (Mojonnier and Hall, 1968). The test 
method was a subjective interviewer ratings, which were compared with a semi-objective 106 
 
ratings of adherence (reference method), based on a 7-day recall and 7-day records of 
diet. Both methods estimated frequency of consumption and not amount and there was a 
better agreement between the test method and the reference method. 
 
However, when the purpose of the method is to estimate nutrient intakes from amount of 
food  derived  from  frequency  questionnaire  then  differences  in  nutrient  databases  may 
contribute  to  differences  between  measures.  In  addition,  the  extensiveness  of  the 
database in ensuring that slight variations in types of foods that arise due to method of 
preparation are acknowledged is important. Sometimes the purpose of the validation is to 
assess  absolute  or  relative  intakes  and/or  group  versus  individual  intakes  and  these 
influence the choice of the method for validation as well. 
3.3.2  Findings and discussion of validation and repeatability of the Quantitative 
Food Frequency Questionnaire (QFFQ) 
3.3.2.1  The Reproducibility assessment procedure and findings 
Detailed  description  of  the  validity  methodology  and  table  of  results  are  published 
elsewhere  (Maclyntyre  et  al.,  2000).  To  test  whether  the  information  collected  from 
quantitative  food  frequency  questionnaire  for  the  THUSA  study  was  reproducible, 
volunteers were recruited from each of the stratum of urbanisation after they had already 
completed the QFFQ once. The first completion of the QFFQ was done during the first 
THUSA  and the  reproducibility  study was done on those volunteers recruited during a 
return visit in about 6 to 12 week after the first dietary studies (Maclntyre et al., 2000).  
 
During the first THUSA, respondents were interviewed by trained field workers in their own 
language. Portion sizes of foods consumed were determined by the photographs of foods 
provided  as  well  as  household  measures  (plates,  cups,  utensils  etc).  On  the  revisit, 
respondents were interviewed again using the same procedure for the first interview but 
not necessarily by the same interviewer. This is because the respondents were randomly 
assigned the  interviewers and thus there was no guarantee  the same interviewer who 
conducted the first interview would be matched up with the same respondents. 
 
The dietary data were analysed using the Food Finder dietary analysis program (Grant et 
al.,.  1992)  and  reproducibility  was  tested  for  energy,  protein,  fat,  carbohydrate,  fibre, 
calcium, iron, vitamin A and C. Reproducibility was also tested for all the food groups as 
used  in  the  QFFQ  (Maclyntyre  et  al.,.  2000).  For  both  the  nutrients and  food  groups, 
Spearman  rank correlation  coefficient  was calculated  and  the  differences between  the 107 
 
means (for the first and second administration of the QFFQ) were tested using the t-test 
statistics with statistical significance level set at 5%. 
 
One hundred and forty-four subjects were sampled for the reproducibility study and an 
average of 58 days was the mean time between the first and second administration of the 
QFFQ.  A  summary  of  the  reproducibility  study  for  nutrients  generally  showed  varied 
correlations for most of the nutrient. The lowest correlation was for calcium (R = 0.14) and 
the highest was for alcohol (R = 0.75). This implied that estimation of mean intakes of the 
above  nutrients  recorded  for  the  first  and second  administration  of  the  QFFQ  showed 
varied associations, implying reproducibility of the QFFQ for estimation of nutrient intakes 
was low and high for the different nutrients. There were also few significant correlations 
between age, gender and urbanisation subgroups. 
 
Varied levels of association between the two administrations of the QFFQ for the different 
nutrients in terms of the differences between mean intake. It is reported in literature that 
differences within 10% is considered an acceptable agreement (Wheeler et al.,. 1994). 
The  highest  percentage  difference  between  the  two  administrations  was  recorded  for 
vitamin  C  (22.0%)  whereas  the  lowest  percentage  difference  was  recorded  for 
carbohydrate  (0.8%)  intake.  Fat  intake  and vitamin  A  intake  also  recorded substantial 
differences between the first and second administrations of the QFFQ.  With the exception 
of alcohol and carbohydrate, the mean intakes of the second administration of the QFFQ 
were higher than the first. Differences between intakes were not significant for six of the 
nutrients tested (Maclntyre et al., 2000). The mean percentage difference for the entire 
sample was 8.5±9.9% (Maclntyre et al., 2000). Protein, carbohydrate, calcium and energy 
all showed differences within 10% whereas alcohol, vitamin A and C, iron, fibre and fat all 
showed differences more  than  10%. Also for all  the nutrients tested for reproducibility, 
there was more that 85% agreement between the first and second administrations of the 
QFFQ. There was good agreement  for  energy, protein, carbohydrate, fat and calcium, 
which all recorded an agreement of 94.5%.  
 
For  food  groups  the  Spearman  rank  correlation  between  the  first  and  second 
administrations of the QFFQ showed varied associations (correlation coefficients ranging 
from 0.2 to 0.6). For all the food groups tested the correlation coefficients were significant, 
indicating good reproducibility between the first and second administrations for the general 108 
 
population. Meat showed the highest level of reproducibility whereas lowest reproducibility 
was for the milk group.  
 
In summary, the reproducibility study showed varied levels of agreement between the first 
and  second  administrations  of  the  QFFQ  for  nutrients  intake  and  for  food  groups. 
Reproducibility was generally low for food groups but the highest was shown for meat. 
Five  of  the  nutrients  tested  (energy,  protein,  carbohydrate,  fat  and  calcium)  recorded 
acceptable reproducibility. 
3.3.2.2  The validity assessment procedure and findings 
Detailed  description  of  the  validity  methodology  and  table  of  results  are  published 
elsewhere  (Maclyntyre  et  al.,  2000).  This  thesis  presents  a  summary  of  it.  The 
development of the QFFQ for the THUSA study required testing for reproducibility and 
relative validity of the method in the target population and Maclntyre et al.,. 2000 have 
published  detailed  procedures  of  the  test  for  reproducibility  and  validity.  The  relative 
validity of the QFFQ for the THUSA study was determined using the 7-day weighed food 
records and biomarkers (urinary nitrogen excretion and basal metabolic rate).  
 
Eighty-five (85) and 104 volunteers were recruited for the 7-day weighed record and the 
24-hour  urinary  nitrogen  studies  respectively.  These  volunteers  were  recruited  from 
participants of the THUSA study. For the weighed food intake, 85 respondents recorded 
their food and drink intake for seven consecutive days. Each respondent was given a scale 
with a capacity of  500g and 5g graduations (EKS, France), measuring jug with a capacity 
of 500ml and 25ml graduations and a set of four measuring spoons (1, 2, 5 and 25 ml) 
(Maclntyre et  al.,. 2000) with detailed  instructions  on how to complete  the diaries and 
weigh  the  foods  and  drinks.  Nutrients  levels  of  the  foods  were  analysed  using  the 
FoodFinder programme (Grant et al., 1992).  
 
Each respondent also collected a 24-hour urine into 2-litre plastic bottles marked with the 
study number, in an opaque bag, a jug (female respondents), a safety pin to attach to his 
or her underwear as a reminder (Maclntyre et al.,. 2000). Respondents also received the 
PABA tablets, an instruction sheet and form to record the time of each urine output and 
any  medications  taken.  Further,  completeness  of  the  24-hour  urine  collections  was 
checked by three 80mg para-aminobenzoic acid tablets (PABA; PABAcheck, laboratories 
for Applied Biology, London) taken with meals on the day of urine collections.  
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Specimens  containing  less  than  85%  (204mg)  PABA  were  considered  incomplete 
(Bingham, 1983).  Respondents sent the urine collected to the research centre on the 
morning of the last collection and the volume was recorded and four aliquots stored at -
20
oc before analysis (Maclntyre et al., 2000). The PABA contents of the urine specimens 
were  analysed  by  chromatography  (Bingham  and  Cummings,  1983),  nitrogen  was 
determined by the Kjeldahl technique, and equivalent protein intake to nitrogen content of 
the urine was adjusted for skin and faecal losses with the formula: 
Protein intake (gday
-1) = 6.25 (UUN + 0.031 BW) 
Where UUN is urine urea nitrogen and BW is body weight (Maroni et al., 1995). BMR was 
calculated  using  the  Schofield  equations  (Schofield,  1985)  and  ratios  of  energy  intake 
BMR  less  than  1.2  were  considered  an  indication  of  underreporting  (Bingham,  1991). 
Ratios of urine nitrogen to dietary nitrogen were calculated for each volunteer for both the 
QFFQ and the 7-day weighed intake (Maclntyre et al., 2000). 
 
In all 87% (74) of the volunteers’ weighed food diaries were usable and this comprised 59 
(80%) and 15 (20%) females and males respectively and majority of them were middle –
class urban dwellers.  Spearman rank correlation between the 7 day weighed record and 
the QFFQ was done for 10 nutrients (energy, protein, carbohydrate, fat, fibre, calcium, 
iron, vitamin A, C and alcohol).  
 
The  results  of  the  validation  showed  generally  varied  correlations  between  the  7-day 
weighed  record  and  the  QFFQ  ranging  from  0.14  for  fibre  and  0.60  for  vitamin  C 
(Maclntyre et al.,. 2000). However, the correlations for all the nutrients between the two 
methods  were  significant  (p<0.05),  except  for  iron  and  vitamin  A  indicating  good 
association between the two methods.  
 
It was found that the mean intakes of nutrients recorded from the weighed intakes were 
slightly higher than the QFFQ for all the nutrients except for carbohydrate and vitamin C. 
However, the only significant differences were for protein and alcohol, which imply that the 
level of agreement between the two methods was quite desirable. Furthermore, a Bland-
Altman method (Bland and Altman, 1986) was used to describe the level of agreement 
between the reported nutrient intakes from the QFFQ and the weighed intakes and none of 
the plots showed proportional bias (Maclntyre et al., 2000). Moreover, more than 90% of 
the respondents fell within the limits of agreement for all the nutrients, which implied that 110 
 
less  than  10%  were  outside  the  agreed  limits.  This  is  also  an  indication  of  strong 
agreement between the two methods. 
 
Concerning the food groups, a Spearman rank correlation between the QFFQ and the 
weighed  intakes  derived  from  a  paired  t-test  analysis  showed  the  lowest  correlation 
coefficient for milk (0.14) and the highest for sugar and maize meal; both recording 0.56. 
 
The results of the 24-hour urine collections showed a sample of 88 urine collections of 
which  32  (36.4%)  contained  85%  or  more  of  the  administered  PABA.  There  was  no 
significant correlation between the protein intakes estimated from the urinary nitrogen and 
the reported intake from the QFFQ for either the entire sample (R = -0.07; 95% CI -0.28 to 
0.14) or for the complete specimens only (R = 0.01; 95% CI -0.34 to 0.36) (Maclntyre et 
al., 2000). This result thus indicates a low correlation between the two methods. However 
the  number  of  respondents  who  completed  the  24-hour  urine  collection  was  very  low 
(36.4%) and this made the urinary nitrogen and unreliable method for the validation of 
dietary intake. 
 
3.3.2.3 Discussion of reproducibility and validity findings  
Summary of the repeatability study showed that there was fair to good agreement between 
the  first  and  second  administration  of  the  QFFQ.  Though  the  correlation  coefficients 
between the two methods for the estimation of the food nutrients were quite low, the level 
of agreement was statistically significant for six of the nutrients. However, percent mean 
differences between the first and second administration of the QFFQ was within the 10% 
acceptable limit for only 3 nutrients (energy, carbohydrate and calcium) indicating that the 
repeatability of the QFFQ in estimating nutrient intake may have been lower.  
 
Findings of the validity study showed that the mean intakes of nutrients recorded from the 
weighed  intakes  were  slightly  higher  than  the  QFFQ  for  all  the  nutrients  except  for 
carbohydrate and vitamin C. However, the only significant differences were for protein and 
alcohol, which imply that the level of agreement between the two methods was very high. 
Furthermore, a Bland-Altman method (Bland and Altman, 1986) was used to describe the 
level of agreement between the reported nutrient intakes from the QFFQ and the weighed 
intakes and none of the plots showed proportional bias (Maclntyre et al., 2000). Moreover, 
more than 90% of the respondents fell within the limits of agreement for all the nutrients, 111 
 
which  implied  that  less  than  10%  were outside  the  agreed  limits, an  indication  strong 
agreement between the two methods and therefore a good validity. 
 
With regards to the foods and food groups, the agreement between the first and second 
administrations of the QFFQ was again varied. Fruit, bread, sugar and fat recorded fair 
agreement  whereas  maize  meal,  vegetable  and  meat  recorded  moderate  agreement 
based on the correlation coefficients. Comparing nutrients and food groups, repeatability 
was better for the food groups than for the nutrients and this implied that the QFFQ was 
better at estimating food intake than nutrient intake in this population.  
 
However, for the validity study, Spearman rank correlation between the QFFQ and the 
weighed  intakes  for  foods  derived  from  a  paired  t-test  analysis  showed  the  lowest 
correlation  coefficient  for  milk  (0.14)  and  the  highest  for  sugar  and  maize  meal,  both 
recording 0.56. The results of the 24-hour urine collections showed a sample of 88 urine 
collections of which 32 (36.4%) contained 85% or more of the administered PABA. There 
was  no  significant  correlation  between  the  protein  intakes  estimated  from  the  urinary 
nitrogen and the reported intake from the QFFQ for either the entire sample (R = -0.07; 
95% CI -0.28 to 0.14) or for the complete specimens only (R = 0.01; 95% CI -0.34 to 0.36) 
(Maclntyre  et  al.,  2000).  This  result  thus  indicates  a  low  correlation  between  the  two 
methods for the estimation of protein intake. However the number of respondents who 
completed the 24-hour urine collection was very low (36.4%) and this might have reduced 
the reliability of the 24-hour urine collection as a gold standard.  
 
The question worth asking is which statistical approach is most appropriate to describe 
levels  of  agreement  between  a chosen  method  and  a  ‘gold  standard’.  The correlation 
coefficient has been shown to measure the strengths of relation between two variables but 
does  not  measure  agreement  between  the  variables.  Thus,  even  when  the  test  for 
significance is high, it only means that the methods are related, rather than the fact that 
they agree, which implies that the test of significance is irrelevant to agreement (Bland and 
Altman,  1986).  Moreover, data, which seems to  be  in poor agreement, can  have high 
correlations (Serfontein and Jaroszewicz, 1978). 
  
However, the Bland Altman plot is a graphical statistical method used to compare two 
measurement techniques. In this method, the differences between the two techniques are 
plotted against the averages of the two techniques (Bland and Altman, 1986). It is probably 112 
 
unlikely to have absolute agreement between two methods. However the Bland-Altman 
plots analyses whether the differences between two different methods are such small that 
one method could be use in place of the other. 
 
In  both  the  repeatability  and  validity  assessment  of  the  QFFQ the  Bland-Altman plots 
indicated good agreement for repeatability and validity although the correlation coefficient 
were low to moderate (Maclntyre et al., 2000). This implied that the QFFQ agreed well with 
the weighed method (standard dietary assessment method) in estimating food and nutrient 
intakes within the study population. The difficulty that exists with finding the best method to 
assess  dietary  intake  and  the  biases  that  could  arise  when  using  the  weighed  intake 
method enabled the acceptance of the results of the QFFQ from the study as a reliable 
and representative estimation of food and nutrient intake within the study population. 
3.4  Statistical analysis 
The data for this study were analysed using SPSS version 14. Means, standard errors and 
statistical significance (p-values) were presented for the variables stratified by gender and 
by HIV infection status. Each of the variables (exposures and outcomes) was tested for 
normality using the one sample Kolmogorov-Smirnov test for normality. A p-value below 
0.05 denoted a non-normal distribution and where a variable was not normally distributed, 
log10  transformation was  done  for  further  analyses  to  be  carried out.  Spearman  Rank 
correlation was used to analyse associations between exposures and outcomes and test 
for significance of difference was done using one-way Analysis of Variance (ANOVA) for 
continuous data. For categorical data, non-parametric test such as chi-square test was 
used to determine significance of association. A p-value below 0.05 in all cases was used 
to denote statistical significance, unless otherwise stated. Most of the analyses were also 
controlled for age, sex and year of study to ensure that these did not confound the results. 
 
The  dietary  data  obtained  from  the  quantitative  food  frequency  questionnaire  were 
analysed with a programme based on the South African food composition table. Dietary 
patterns of the general population and stratified by HIV status were determined using the 
SPSS programme known as principal component analysis (details of which is explained in 
the next section). In addition, patterns of nutrient intake, anthropometrics and nutritional 
biochemistry were determined with PCA. Scores generated from PCA analysis, usually the 
score for the first principal component were used to depict dietary, nutrient, or biochemical 
score where appropriate. 113 
 
3.4.1     Assessment of normality of variables 
The data available for analysis was food intake data in grams obtained from the QFFQ. 
Data of nutrients intake (energy, proteins, fat, carbohydrate, vitamins and minerals) were 
determined from the dietary data using South African food composition tables and were 
available in grams of intake. Levels of serum nutrients and other metabolic parameter such 
as the liver enzymes and some markers of inflammation were obtained from the THUSA 
study. Lastly, body weight, height, BMI, lean body mass, body fat, and other markers of 
skinfold thickness and body composition were available. 
 
The anthropometric, biochemical, metabolic, food and nutrient variables were tested for 
normality  using  the  Kolmogorov-Smirnof  statistical  analysis.  A  p-value  <0.05  for  the 
Kolmogorov-Smirnof test for each variable indicated non-normal distribution of the data 
and where the data was not normally distributed, a log transformation was applied to the 
data  before  further  analysis  were  conducted,  otherwise,  non-parametric  analyses  was 
used for further analyses. 
3.4.2  Principal Component Analysis 
Principal  Component Analysis  is  a method  of  factor analysis that  aims  to  simplify  the 
correlations between numerous interrelated variables. It is a way of identifying patterns in 
data,  and  expressing  the  data  in  such  a  way  as  to  highlight  their  similarities  and 
differences. Since patterns in data can be hard to find in data of high dimension, where the 
luxury of graphical representation is not available, PCA is a powerful tool for analysing 
data (Smith, 2002). 
 
Principal Component Analysis can be used to identify underlying dimensions of dietary 
patterns and to summarise correlations within a set of dietary variables by extracting a 
relatively small number of components (Gregory et al., 1990). Each component explains 
the dietary pattern of a group of people and gives an understanding of the dietary pattern 
of population. For instance one could find a trend that people consuming vegetable related 
foods  also  consume  semi  or  skimmed  milk  or  less  red  meat  shown  by  a  particular 
components.  
 
The PCA technique has been used to identify three distinct eating patterns using dietary 
information  from Swiss adults (Gex-Fabry, 1988). Ma  et al., (2002), also used PCA to 
assess fruit and vegetable intake among young adults. PCA was used in a study among 
pregnant women in the 3
rd trimester (Northstone et al., 2008). DiBello et al., (2008) using 114 
 
principal  component  analysis  characterised  four  dietary  patterns  associated  with 
myocardial  infarction  in  a  Costa  Rican dietary  intake  data.  The  use of  PCA  in dietary 
assessment  has  also  been  reviewed  and  found  to  be  appropriate  by  McCann  et  al., 
(2001). The first component identified by Principal Component Analysis is the combination 
of variables that explains the largest variation in the sample. The second component is the 
second largest and follows the first; the third, fourth etc follow in that order.  
For this thesis, Principal Component Analysis technique was used to determine dietary 
patterns, nutrient intake patterns, serum nutrients and metabolic patterns and nutritional 
anthropometric  patterns of the  HIV infected population,  and the  uninfected group. The 
dietary patterns were generated from grams of intakes of 17 foods and the nutrient intake 
patterns were generated from intakes of 13 nutrients (energy, protein, fat, calcium, iron, 
zinc, vitamins  A,  B1,  B5, folic acid, and  vitamins  C,  D and E).  Nutritional biochemistry 
patterns were generated from serum liver enzymes, lipids, proteins and vitamins. Separate 
patterns were determined form serum lipids,  proteins, liver  enzymes and vitamins and 
associations between these patterns were compared. For anthropometric patterns, nine 
variables  (body  weight,  height,  BMI,  lean  body  mass,  triceps  skinfold  thickness,  waist 
circumference, waist-to-hip ratio, body fat and percentage body fat) were used. 
3.4.3  Assessment  of  association  between  dietary  patterns  and  markers  of 
nutritional and disease state 
As part of the principal component analysis, each subject was attributed a score on each 
of the components identified; in this case the first four components which explained most 
of the variation within the study population. These score represented the values which 
subjects  could  have  recorded  supposed  it  was  possible  to  measure  the  components 
directly.  To enable the association between these  dietary components or patterns and 
disease or nutritional state to be explored, a Spearman rank correlation was performed for 
each of the dietary components and outcome measures. Statistical significance was set at 
5% (p<0.05). 
3.4.4    Binary and multinomial regression analyses and graphical chain modelling 
techniques 
Logistic  regression  models  were  used  to  determine  associations  and  predictors  of 
outcomes in the study populations. In the first results chapter binary logistic regression 
was  used  to  determine  which of the socio-demographic,  biochemical,  anthropometrics, 
nutrients and dietary patterns were significant predicators of HIV infection status in the 
study  population.  The  purpose  of  these  analyses  was  to  identify  the  most  important 
predictors  of  HIV  status.  In  the  second  results  chapter,  the  aim  was  to  establish  if  a 115 
 
specific dietary pattern was associated with better outcomes and predicted better socio-
demographic,  nutrients,  biochemical  and  anthropometrics  and  to  show  whether  these 
determinants were different in the PLWH compared to the general population. Multinomial 
logistic regression analyses were used to determine how different levels of dietary scores 
(upper, middle and lower) were associated with different levels of outcomes. For the third 
results chapter, graphical chain modelling approach was used to determine the pathway/s 
or framework of dietary patterns, nutrient intake, nutritional biochemistry and markers of 
disease progression in PLWH compared to an uninfected population.  
 
3.4.5  Graphical Chain Modelling 
Graphical chain modelling is a statistical technique which enables the determination of 
interactions (both causal and associative interactions) between exposures and outcome 
variables in the form of chain graphs. These models are useful tools to treat hierarchical 
data, especially if one is interested in relations among variables at different levels of the 
hierarchy.  (Gottard  and  Rampichini,  2007).  Multiple  time-dynamic  and  interrelated  risk 
factors are usually involved in the complex aetiology of disorders. This implies that in the 
analysis of interactions between diseases and their causes, there is usually a complex 
interrelationship within the causes and between these causes and the outcomes and there 
may be levels of exposures such that one level leads the other in a hierarchical fashion. 
Graphical  chain  models  are  able  to  describe  these  variables  and  their  dependence 
structure with a single graph (Cox and Wermuth, 1996).  
 
Chain graph models (e.g. Wermuth and Lauritzen, 1990) are a class of probability models 
whose conditional independence structure can be represented by a chain graph (T= {V, 
E}) with a set of nodes and a set of edges. The graph consists of vertices V, representing 
the  variables  and  a  set  of  edges  E,  representing  the  associations  between  pairs  of 
variables. E is a set of ordered pairs (A, B), A, B   V. The chain graph is based on the 
partitioning of V into disjoint subsets called blocks or chain components (Aburatani et al., 
2005) 
 
The sequence of blocks assigns specific roles to random variables: the ones in the first 
block, on the far right, are pure explanatory variables, those in the last block, on the left, 
are treated as response variables, while the remainder are considered as intermediate 
variables (Cox and Wermuth, 1996). Variables in the same block are considered on an 
equal footing and their association structure is taken to be symmetric. When two variables 116 
 
belong to different blocks, the variable in the lower-numbered block is considered logically 
antecedent (or ‘causal’) to the variable in the higher-numbered block (Di Serio and Vicard, 
2002). Thus edges within blocks are undirected, reflecting the systematic associations and 
the edges between blocks are arrows pointing from blocks with lower index numbers to 
those with higher indices (Aburatani et al.,. 2005). 
 
Since chain graphs contain both directed and undirected edges they represent at the same 
time and by means of one single picture the association structure and the causal relations 
(Di Serio and Vicard, 2002). A crucial point in the use of graphical chain models is the 
possibility to describe and to read independencies from the graph. The absence of an 
edge between variables or an arrow missing from a variable to another implies that the 
associated variables are independent conditionally on all the variables in the blocks. 
 
Graphical chain modelling techniques have been used in both social sciences and clinical 
researches.  Di Serio and Vicard (2002) used it to model the multifactorial structure of 
complex  genetic  diseases. Aburatani et  al.,  (2006) used  this  technique  to  analyse the 
expression profiles of genes that can be classified into several blocks in a natural order. 
This approach was also used to study the determinants of neonatal and post-neonatal 
mortality  in  Malaysia.  Graphical  chain  modelling  was  shown  to  provide  an  easily 
interpretable empirical description and illustrated explicitly the conditional independence 
structure between each pair of variables in the Malaysian study (Mohamed et al., 1998).  
Aburatani and colleagues used graphical chain modelling for inferring regulatory system 
networks  from  gene  expression  profiles  (Aburatani  et  al.,  2005).  In  Social  Sciences 
research, the graphical chain technique was used to model the reciprocal relationships 
between women’s gender role attitudes and labour force participation (Berrington et al., 
2008). 
 
The graphical chain approach has been described as a powerful tool but under utilized. 
Since graphical chain modelling describes the relationship between variables at different 
levels and outcomes, there must be some level of understanding of the expected biological 
pathway between the variables in order to determine the arrangement of the blocks. For 
this study, the hierarchical order between the dietary patterns, nutritional status and HIV 
infection used was based on the biological relationships between nutritional status and 
infections  in  general  and  HIV  specifically  which  have  been  described  proficiently  by 
several authors (Scrimshaw and Giovanni, 1997; Calder and Jackson, 2000; Piwoz and 117 
 
Preble  2000  and  Semba  and  Tang,  1999).  For  this  study,  it  was  conceptualised  that 
different  dietary  patterns  could  influence  dietary  nutrient  intake,  which  in  turn  would 
influence of serum nutrients status. Serum nutrients status would influence body mass and 
metabolic integrity. The socio-demographic status of the subjects was likely to influence 
dietary  intake.  The  interrelationships  were  however  likely  to  be  very  complex  and  the 
associations between the  levels of exposures to the outcomes were likely  to be much 
intertwined. 
 
In  the  review  of  available  literature,  this  approach  had  not  been  used  to  explore  the 
relationship between different dietary patterns, nutritional status and metabolic integrity in 
an  HIV  infected  population.  Thus,  this  study  was  the  first  to  use  the  graphical  chain 
modelling technique in this fashion.   
 
3.5  Post hoc power calculation 
Usually, pre-study sample size calculations are mandatory for research and are required 
by ethics. For every study there is the need to determine a sample size which will allow a 
reasonable chance (power) of detecting a pre-determined difference (effect size) in the 
outcome variable, at a given level of statistical significance (ICH Harmonised Tripartite 
Guideline, 2001). Sample size  is critically dependent on the purpose  of the study, the 
endpoint, or outcome measure and how it is summarized, the proposed effect size, and 
the method of calculating the test statistic (Walters et al., 2001 and 2004). However, there 
are instances when a study recruits fewer patients that required in the initial pre-study 
sample size calculation. When this happens, the study may be inadequately powered to 
detect  the  pre-specified  treatment  effect  and  the  statistical  analysis  of  the  collected 
outcome data may or may not report a statistical significant result (Walters, 2008). One 
may want to ask that “Given the actual final study size, what is the power of this study, 
now to detect a significant effect and would the effect found be significant if the study was 
well powered” (Walters, 2008).  
 
A level of 80% power is frequently accepted to reject the null hypothesis and the factors 
which influence statistical power are: 
•  The statistical test used in the analysis: some tests are more power and give higher 
power and significant results 
•  The  sample  size;  larger  sample  size  provides  greater  power,  but  very  large 
samples will come with higher costs (money and time) 118 
 
•  The size of the experimental effects; the magnitude of difference in null hypothesis 
affects the power (smaller power will result from small differences) 
•  The level of error in experimental measurements; errors act as noise that hide the 
real  effect.  Thus,  a  well  designed  and  planned  experiment  will  have  higher 
accuracy  and  precision,  which  in  turn  reduces  the  noise  and  increases  the 
statistical power. 
 
There are two types of errors that should be considered when power is calculated. Type I 
errors is when the alternative hypothesis (H1) is accepted though it is incorrect and the H0 
which  is  correct  is  rejected.  Type  II  errors  are  usually  associated  with  rejecting  the 
alternative hypothesis and incorrectly accepting the null hypothesis.  
 
For  cross sectional studies  involving correlation,  if  a correlation  coefficient  d*  is  to  be 
detected at a significance level of α, two tailed, with power 1- β ,  then the number of 
individuals with data to be sampled can be calculated with the equation; 
 
n=
    
  (Z1-α/2  + Z1-β)
2      
+5 
                 d*
2/(1-d*
2)         
Power can be derived from  
Z1-β=   d*
2 (n - 5)
        - zα/2 
                   
1-d*
2         
Source: Zar, 1984. Biostatistical Analysis, 2
nd edition 
 
Power can be derived from Z 1-β using normal distribution tables. A negative Z 1-β means 
that the study power is less than 50%.  
 
If a comparison is being made between means, then sample size calculation can be made 
with this equation:  
n=
    
  (Z1-α/2  + Z1-β)
2       
                 (d*/σ) 
2      
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z1-β   =  f
           n
                
-
   
Z1-α/2
  
       
         
2 
Where  n  is  sample  size,  d*  is  the  effect  size,  σ  is  the  standard  deviation,  α  is  the 
significance level and β is the  power. Z1-α/2  + Z1-β  are derived  from  normal distribution 
tables. 
 
For this study, post-hoc power calculations have been made for some of the outcome 
variables  that were  not  significantly  different  between  the  HIV  infected  and uninfected 
population. Also, within the HIV infected group, post-hoc power calculations have been 
made for the associations between the different dietary patterns and outcomes which were 
not statistically significant. Details of post-hoc power calculations have been presented in 
Appendix V. 
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4.0  Results and discussion of basic descriptive characteristics and predictors 
of HIV infection in the study population  
4.1         Introduction 
The purpose of this chapter was to present basic descriptive characteristics of the study 
population and to show how certain demographic and socio-economic characteristics were 
distributed within the study population stratified by gender and by HIV status. Baseline 
anthropometric,  nutritional  biochemistry,  dietary  and  nutrient  intakes  have  also  been 
summarised for the population and to show whether these parameters differ between the 
HIV infected and uninfected subgroups. Finally, this section presents models to show how 
the  socio-demographic  variables  predicted  HIV  infection  in  the  study  population  using 
binary regression analyses. 
4.2   Socio-demographic  characteristics  of  study  participants  stratified  by  HIV 
infection  
Summary of baseline characteristics of the study population for males (Table 4.1), females 
(Table 4.2) and the overall study sample (Table 4.3), stratified by HIV status have been 
presented below. Socio-demographic characteristics of 1854 (781, 42.9% males and 1040, 
57.1% females) subjects have been presented. The female participants formed a greater 
proportion (57.1%) of the study participants compared to the males. Two hundred and 
sixteen (216, 11.9%) of the participants were HIV infected leaving 1595 (88.1%) uninfected 
with HIV. Out of the 216 infected with HIV, 120 (55.6%) were females and this represented 
11.4% of the total number of female participants. Ninety-six (44.4%) of the HIV infected 
subjects were males and this represented 12.3% of the total number of male participants. 
This  implied that although there were  more females living with HIV  in absolute  terms, 
males were more in terms of proportion. HIV infected participants were younger than the 
uninfected  (mean  age  for  HIV  infected  was  34.9  years  compared  with  37.9  years  for 
uninfected, p<0.01) participants but similar to the mean age of the overall population (34.9 
years) 
  
In  the  combined  population,  the  25-34  year  olds  recorded  the  largest  (462  subjects, 
25.5%)  whereas  the  65+  year  olds  recorded  the  least  (84  subjects,  4.6%)  number  of 
participants. Within the HIV infected group, the age group with the most participants was 
the 25-34 year olds (72 subjects, 33.3%) whereas the age group with least subjects was 
the 65+ group (8 subjects, 3.7%). Within the male and female subgroups, HIV infection 
was again highest in the 25-34 year olds, (32.3% for males and 34.2% for females) and 122 
 
least  in  the  65+  year  olds  (3.1%  for  males  and  4.2%  for  females)  just  like  the  total 
population.  
 
Majority (74.3%) of the study subjects spoke Tswana as their first language and they were 
followed by other languages (11.3%), Xhosa (10.5%), Afrikaans (2.0%), Xulu (1.9%) and 
English (0.1%). Similarly, 70.8% (153 subjects) of the HIV infected sample spoke Tswana 
as a first language. The least number of HIV uninfected subjects was recorded by the 
English speakers. Within the male and female subgroups HIV infection was highest in the 
Tswana  speakers  (70.8%  in  both  males  and  females)  and  least  in  Afrikaans  (1.7%) 
speakers for females but English (1.0%) and Zulu’s (1.0%) respectively in males.  
 
Of the total HIV infected population, the proportion of never married subjects was highest 
(59%), followed by the married group (32.4%) and lowest in the divorced (1.9%) subjects. 
Similarly, the highest percentage of HIV infection was recorded in the male (62.5%) and 
female (56.1%) never married group and least in the divorced females (1.7%) but divorced 
(2.1%) and widowed (2.1%) males. There was however slightly more never married male 
HIV infected than females.  
 
Regarding educational attainment, the proportion of HIV infected was highest in subjects 
with less than standard six (29.2%), followed by standard 6-8 (25.9%) and least within 
subjects with standard 9-10 academic (7.4%). In males and females HIV infection was 
highest in below standard six education group but the proportion of females (31.7%) was 
greater than the males (26.0%). HIV infection seemed be higher in the lower education 
groups (72.2% of all HIV infected subjects were within the no education to standard 8 in 
the combined population). Similar proportions were observed in males and females.  
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Table 4.1: Frequencies, percentages and ANOVA for socio-demographic 
characteristics of the male participants by HIV status 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    HIV POSITIVE  HIV 
NEGATIVE 
COMBINED  F 
ratio 
P 
value 
      Count  %  Count  %  Count  %     
age grouped  15-24   24  25  177  26.1  201  26     
25-34   31  32.3  152  22.5  183  23.7     
35-44  17  17.7  115  17  132  17.1     
45-54   10  10.4  119  17.6  129  16.7     
55-64   11  11.5  75  11.1  86  11.1     
65+  3  3.1  39  5.76  42  5.4     
Group Total     96  100  677  100  773  100  1.4  0.2 
First 
language 
Tswana  68  70.8  496  72.7  564  72.5     
Afrikaans  2  2.1  17  2.49  19  2.4     
English  1  1.0        1  0.1     
Xhosa  9  9.4  79  11.6  88  11.3     
Xulu  1  1.0  12  1.76  13  1.7     
Other  15  15.6  78  11.4  93  12     
Group Total     96  100  682  100  778  242  1.8  0.1 
Marital 
Status 
Not Married  30  62.5  146  53.3  176  54.7     
Married  16  33.3  107  39.1  123  38.2     
Divorced  1  2.1  6  2.19  7  2.2     
Widowed  1  2.1  15  5.47  16  5.0     
Group Total 
 
   48  100  274  100  322  100  0.6  0.59 
Education  None  18  18.8  171  25.2  189  24.4     
< std 6  25  26.0  189  27.9  214  27.6     
st6-8   22  22.9  131  19.3  153  19.8     
st9-10  24  25 
 
133  19.6 
 
157  20.3 
 
   
st9-
10/academic 
7  7.3  54  7.96  61  7.88     
Group total     96  960  678  100  774  100  0.83  0.5 
Total 
income 
R0-100  16  16.7  119  17.4  135  17.3     
R101-500  26  27.1  200  29.2  226  29     
R501-1000  25  26.0  157  23  182  23.3     
R1001-2000  16  16.7  109  15.9  125  16     
R2001-3000  3  3.1  47  6.87  50  6.4     
R3000+  10  10.4  52  7.6  62  7.9     
Group total     96  100  684  100  780  100  0.7  0.7 
Stratum  Rural  15  15.6  185  27  200  25.6    15 
Farm  9  9.4  111  16.2  120  15.4    9 
Informal   15  15.6  123  18  138  17.7    15 
Urban  52  54.2  185  27  237  30.3    52 
upper  1  5.2  81  11.8  86  11.0    1 
Group total    96  100  685  100  781  100.0  2.7  96 
Smoking 
status 
Yes  55  57.3  386  56.4  441  56.5     
No  41  42.7  298  43.6  339  43.5     
Group total    96  100  684  100  780  100  0.02  0.8 124 
 
Table 4.2: Frequencies, percentages and ANOVA for socio-demographic  
      characteristics of the female participants by HIV status 
 
    HIV infected  HIV 
uninfected 
Total      
    Count  %  Count  %  Count  %  F 
ratio 
p 
value 
Age group  15-24   28  23.3  173  18.8  201  19.4     
25-34   41  34.2  238  25.9  279  26.9     
35-44  25  20.8  209  22.8  234  22.5     
45-54   15  12.5  164  17.9  179  17.2     
55-64   6  5  97  10.6  103  9.9     
65+  5  4.2  37  4.0  42  4.0     
Group total     120  100  918  100  1038  100  1.8  0.17 
First 
language 
Tswana  85  70.8  702  76.3  787  75.7     
Afrikaans  2  1.7  15  1.6  17  1.6     
Xhosa  18  15  84  9.1  102  9.8     
Xulu  3  2.5  18  1.9  21  2.0     
Other  12  10  101  11.0  113  10.9     
Group total     120  100  920  100  1040  100  1.1  0.35 
Marital 
Status 
Not Married  32  56.1  170  46.7  202  48.0     
Married  18  31.6  137  37.6  155  36.8     
Divorced  1  1.7  7  1.9  8  1.9     
Widowed  6  10.5  50  13.7  56  13.3     
Group total    57  100  364  100  421  100  0.59  0.62 
Education  None  19  15.8  178  19.4  197  19.0     
< std 6  38  31.7  323  35.2  361  34.8     
st6-8   34  28.3  190  20.7  224  21.6     
st9-10  20  16.7 
 
160  17.5 
 
180  17.4     
st9-
10/academic 
9  7.5  65  7.1  74  7.1     
Group total     120  100  916  100  1036  100  1.0  0.4 
Total 
household 
income  
R0-100  25  20.8  173  18.8  198  19.0     
R101-500  40  33.3  298  32.4  338  32.5     
R501-1000  30  25  239  26.0  269  25.9     
R1001-2000  16  13.3  129  14.0  145  13.9     
R2001-3000  6  5  31  3.4  37  3.5     
R3000+  3  2.5  50  5.4  53  5.1     
Group total     120  100  920  100  1040  100  0.58  0.7 
Type of 
housing 
Rural  27  22.5  75  29.9  302  29.0     
Farm  13  10.8  39  15.1  152  14.6     
Informal  32  26.7  49  16.2  181  17.4     
Urban,  38  41.7  61  28.4  299  28.8     
upper  10  8.3  96  10.4  106  10.2     
Group total  Total  120  100  920  100  1040  100.0  8.0  0.000 
Smoking 
status 
Yes  20  16.7  158  17.2  178  17.1     
No  100  83.3  762  82.8  862  82.9     
Group total 
 
  120  100  920  100  1040  100  2.6  0.05 125 
 
 
Table 4.3: Frequencies, percentages and ANOVA for socio-demographic 
characteristics of the total study participants by HIV status 
    HIV infected  HIV 
uninfected 
Total   F 
ratio 
p 
value 
    Count  %  Count  %  Count  % 
age grouped  15-24   52  24.1  350  21.9  402  22.2     
25-34   72  33.3  390  24.5  462  25.5     
35-44  42  19.4  324  20.3  366  20.2     
45-54   25  11.6  283  17.7  308  17     
55-64   17  7.9  172  10.8  189  10.4     
65+  8  3.7  76  4.8  84  4.6     
Group Total     216  100  1595  100  1811  100  2.5  0.027 
First 
language 
Tswana  153  70.8  1198  74.8  1351  74.3     
Afrikaans  4  1.8  32  2  36  2.0     
English            1  0.1     
Xhosa  27  12.5  163  10.2  190  10.5     
Xulu  4  1.8  30  1.9  34  1.9     
Other  27  12.5  179  11.2  206  11.3     
Group Total     216  100  1602  100  1818  100  1.8  0.1 
Marital 
Status 
Not Married  62  59  316  49.5  378  50.9     
Married  34  32.4  244  38.2  278  37.4     
Divorced  2  1.9  13  2.04  15  2.0     
Widowed  7  6.7  65  10.2  72  9.7     
Group Total    105  100  638  100  743  100  1.2  0.3 
Education  None  37  17.1  349  21.9  386  21.3     
< std 6  63  29.2  512  32.1  575  31.8     
st6-8   56  25.9  321  20.1  377  20.8     
st9-10  44  20.4 
 
293  18.4 
 
337  18.6 
 
   
st9-
10/academic 
16  7.4  119  7.5  135  7.5     
     216  100  1594  100  1810  100  1.5  0.2 
Household 
income 
R0-100  41  19  292  18.2  354  19.2     
R101-500  66  30.6  498  31  564  30.6     
R501-1000  55  25.5  396  24.7  451  24.5     
R1001-2000  32  14.8  238  14.8  270  14.7     
R2001-3000  9  4.2  78  4.9  87  4.7     
R3000+  13  6.0  102  6.4  115  6.2     
     216  100  1604  100  1841  100  0.07  0.1 
Urbanisation 
level 
Rural  42  19.4  460  28.7  505  27.4     
Farm  22  10.2  250  15.6  272  14.8     
Informal  47  21.8  272  16.9  321  17.4     
Urban  90  41.7  446  27.8  538  29.2     
Upper  15  6.9  177  11.0  193  10.5     
Group total    216  100  1605  100.0  1829  100  8.3  0.003 
Smoking 
status 
Yes  75  34.7  544  33.9  619  34     
  No  141  65.3  1060  66.1  1201  66     
    216  100  1604  100  1820  100  0.05  0.8 126 
 
 
 
Total household income varied greatly within the study population. In the overall population 
about half of the study subjects had a household income below 500 Rand (≈ £32) and this 
group were followed by households that earned between R501-1000, 25.5%. The highest 
income of R3000 (≈£185) and above was found among only 6.0% of the subjects.  In the 
total  household  income  subgroup,  the  percentage  of  the  HIV  infected  increased  with 
decreasing household income in the combined population as well as by gender.  
 
In the HIV infected group of the total study population, (75, 34.1%) subjects were smokers 
and 441 (71.2%) were non-smokers. Within the uninfected group on the other hand 544 
(33.9%)  subjects  were  smokers  whereas  1060  (66.1%)  were  non-smokers.  Within  the 
male population there were more HIV infected smokers (55, 57.3%) than non-smokers (42, 
42.7%). Within the female sub-group however, there were fewer HIV infected smokers (20, 
16.7%) than non-smokers (100, 83.3%).  
 
Regarding  the  urbanisation  levels  HIV  infection  was  highest  in  the  urban settlers  (90, 
41.7%) followed by informal settlers (47, 21.8%). The least percentage was recorded in 
the upper class participants (6.9%).  Within the male study group, HIV infection was again 
highest  in  the  urban  group  (54.2%)  and  least  in  the  upper  class  participants  (5.2%). 
Similarly, HIV infection was highest in the female urban population (41.7%) and least in the 
upper class participants (8.3%) groups.  
 
Analysis of variance indicated that statistical differences existed in the prevalence of HIV 
infection between the different age groups (F ratio 2.5, p=0.03) and urbanisation levels (F 
ratio 8.0, p=0.003) in the total population. However the trends observed for educational 
levels,  household  income,  smoking  status,  marital  status  and  first  language  were  not 
different statistically.  In  the  male  and  female sub  grouping, statistical significance  was 
observed between urbanization level levels only.  
 
Post hoc analysis of the differences in HIV infection between the different urbanization 
levels in the total population showed that differences observed between rural and urban, 
farm and urban, and urban and upper class settlers were statistically significant. There 
were no statistical significance for the differences between rural and farm dwellers, rural 
and informal dwellers and rural and upper dwellers.  This implied that HIV prevalence was 
significantly different between urban dwellers and all other strata except for the informal 127 
 
stratum. Likewise, post hoc analysis of the differences observed for age group showed 
that differences in HIV prevalence were significant between the 15-24 year olds and the 
45-54 year olds, between the 25-34 and the 45-54 year olds and between the 25-34 and 
55-64 year olds (Table 4.5).  
 
Table  4.4: Post  hoc analysis  of  the differences in  HIV prevalence by age group: 
Statistical significance and 95% confidence interval  
  
age grouped  age group 
(years) 
Statistical 
significance 
95% Confidence Interval 
         Lower Bound  Upper Bound 
15-24  25-34  0.200  -0.020  0.070 
  35-44  0.500  -0.060  0.030 
  45-54  0.040
£  -0.100  0.000 
  55-64  0.200  -0.100  0.020 
  65 and over  0.400  -0.110  0.040 
25-34  35-44  0.070  -0.090  0.000 
  45-54  0.002
£  -0.120  -0.030 
  55-64  0.020
£  -0.120  -0.010 
  65 and over  0.100  -0.140  0.010 
 35-44  45-54  0.200  -0.080  0.020 
   55-64  0.400  -0.080  0.030 
   65 and over  0.600  -0.100  0.060 
45-54   55-64  0.800  -0.050  0.070 
   65 and over  0.700  -0.060  0.090 
55-64   65 and over  0.900  -0.080  0.090 
 
£ denotes statistically significant difference at p=<0.05 
 
Within the males however, HIV prevalence was not statistically different for various age 
groups,  marital  status,  education,  total  household  income.  Statistical  differences  were 
observed for only urbanization level (stratum) (F ratio =8.3, p=0.000). Post hoc analysis 
showed that differences existed between urban settlers and rural, informal, farm and upper 
class  settlers.  Similarly,  within  the  females,  prevalence  of  HIV  infection  was  only 
statistically  significant  between  the  different  urban  groups  and  not  in  any  other  socio-
demographic group. Post hoc analysis showed that this difference existed between rural 
and  informal settlements only.  Thus  the urban group showed a  higher  and statistically 
significant HIV prevalence than the other groups especially among the male participants 
and was different from the other residency types. 
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Table 4.5: Post hoc analysis of the differences in HIV prevalence by urbanisation 
level: Statistical significance and 95% confidence  
(I) Stratum  (J) Stratum  Statistical Significance  95% Confidence Interval 
Total population       
Rural  Farm  1.000  -0.070  0.070 
Rural  Informal  0.057  0.000  0.130 
Rural  Urban,  0.000  0.030  0.140 
Rural  Upper  1.000  -0.080  0.070 
Farm   Informal  0.123  -0.010  0.140 
Farm  Urban,  0.003  0.020  0.150 
Farm  Upper  1.000  -0.090  0.080 
Informal  Urban,  1.000  -0.040  0.080 
Informal  Upper  0.185  -0.150  0.010 
Urban  upper  0.009  -0.170  -0.010 
Males         
Rural  Farm  1.000  -0.100  0.100 
Rural  Informal  1.000  -0.070  0.130 
Rural  Urban  0.000  0.060  0.230 
Rural  Upper  1.000  -0.130  0.100 
Farm  Informal  1.000  -0.080  0.150 
Farm  Urban  0.001  0.040  0.250 
Farm  Upper  1.000  -0.150  0.110 
Informal  Urban  0.014  0.010  0.210 
Informal  Upper  1.000  -0.180  0.070 
Urban  Upper  0.001  -0.280  -0.050 
Female         
Rural  Farm  1.000  -0.090  0.090 
 Rural  Informal  0.036  0.000  0.170 
 Rural  Urban  1.000  -0.040  0.110 
 Rural  Upper  1.000  -0.100  0.110 
 Farm  Informal  0.093  -0.010  0.190 
 Farm  Urban  1.000  -0.050  0.130 
 Farm  Upper  1.000  -0.100  0.120 
Informal   Urban  0.979  -0.130  0.030 
 Informal  upper  0.346  -0.190  0.030 
Urban   upper  1.000  -0.130  0.070 
4.2.1  Summary of Socio-demographic status 
In  the  total  population  and  also  by  gender,  HIV  prevalence  seemed  to  decrease  with 
increased age and the highest prevalence was in the 25-34 year olds. HIV infection was 
most  prevalent  in  never  married,  Tswana  speakers  with  lower  educational  attainment 
(below standard 6) and a household income less than 1000R (about £62) irrespective of 
gender.  Prevalence  was  also  highest  in  urban  dwellers  compared  with  the  other 
urbanisation levels and smokers compared with non-smokers. Statistically, the differences 
in HIV prevalence observed were significant for stratum (residency type) and age group in 
the total population but for only stratum within the male and female subgroups.  
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4.3         Anthropometrics characteristics  of  the  study  population  stratified  by  HIV 
infection status  
Mean  and  standard  errors  for  anthropometric  and some  markers  of  body  composition 
within the study population stratified by HIV infection status are presented in Tables 4.6 
(for  males),  4.7  (for  females),  and  4.8  (for  total  population).  Differences  between  the 
means for HIV infected and uninfected groups were determined using one-way ANOVA 
and statistical significance is denoted by p<0.05.  
 
Table 4.6: Mean and standard error of mean for anthropometric characteristics of 
the male participants stratified by HIV status 
      
Difference between the means of the overall HIV infected and uninfected subjects were determined by one way ANOVA. P 
value <0.05 denotes statistical significance. 
 
Within  the  male  study  population  slight  differences  existed  for  these  anthropometric 
characteristics but none of these differences were statistically significant implying that the 
male study population was similar in terms of body shape and size. In the male subgroup 
(Table 4.6), the HIV uninfected were slightly older and had slightly higher weight, height, 
BMI,  waist circumference, triceps skinfold  thickness,  body  fat  and  lean  body  mass.  In 
terms of skinfolds, the HIV infected had slightly lower triceps, subscapular, supraspinal, 
abdominal and thigh skinfolds whereas the uninfected had lower iliac crest. None of these 
differences  reached  any  statistical  significance.  Low  eta  squared  values  for 
 
 
HIV infected 
(Mean±SE) 
HIV 
uninfected 
Mean±SE 
Total 
Mean±SE 
F ratio  P value  Eta
2 
N  96  685  781       
Age (years)  35.1±1.4  36.6±0.6  37.4±0.6  2.3  0.100  0.3 
Weight (kg)  59.4±0.7  59.9±0.5  59.9±0.4  0.2  0.700  0 
Height (m)  168.1±1.0  168.2±0.3  168.2±0.3  0  0.900  0 
BMI (kg/m
2)  21.0±0.3  21.2±0.2  21.1±0.1  0.3  0.600  0 
Waist circumference (cm)  73.7±0.8  74.7±0.4  74.6±0.3  1.0  0.300  0.1 
Waist-Hip Ratio  0.85±0.1  0.84±0  0.84±0  0.4  0.600  0 
Lean Body Mass (kg)  53.3±1.2  53.4±0.5  53.4±0.5  0.2  0.311  0.2 
Body Fat (kg)  6.1±0.9  6.5±0.3  6.5±0.3  1.2  0.192  0 
Fat Percent (%)  10.3±0.2  10.8±0.4  10.8±0.3  0.4  0.395  0.1 
Triceps skinfold (mm)  8.0±0.5  8.4±0.2  8.3±0.2  0.4  0.516  0.1 
Subscapular skinfold (mm)  10.6±0.6  10.8±0.2  10.8±0.2  0.2  0.692  0 
Iliac-crest skinfold (mm)  12.2±1.1  11.8±0.4  11.8±0.4  0.1  0.720  0 
Supraspinal skinfold (mm)  7.1±0.6  7.7±0.3  7.7±0.3  1.2  0.280  0.3 
Abdominal skinfold (mm)  13.6±1.0  14.1±0.5  14.0±0.4  0.2  0.642  0.1 
Thigh skinfold (mm)  10.9±0.8  11.8±0.5  11.7±0.4  0.6  0.422  0.2 130 
 
anthropometrics implied that very little of the variability between the male participants was 
due to anthropometrics. 
 
Table 4.7: Mean and standard error of mean for anthropometric characteristics of 
the female participants stratified by HIV status 
Difference between the means of the overall HIV infected and uninfected subjects were determined by one way ANOVA. P 
value <0.05 denotes statistical significance 
 
Similar to the males, anthropometric and body composition characteristics of the female 
subjects were not different between the HIV infected and uninfected except for the fact that 
the  HIV  infected  females  were  younger  than  the  uninfected  (about  3  years  younger, 
p=0.01). Also, the  HIV uninfected females had slightly higher mean body weight,  BMI, 
waist circumference, triceps skinfold thickness and lean body mass, where as the HIV 
infected recorded slightly higher height and body fat. In terms of the skinfolds also, slight 
differences were observed between  infected and uninfected groups. However, none of 
these parameters were statistically different.  
 
Likewise, anthropometric characteristics of the combined population were similar by HIV 
infection status. There were slight differences for most of the anthropometric and body 
composition  parameters  between  the  HIV  infected  and  uninfected  groups.  The  HIV 
infected  had  slightly  lowered  skinfold  thickness  for  triceps  and  subscapular  skinfolds 
whereas  mean  values  for  abdominal,  iliac  crest,  supraspinal  and  thigh  skinfolds  were 
slightly higher. However these differences were not statistically significant as indicated by 
  HIV infected 
(Mean±SE) 
HIV uninfected 
(Mean±SE) 
Total 
 
F ratio  P value  Eta
2 
N  120  920  1040       
Age (years)  34.8±1.2  38.1±0.5  37.8±0.4  6.7  0.010  0.6 
Weight (kg)  65.4±1.4  66.9±0.6  66.7±0.5  0.8  0.400  0.1 
Height (kg)  158.1±0.6  157.4±0.4  157.5±0.2  1.4  0.200  0.1 
BMI (kg/m
2)  26.1±0.5  27.2±0.2  26.9±0.2  1.0  0.200  0.2 
Waist_ minimum (cm)  76.8±1.0  78.3±0.4  78.1±0.4  1.3  0.300  0.1 
Waist-Hip Ratio  0.8±0  0.78±0  0.76±0  0.2  0.600  0 
Lean Body Mass (kg)  38.9±1.4  42.4±0.7  41.9±0.6  0.6  0.211  0.5 
Body Fat (kg)  26.5±1.0  24.5±0.5  24.8±0.4  0.1  0.183  0.5 
Fat Percent (%)  40.5±2.7  36.6±1.0  37.2±1.0  2.0  0.157  0.6 
Triceps skinfold (mm)  19.8±0.9  21.1±0.4  21.0±0.3  1.5  0.222  0.2 
Subscapular skinfold (mm)  20.9±1.2  21.9±0.4  21.8±0.4  0.5  0.461  0.1 
Iliac-crest skinfold (mm)  20.9±1.5  18.9±0.6  19.2±0.6  1.7  0.189  0.5 
Supraspinal skinfold (mm)  16.2±1.4  14.8±0.5  15.0±0.5  1.0  0.322  0.3 
Abdominal skinfold (mm)  25.5±2.0  23.3±0.7  23.6±0.7  1.3  0.261  0.4 
Thigh skinfold (mm)  36.8±2.2  32.9±0.8  33.5±0.8  3.3  0.069  1.0 131 
 
the  F  ratios  and  significance  values  (Table  4.8).  Low  eta  squared  values  for 
anthropometrics implied that very little of the variability between the participants was due 
to anthropometrics. 
 
Table 4.8: Mean and standard error of mean for anthropometric characteristics of 
the total participants stratified by HIV status 
        
 Difference between the means of the overall HIV infected and uninfected subjects were determined by one way ANOVA. 
 P value <0.05 denotes statistical significance. 
4.3.1  Principal Component Analysis (PCA) to show anthropometric patterns 
Anthropometric  pattern/profile  (score)  was  generated  from  9  indicators  (body  weight, 
height,  BMI,  waist  circumference,  lean  body  mass,  body  fat,  waist-to-hip  ratio,  triceps 
skinfold thickness and fat percent) using PCA. The purpose of this was to show if any 
pattern/s were observable and if the HIV infected and uninfected were similar or different 
in terms of an overall anthropometric profile. As shown by Table 4.9, the first principal 
component for nine anthropometric variables showed positive factor loadings for seven of 
the  variables  and  negative  factor  loadings  for  stature  and  waist-to-hip  ratio.  This 
component thus described the variation between subjects who were likely to have high 
BMI, triceps skinfold, waist circumference, lean body mass (LBM), body fat and fat percent 
and low waist-to-hip ratio and height. Hence, a high anthropometric score was likely to 
depict relatively higher BMI, LBM, triceps skinfold, waist circumference, body fat and fat 
percent. The second anthropometric score depicted subjects who were likely to have low 
  HIV infected 
(Mean±SE) 
HIV uninfected 
(Mean±SE) 
Total 
 
F ratio  P value  Eta
2 
N  216  1605  1821       
Age (years)  34.4±1.8  38.3±0.9  37.6±0.3  8.1  0.005  0.4 
Weight (kg)  62.7±0.4  64.0±0.4  63.8±0.4  1.3  0.260  0.1 
Height (kg)  163.9±0.8  163.19±0.35  162.1±0.2  0.9  0.340  0.1 
BMI (kg/m
2)  23.8±0.4  24.5±0.2  24.4±0.2  2.5  0.120  0.1 
Waist_ minimum (cm)  75.5±0.7  76.8±0.5  76.6±0.3  2.7  0.090  0.1 
Waist-Hip Ratio  0.8±0  0.8±0  57.9±0.4  0.1  0.720  0.1 
Lean Body Mass (kg)  47.7±1.3  49.5±0.6  49.6±1.0  0.1  0.740  0 
Body Fat (kg)  15.0±1.0  14.4±0.6  14.2±0.5  0.1  0.720  0 
Fat Percent (%)  24.0±0.7  22.6±0.4  22.2±0.2  0.5  0.460  0.1 
Triceps skinfold (mm)  13.8±0.7  15.1±1.5  14.9±0.2  2.7  0.098  0.2 
Subscapular skinfold (mm)  15.7±0.8  16.7±0.3  16.6±0.3  1.2  0.266  0.1 
Iliac-crest skinfold (mm)  16.1±1.0  15.0±0.4  15.2±0.4  1.2  0.275  0.2 
Supraspinal skinfold (mm)  11.2±0.8  11.0±0.3  11.0±0.3  0.6  0.810  0 
Abdominal skinfold (mm)  18.9±1.2  18.3±0.5  18.4±0.4  0.3  0.589  0 
Thigh skinfold (mm)  22.7±1.6  21.3±0.6  21.6±0.6  0.6  0.427  0.1 132 
 
body  fat  and  fat  percent  and  triceps  skinfold  but  high  body  weight,  height,  waist 
circumference and lean body mass. This component showed a variation between subjects 
with low body fat and high lean body mass and subjects with high body fat with low lean 
body mass. 
 
A summary of analysis of variance for the anthropometric scores (first PCA) between the 
HIV infected and uninfected study groups have been presented by Table 4.10. The mean 
anthropometric scores were not different by HIV infection status and a low F ratio (0.4) and 
statistical significance of p=0.5 were recorded.  This implied that anthropometric-wise the 
HIV  infected population  was  similar  to the  uninfected  population  and  patterns  of  body 
shape and size within the study population were similar by HIV infection status confirming 
the findings when the means were compared. 
 
Table 4.9: Summary of factor loadings from Principal component analysis for nine 
anthropometric variables  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.10: Analysis of variance (F ratios and p values) between HIV infected and 
uninfected subjects for first anthropometric pattern generated by PCA 
 
 
 
 
 
 
 
Anthropometric indicator  Factor loading 
   Component 1  Component 2 
% of variation explained  50.4  28.1 
BMI  0.9   
Mass        0.8  0.5 
Height  -0.2  0.7 
Triceps   0.8  -0.4 
Waist to hip ratio  -0.1  0.7 
Waist-Min  0.7  0.6 
Lean body mass   0.8  0.5 
Body fat  0.7  -0.5 
Fat percent  0.8  -0.5 
    Mean 
square 
F ratio  P value 
score for 9 anthropometric 
parameters by HIV 
infection status 
  
  
Between 
Groups 
0.4  0.4  0.500 
Within 
Groups 
1.0       
Total          133 
 
4.3.2  Summary of anthropometric characteristics  
The  means  for  9  anthropometric  indices  were  similar  between  the  HIV  infected  and 
uninfected. PCA revealed two main anthropometric patterns: the first pattern depicted the 
variation between subjects with higher lean body mass, body weight, BMI, triceps, waist 
circumference, body fat and fat percent and those with higher height and waist-to-hip ratio 
and explained majority (50.4%) of the variation within the population. Analysis of variance 
of  the  first  anthropometric  pattern  by  HIV  infection  status  did  not show  any  statistical 
significance implying the HIV infected and uninfected were unlikely to be different in terms 
of an overall body shape or composition profile. 
4.4   Biochemical characteristics of study population stratified by HIV infection 
status 
Table 4.11: Mean and standard error of mean for biochemical characteristics of the 
male participants by HIV infection status 
 
 
Difference between the means of the overall HIV infected and uninfected subjects were determined by one way ANOVA. P 
value <0.05 denotes statistical significance. 
 
 
Variable  HIV infected 
(Mean±SE) 
HIV 
uninfected  
(Mean±SE) 
Total 
(Mean±SE) 
F ratio  P value  Eta
2 
Calcium mmol/l  2.28±0  2.3±0  2.29±0  4.3  0.040  0.6 
Total protein g/l  77.2±0.8  74.1±0.2  74.5±0.2  29.0  0.000  2.7 
Albumin g/l  42.8±0.6  44.4±0.2 
 
44.2±0.2  8.9  0.001  1.2 
Globulin g/l  34.4±0.9  29.7±0.2  30.3±0.2  53.8  0.000  7.0 
Total bilirubin mg/dl  7.0±0.6  6.9±0.2  7.0±0.2  0.02  0.900  0 
Direct bilirubin mg/dl  3.5±0.3  3.2±0.1  3.2±0.1  2.0  0.200  0.3 
ALP IU/l  90.5±509  84.4±1.9  85.2±1.8  1.3  0.300  0.2 
GGT IU/l  50.0±7.2  55.8±6.1  55.0±5.4  0.1  0.700  0 
ALT IU/l   17.6±3.0  13.9±0.5  14.4±0.6  4.2  0.040  0.6 
AST IU/l  41.7±1.3  26.2±0.9  28.2±1.9  9.0  0.003  1.2 
Total cholesterol 
mmol/l 
3.8±0.9  4.0±0.0  4.0±0.04  5.4  0.020  0.7 
HDL  mmol/l  1.1±0.0  1.2±0  1.2±0  5.6  0.020  0.8 
LDL  mmol/l  2.3±0.1  2.4±0  2.4±0  0.7  0.400  0.1 
Triglycerides  mmol/l  1.0±0  1.2±0  1.2±0  4.8  0.030  0.7 
Haematocrit %  43.9±0.5  45.4±0.2  45.2±0.2  9.8  0.020  1.3 
Haemoglobin g/dl  13.3±0.3  13.5±0.1  13.5±0.1  1.9  0.200  0.2 
LDL:HDL  2.3±0.2  2.2±0.1  2.2±0.1  0.3  0.600  0.1 
Vitamin A mg/dl  46.4±1.5  48.7±0.7  48.4±0.6  1.4  0.200  0.2 
Vitamin E mg/l  8.7±0.3  8.6±0.1  8.6±0.1  0.1  0.700  0 
Folic acid mmol/l  14.1±1.4  13.0±0.7  13.1±0.7  0.7  0.400  0.9 
Vitamin B12 mmol/l  464.8±67.2  364.3±15.4  367.6±15.1  0.5  0.500  0.6 
Vitamin B6 mmol/l  36.7±5.2  35.6±1.9  35.2±1.8  0.5  0.500  0.6 134 
 
Table 4.11 is a summary of mean, standard error and analysis of variance for baseline 
nutritional biochemistry characteristics of the male participants stratified by HIV infection 
status. Within the male  participants,  the HIV  uninfected group  had lower  haemoglobin, 
haematocrit; serum total cholesterol, HDL, LDL, triglycerides, serum vitamin A, albumin 
and  calcium  than  the  uninfected.  The  differences  observed  for  albumin  (p=0.03), 
haematocrit  (p=0.02),  triglycerides  (p=0.03),  HDL  (p=0.02)  and  calcium  (p=0.04)  were 
significant. On the other hand, PLWH recorded higher serum liver enzymes (ALT, AST and 
ALP), total and direct bilirubin, total protein and globulins, and vitamins E, B12, B6 and folic 
acid.  
 
Table 4.12: Mean and standard error of mean for biochemical characteristics of the 
female participants by HIV infection status 
 
Difference between the means of the overall HIV infected and uninfected subjects were determined by one way ANOVA. P 
value <0.05 denotes statistical significance. 
 
Statistically, differences observed for serum globulins (p=0.000), ALT (p=0.04) and AST 
(p=0.006) but none of the differences for serum vitamins and both total and direct bilirubin 
were statistically significant. Generally, eta squared showed low variability explained by 
Variable  HIV infected 
(Mean±SE) 
HIV uninfected  
(Mean±SE) 
Total 
(Mean±SE) 
F ratio  P value  Eta
2  
Calcium mmol/l  2.2±0  2.3±0  2.2±0  21.0  0.000  2.1 
Total protein g/l  78.5±0.9  73.6±0.2  74.2±0.2  54.2  0.000  5.2 
Albumin g/l  40.2±0.5  43.0±-0.1  42.7±0.1  47.8  0.000  4.6 
Globulin g/l  38.3±1.2  30.8±0.2  31.7±0.2  128.3  0.000  11.5 
Total bilirubin  4.6±0.3  5.6±0.1  5.5±0.1  7.3  0.007  0.9 
Direct bilirubin  2.3±0.2  2.5±0.1  2.5±0.1  1.2  0.300  0.1 
ALP IU/l  72.5±2.8  72.0±0.9  72.1±0.8  0.0  0.900  0 
GGT IU/l  39.4±9.1  31.0±1.5  31.9±1.7  0.9  0.300  0.1 
ALT IU/l   14.4±2.0  11.0±0.3  11.4±0.4  6.1  0.013  0.6 
AST IU/l  23.7±1.5  19.1±0.4  19.7±0.4  25.8  0.000  2.5 
Total cholesterol 
mmol/l 
3.9±0.1  4.3±0  4.2±0  13.0  0.000  1.3 
HDL  mmol/l  1.0±0  1.2±0  1.2±0  19.4  0.000  1.9 
LDL  mmol/l  2.5±0.1  2.7±0  2.7±0  3.4  0.070  0.3 
Triglycerides  
mmol/l 
1.1±0  1.2±0  1.2±0  3.0  0.080  0.3 
Haematocrit %  39.3±0.5  41.4±0.2  41.1±0.2  20.3  0.000  2.0 
Haemoglobin g/dl  11.8±0.2  12.2±0.1  12.2±0.1  5.7  0.020  0.6 
LDL:HDL  2.6±0.1  2.6±0.1  2.6±0.1  0.04  0.800  0 
Vitamin A mg/dl  42.4±1.2  44.5±0.5  44.2±0.5  1.8  0.200  0.2 
Vitamin E mg/l  9.0±0.2  9.2±0.1  9.2±0.1  0.3  0.600  0 
Vitamin B12 
mmol/l 
266±28.8  328.2±16.7  323.0±15.6  1.2  0.300  1.3 
Folic acid mmol/l  18.6±1.0  12.2±0.8  12.7±1.0  3.2  0.080  3.3 
Vitamin B6 mmol/l  28.4±5.2  32.7±2.0  32.3±1.9  0.4  0.500  0.4 135 
 
majority of the biochemical parameters but a few parameters such as globulin (7%) and 
total protein (2.3%) explained more variation within the males. 
 
The similarities between the males and females were that both groups recorded higher 
serum  liver  enzymes  and  globulins  for  HIV  infected  and  lower  haemoglobin  and 
haematocrit, serum lipids (total cholesterol, HDL, LDL and triglycerides), vitamin A and 
albumin for the HIV infected group. The differences between the two groups however were 
that in the males PLWH recorded higher but statistically insignificant serum vitamins (E, 
B6, B12 and folic  acid) whereas in  female participants HIV  infected recorded  lower but 
statistically not significant serum vitamins  (E, B6, B12 and folic acid).     
 
Table 4.13: Mean and standard error for biochemical characteristics of the total 
study population by HIV infection status 
 
Difference between the means of the overall HIV infected and uninfected subjects were determined by one way ANOVA. 
P value <0.05 denotes statistical significance. 
 
However when both  male  and  female  participants  were combined  and  these  baseline 
biochemical characteristics were compared, the differences between the HIV infected and 
Variable  HIV infected 
(Mean±SE) 
HIV 
uninfected  
(Mean±SE) 
Total 
(Mean±SE) 
F ratio  P value  Eta
2 
Calcium mmol/l  2.24±0  2.28±0  2.28±0  22.0  0.000   
Total protein g/l  78.0±0.6  73.8±0.2  74.3±0.2  72.5  0.000  3.6 
Albumin g/l  41.4±0.4  43.6±0.1  43.3±0.1  45.2  0.000  2.9 
Globulin g/l  36.6±0.8  30.3±0.1  31.1±0.2  175.2  0.000  7.9 
Total bilirubin  5.7±0.3  6.2±0.1  6.1±0.1  1.6  0.200   
Direct bilirubin  2.9±0.2  2.8±0.04  2.8±0.05  0.2  0.600   
ALP IU/l  80.5±3.1  77.3±0.9  77.6±0.9  1.4  0.200  0 
GGT IU/l  44.0±6.0  41.4±2.8  41.8±2.5  0.1  0.700  0 
ALT IU/l   15.8±1.7  12.2±0.3  12.7±0.3  12.5  0.000  0.4 
AST IU/l  31.7±6.0  22.1±0.4  23.3±0.8  14.4  0.000  1.8 
Total cholesterol 
mmol/l 
3.8±0.1  4.2±0.03  4.1±0.03  18.9  0.000  1.1 
HDL  mmol/l  1.1±0.02  1.2±0  1.2±0  18.8  0.000  1.5 
LDL  mmol/l  2.4±0.06  2.6±0.03  2.6±0.02  5.5  0.020  0.2 
Triglycerides  mmol/l  1.1±0.03  1.2±0.02  1.2±0.2  7.6  0.006   
Haematocrit %  41.4±0.4  43.1±0.1  42.9±0.1  22.2  0.000  1.3 
Haemoglobin g/dl  12.5±0.2  12.8±0.1  12.7±0.05  4.1  0.040  0.4 
LDL:HDL  2.5±0.1  2.4±0.05  2.4±0.04  0.2  0.600  0 
Vitamin A mg/dl  44.2±1.0  46.3±0.4  46.1±0.4  3.2  0.070  0.2 
Vitamin E mg/l  8.8±0.2  8.9±0.1  8.9±0.1  0.1  0.700  0 
Vitamin B12 mmol/l  325.9±36.9  344.9±11.5  343. ±11  0.2  0.600  0 
Folic acid mmol/l  16.7±5.1  12.6±0.5  12.9±0.6  3.1  0.100  0.7 
Vitamin B6 mmol/l  29.3±3.6  34.0±1.4  33.7±1.3  0.9  0.300  0.4 136 
 
uninfected were even more profound. As shown by Table 4.13, the HIV infected subjects 
had significantly higher serum AST (p=0.000) and ALT (p=0.000) levels; higher serum total 
proteins  (p=0.000)  and  globulin  (p=0.000)  than  the  HIV  uninfected  group.  The  HIV 
uninfected  on  the  other  hand  had  higher  haemoglobin  (p=0.008)  and  haematocrit 
(p=0.000); and serum HDL (p=0.000), LDL (p=0.04), total cholesterol (p=0.000) albumin 
(p=0.000) and triglycerides (p=0.03).  
 
4.4.1    PCA for biochemical parameters by HIV infection status 
Principal Component Analysis was used to define patterns of nutritional biochemistry and 
metabolism within the study population stratified by HIV infection status. Separate PCA 
was performed for the serum lipids, vitamins and for liver enzymes/proteins comparing the 
HIV  infected  and  uninfected  groups  (summary  of  factor  loadings  for  PCA  have  been 
presented in Table 4.14). For the serum lipids, the first principal component explained 54% 
and 57% of variability in the HIV infected and uninfected populations respectively. Thus 
the first component for the serum lipids was selected to represent the serum lipid profile of 
the study populations.  
 
The first component however showed positive factor loadings for total cholesterol (Table 
4.14), LDL, triglycerides and HDL: LDL ratio in both HIV infected and uninfected groups. 
Negative factor loading was recorded for HDL.  Thus this pattern described the variation 
between subjects with high serum total cholesterol, LDL, triglyceride and HDL: LDL ratio 
and low serum HDL and subjects with high HDL but low cholesterol, LDL, triglyceride and 
HDL:  LDL  ratio.  High  score  for  this  component  therefore  depicted  high  LDL,  total 
cholesterol and triglyceride and low HDL. 
 
For the serum proteins the first principal components accounted for 72% and 61% of the 
variability within the HIV infected and uninfected groups respectively. This component in 
the HIV infected groups showed positive factor loadings for globulin and total proteins and 
negative  loading  for  serum  albumin.  This  pattern  thus  described  the  group  with  high 
globulin  but  low  albumin  status.  High  score  for  this component  therefore  implied  high 
globulin  and  low  albumin  status  whereas  low  score  implied  lower  globulin  and  higher 
albumin.  In  the  HIV  uninfected  population  the  first  component  showed  positive  factor 
loadings for all the serum proteins. This component thus described people with high serum 
globulin and albumin status. High score thus implied high albumin and globulin and low 
score depicted low serum albumin and globulin.  137 
 
 
With regards to the serum vitamins the first principal component in the HIV infected, and 
uninfected populations respectively explained 50% and 33% of the variability within these 
populations. In the HIV infected population this component showed positive factor loadings 
for serum vitamins A, E and B6 and negative loadings for serum vitamins B12 and folic acid. 
This component thus described HIV infected persons with high serum vitamins A, E and B6 
but  low  serum  vitamins  B12  and  folic  acid.  Within  the  HIV  uninfected  and  combined 
populations, the first serum vitamins component recorded high positive loadings for serum 
vitamins A, E, B6 and folic acid. This component in the HIV uninfected population thus 
described subjects with high serum status for vitamins A, E, B6 and folic acid. This implied 
that for serum vitamins the main pattern within the HIV infected population was similar to 
the HIV uninfected except for folic acid. 
 
Table  4.14:  Summary  of  factor  loadings  of  first  principal  components  for  serum 
nutrient status (lipids, liver enzymes, proteins and vitamins) by HIV infection 
status 
  HIV infected  HIV uninfected 
Serum proteins  High globulin and low albumin  High serum proteins 
Variation explained  72%  61% 
Serum Protein  0.9  0.9 
Serum Albumin  -0.7  0.6 
Serum Globulins  0.9  0.7 
Liver enzymes  High liver enzymes  High liver enzymes 
 Variation explained  55%  47% 
Serum ALP  0.6  0.2 
Serum GGT  0.6  0.7 
Serum ALT  0.9  0.8 
Serum AST  0.9  0.9 
Serum lipids  Low HDL but high LDL and other 
lipids 
Low HDL and high LDL and 
other lipids 
Variation explained  54%  57% 
Serum TC  0.8  0.8 
Serum HDL  -0.2  -0.3 
Serum LDL  0.9  0.9 
Serum TG  0.5  0.6 
HDL:LDL  0.8  0.9 
Serum vitamins  High serum vitamin A, E and B6 low 
serum vitamin B12 and folic acid 
High serum vitamin A, E, 
B6 and folic acid 
Variation explained  50%  33% 
Serum  Vitamin A  0.9  0.8 
Serum Vitamin E  0.7  0.7 
Serum  Vitamin B12  -0.5   
Serum Folate  -0.8  0.4 
Serum vitamin B6  0.7  0.6 138 
 
   
For the serum liver enzymes and proteins, the first PCA explained 30% and 27% of the 
variability in the HIV infected and uninfected populations respectively. In the HIV infected 
group, this component recorded positive loadings for all the serum liver enzymes (serum 
AST, ALT, ALP and GGT) and total bilirubin. This pattern thus depicted high status of 
serum liver enzymes and total bilirubin. In the HIV uninfected population the first PCA for 
serum liver  enzymes also showed positive  loadings  for  all  the liver  enzymes including 
bilirubin. However the factor loadings for the liver enzymes in the HIV uninfected were 
lower  which  implied  that  levels  of  these  markers  were  likely  to  be  lower  in  the  HIV 
uninfected although the factor loadings were positive. 
4.5  Characteristics of the diet 
4.5.1  Dietary Nutrients intake and patterns of the study population 
A summary of means and standard error of the means for intakes of food nutrients in the 
female study population stratified by HIV infection status is presented in Table 4.15 (for 
females), Table 4.16 (for males) and Table 4.17 (for the combined population). Within the 
female group, intakes of most of the nutrients were not different by HIV infection status 
and  none of  the  mean intakes for nutrients were statistically different by  HIV infection 
status. However intake of fibre was higher in the HIV infected by 1.1 grams and a few of 
the dietary vitamins recorded slight differences in favour of the HIV infected. Moreover 
these differences were indeed low. Analysis of Variances of the mean intakes between the 
HIV  infected  and  uninfected  yielded  very  low  F  ratio,  and  insignificant  p  values.  Eta 
squared values generated also depicted low proportion of explained variation between HIV 
infected and uninfected. With the exception of total fat, food energy, polyunsaturated fat, 
fibre and nicotinamine intakes which recorded F ratios above 1, the rest of the nutrients 
had very low F ratios.  
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Table 4.15: Mean, standard error of mean and statistical significance for intakes of 
nutrients between HIV infected and uninfected female population 
 
In the male category (Table 4.16), the HIV infected group had a higher intake of total food 
energy  than  the  uninfected  by  about 610  KJ  (145.7  kcal) which was quite substantial 
though was not different statistically. Slight differences were also observed between the 
HIV  infected  and  uninfected  males  for  food  nutrients  such  as  protein,  total  fat, 
monounsaturated and polyunsaturated fat intakes all in favour of the HIV infected. Again, 
these differences did not reach statistical significance. With regards to the micronutrients, 
calcium, ascorbic acid and iron intakes were a little higher for the HIV infected whereas 
vitamin A, B1, B2, D, E, and folic acid were a little higher for the HIV uninfected. It does 
seem that dietary nutrient intakes in absolute terms varied a little by HIV infection status in 
the male population. Yet again, further analysis of the variances observed between intakes 
of nutrients in this category by HIV infection status did not yield any significant p value. 
Some of the F ratio values especially for energy, iron, fibre and folic acid were nearly 2 but 
then again the p values were all above 0.05 indicating non-significance. 
 
NUTRIENT   MEAN±STANDARD ERROR   
TOTAL  HIV 
POSITIVE 
HIV 
NEGATIVE 
F 
ratio 
P 
value 
Eta
2  
Total energy (plus alcohol) KJ  8384.4±28  7932.6±10  7985.6±96.3  2.3  0.100  0.2 
Energy (minus alcohol) KJ  8270.5±28  7850.8±10  7900±95.2  2.0  0.200  0.2 
Total protein (g)  58.9±2  57.7±0.8  57.9±0.7  0.3  0.600  0 
Total fat (g)  56.6±2.6  54.1±0.9  54.4±0.8  1.0  0.300  0.1 
Percent energy from fat ) (g)  25.5±0.6  25.9±0.2  25.8±0.2  0.2  0.600  0 
Saturated fat (g)  17.8±0.9  17.0±0.3      17.1±0.3  0.8  0.400  0.1 
Monounsaturated fat (g)  19.1±0.9  18.4±0.3  18.5±0.3  0.4  0.500  0 
Polyunsaturated fat (g)  14.4±0.7  13.5±0.2  13.6±0.2  1.6  0.200  0.2 
Cholesterol  279.5±17  283.6±6.8  283.4±6.3  0.05  0.800  0 
Fibre (g)  17.3±0.7  16.2±0.2  16.4±0.2  1.9  0.200  0.2 
Calcium (mg)  405.4±19  407.6±8.2  407.4±7.6  0.1  0.900  0 
Iron (mg)  8.9±0.4  8.5±0.1  8.6±0.1  0.9  0.300  0.1 
Zinc (mg)  8.2±0.3  8.0±0.1  8.0±0.1  0.3  0.600  0 
Copper (mg)  1.2±0.04  1.1±0.01  1.1±0.01  2.3  0.100  0.2 
Vitamin A (µg)  741.4±53  764.1±24  761.4±22  0.1  0.700  0 
Thiamine (mg)  1.1±0.05  1.1±0.01  1.1±0.01  0.8  0.300  0.1 
Vitamin D  (µg)  4.3±0.3  4.3±0.1  4.3±0.1  0  0.900  0 
Vitamin E (mg)  10.7±0.6  10.2±0.2  10.2±0.2  0.8  0.400  0.1 
Riboflavin (mg)  1.3±0.1  1.3±0.02  1.3±0.02  0.01  0.900  0 
Nicotinamine (mg)  12.9±0.6  12.3±0.2  12.4±0.2  1.1  0.300  0.1 
Ascorbic acid (mg)  40.0±4.3  38.8±1.4  38.9±1.3  0.1  0.800  0 
Folic acid (mg)  197.1±7.4  192.1±2.7  192.7±2.6  0.4  0.500  0 140 
 
Table 4.16: Mean and standard error of the mean for intakes of nutrients between 
the HIV infected and uninfected male population 
 
However, considering the overall study population (Table 4.17), total energy intake was 
significantly higher in the HIV infected (F ratio =4.5, p=0.03). Moreover, the HIV infected 
population  consumed  more  polyunsaturated  fat  (p=0.04)  and  fibre  (p=0.04)  than  the 
uninfected group. Intake of dietary copper was also higher in the HIV infected and nearly 
significant (p=0.06). Analysis of variation between mean intakes of the rest of the nutrients 
did not reveal any statistical significance. This was signified by the high p values and low F 
ratios for these variances. Generally eta squared values were also low with several of the 
nutrients recording zero implying low proportion of variability explained by these variables 
between the HIV infected and uninfected. 
 
 
 
 
 
 
 
NUTRIENT (grams)  MEAN±STANDARD ERROR   
HIV POSITIVE  HIV 
NEGATIVE 
ALL  F 
ratio 
P 
value 
Eta
2  
Total energy (plus alcohol) 
KJ 
10099±464  9486.8±148  9563±141.9  2.0  0.100  0.3 
Energy (minus alcohol) KJ  9379.5±384.5  8961±134.9  9013.4±127  2.0  0.300  0.2 
Total protein (g)      68.2±2.9  66.2±1.0  66.4±1.0  1.2  0.500  0.1 
Total fat (g)      60.7±3.0  58.9±1.0  59.1±1.0  0.5  0.500  0.1 
Percent energy from fat   24.4±0.7  24.9±0.3  24.8±0.3  0.4  0.500  0 
Saturated fat (g)  17.8±1.0  18.2±0.4  18.1±0.3  0.3  0.700  0 
Monounsaturated fat (g)  21.0±1.1  20.2±0.4  20.3±0.4  0.2  0.400  0.1 
Polyunsaturated fat (g)  16.4±1.1  14.9±0.3  15.1±0.3  2.6  0.100  0.2 
Cholesterol  344.5±26.7  343.2±8.8  343.4±8.4  0  1.000  0 
Fibre (g)  19.6±1.1  18.1±0.4  18.3±0.3  2.1  0.100  0.2 
Calcium (mg)  448.0±25.7  462.4±10.6  460.6±9.8  0  0.600  0 
Iron (mg)  9.1±0.5  9.2±0.2  9.2±0.2  2.1  0.900  0 
Zinc (mg)  9.1±0.4  8.9±0.1  8.9±0.1  0.2  0.600  0 
Copper (mg)  1.3±0.1  1.2±0.02  1.2±0.02  0  0.300  0.2 
Vitamin A (µg)  763.5±67.5  696.4±24.2  704.8±22  0.2  0.300  0 
Thiamine (mg)  1.2±0.05  1.18±0.02  1.19±0.01  1.2  0.500  0.1 
Vitamin D  (µg)  5.5±0.5  5.3±0.2  5.4±0.1  0.9  0.700  0 
Vitamin E (mg)  12.4±1.0  11.5±0.2  11.6±0.2  0.4  0.300  0.1 
Riboflavin (mg)  1.5±0.1  1.48±0.02  1.49±0.02  0.1  0.900  0 
Nicotinamine (mg)  16.0±1.1  15.0±15.1  15.1±0.3  1.1  0.300  0.1 
Ascorbic acid (mg)  33.5±3.3  34.9±1.4  34.8±1.3  0.1  0.700  0 
Folic acid (mg)  236.7±14.1  220.9±3.9  22.8±3.8  1.9  0.200  0.3 141 
 
Table 4.17: Mean, standard error of mean and statistical significance for intakes of 
nutrients between HIV infected and uninfected of combined population 
 
4.5.2     Nutrient intake patterns generated from principal component analysis   of 13 
dietary   nutrients 
Principal  component  analysis  of  dietary  nutrients  was  performed  in  order  to  identify 
patterns of dietary nutrient intakes and to show if differences existed in these patterns 
between the PLWH and their uninfected counterpart. Table 4.18 presents summary of the 
factor loadings (correlations) for the three main nutrient intake patterns generated from 
PCA. The first nutrient pattern explained 57% and 58% of the variations within the HIV 
infected  and  uninfected  groups  respectively.  The  first  nutrient  pattern  showed  large 
positive factor loadings for energy, protein and all the micronutrients in both HIV infected 
and uninfected population. This nutrient profile was associated with high intakes of energy, 
total protein, total fat and micronutrients.  
 
NUTRIENT (grams)  MEAN±STANDARD ERROR   
HIV infected  HIV 
uninfected 
Total   F 
ratio 
P 
value 
Eta
2 
Total energy (plus alcohol) 
KJ 
9137±266  8588±88  8654±84  4.5  0.030  0.3 
Energy (minus alcohol) KJ  8757±236  8319±83  8372±78  3.3  0.060  0.2 
Total protein (g)  63±1.7  61.3±0.7  56.4±0.6  1.0  0.300  0.1 
Total fat (g)  58.4±1.9  56.1±.07  56.4±0.6  1.4  0.200  0.1 
Percent energy from fat ) 
(g) 
25.0±0.5  25.5±0.2  25.4±0.2  0.6  0.400  0 
Saturated fat (g)  17.8±0.6  17.5±0.2  17.6±0.2  0.2  0.700  0 
Monounsaturated fat (g)  19.9±0.7  19.2±0.2  19.3±0.2  1.1  0.300  0.1 
Polyunsaturated fat (g)  15.3±0.6  14.1±0.2  14.3±0.2  4.3  0.040  0.2 
Cholesterol  308±15.5  309±5.4  308.9±5.1  0  0.900  0 
Fibre (g)  18.3±0.6  17.0±0.2  17.2±0.2  4.1  0.040  0.2 
Calcium (mg)  424±15.8  430.7±6.5  429.9±6.1  0.1  0.700  0 
Iron (mg)  9.0±0.3  8.8±0.1  8.8±0.1  0.5  0.500  0 
Zinc (mg)  8.6±0.3  8.3±0.1  8.4±0.1  0.6  0.400  0 
Copper (mg)  1.2±0.04  1.15±0.01  1.2±0.01  3.6  0.060  0.2 
Vitamin A (µg)  751±41.8  735.5±17  737.4±16  0.1  0.700  0 
Thiamine (mg)  1.15±0.03  1.1±0.01  1.1±0.01  1.3  0.300  0.1 
Vitamin D  (µg)  4.8±0.3  4.7±0.1  4.7±0.1  0.1  0.700  0 
Vitamin E (mg)  11.4±0.5  10.7±0.1  10.8±0.1  2.1  0.100  0.1 
Riboflavin (mg)  1.4±0.05  1.4±0.02  1.4±0.02  0.03  0.800  0 
Nicotinamine (mg)  14.3±0.6  13.4±0.2  13.5±0.2  2.4  0.100  0.1 
Ascorbic acid (mg)  37.1±2.8  37.1±1  37.1±0.9  0  1.000  0 
Folic acid (mg)  214.4±7.5  204.2±2.3  205.4±2.2  2.3  0.100  0.1 142 
 
The second nutrient pattern showed some differences by HIV infection status. In the HIV 
infected  group,  this  pattern  showed  positive  factor  loadings  for  vitamin  A,  C,  B1,  and 
calcium and negative factor loadings for vitamins D, E, and pantothenic acid. This nutrient 
pattern thus described a variation between subjects with vitamins A, C, B1 and calcium 
intake without vitamins D, E and B5. Within the HIV uninfected population, the second 
nutrient pattern showed positive factor loadings for vitamin D and E and negative factor 
loadings for vitamin A, B1 and C. This nutrient pattern therefore described HIV uninfected 
population whose nutrient intake were likely to include vitamin D and E and not vitamin A, 
B1  and  C.  This  implied  that  there  was  sharp  contrast  between  the  HIV  infected  and 
uninfected  subjects  for  the  second  nutrient  pattern.  Nutrients  which  recorded  positive 
factor  loadings  within  the  HIV  infected group  recorded  negative  factor  loadings  in  the 
uninfected groups and vice versa.  
 
Table 4.18: Factor loadings for nutrient patterns of the study population derived 
from PCA, stratified by HIV infection status 
 
The third nutrient pattern within the HIV infected subjects recorded negative loadings for 
energy, protein and folic acid and positive loadings for the vitamins and fat. In the HIV 
uninfected  group,  positive  factor  loadings  were also  recorded  for  the  vitamins  and  fat 
whereas negative factor loadings were recorded for energy, protein and the minerals. This 
nutrient pattern thus described a profile commensurate with vitamins and fat intake and not 
   Nutrient pattern 1  Nutrient pattern 2 
 
Nutrient pattern 3  
Variability 
explained 
HIV infected 
(57%) 
HIV 
uninfected 
(58%) 
HIV infected 
(9%) 
HIV uninfected 
(10%) 
HIV 
infected 
(8%) 
HIV 
uninfected 
(8%) 
 
Depicting high 
macronutrients and 
micronutrients 
Depicting 
vitamin A, B1, C, 
and calcium 
Depicting 
vitamins D and E 
 
 
 
total fat, 
vitamin A, C, 
D and E 
vitamin A, 
B1, B5, C, D 
and E 
Total energy  0.8  0.9      -0.2  -0.3 
Total protein  0.9  0.9      -0.2  -0.2 
Total fat  0.8  0.9      0.3  0.2 
Calcium   0.6  0.7  0.2       
Iron  0.9  0.8        -0.3 
Zinc  0.9  0.9        -0.2 
Vitamin A  0.5  0.5  0.5  -0.4  0.2  0.4 
Vitamin B1  0.8  0.8  0.3  -0.3    0.2 
Folic acid  0.8  0.8      -0.3   
Vitamin C  0.5  0.5  0.5  -0.5  0.5  0.4 
Vitamin B5  0.9  0.9  -0.2      0.2 
Vitamin D  0.5  0.4  -0.6  0.7  0.2  0.4 
Vitamin E  0.5  0.7  -0.4  0.5  0.6  0.2 143 
 
energy, protein or minerals and this was similar between the HIV infected and uninfected 
subgroups. 
 
The  first dietary  nutrient pattern  was chosen  to  represent  the  main  pattern of nutrient 
intake pattern since it explained a very large proportion of variation in both the HIV infected 
(57%) and uninfected groups (58%) and hence scores for the first nutrient pattern were 
used as overall dietary nutrient intake score for further analysis in the next chapters 
 
Analysis of variation for the three nutrient patterns between HIV infected and uninfected 
showed  that  the  mean  scores  for  the  nutrient  patterns  between  HIV  infected  and 
uninfected groups were not different statistically. For all the three dietary nutrient patterns 
the F ratio and p values did not show any statistical significance implying that the patterns 
of nutrient intake were not different between the HIV infected and uninfected groups. 
4.5.3  Summary of nutrient patterns 
Dietary  nutrient  intake was  similar  between  the  HIV  infected and  uninfected  when  the 
males and females were analysed separately. However in the combined population total 
energy intake was significantly higher in the HIV infected (F ratio =4.5, p=0.03). Moreover, 
the  HIV  infected  population  consumed  more  polyunsaturated  fat  (p=0.04)  and  fibre 
(p=0.04)  than  the  uninfected  group.      Regarding  nutrient,  three  main  patterns  were 
generated by PCA and these were not different between the HIV infected and uninfected 
using ANOVA. The first pattern explained 57% and 58% of the variability within the HIV 
infected and uninfected groups respectively and recorded large positive factor loadings for 
energy,  protein  and  micronutrients.  This  pattern  therefore  described  a  generally  good 
intake of nutrients and since this component explained close to 60% of the variation, it was 
used to depict the main pattern in the study group in subsequent analysis. Thus a high 
score for this component depicted high macro and micronutrient intake whereas a low 
score depicted low nutrient intake.  
4.5.4  Food intake and dietary patterns of the study participants 
A summary of mean intakes of foods and food groups for the study population stratified by 
HIV infection status are presented in Tables 4.19 (for males), 4.20 (for females) and 4.21 
(combined population). Generally, intake of the various foods were similar between the 
HIV infected and uninfected males though slight differences were observed. An analysis of 
the variation between means of intakes for the various foods within the male population did 
not show any statistical significance since none of the p values were below 0.05. However, 
an assessment of the absolute amounts of food intakes within the male study population 144 
 
revealed that the HIV uninfected had higher intakes of milk, chicken, fruits and fat whereas 
the  HIV  infected  population  had  slightly  higher  intakes  of  legumes,  vegetables,  maize 
meal, rice and breakfast cereal. 
 
Table 4.19: Mean, standard error of mean and statistical significance for intakes of 
food in males by HIV infection status 
 
Similar  to  the  male  population,  food  intake  within  the  female  subgroup  did  not  differ 
significantly  by  HIV  infection  status  (Table  4.20)  although  slight  differences  existed 
between  the  HIV  infected  and  uninfected  participants.  The  HIV  infected  females  had 
slightly higher intakes for foods such as fruits, potato, maize meal, rice, sugar, bread and 
cereals whereas intakes for milk, red meat, chicken and vegetables were slightly higher in 
the HIV uninfected females. However none of the F ratios between the HIV infected and 
uninfected  were  high  enough  and  no  statistical  significances  were  observed.  The  eta 
squared  values  from  the  analyses  of  variances  were  all  very  low  and  indicating  low 
proportions of variation explained by the differences between the mean intakes of foods 
between HIV infected and uninfected were all very low.  
 
 
 
 
 
 
FOOD ITEM 
(grams) 
MEAN±STANDARD ERROR   
HIV positive  HIV 
negative 
All  F ratio  P 
value 
Eta
2 
Milk  136.1±15.7  167.76±7.0  163.7±6.5  2.6  0.100  0.4 
Red meat  41.±5.3  41.9±1.7  41.8±1.6  0.02  0.900  0 
Chicken  13.4±1.8  15.3±0.8  15.1±0.7  0.7  0.400  0.1 
Fish  10.8±1.4  10.±0.7  10.7±0.6  0.01  0.900  0 
Legumes  38.6±4.6  36.3±1.4  36.6±1.3  0.3  0.600  0 
Eggs  51.3±6.0  50.1±2.0  50.3±1.9  0.04  0.800  0 
Fruits  87.8±10.1  96.6±4.7  95.5±4.3  0.1  0.700  0.1 
Vegetables  70.1±4.6  68.3±1.9  68.5±1.7  0.1  0.700  0 
Potato  31.5±2.8  34.8±1.4  34.4±1.3  0.7  0.400  0.1 
Maize meal  154.8±14.8  139.3±4.8  141.2±4.5  1.3  0.200  0.2 
Rice  43.7±4.4  39.8±1.7  40.3±1.6  0.6  0.400  0.1 
Sugar  35.7±5.7  30.3±1.7  31.0±1.6  1.2  0.200  0.2 
Bread  106.2±8.6  107.2±4.0  107.1±3.6  0.0  0.900  0 
Other cereal  33.7±6.4  35.4±2.9  35.2±2.6  0.04  0.800  0 
Breakfast cereal  32.3±4.8  24.9±1.6  25.9±1.5  2.4  0.100  0.3 
Fat  11.4±1.3  12.2±0.7  12.1±0.6  0.2  0.700  0 
   Cold drink  160.4±29.2  149.5±11.2  150.9±10.5  0.1  0.700  0 145 
 
Table 4.20: Mean, standard error of mean and statistical significance for intakes of 
food in females by HIV infection status 
 
 
Table 4.21 Mean, standard error of mean and statistical significance for intakes of 
food in the total population by HIV infection status 
 
 
FOOD ITEM 
(grams) 
MEAN±STANDARD ERROR   
HIV infected  HIV 
uninfected 
All  F 
ratio 
P 
value 
Eta
2 
 
Milk  146.8±11.7  151.3±5.3  150.8±4.8  0.1  0.800  0 
Red meat  37.0±3.3  41.8±1.4  41.2±1.3  1.3  0.200  0.1 
Chicken  15.0±1.9  16.3±0.7  16.2±0.7  0.4  0.500  0 
Fish  11.0±1.4  9.9±0.5  10.0±0.5  0.6  0.400  0.1 
Legumes  39.0±3.8  36.6±1.3  36.9±1.2  0.4  0.500  0 
Eggs  37.6±3.8  37.5±1.5  37.5±1.4  0  1.000  0 
Fruits  114.8±13.7  101.1±4.3  102.7±4.1  1.1  0.300  0.1 
Vegetables  72.5±4.7  76.1±1.9  75.7±1.8  0.4  0.500  0 
Potato  36.2±2.8  31.6±1.1  32.2±1.1  2.0  0.090  0.2 
Maize meal  115.2±9.1  113.3±3.6  113.5±3.4  0.03  0.900  0 
Rice  45.5±4.2  39.1±1.3  39.9±1.2  2.8  0.090  0.3 
Sugar  38.2±7.3  29.5±1.3  30.5±1.4  3.9  0.050  0.4 
Bread  95.4±8.5  90.1±2.6  90.7±2.5  0.5  0.500  0 
Other cereal  56.5±9.2  45.4±2.8  46.8±2.7  1.8  0.200  0.2 
Breakfast cereal  24.7±3.0  25.2±1.4  25.2±1.2  0.01  0.900  0 
Fat  12.9±1.5  11.5±0.5  11.6±0.5  0.9  0.300  0.1 
   Cold drink  141.2±25.4  147.5±11.4  146.8±10.
4 
0.04  0.800  0 
FOOD ITEM 
(grams) 
MEAN±STANDARD ERROR   
HIV infected  HIV uninfected  All  F 
ratio 
P 
value 
Eta
2 
Milk  142.1±9.5  137.9±9.5  158.2±4.3  1.8  0.200  0.1 
Red meat  41.5±1.0  39.8±2.9  41.8±1.1  0.9  0.300  0.1 
Chicken  15.6±0.5  14.2±1.3  15.8±0.5  1.0  0.300  0.1 
Fish  10.2±0.4  10.9±0.9  10.2±0.4  0.4  0.500  0 
Legumes  36.7±1.0  38.9±2.9  36.5±1.0  0.7  0.400  0 
Eggs  42.9±1.2  43.5±3.4  42.8±1.2  0.04  0.800  0 
Fruits  99.7±3.0  129.5±8.9  99.2±3.2  0.2  0.700  0 
Vegetables  72.7±1.3  71.5±3.3  72.8±.4  0.1  0.700  0 
Potato  33.1±0.8  34.2±2.0  33.0±0.9  0.2  0.600  0 
Maize meal  125.2±2.7  132.4±8.2  124.3±2.9  0.9  0.300  0.1 
Rice  40.1±1.0  44.7±3.0  39.4±1.0  3.1  0.100  0.2 
Sugar  30.7±1.1  37.1±4.8  29.9±1.0  4.9  0.200  0.3 
Bread  97.6±2.1  100.1±6.1  97.3±2.3  0.2  0.700  0 
Other cereal  41.9±1.9  46.6±5.9  41.2±2.0  0.8  0.300  0 
Breakfast 
cereal 
25.5±1.0  28.0±2.7  25.1±1.0  0.9  0.300  0.1 
Fat  11.9±0.4  12.2±1.0  11.8±0.4  0.1  0.700  0 
   Cold drink  150±19.1  148.4±8.1  148.6±7.5  0  0.900  0 146 
 
When the mean intakes of the foods were compared between the combined male and 
female population stratified by HIV infection (Table 4.21), there were still no statistically 
significant differences between the HIV infected and uninfected for any of the foods. This 
could be observed in the low F ratio values between the means of the HIV infected and 
uninfected and the fact that very few were above 1. None of the p values were below 0.05 
and eta squared values were low. However slight differences were again observed for 
most of the foods just like for the male and female subgroups. 
4.5.5  Principal  Component  Analysis  of  Food  intake  in  the  study  population     
stratified by HIV infection state 
The purpose of the principal component analysis was to identify a group of foods from the 
large number of foods and food groups that explained the patterns of intake in the study 
population in order to explain variations of dietary intake within the study population within 
the general population and by HIV infection status. From PCA, the dietary intake of the 
overall study population could be summarised into 4 main patterns (Table 4.22). The first 
four components generated by PCA explained close to half the variation within the study 
sample. This implied that four main dietary patterns existed within the study group and 
these were observed in about half of the study group. The first component explained about 
18% of the variation and the second explained 10.9%. The third and fourth components 
respectively explained 8.6% and 7.6% of the variation in the total sample.  
 
Likewise in the HIV infected population, four components were shown to explain about 
44% of the variations in diet (Figure 4.1). The first component explained about 17% of the 
variation followed by the 10% for the second component, 8.6 for the 3
rd and 7.7% for the 
fourth component. In the HIV uninfected the first component accounted for 14.8% of the 
variation, followed by component 2, 11.7%. Component 3 and 4 respectively explained 
9.3% and 8.5% of the total variation within the HIV uninfected group. Cumulatively, these 
four  components  accounted  for  about  44%  of  the  observed  variation  within  the  HIV 
uninfected subgroup (Figure 4.2). Thus four components each were shown to explain most 
of  the variation in dietary  patterns within  the HIV  infected and uninfected groups. The 
Scree plots for the HIV infected and uninfected populations were similar to that of the 
combined  population  and  confirmed  the  fact  that  four  main  components  (patterns)  of 
dietary intake existed within the study participants.  
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Figure 4.1: Scree plot showing dietary components and levels of variation        
explained by these components for the combined population 
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Figure 4.2: Scree plot showing dietary components and levels of variation explained 
by these components for the HIV infected population 
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Figure 4.3: Scree plot showing dietary components and levels of variation explained 
by these components for the HIV uninfected population 
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4.5.5.1  Component 1 (described predominantly animal-based diet and fat with fruits 
and vegetables without maize meal 
The first component recorded positive factor loadings for red meat, chicken, fish, fruits, 
vegetables and fat in the HIV infected group. Negative factor loadings were recorded for 
maize  meal  (Table  4.22).  Similar  factors  loading were  observed  in the  HIV  uninfected 
subjects.  The  positive  factor  loadings  were  thus  associated  mainly  with  animal  based 
foods (that is red meat, fish, chicken) and fat which could possibly be due to high intakes 
of the animal based foods. The negative factor loading for maize implied that subjects 
whose consumption of the animal based foods was high were likely to consume low levels 
of maize meal. This dietary pattern thus showed a variation of subjects consuming animal 
foods on one hand and subjects who consumed maize meal on the other hand. Subjects 
with the animal based diet were unlikely to consume maize meal and subjects whose diet 
was predominantly maize meal based were unlikely to consume animal based foods. The 
difference between the HIV infected and uninfected participants for this dietary pattern was 
that for the HIV for the HIV positive subjects, a negative factor loading was recorded for 
sugar as well. This dietary pattern could be referred to as predominantly animal based. 
4.5.5.2  Component 2 (described broad and varied foods and was closest to current 
recommended  guidelines  for  the  HIV  infected  group  and  was  denoted 
‘healthy or ‘recommended’) 
The second dietary component recorded positive factor loadings for fruits and vegetables, 
potato, bread, cereals and milk for the HIV infected. Foods with negative factor loadings 
were fat, fish and maize meal. The range of foods presented showed that compared to the 
first component described as predominantly animal based, this component represented a 
broad  and  varied  dietary  pattern  similar  to  current  recommended  guidelines  for  HIV 
infected people in this population. Foods that recorded positive factor loadings in the HIV 
infected also showed similar values in the uninfected, likewise foods that showed negative 
factor loadings. This dietary pattern described subjects who consumed very little animal 
foods and fat. There were no striking differences between the HIV uninfected and PLWH 
for this component except for the fact that this component accounted for more variation in 
the HIV infected (11.7%) group than the HIV negative population (10.2%). This dietary 
pattern thus depicted what could be described as ‘recommended’ dietary guidelines. 
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4.5.5.3  Component  3  (Described  staple  or  maize  meal  based  with  eggs  for  HIV 
infected, and maize meal with high legumes and sugar for HIV uninfected, 
was broadly labelled as staple based 1) 
In the HIV infected population the third dietary component showed large positive factor 
loadings for maize meal, moderate loadings for eggs and bread and low factor loading for 
fruits. Negative loadings were recorded for milk and legumes. This could be referred to as 
staple based in the HIV infected population. Within the HIV uninfected population, the third 
dietary component showed large positive factor loadings for sugar and legumes, moderate 
loadings for maize meal and low factor loadings for bread and potatoes. Negative loadings 
were recorded for chicken, red meat, and fruits. This could be referred to as staple based 
with legumes in the HIV uninfected population. 
T denotes total population; H- and H+ denote HIV sero-negtives and postives respectively 
 
 
 
 
 
 
Table  4.22:  Factor  loadings  for  four  main  dietary  components  derived  from  principal 
component analysis stratified by HIV infection status  
  Component 1  Component 2  Component 3  Component 4 
 
  T  H-  H+  T  H-  H+  T  H-  H+  T  H-  H+ 
% variation 
explained 
18  14.8  17.0  10.9  11.7  10.0    9.3  8.6  7.6  8.5  7.7 
Milk       0.4      0.2      -0.5    -0.2   
Red Meat   0.3  0.6  0.7          -0.3    -0.2    -0.3 
Chicken   0.6  0.6  0.5          -0.3        -0.5 
Fish   0.6  0.7  0.8    -0.7  -0.7            0.3 
Legumes   0.7      -0.7  0.3      0.7  -0.4    -0.2  0.5 
Egg         0.2          0.4    0.4   
Fruits    0.2  0.3    0.2  0.4    -0.2  0.2  0.4     
Vegetables   0.5  0.3  0.3  0.4  0.3  0.6            0.3 
Potato   0.6  0.4    0.3  0.4  0.5    0.2        0.4 
Maize meal   0.4  -0.2    0.2  -0.3  -0.3    0.3  0.6    0.4   
Rice  -0.2  0.3  0.3  -0.3  0.3          0.4     
Sugar   0.3    -0.2  0.2        0.7        0.4 
Bread           0.3  0.4    0.2  0.4    0.5  0.2 
Breakfast  
cereal  
      0.3    0.3        0.5  0.4   
Other 
cereal  
        0.5  0.2        0.3     
Fat    0.8  0.8  0.4  -0.7  -0.7            0.3 150 
 
4.5.5.4  Component 4 (described legumes, vegetable, potato, cereal, sugar and for 
HIV  infected  and  maize  meal,  egg,  bread  and  cereal  was  labelled 
carbohydrate, legumes and vegetable for HIV infected and staple based 2 
for HIV uninfected) 
 
The fourth dietary pattern in the HIV infected population recorded positive factor loadings 
for legumes, potatoes, fish, vegetables, sugar, bread and cereals. Negative factor loadings 
were  recorded  for  meat  and  chicken.  This  dietary  pattern  was  thus  referred  to  as 
carbohydrates with legumes and vegetables in  the HIV  infected. In  the  HIV uninfected 
population this dietary component  showed positive loadings for eggs, maize meal, bread, 
sugar and fat and negative loadings for milk and legumes. This dietary pattern therefore 
described a diet that was mostly made up of bread, cereals eggs and maize meal and was 
thus termed staple based 2 in the HIV uninfected population.  
4.5.6  Analysis of Variation between dietary patterns by HIV infection status 
Although  the  four  dietary  patterns  observed  within  the  study  population  were  similar 
between the HIV infected and uninfected subgroups, slight variations were observed for 
the factor loadings of the dietary components between the two groups. Thus a one-way 
analysis of variance was performed to test the significance of variations of factor loadings 
by  HIV  status  (Table  4.23).  Analysis  of  Variance  showed  no  statistically  significant 
differences  for  any  of  the  dietary  patterns  between  the  HIV  infected  and  uninfected 
populations. The first dietary component (animal based diet) recorded the highest F ratio 
(2.8) but this did not reach a statistical significance (p=0.09). Likewise, the other 3 dietary 
patterns failed to show significant F ratios and p values. The ANOVA results presented in 
Table 4.23 implied that the dietary patterns observed in this study population were similar 
between the HIV infected and uninfected population. 
 
 
Table 4.23: Summary of a one-way analysis of variance (F ratios and p values) for 
the  four  dietary  patterns  observed  in  the  study  population  between  HIV 
infected and uninfected subgroups 
 
 
 
 
 
 
 
 
 
ANOVA for dietary component between 
HIV infected and uninfected 
F ratio  P value 
Animal based diet 
 
Between Groups  2.8  0.090 
Recommended 
diet 
Between Groups  1.0  0.300 
Staple based diet 
1 
Between Groups  0.0  0.900 
Staple based 2  Between Groups  1.3  0.200 151 
 
4.5.7  Summary of dietary patterns 
Four dietary patterns were generated by PCA and these were not different between PLWH 
and the uninfected. The first and main pattern depicted an animal based dietary pattern 
with fruits and vegetables, the second described a varied or broad  based dietary pattern 
also referred as ‘recommended’ or ‘healthier’ option, the third pattern described a staple 
(maize meal) based dietary pattern for both HIV infected and uninfected groups and was 
labelled staple based and the fourth dietary pattern was referred as carbohydrate legumes 
and vegetables based in the HIV infected and staple based 2 in the HIV uninfected.  
4.6      Binary regression analysis to determine predictors of HIV infection 
The aim for this section was to show which baseline variables were significant predictors 
of HIV infection. In the first part comparison of means and frequencies (%) for the baseline 
anthropometric, biochemical, nutrients and foods intake/patterns were made to find if these 
variables were different between the HIV infected and uninfected. In this section further 
analysis was used to identify how these variables predicted HIV infection status in the 
study sample. Backward stepwise elimination binary logistic regression models were used 
to identify the most important independent predictors of HIV infection status.  
4.6.1  Identifying socio-demographic predictors of HIV infection status by binary 
logistic regression analysis 
Summary of the socio-demographic variables which were considered significant predictors 
of  HIV  infection  status  considering  all  the  variables  in  a  backward  stepwise  logistic 
regression analysis are presented  in Table  4.24. Age group  and stratum (urbanization 
status) were  the  variables  which significantly  influenced  (predicted)  HIV status.  All  the 
other  socio-demographic  variables  were  eliminated  in  the  final  step  of  the  regression 
analysis. In the final model, subjects who were 25-34 years were 1.2 times more likely to 
be in the HIV infected category and those who lived in informal (OR 1.8, 95% CI 1.2-2.8) 
and urban settlers (OR=2.1, 95% CI 1.4-3.2) were more likely to be in the HIV infected 
category  compared  to  rural  dwellers  and  those  who  lived  in  farms.  Thus  Logistic 
regression modelling showed age and stratum (urbanization level) as the most important 
and independent socio-demographic predictors of HIV infection. The odds of being HIV 
infected were highest within the 25-34 year olds, compared to the other age groups; and 
higher in informal and urban dwellers compared with the other urbanisation levels. 
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Table 4.24: Odds ratio, 95% confidence interval and p-values of backward 
regression analysis to identify the most important socio-demographic 
predictors of HIV status  
 
  N  Odds ratio  P value  95% C.I. for EXP(B) 
         Lower  Upper 
Residency           
Rural    1.0          
Farm  40  1.0  0.800  .5  1.6 
Informal settlements  88  1.8  0.009  1.2  2.8 
 Urban  603  2.1  0.000  1.4  3.2 
 Upper class  12  0.8  0.500  .4  1.5 
Age group           
 15-24  102  1.0       
25-34  186  1.3  0.600  0.6  2.2 
35-44  146  0.6  0.200  0.3  1.3 
45-54  132  0.4  0.030  0.2  0.9 
55-64  102  0.5  0.100  0.2  1.2 
 65+  75  0.6  0.200  0.2  1.4 
4.6.2  Summary of socio-demographic predictors of HIV infection status 
Age and urbanization levels were shown to be the significant predictors of HIV infection 
status. The  other socio-demographic variables  were eliminated  in  the  final  step  of  the 
backward  regression  analysis.  Study  participants  within  25-34  years  had  1.3  odds  for 
being HIV infected compared with the 15-24 year olds and informal and urban dwellers 
were 1.8 and 2.1 more likely to be HIV infected compared to rural and farm dwellers.  
4.6.3  Identifying the anthropometric predictors of HIV infection status by binary 
regression analysis 
A backward stepwise elimination binary regression analysis was used to identify which 
anthropometric variables were most important in modelling the association between HIV 
infection status and anthropometrics. In the first instance, the anthropometric indicators 
alone were used in the model whereas a further analysis including the relevant socio-
demographic indicators was also conducted. The reason for the second analysis was to 
show  which  anthropometric  indicators  predicted  HIV  infection,  controlling  for  socio-
demographic status. In the first model (without socio-demographic variables), body weight, 
body fat and triceps skinfold thickness and waist circumference remained in the final step 
of  the  regression  analysis  (Table  4.25).  This  implied  that  among  the  anthropometric 
variables, these were independent predictors of HIV infection status. Although BMI was 
not in the final model, subjects within BMI range above 25 kg/m
2 recorded an odds ratio of 
0.3  (p=0.100)  compared with subjects  within  the  underweight  group.  This  implied  that 
higher BMI was associated with less than half odds for HIV infection compared with a BMI 153 
 
<18.5kg/m
2.  HIV  infection  was  also  associated  with  lower  lean  body  mass  (OR=0.3, 
p<0.001), triceps (OR=0.2, p=0.002), supraspinal (OR=0.5, p=0.143) and thigh (OR=0.2, 
p=0.007) skinfolds, and waist circumference (OR=0.4, p=0.004). 
 
Table 4.25: Crude odds ratio, 95% confidence interval and p-values of important 
anthropometric predictors of HIV infection  
 Variable(s) entered on step 1: mass, stature, BMI, lean body mass, body fat, waist circumference, Triceps skinfold, PCA of 
BMI and LBM, waist-hip ratio, anthropometric score. Goodness of fit =0.2, Nagelkerke R square 0.2. 
 
On the other hand high body fat and iliac crest skinfolds were associated with higher odds 
for being HIV infected. Subjects within the upper thirds for body fat (OR) =4.7, (95% CI 1.1, 
17.7) and iliac crest skinfold (OR) =1.9, (95% CI=0.8-4.5) were more likely to be in the HIV 
infected  category  compared  with  subjects  within  the  lower  thirds.  Thus  among  the 
anthropometric  variables without  controlling  for the socio-demographic  parameters,  the 
odds of  being HIV infected were significantly higher for subjects with lower lean body 
mass, triceps and thigh skinfolds, and waist circumference but with higher body fat. 
 
When the association between the anthropometric variables and HIV infection status was 
adjusted  for  the  relevant  socio-demographic  variables,  the  results  were  similar  (Table 
    unadjusted 
odds ratio 
Statistical 
significance 
95.0% C.I. for 
odds ratio 
         Lower  Upper 
BMI  <18.5 kg/m
2   1.0          
18.5 to 24.99 kg/m
2  1.2  0.600  0.6  2.3 
> 25 .0 kg/m
2  0.4  0.100  0.1  1.2 
Lean body mass  lower third  1.0         
middle third  0.3  0.000  0.2  0.4 
upper third  0.3  0.000  0.2  0.4 
Body fat  lower third  1.0          
middle third  1.2  0.619  0.5  2.7 
upper third  4.7  0.008  1.1  17.7 
Waist circumference  lower third  1.0          
middle third  0.4  0.004  0.3  0.8 
upper third  0.6  0.100  0.3  1.2 
Triceps skinfold thickness  lower third  1.0          
middle third  0.3  0.002  0.2  0.7 
upper third  0.2  0.002  0.1  0.6 
Supraspinal skinfold 
thickness 
Lower third  1.0       
Middle third  1.2  0.589  0.6  2.3 
Upper third  0.5  0.143  0.2  1.3 
Iliac crest skinfold 
thickness 
Lower third  1.0       
Middle third  0.9  0.912  0.5  1.7 
Upper third  1.9  0.136  0.8  4.5 
Thigh skinfold thickness  Lower third  1.0       
Middle third  0.6  0.216  0.3  1.3 
Upper third  0.2  0.007  0.1  0.7 154 
 
4.26) because the same anthropometric variables (triceps skinfold thickness and body fat, 
lean body mass and waist circumferences) were retained in the final model. Lower triceps 
and thigh skinfolds, lean body mass and waist circumference were associated with higher 
odds for HIV infection whereas high body fat was associated with higher odds for HIV 
infection. Again, high BMI (p=0.08) was associated with lower odds for HIV infection. The 
socio-demographic parameters which remained in the model were urbanisation levels and 
age group. Compared to living in rural dwellers, informal settlement and urban dwellers 
were more likely to be HIV infected. The odds of HIV infection also decreased with age. 
Thus HIV infection prevalence was associated with subjects living in urban areas, with low 
lean body mass, BMI, waist circumference, triceps and thigh skinfolds but higher body fat. 
 
Table 4.26: Adjusted odds ratio, 95% confidence interval and p-values of the 
anthropometric predictors of HIV infection  
Goodness of fit =0.2, Nagelkerke R square 0.2. Adjustment was made for significant socio-demographic factors 
    Adjusted odds 
ratio 
Statistical 
Significance 
95.0% C.I. for  
odds ratio 
         Lower  Upper 
BMI  
 
 <18.5 kg/m
2  1.0         
18.5 – 24.99 kg/m
2  1.1   0.700  0.6  2.2 
 >25 kg/m
2  0.4  0.080  0.1  1.1 
Lean body mass  Lower third  1.0          
Middle third  0.3  0.000  0.2  0.6 
Upper third  0.3  0.000  0.2  0.5 
Body fat  Lower third  1.0          
Middle third  1.6  0.314  0.7  3.6 
Upper third  6.6  0.008  1.7  26.6 
Waist 
circumference 
Lower third  1.0          
Middle third  0.5  0.007  0.3  .8 
Upper third  0.6  0.200  0.3  1.3 
Triceps skinfold  Lower third  1.0          
Middle third  0.3  0.003  0.2  0.7 
Upper third  0.3  0.006  0.1  0.7 
Thigh skinfold  Lower third  1       
Middle third  0.5  0.117  0.2  1.2 
Upper third  0.1  0.0020  0.04  0.5 
Stratum 
(urbanisation 
level) 
Rural  1.0          
Farm  1.3  0.500  0.6  2.8 
Informal  1.6  0.100  0.9  3.0 
Urban  2.2  0.007  1.2  3.8 
Upper class  0.0  1.000  0.000   
Age group   15-24  1.0       
25-34  0.9  0.570  0.5  1.4 
35-44  0.8  0.461  0.4  1.4 
45-54  0.4  0.011  0.2  0.8 
55-64  0.5  0.047  0.2  0.9 
 65+  0.2  0.009  0.1  0.7 155 
 
4.6.4  Summary of anthropometric predictors of HIV infection 
In summary binary regression analysis showed that among the anthropometric variables 
considered together and adjusted for the most important socio-demographic parameters, 
HIV  infection  was  associated  with  higher  body  fat  (OR=6.6,  p<0.001)  and  iliac  crest 
skinfold  (OR=1.9,  p=0.147)  and  lower  lean  body  mass  (OR=0.3,  p<0.001),  waist 
circumference (OR=0.5, p=0.007), triceps (OR=0.3, p=0.006) and thigh (OR=0.1, p=0.002) 
skinfolds. Thus the independent  anthropometric predictors of  HIV infection status were 
lean body mass, waist circumference, triceps skinfold and body fat. High BMI also showed 
reduced likelihood for HIV infection but was not statistically significant.  
4.6.5  Identifying  the  biochemical  predictors  of  HIV  infection  status  binary 
regression analysis 
Backward regression models were used to determine the important biochemical markers 
associated  with  HIV  infection  status,  with  and  without  considering  socio-demographic 
status. This model recorded a Nagelkerke R and goodness of fit statistics of 0.2 each. The 
former suggested that about 20% of the observed variation for the biochemical variables 
within the study population could be explained by this model. A goodness of fit statistics of 
0.05 and above is acceptable and since the observed statistics was 0.2, the model was 
deemed appropriate in describing the population. 
 
The biochemical markers  which remained in  the final  step  of the  backward regression 
analysis without controlling for the socio-demographic variables were serum globulin, AST, 
haematocrit, LDL, HDL and calcium (Table 4.27). This implied that these parameters were 
independent predictors of HIV infection status in the study population. Higher levels of 
haematocrit, serum LDL, HDL and calcium were associated with lower odds for being HIV 
infected whereas high values for serum globulin and AST were associated with higher 
odds for being HIV infected.  
 
This implied that when all the biochemical markers were considered together the most 
relevant ones in terms of association with HIV infection status were haematocrit, LDL, 
HDL, calcium, globulin and AST. As serum AST and globulin levels increased the odds of 
being in the HIV infected category increased and as LDL, HDL, calcium and haematocrit 
status  increased,  the  odds  of  being  in  the  HIV  infected  category  reduced.  Serum 
haemoglobin, ALT, triglycerides, total cholesterol, vitamin A, vitamin E and albumin were 
eliminated at the final step of the backward stepwise analysis. Also, serum ALP, ALT and 
GGT were also eliminated at the final step of the regression analysis. This implied that 156 
 
when all the biochemical markers were taken into consideration, without controlling for 
socio-demographic parameters, these markers were not significant independent predictors 
of HIV status. 
 
Table 4.27: Crude odds ratios, 95% confidence intervals and p values for 
biochemical predictors of HIV infection status  
 
    Adjusted odds 
ratio 
P value  95% confidence interval 
for odds ratios 
 
 
       Lower limit   Upper limit 
LDL  Lower third  1.0         
Middle third  1.0  0.900  0.7  1.4 
Upper third  0.6  0.010  0.4  0.8 
Haematocrit 
  
 
Lower third  1.0          
Middle third  1.0  0.900  0.6  1.4 
Upper third  0.6  0.040  0.4  1.0 
Serum calcium 
 
Lower third  1.0          
Middle third  0.6  0.002  0.4  0.8 
Upper third  0.5  0.001  0.3  0.8 
Serum globulin  Lower third  1.0          
Middle third  1.7  0.040  1.2  2.7 
Upper third  4.4  0.000  2.8  6.7 
Serum AST 
 
Lower third   1.0         
Middle third  1.5  0.000  1.0  2.3 
Upper third  2.4   0.000  1.5  3.7 
Serum HDL 
 
Lower third  1.0         
Middle third  0.6  0.030  0.4  0.9 
Upper third  0.4  0.000  0.3  0.6 
Nagelkerke R =0.2, goodness of fit =0.2 and for adjusted model the Nagelkerke R and goodness of fit statistics were 
respectively 
 
Table 4.28 is a summary of odds ratios, statistical significance and 95% confidence for 
final  step  of  the  backward  logistic  regression  of  the  association  between  biochemical 
markers and HIV infection status controlling for important socio-demographic parameters. 
The Nagelkerke R recorded for this model was 0.3 which implied that about 30% of the 
variation within the population was explained by this model. The goodness of fit statistic for 
this model was 0.6 (not less than 0.05) which meant that this model was adequate or 
appropriate to describe the study population.  
 
The biochemical parameters which were shown to be significant independent predictors of 
HIV infection status in the controlled model were serum LDL, AST, globulin and albumin. 
Subjects within upper thirds for AST (OR 2.9, 95% CI 1.6-5.5) and globulin (OR= 7.2, 95% 
CI 3.4-13) were more likely to be HIV infected compared with those within lower thirds 157 
 
whereas subjects within upper and/or middle thirds for serum LDL (OR 0.5, 95% CI 0.3-
0.9) and serum albumin OR 0.5, 95% CI 0.3-0.9) were less likely to be in the HIV infected 
category  compared  with  subjects  within  lower  thirds.  This  meant  that  the  biochemical 
markers that distinguished the HIV infected from the uninfected group were serum AST, 
LDL, albumin and globulin and haematocrit (not statistically significant). 
 
Table  4.28  Adjusted  odds  ratios,  95%  confidence  intervals  and  p  values  for 
biochemical predictors of HIV infection status - adjusted for important socio-
demographic indicators 
 
 
 
 
 
 
 
 
Nagelkerke R =0.3, goodness of fit =0.6  
4.6.6  Summary of biochemical predictors of HIV infection 
In summary, binary logistic regression analyses have shown that among the biochemical 
markers, haematocrit and serum LDL, AST, globulin, albumin and direct bilirubin levels 
were  likely  independent  predictors  of  HIV  infection  status  within  the  study  population. 
 
Adjusted odds 
ratio 
Statistical  
Significance 
95.0% C.I. for 
Odds ratios 
        Lower  Upper 
Age  0.9   0.000  0.9  0.9 
smokers  0.6   0.010  0.3  0.9 
Farm dwellers  1.0   0.200       
informal dwellers  6.6   0.080  0.8  54.6 
Urban dwellers  8.3   0.040  1.03  67.0 
Upper class  0.0   0.900  0.0  . 
LDL         
Lower third  1.0          
Middle third  0.7   0.100  0.4  1.1 
Upper third  0.5   0.020  0.3  0.9 
AST         
Lower third  1.0          
Middle third  1.8   0.060  1.0  3.4 
Upper third  2.9  0.001  1.6  5.5 
Serum Globulin         
Lower third  1.0          
Middle third  2.3  0.009  1.2  4.4 
Upper third  7.2   0.000  3.4  13.0 
Serum Albumin         
Lower third  1.0          
Middle third  0.5  0.020  0.3  0.9 
Upper third  0.6  0.100  .  1.1 
Haematocrit         
Lower third  1.0          
Middle third  1.2   0.600  0.7  2.0 
Upper third  0.6   0.100  0.3  1.1 158 
 
Subjects with upper thirds for AST (OR 2.9, 95% CI 1.6-5.5) and globulin (OR= 7.2, 95% 
CI 3.4-13) were more likely to be HIV infected compared with those within lower thirds 
whereas subjects within upper and/or middle thirds for serum LDL (OR 0.5, 95% CI 0.3-
0.9), serum albumin OR 0.5, 95% CI 0.3-0.9) and haematocrit (OR 0.6, 95% CI 0.3-1.1), 
were less likely to be in the HIV infected category compared with subjects within lower 
thirds.  
4.6.7  Identifying  the  dietary  patterns  and  nutrient  predictors  of  HIV  infection 
status by binary regression analysis  
The final step of backward regression analysis showed that none of the dietary patterns 
predicted HIV infection status. None of the dietary patterns remained in the final step of the 
regression analysis (Figure 4.29). This implied that the four dietary patterns derived for the 
study  population  were  not  different  between  the  HIV  infected  and  their  uninfected 
counterparts. However, high intakes for red meat, chicken, eggs, fat, and potatoes were 
associated with the animal based dietary pattern whereas lower intakes of maize meal, 
bread and cereal were associated with  this dietary pattern, confirming that  this dietary 
pattern was predominantly animal based (Appendix VIa). On the other hand the predictors 
of  high  ‘recommended  or  healthy’  dietary  pattern  were  legumes, chicken,  potato,  rice, 
sugar, bread and cereal describing this dietary pattern to be varied and broad with low fat. 
Hence this pattern was denoted as ‘recommended’ (Appendix VIb). 
 
Table 4.29: Odds ratio, 95% confidence intervals and p values for dietary patterns as 
of HIV infection  
 
  Odds 
ratio 
P value  95.0% C.I. for odds ratio 
     Lower  Lower  Upper 
Step 
1(a) 
Animal based   0.9  0.468  0.8  1.1 
   Recommended   0.9  0.257  0.8  1.1 
   Staple based 1  1.1  0.251  0.9  1.3 
   Dietary pattern 4  1.1  0.259  0.9  1.3 
Step 
2(a) 
Recommended   0.9  0.282  0.8  1.1 
   Staple based 1  1.1  0.266  0.9  1.3 
   Dietary pattern 4  1.1  0.252  0.9  1.3 
Step 
3(a) 
Staple based 1  1.1  0.257  0.9  1.3 
   Dietary pattern 4  1.1  0.254  0.9  1.3 
Step 
4(a) 
Staple based 1  1.1  0.254  0.9  1.3 
Step 5  constant         
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4.6.8  Binary logistic regression to model the association between dietary nutrient 
intake and HIV infection status  
 
 Table 4.30: Odds ratio, 95% confidence intervals and p values for nutrients which 
predicted HIV infection - crude and socio-demographic adjusted 
 
Variable(s) entered on step 1: energy, total protein, total fat, % energy from fat, saturated fat, monounsaturated fat, 
polyunsaturated fat, cholesterol, fibre, calcium, iron, pantothenic acid, biotin, vitamin A, thiamine, riboflavin, vitamin D, 
vitamin E, nicotinamine, folate, ascorbic acid, zinc, copper and sodium. Nagelkerke R =0.01, goodness of fit statistic = 0.7 
 
Without adjusting for the socio-demographic variables total energy and ascorbic acid were 
the only nutrients that remained in the final step of the regression model (Table 4.30). This 
implied that total energy and ascorbic acid intakes were the most important predictors of 
HIV  infection  in  the  study  population  considering  all  the  nutrients.  For  total  energy, 
subjects within the upper thirds of intake groups were 1.5 times more likely to be HIV 
infected compared with subjects within the lowest third. There was no difference in odds 
ratio between the lowest and middle third groups implying that only high differences in 
  Adjusted 
odds ratio 
significance  95% confidence interval of 
odds ratio 
Without socio-demographic characteristics  Lower  Upper 
Total energy         
Lower third   1.0         
Middle third  1.0  1.000  0.7  1.5 
Upper third  1.5  0.040  1.0  2.1 
Ascorbic acid         
Lower third   1.0         
Middle third  1.4  0.060  0.1  2.0 
Upper third  0.9  0.500  0.6  1.3 
With socio-demographic variables     
Total protein         
Lower third  1.0          
Middle third  1.5  0.070  1.0  2.3 
Upper third  2.2  0.002  1.3  3.6 
Total cholesterol         
Lower third  1 .0         
Middle third  0.5  0.020  0.3  0.9 
Upper third  0.2  0.001  0.1  0.5 
Vitamin D         
Lower third  1.0          
Middle third  1.1  0.700  0.6  2.0 
Upper third  2.8  0.020  1.1  6.8 
Socio-demographic variables which remained in final model 
Rural dwellers  1.0   0.200       
Farm dwellers  9.0  0.030  1.2  67.9 
Squatter camps  7.2  0.050  1.0  52.9 
Township  0  1.000  0   160 
 
intakes  for  energy  within  the  study  group  were  associated  with  HIV  infection.  This 
observation could also mean that the HIV infected subjects consumed more energy than 
the HIV infected.  
 
The difference in odds ratio between the lowest and upper thirds of intake for energy was 
statistically significant (p=0.04, 95 CI 1.1, 2.1). With regards to ascorbic acid the direction 
of odds ratio was opposite. Subjects within the highest third of intake recorded the least 
odds ratio whereas subjects within the lowest middle third showed the highest odds ratio. 
Thus a trend of increasing odds of HIV infection with vitamin C intake seemed to show 
from the lower to the middle thirds of vitamin C intake followed by decreasing odds as 
intakes increased from the middle to the highest third. Statistically, this observation was 
not significant.   
 
In the socio-demographic adjusted regression analysis however the most important dietary 
nutrient predictors of HIV infection status seemed to be different. In the final, vitamin D, 
total cholesterol and total protein were the nutrients which remained in the model and not 
ascorbic acid and energy (Table 4.30). Total cholesterol intakes seemed to increase with 
decreasing  odds  of  HIV  infection  whereas  total  protein  and  vitamin  D  intakes  were 
associated with increasing odds of HIV infection. This implied that as intakes of dietary 
protein and vitamin D increased, odds being HIV infected also increased. It could also 
have meant that the HIV infected subjects consumed more vitamin D and protein than the 
HIV uninfected. For total cholesterol, the trend of association was in the opposite direction 
as  odds  ratios  decreased  with  increasing  intakes.  Subjects  in  the  upper  third  of  total 
cholesterol consumption recorded odds ratio of 0.2 (95% CI 0.1 to 0.5) compared with the 
lowest  third  of  cholesterol  intakes  implying  that  HIV  infected  subjects  consumed 
significantly more cholesterol than the HIV uninfected or that the higher the intake of total 
dietary cholesterol, the lower  the chances that a subject belonged to  the HIV  infected 
category. 
4.6.9  Summary of dietary nutrient predictors of HIV infection 
In  summary  regression  analysis  showed  that  none  of  the  dietary  patterns  significantly 
predicted  HIV  infection  status  implying  that  dietary  patterns  were  not  different  by  HIV 
infection status. High intake of red meat, chicken, eggs, fat, and potato were associated 
with the predominantly animal based dietary pattern and this confirmed the description of 
this dietary pattern as predominantly animal based. For dietary nutrient intake, regression 
analysis  showed  that  total  energy  and  ascorbic  acid  were  the  only  nutrients  which 161 
 
predicted HIV infection status without controlling for socio-demographic characteristics. In 
the adjusted model, ` total  cholesterol,  total  protein  and  vitamin  D  were  significant 
independent  predictors  of  HIV  infection  status.  Lower  total  cholesterol  but  higher  total 
protein and vitamin D were associated with HIV infection. 
4.7  Chapter Summary 
In  the  total  population  and  also  by  gender,  HIV  prevalence  seemed  to  decrease  with 
increased age and the highest prevalence was in the 25-34 year olds. HIV infection was 
most prevalent  in never married, Tswaana speakers with lower educational attainment 
(below standard 6) and a household income less than 1000R (about £62) irrespective of 
gender. Prevalence was also highest in urban dwellers, followed by the informal settlers 
compared with the other urbanisation levels and smokers compared with non-smokers. 
Statistically,  the  differences  in  HIV  prevalence  observed  were  significant  for  stratum 
(urbanisation level) and age group in the total population but for only stratum within the 
male  and  female subgroups and  binary  logistic  regression  modelling  showed  age and 
urbanisation level as independent predictors of HIV  infection  status. Study  participants 
within 25-34 years had 1.3 odds for being HIV infected compared with the 15-24 year olds 
and informal and urban dwellers were 1.8 and 2.1 odds respectively for being HIV infected 
compared to rural and farm dwellers. 
 
Means for anthropometric indices were similar between the HIV infected and uninfected. 
PCA revealed two main anthropometric patterns: the first pattern depicted the variation 
between  subjects  with  higher  lean  body  mass,  body  weight,  BMI,  triceps,  waist 
circumference, body fat and fat percent and those with higher stature (height) and waist-to-
hip  ratio.  Analysis  of  variance  of  the  first  anthropometric  pattern  did  not  reveal  any 
statistical significance, implying that the HIV infected and uninfected were generally not 
different in terms of anthropometric profile. Binary regression analysis showed that among 
the  anthropometric  variables  considered  together  and  adjusted  for  the  most  important 
socio-demographic  parameters,  HIV  infection  was  associated  with  higher  body  fat 
(OR=6.6, p<0.001) and iliac crest skinfold (OR=1.9, p=0.147) and lower lean body mass 
(OR=0.3,  p<0.001), waist  circumference  (OR=0.5,  p=0.007),  triceps  (OR=0.3,  p=0.006) 
and thigh (OR=0.1, p=0.002) skinfolds. Thus the independent anthropometric predictors of 
HIV infection status were lean body mass, waist circumference, triceps skinfold and body 
fat. High BMI also showed reduced likelihood for HIV infection but was not statistically 
significant.  
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In terms of the biochemical parameters, profound differences were observed between the 
HIV infected and uninfected groups, for the total population and also by gender. The HIV 
infected subjects had significantly higher serum AST (p=0.000) and ALT (p=0.000) levels; 
higher  serum  total  proteins  (p=0.000)  and  globulin  (p=0.000)  than  the  HIV  uninfected 
group.  The  HIV  uninfected  on  the  other  hand  had  higher  haemoglobin  (p=0.008)  and 
haematocrit (p=0.000); and higher serum HDL (p=0.000), LDL (p=0.04), total cholesterol 
(p=0.000),  albumin  (p=0.000)  and  triglycerides  (p=0.03).  Binary  logistic  regression 
analyses confirmed these differences revealing that that among the biochemical markers, 
haematocrit and serum LDL, AST, globulin, and albumin were independent predictors of 
HIV infection status within the study population. Subjects within upper thirds for AST (OR 
2.9, 95% CI 1.6-5.5) and globulin (OR= 7.2, 95% CI 3.4-13) were more likely to be HIV 
infected compared with  those within  lower thirds whereas subjects within  upper  and/or 
middle thirds for serum LDL (OR 0.5, 95% CI 0.3-0.9) and serum albumin (OR 0.5, 95% CI 
0.3-0.9) were less likely to be in the HIV infected category compared with subjects within 
lower thirds. 
 
Four dietary patterns were generated by PCA and these were not different between PLWH 
and the uninfected. The first and main pattern depicted an animal based dietary pattern 
with fruits and vegetables, the second described a varied or broad  based dietary pattern 
also referred as ‘recommended’ or ‘healthier’ option, the third pattern described a staple 
(maize meal) based dietary pattern for both HIV infected and uninfected groups and was 
denoted staple based and the fourth dietary pattern was referred as carbohydrate legumes 
and  vegetables  in  the  HIV  infected  and  staple  based  2  in  the  HIV  uninfected.  Using 
regression analysis high intake of red meat, chicken, eggs, fat, and potato predicted the 
first dietary pattern confirming that this dietary pattern was predominantly animal based. 
However, none the dietary patterns predicted HIV infection status suggesting that patterns 
of dietary intake were not different by HIV infection status.  
 
Dietary  nutrient  intake was  similar  between  the  HIV  infected and  uninfected  when  the 
males and females were analysed separately. However in the combined population total 
energy intake was significantly higher in the HIV infected (F ratio =4.5, p=0.03). Moreover, 
the  HIV  infected  population  consumed  more  polyunsaturated  fat  (p=0.04)  and  fibre 
(p=0.04) than the uninfected group. Three main dietary nutrient patterns were generated 
by  PCA  and  these  were  not  different  between  the  HIV  infected  and  uninfected  using 
ANOVA. The first pattern explained majority (about 58%) of the variability within the study 163 
 
population and showed large positive factor loadings for all the nutrients. This implied that 
this nutrient profile was likely to be more desirable compared with the second and third 
nutrient patterns which showed positive loadings for some nutrients. In the final model of 
the  backward  binary  regression  analysis,  total  energy  and  ascorbic  acid  were  the  two 
nutrients which independently predicted HIV infection status without controlling for socio-
demographic  characteristics.  When  controlled  for  significant  socio-demographic 
characteristics, total cholesterol, total protein and vitamin D were significant independent 
predictors  of  HIV  infection  status.  Lower  total  cholesterol  but  higher  total  protein  and 
vitamin D were associated with HIV infection. 
4.8  Chapter Discussion 
4.8.1  Discussion  of  baseline  Socio-demographic  characteristics  of  the  study 
population 
In  the  total  population  and  also  by  gender,  HIV  prevalence  seemed  to  decrease  with 
increased age and the highest prevalence was in the 25-34 year olds. HIV infection was 
most prevalent  in never married, Tswaana speakers with lower educational attainment 
(from  none  to  standard  6-8)  and  a  household  income  less  than  1000R  (about  £62) 
irrespective of gender. Prevalence was also highest in urban dwellers compared with the 
other strata and smokers compared with non-smokers. Statistically, the differences were 
significant for urbanisation level and age in the total population but for only urbanisation 
level when HIV prevalence was compared in males and females. However HIV infection 
was  more  prevalent  in  male  smokers  than  non-smokers,  whereas  in  the  females  HIV 
infection was more prevalent in non smokers than smokers. This was probably due to the 
fact that the females were predominantly non-smokers.  
 
Logistic regression modelling showed age and stratum (urbanisation level) as the most 
important and independent socio-demographic predictors of HIV infection. The odds for 
HIV infection decreased with age and increased with urbanisation. This implied that socio-
demographic  status  influenced  HIV  prevalence  in  the  study  population.  Studies  have 
shown that socio-economic and life style factors might predispose people to HIV infection 
in South Africa. For instance in a cross sectional survey to understand the relationship 
between  HIV,  gender,  race  and  socio-economic  status  among  South  Africans,  Zungu-
Dirwayi and colleagues reported an association between HIV and gender, race and socio-
economic confirming what this study found (Zungu-Dirwayi et al., 2007).  
 164 
 
Zungu-Dirwayi and colleagues also reported that HIV prevalence was highest in 25-35 
years  and  36-49  years  male  and  female  African  educators  (or  those  who  taught) 
respectively.  Also,  subjects  with  higher  income  and  higher  education  had  higher  HIV 
prevalence in this study. This probably might be due to the fact that high income earners 
lived  in  urban  areas  where  HIV  prevalence  was  higher.  High  income  could  also  be 
associated with  increased high  risk  factors  such  as  multiple  sexual  partners and  drug 
abuse commonly found again in urban populations. Migration and marital status were also 
found to play a role in HIV infection status (Zungu-Dirwayi et al., 2007) just as found by 
this  study  which  showed  an  increased  odds  for  HIV  infection  within  informal  dwellers 
compared with rural and farm dwellers.  
 
Connolly et al., (2004) in a study of South Africans recorded an HIV infection prevalence of 
11.4%, similar to the prevalence in this particular population. HIV prevalence was also 
found to be higher in informal settlements in urban areas by Connolly et al., 2004 similar to 
this population which showed the highest odds for infection for people living in squatter 
camps (informal urban dwellers). The findings within this population were also consistent 
with  South  African  Department  of Health  estimates.  In trying to  understand the sexual 
behaviours of HIV infected patients in South African, Lurie et al., (2008) found that urban 
residents  were  more  likely  to  use  condom  consistently  than  rural  partners.  Thus  HIV 
infection should be less prevalent in urban dwellers, contrary to the findings of this study. 
However this contrast could be due to other factors associated with urbanisation such as 
more income, affluence and education which could predispose individual to the risk factors 
of HIV infection.  
 
In terms of marital status, HIV infection was more prevalent in non married South Africans 
similar  to  findings  by  Shisana  et  al.,  2004,  who  reported  a  higher  prevalence  of  HIV 
infection in non married South Africans though not statistically significant. The reasons 
again could be attributable to the fact that the non married were likely to be younger and 
probably  more  sexually  active  and  could  also  be  associated  with  lifestyles  that  are 
associated with increased HIV infection, such as low condom usage and multiple sexual 
partners (Lurie et al., 2008). 
 
The  findings  also  showed  a  trend  of  increasing  HIV  prevalence  with  decreasing 
educational attainment. The group with the highest HIV prevalence in terms of educational 
attainment  was  those  below  standard  6  and  the  group  with  the  least  prevalence  was 165 
 
subjects within the highest educational attainment group (that is those within the standard 
9-10, academic group). Similarly, in the male and female subgroups, HIV infection was 
again most prevalent in the group with lower education and least in the highest educational 
level. HIV infection prevalence in this study group thus tended to increase with decreasing 
educational attainment in line with findings from other studies (Nyindo, 2005) carried out in 
both South Africa and in other countries within the Sub Saharan region which have shown 
that  illiteracy  and  ignorance of  ones status  among  other  factors were associated  with 
higher HIV prevalence. However, these findings also contradict other findings which have 
shown that individuals with higher education had high prevalence because of increased 
risk behaviours within such groups (Smith et al., 1999). Education could be confounded by 
urbanisation level since HIV infection was more prevalent in urban areas, which is usually 
associated with higher education and literacy. 
 
However,  considering  the  various  socio-demographic  variables  together  in  a  logistic 
regression analysis showed that the only independent predictors of HIV infection were age 
and urbanisation level. HIV infection was highest in urban and informal dwellers and within 
25-34 years of age. This implied that although the other socio-demographic variables were 
likely to be important, the effects of these variables could be modified or confounded by 
other socio-demographic variables.  
4.8.2  Discussion of biochemical and serum nutrients status findings 
The  differences  in  biochemical  parameters  between  the  HIV  infected  and  uninfected 
population could be indicative of altered metabolism in the HIV infected. The HIV infected 
population recorded higher means for serum AST (p=0.000) and ALT (p=0.000) levels; 
serum total proteins  (p=0.000)  and globulin (p=0.000) compared to the  HIV uninfected 
group.  The  HIV  uninfected  on  the  other  hand  had  higher  haemoglobin  (p=0.008)  and 
haematocrit (p=0.000); and higher serum HDL (p=0.000), LDL (p=0.04), total cholesterol 
(p=0.000) albumin (p=0.000) and triglycerides (p=0.03).  
 
Among  the  biochemical  markers,  serum  LDL,  AST,  globulin  and  albumin  were 
independent predictors of HIV infection status within the study population. This implied that 
the  HIV  infected  subjects  were  different  from  the  uninfected  by  these  biochemical 
parameters. Subjects in the upper thirds for serum AST and globulin were 2.9 and 7.2 
times respectively more likely to be HIV infected implying that serum AST and globulin 
levels were much higher in the HIV infected groups and predicted HIV infection whereas 
subjects  within  the  lower  thirds  for  albumin  (p=0.02),  LDL  (p=0.02),  and  haematocrit 166 
 
(p=0.1)  were  associated  with  lower  odds  for  HIV  infection.  These  findings  meant  that 
marked  differences  existed  in  levels  of  these  biochemical  markers  between  the  HIV 
infected and uninfected.  
 
Regarding a general biochemical profile derived from principal component analysis, the 
HIV infected seemed to exhibit a less desirable status. The relatively higher serum liver 
enzymes,  lower  serum  albumin  associated  with  higher  serum  LDL  but  low  HDL  was 
suggestive  of  altered  metabolism,  chronic  inflammation,  possible  liver  damage  and 
malnutrition. There is evidence of visceral abnormal visceral fat distribution in HIV infected 
patients,  and  inflammatory  changes  in  HIV  infected  patients  drive  the  initiation, 
progression and, ultimately, thrombotic clinical complications induced by atherosclerosis. 
Visceral adipose tissue, a virtual factory for manufacturing pro-inflammatory mediators, 
affects the liver function. The inflamed liver promotes the development of pro-atherogenic 
dyslipidaemia (De-Lorenzo et al., 2008). Low serum albumin levels were associated with 
rapid HIV disease progression and were strong independent prognostic factors for risk of 
AIDS and death regardless of gender in some studies (Shah et al., 2007 and Feldman et 
al., 2000).  
 
Although  dietary  patterns  and  anthropometrics  were  quite  similar  between  the  HIV 
uninfected  and  infected,  the  serum  markers  of  nutritional  and  metabolic  status  were 
markedly different. Thus altered metabolism and probably liver damage associated with 
the  chronic  inflammatory  process  (Harris,  2008)  were  already  manifested  in  the  HIV 
infected population. This coupled with the fact that the HIV infected were asymptomatic 
probably implied that biochemical markers of disease progression may deteriorate at early 
stages of the infection when AIDS related illnesses have not began to manifest. 
 
Among the  serum  micronutrients measured, the  HIV infected groups  had lower serum 
vitamin A (p=0.07) than the HIV uninfected. The HIV infected had slightly lower serum 
vitamin  E,  B6,  B12  and  folate.  In  the  regression  model  however,  none  of  the  serum 
micronutrients  were  significant  independent  predictors  of  HIV  infection  status.  It  is 
important  to note  that  for  these  micronutrients,  data  were  available  on  fewer  subjects 
compared to the other biochemical markers. In fact less than 50 subjects had data for 
these micronutrients and this could have resulted in inadequate powered study to observe 
a significant difference. Moreover, the lack of statistical significance did not necessarily 
mean that these differences were not significant biologically. 167 
 
  
Reviewing  the  literature,  micronutrients  supplementation  was  found  to  increase  serum 
micronutrients status in PLWH and high plasma micronutrients status (vitamin A, B12, zinc, 
selenium and magnesium) was associated with improved CD4 cell count, and delayed 
disease progression. Micronutrient supplementation including selenium, zinc, vitamins B12, 
vitamin A, vitamin B1, C and niacin  have been associated with lower mortality or risk of 
dying in HIV infected studies (Austin et al., 2006; Baum et al., 2003, 1997, and 1995; 
Fawzi et al., 2004; Jiamton et al., 2003; Tang et al., 1993). Tang and colleagues however 
found HIV infected subjects who took vitamin A supplements above 4-5 times the RDA 
progressed faster and had higher risk of mortality than those whose intakes were 2-3 times 
the RDA, suggesting that very high doses of vitamin A could be toxic (Tang et al., 1993). 
However, the findings of this study did not support the above literature and the above 
study probably due to the reasons mentioned in the last paragraph. 
ALT, AST, and GGT, are liver enzymes whose serum levels could indicate liver damage 
and dysfunction in humans (Patel et al., 2007; Arndt et al., 1998). ALT and AST are both 
present in hepatocytes and their levels are raised during acute liver damage because they 
leak into the blood when liver cells are damaged (Kumar and Clark, 1999).  ALP is an 
enzyme in the lining of the biliary ducts of the liver and its levels are raised with large bile 
duct obstruction or infiltrative diseases of the liver. Bilirubin is formed by the breakdown of 
haeme and the liver clears the blood of bilirubin by taking it up into the liver, conjugating 
and then secreting it into the bile. Raised serum levels of bilirubin could therefore be an 
indication of liver problems among other factors. GGT levels could also be elevated in liver 
disease (Kumar and Clark, 1999). Certain studies have also shown that raised levels of 
these  enzymes  could  be  indicative  of  an  inflammatory  response  to  the  HIV  infection 
(Sterling et al., 2008; Livry et al., 2003; Rathi et al., 1997; Ejilemele et al., 2007; Ofotokun 
et al., 2007).  
Alcohol intake has also been shown to be a determinant of elevated serum liver enzyme 
(Whitehead  et al., 1996).  However some studies have also indicated  that body  weight 
rather than alcohol consumption may be the major factor in determining the serum level of 
liver enzymes (Lee et al., 2001) and many studies have shown a relationship between 
body weight and/or BMI and abnormal liver enzyme levels (Lee et al., 2001; Robinson and 
Whitehead, 1989; Khedmat et al., 2007). Moreover associations between increased liver 
enzymes  and  dyslipidaemia  (Khedmat  et  al.,  2007)  and  in  Anorexic  Nervosa  patients 
(Fong et al., 2008) have been reported.   168 
 
For the liver enzymes, serum AST, ALT and GGT and ALP were all shown to be relatively 
higher in the HIV infected compared to the uninfected. However, serum AST was the only 
independent predictor of HIV infection status. The relative increase of these enzymes in 
the HIV  infected  compared with  the uninfected counterparts coupled with lower  serum 
albumin  in  PLWH  was  suggestive  of  chronic  inflammation,  liver  damage  and  altered 
metabolism which could be due to the HIV infection. 
Elevated  liver  enzyme  levels  are  common  in  many  studies  involving  HIV  infected 
populations (Sterling et al., 2008; Livry et al., 2003; Rathi et al., 1997; Ejilemele et al., 
2007; Ofotokun et al., 2007) and not associated with alcohol abuse, hepatitis or genetic 
liver disease (Ingiliz et al., 2008). Some studies showed increased enzymes levels in HIV 
infection receiving anti-retroviral therapy (Maida et al.,. 2006; Stapleton et al., 2007; Ingiliz 
et  al.,  2008),  whereas  for  some  other  studies,  changes  in  these  enzymes  were  not 
associated with anti retroviral treatment (Torti et al., 2005; Livry et al., 2003). Hence the 
relative higher levels of these enzymes in the present study confirmed the findings from 
other  studies. What  could  not  be  established  at  this  point  was  whether  elevated  liver 
enzymes were consequence of HIV infection or whether prior to being infected, subjects 
within  the  HIV  infected  group  had  other  diseases  which  could  have  raised  their  liver 
enzymes and this was likely. However,  the relatively differences between the  two HIV 
groups in a supposedly asymptomatic PLWH and probably early stage of HIV infection 
was  indicative of early alterations  in metabolic  integrity  and liver damage, which could 
have dire consequences on disease progression in later stages (De-Lorenzo et al., 2008).  
 
Among  the  serum  lipids,  the  HIV  uninfected  had  higher  serum  HDL  (p=0.000),  LDL 
(p=0.04),  total  cholesterol  (p=0.000)  than  the  infected.  Backward  regression  analysis 
showed  that  HIV  infection  was  associated  with  lower  LDL  and  HDL.  However  when 
controlled  for  socio-demographic  factors,  serum  LDL  was  the  only  parameter  which 
independently predicted HIV infection status. Several studies have reported changes in 
serum lipid profile in HIV infection and since the early days of the HIV epidemic, the effects 
of HIV disease on serum lipids have been described. Studies reported low cholesterol and 
high triglyceride levels in patients with advanced HIV disease (Grunfield et al., 1989 and 
1992; Constans et al.,1994; Kotler et al., 1985). These were however studies involving 
subjects who were not on antiretroviral drugs and were in later stages of HIV infection. 
Constans  and  colleagues  found  that  in  HIV-positive  patients,  regardless  of  CD4 
lymphocyte count, HDL-C and apoA1 were lower than controls and lowered cholesterol 
was associated with low CD4 cell count (Constans, 1994).   169 
 
Baza-Caraciolo and colleagues found  that HIV infected  patients  had lower cholesterol, 
HDL  and  higher  rates  of  cardiovascular  diseases.  They  concluded  that  untreated  HIV 
infected patients’ lipid profile was different from the  HIV uninfected subjects and there 
were decreases in HDL from the beginning of the infection that persist along all the CD4 
levels (Baza-Caraciolo et al., 2007). The findings of the present study showed lower total 
cholesterol and HDL in the HIV infected group consistent with these studies and if lowered 
cholesterol was associated with lower CD4 cell count and lower HDL was associated with 
higher cardiovascular diseases risk, then it was likely that HIV infection was progressing 
although the PLWH were asymptomatic. Also decreases in HDL in HIV infection could 
multiply  global  CVR  in  HIV  infected  individuals,  independently  of  other  risk  factors. 
Moreover,  changes  in  lipid  profile  for  this  HIV  infected  could  indicate  altered  lipid 
metabolism just as observed for the liver enzymes. 
Studies have shown that HAART treatment among HIV infected persons was associated 
with high serum lipid levels and increased risk for cardiovascular disease (Koppel et al., 
2000). A significant number of the HAART patients had very high levels
 of Lipoproteins 
and various combinations of increased lipid values
 associated with considerably increased 
risk for CHD (Koppel et al., 2000). El-Sadir and colleagues also showed that PLWH with 
less advanced HIV disease, i.e. higher CD4 lymphocyte count and lower HIV RNA, were 
more likely to have higher HDL cholesterol concentration (El-Sadir et al., 2005). They also 
demonstrated that low CD4 lymphocyte count, high HIV RNA level and a history of AIDS-
defining  events,  all  markers  of  more  advanced  HIV  disease,  were  all  associated  with 
higher concentrations of VLDL cholesterol and  triglycerides (Sadir  et al.,  2005). These 
studies were in subjects on antiretroviral treatment which implied that HAART may even 
predispose HIV infected subjects to unfavourable lipid profiles and thus increase risk for 
cardiovascular diseases in PLWH. Riddler et al., (2003) also reported significant increases 
in total cholesterol, LDL, HDL which could predispose subjects to cardiovascular disease. 
Thus  the  HIV  infected  subjects  could  be  burdened  with  the  need  to  delay  disease 
progression  as  well  as  prevent  chronic  diseases  such  as  CVDs  as  well  as  metabolic 
alterations  that  could  arise  from  HAART  use  and  the  chronic  inflammatory  process. 
Adequate nutritional status would be crucial and more so in the HAART era to prevent 
rapid and uncontrollable wasting and altered metabolism (altered serum lipid profiles) and 
dietary intake could play an important role in this regard.  170 
 
Among the serum proteins, HIV infection was associated with lowered serum albumin and 
high  serum  globulin  and  total  proteins.  High  serum  globulins  and  low  albumin  were 
associated with HIV infection status in this present population. Subjects in higher globulin 
were more likely to be HIV infected (OR= 7.2, 95% CI 3.4-13) whilst those in relatively 
lower levels for albumin (OR 0.5, 95% CI 0.3-0.9) had higher odds of being HIV infected, 
implying  that  the  HIV  infected  had  significantly  high  serum  globulin  and  low  albumin 
concentrations. Low albumin in HIV infection as mentioned earlier could be due to chronic 
inflammation malnutrition, liver disease and some other conditions. Since inflammation is a 
major  feature  of  HIV  infection,  these  findings  thus  confirmed  that  inflammation  was 
common in this population. Also lowered serum albumin could be indicative of disease 
progression (Shah et al., 2007; Mehta et al., 2006; Feldman et al., 2000; Graham et al., 
2007) as observed in literature. 
In summary, the HIV infected and uninfected in terms biochemical parameters showed 
differences in status compared with all other markers of nutritional status on. The findings 
were  suggestive  of  increase  chronic  inflammation,  altered  metabolism  and  possible 
disease progression in the HIV infected population even at supposedly asymptomatic and 
probably earlier stages of HIV infection in which the present study population belonged to.  
4.8.3  Discussion of anthropometric findings 
Malnutrition and weight loss have been recognized as common and major complications of 
HIV infections (Mulligan et al., 2005; Tang, 2003; Summerbell, 1994; Kotler et al., 1989; 
Kotler, 1989), which may occur from the onset (Ott et al., 1993) or more frequently in the 
later stages of the disease (Ysseldyke, 1991) and associated with disease progression 
and mortality (Villarmor et al., 2005; Steinhart, 2001; Mangili et al., 2006). The impact of 
malnutrition, even if mild, has been shown to be clearly adverse on the outcome of HIV 
infection (Süttmann, 1996) and malnutrition have also been shown to accelerate disease 
progression  in  HIV  (Oguntibeju et  al.,  2007). Thus,  malnutrition  must  be  prevented or 
treated  in  order  to  enhance  the  survival  and  well  being  of  the  infected.  Opportunistic 
infections can cause symptoms such as diarrhoea, nausea, vomiting and pain (Kalrsson & 
Nordstrom, 2001) and can cause loss of more than 5% of normal weight in less than 28 
days (Nerad & Gorbach 1994). Thus, such cut-offs are used in many studies as criteria for 
wasting. Patients can however maintain a normal weight in the absence of opportunistic 
infections but in most instances these secondary infections prevent weight maintenance in 
PLWH.  
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In  the  present  analysis  comparison  of  the  means  for  the  various  anthropometric 
parameters (body weight, height, BMI, lean body mass, body fat, triceps skinfold thickness 
and  waist  circumference)  between  the  HIV  infected  and  uninfected  did  not  show  any 
statistically  significant  differences  although  absolute  differences  were  observed.  This 
implied  that  the  HIV  infected  group  was  similar  anthropometric-wise  to  the  general 
population in which they belonged. The most likely explanation for this finding was the fact 
that the HIV infected population for this study was asymptomatic and thus subjects were 
unlikely to be experiencing any AIDS defining illnesses or wasting syndrome. In the design 
of this study, subjects who had fever or ill were excluded and the final study population 
were apparently healthy. The HIV infected subjects were also unaware of their HIV status 
which also confirmed the fact that these subjects were unlikely to be experiencing any 
symptoms. 
 
Although, none of the anthropometric parameters were different between the HIV infected 
and  uninfected  populations  as  shown  by  the  mean  values,  further  analyses  using 
regression analysis revealed that anthropometric status was an important predictor of HIV 
infection  in  the  present  study  population.  A  backward  stepwise  elimination  regression 
analysis  showed  that  among  the  anthropometric  variables  considered  together  and 
adjusted  for  the  most  important  socio-demographic  parameters,    HIV  infection  was 
associated  with  higher  body  fat  (OR=6.6,  p<0.001)  and  iliac  crest  skinfold  (OR=1.9, 
p=0.147) and lower  lean body mass (OR=0.3, p<0.001), waist circumference (OR=0.5, 
p=0.007), triceps (OR=0.3, p=0.006) and thigh (OR=0.1, p=0.002) skinfolds. High BMI also 
showed reduced likelihood for HIV infection but was not statistically significant. There was 
a tendency of changes in some other skinfold measures such as supraspinal (OR=0.5, 
p=0.143) skinfold.  
 
Thus it was observed that although BMI did not predict HIV status in this population, the 
odds  for being  HIV  infected  increased  in  subjects with  higher  body  fat and  iliac crest 
skinfold thickness and those with lower lean body mass, waist circumference, triceps and 
thigh skinfolds. This  finding was suggestive of early changes in body composition and 
abnormal  fat  distribution  (lipodystrophy)  observed  in  HIV  infection  (Shlay  et  al.,  2004; 
McDermott et al., 2005; Guaraldi et al., 2008). The finding is very significant in that in this 
asymptomatic HIV  infected group who were ‘healthy’,  unaware of  their  HIV status and 
probably in early stages of the infection, changes in body composition and fat distribution 
were clearly observable depicting altered metabolism, as shown by other studies (Shlay et 172 
 
al., 2004; McDermott et al., 2005; Guaraldi et al., 2008; Noor et al., 2001; Vigouroux et al., 
1999; Hadigan et al., 2001; Carr and Cooper, 1998; Walli et al., 1998). 
 
In literature, low BMI and body weight (severe wasting and weight loss) due to the rapid 
and unintentional weight loss associated with HIV infection (Malvy et al., 2001; Sharpstone 
et  al.,  1999)  occurs  mainly  in  symptomatic  HIV  and  AIDS  (Ngoma  et  al.,  2008; 
Ausayakhun et al., 2003). Abnormal patterns of fat distribution, dyslipidaemia and insulin 
resistance have been observed in HIV infected patients receiving HAART (Noor et al., 
2001; Vigouroux et al., 1999; Hadigan et al., 2001; Carr and Cooper, 1998; Walli et al., 
1998).  There  is  increasing  evidence  that  antiretroviral  medications,  both  protease  and 
nucleosides reverse-transcriptase inhibitors, may contribute directly to these abnormalities 
(Heath et al., 2001; Joly et al., 2001; Carr et al., 2000; Murata et al., 2000; Mulligan et al., 
2000). This was the observation in the study Karmon et al., (2005), which showed that 
about 7.4% of HIV infected subjects experienced changes in body composition consistent 
with lipodystrophy since the commencement of HAART. In this study, fat redistribution was 
observable even though the population were not on HAART. 
 
Studies have also shown that severe weight loss in HIV infection is predominantly due to 
loss of lean body mass even though body fat remains unchanged. There are insufficient 
data regarding lean body mass changes during the course of HIV infection. However there 
is enough evidence to show that changes in body composition and loss of lean body mass 
have  become more  common  in  HIV  infected persons with  the  advent  of highly  active 
antiretroviral therapy (Grinspoon and Mulligan, 2003). Even though severe weight (wasting 
syndrome) loss in HIV infection  appears to be less common especially in more affluent 
countries, erosion of lean body mass (LBM) – primarily from skeletal muscle) is still evident 
in many patients with HIV infection when body composition was measured (Earthman et 
al.,  2000;  Wanke  et  al.,  2000).  In  the  current  population  studies,  HIV  infection  was 
significantly  associated  with  lower  lean  body  mass  although  the  odds  ratio  for  BMI 
changes was insignificant, whereas body fat tended to increase with HIV infection just as 
observed by Wanke et al., (2000) and Earthman et al., (2000). The tendency for high body 
fat in this population in spite of decreases in lean body mass were likely characteristics of 
metabolic changes associated with HIV infection. 
 
HIV patients with lipodystrophy, compared with control subjects were found to have thinner 
gluteal, suprailiac, and triceps skinfolds and increased waist circumference in a study by 
McDermott et al., (2005). Shlay and colleagues studied changes in body composition and 173 
 
metabolic changes between HIV infected patients receiving protease inhibitors and found 
that   after  8-12 months all  measures  of body  fat  (BIA, skin-fold  thickness,  and  DEXA 
scanning)  began  to  decrease  in  one  group  of  patients  (Shlay  et  al.,  2004).  The  HIV 
infected  population  of  this  study  had  slightly  lower  skinfold  thickness  for  triceps  and 
subscapular skinfolds whereas  mean values for abdominal, iliac crest, supraspinal and 
thigh  skinfolds  were  slightly  higher.  Although  these  differences  were  not  statistically 
significant,  the  observed  trend  probably  depicted  signs  of  abnormal  fat  distribution  or 
lipodystrophy. 
4.8.4  Discussion of nutrient and dietary intake/patterns findings  
With  regards  to  nutrients  intake,  the  findings  presented  earlier  showed  that  total 
cholesterol, protein and vitamin D were the most important predictors of HIV infection in 
the study population. These were the only nutrients that remained in the model final model 
of  the  backward  stepwise  elimination  regression  analyses.  It  did  seem  from  the 
biochemical predictors of HIV infection that both dietary and serum fat were associated 
with HIV infection status.  
Four dietary patterns were generated by PCA and these were not different between PLWH 
and the uninfected. The first and main pattern depicted an animal based dietary pattern 
with fruits and vegetables, the second described a varied or broad  based dietary pattern 
also referred as ‘recommended’ or ‘healthier’ option, the third pattern described a staple 
(maize meal) based dietary pattern for both HIV infected and uninfected groups and was 
denoted staple based and the fourth dietary pattern was referred as carbohydrate legumes 
and  vegetables  in  the  HIV  infected  and  staple  based  2  in  the  HIV  uninfected.  Using 
regression analysis high intake of red meat, chicken, eggs, fat, and potato predicted the 
first dietary pattern confirming that this dietary pattern was predominantly animal based. 
However, none the dietary patterns predicted HIV infection status suggesting that patterns 
of dietary intake were not different by HIV infection status.  
  
The first dietary pattern which was described as predominantly animal based could best 
describe a Western type of diet as well. This dietary pattern recorded high positive factor 
loadings  for  meat  and  meat  products  especially  red  meat,  chicken,  fish,  and  fat  with 
vegetables and fruits, whereas the negative factor loadings were recorded for maize meal. 
The Western type diet have been described in literature as a diet that is characterised by 174 
 
high  intakes  of  red  meat  and  processed  meats,  refined  grains,  French  fries,  deserts, 
sweets and high fat dairy products (Gao et al., 2007; Hu et al., 2000).  
 
Among the four dietary patterns identified, the second dietary pattern was best described 
as  ’healthy’  or  ‘recommended’  because  this  dietary  pattern  was  the  closest  to  the 
recommended dietary guidelines for PLWH in South Africa. Positive factor loadings for 
fruits, vegetables, potato, bread, breakfast cereals and rice, with negative factor loadings 
for fat and fish and no factor loadings for any of the meat and meat products.  The prudent 
diet  has  been  described  as  a  diet characterised  by  high  intakes  of  fruits,  vegetables, 
legumes, whole grains, poultry and low fat (Gao et al., 2008; Meyerhardt et al., 2007; Hu et 
al.,  2000)  and  the  second  dietary  pattern  was  probably  the  closest  to  the  prudent  or 
recommended dietary pattern. This dietary pattern was also closest to the current South 
African  dietary  guidelines  for  PLWH  (Department  of  Health,  South  Africa,  2001).  This 
dietary pattern was also closest to the current food based dietary guidelines for the general 
population in the UK based on the National Food Guide produced by the Nutrition Task 
Force and derived in part from the COMA reference value recommendations (Wearne and 
Day, 1999). The eight guidelines for the National Food Guide are: 
•  Enjoy your food, 
•  Eat a variety of different foods, 
•  Eat the right amount to be a healthy weight, 
•  Eat plenty of foods rich in starch and fibre, 
•  Eat plenty of fruits and vegetables, 
•  Don’t eat too many foods that contain a lot of fat, 
•  Don’t have sugary foods and drinks too often, 
•  If you drink alcohol, drink sensibly. 
Looking at the guidelines above, the second dietary pattern was closest because it was 
associated with a variety of different foods, was less associated with fat intake and animal 
foods unlike the animal based dietary pattern. The third and fourth dietary patterns within 
this study  group  were described  more as  a  staple  based  dietary  patterns  for  the  HIV 
uninfected because of positive loadings for maize meal in both cases. However the fourth 
dietary  pattern  for  the  HIV  infected  was  quite  different  and  was  described  as 
carbohydrates, legumes and vegetables based.  
 
A comparison of the four dietary patterns between the two HIV groups by ANOVA did 
confirm that there were no differences between the HIV infected and uninfected in terms of 
patterns of dietary intake. This implied that within this study population, dietary intake and 175 
 
patterns were similar and that probably changes in dietary intake had not started in the 
HIV infected group. The most possible reason for this however could be due to the fact 
that the HIV infected subjects were asymptomatic and were unlikely to be experiencing 
symptoms such as appetite loss which could have resulted in altered food intake. Also 
since, the original study design was not aimed at HIV infected persons and this was a 
secondary analysis, it was likely that the HIV infected population was not big enough and 
hence this study was unlikely to have been enough powered to show differences between 
the HIV infected and uninfected groups. Other possible reasons such as validity issues 
associated  with  the  QFFQ  used  for  the  dietary  assessment  and  measurement  errors 
associated  with  dietary  assessments  in  general  could  be  associated  with  the  lack  of 
difference in the dietary patterns between the HIV infected and uninfected persons.  
 
In the HIV infected population, it was quite difficult to determine whether any of the dietary 
patterns was a consequence or cause of HIV infection. The main reason was because the 
data were collected by a cross sectional design. Secondly, the HIV infected group did not 
know they were HIV infected and were therefore unlikely to have changed their dietary 
pattern. Thirdly, the HIV infected population were asymptomatic as mentioned earlier and 
were unlikely  to have made changes  to what they ate, which  normally  happens when 
symptoms of AIDS begin to manifest. 
 
None of the four main dietary patterns were shown to predict HIV status using regression 
analysis and this implied that the different dietary patterns were not associated with the 
odds for being HIV infected within this study population. The extent to which this was true 
could not be assessed with this data.  However, this implied that neither the animal based, 
‘recommended’, staple based 1 nor the fourth dietary pattern (carbohydrate, legumes and 
vegetables based and staple based 2 for HIV infected and uninfected groups respectively) 
diets was associated with an increased likelihood for being in the HIV infected group or 
not. The question asked at this point  therefore was  that:  “Was any  of the four dietary 
patterns associated with a more optimal nutritional status, better metabolic and functional 
integrity and better disease state in the PLWH”? These have been explored in Chapters 5 
and 6.  
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5.0  The influence of different dietary patterns on nutritional status, metabolic 
integrity and disease state  
5.1  Introduction 
One of the objectives of this study was to explore the relationship between different dietary 
patterns  and  markers  of  nutritional  and  disease  state  in  the  HIV  positive  population 
compared to the uninfected population. The purpose of this was to have an understanding 
as to what diet could possibly be associated with more optimal nutritional status, metabolic 
integrity  and  disease  progression.  As  part  of  the  principal  component  analysis,  each 
subject was attributed  a score  for  each dietary  component  and  the  score  represented 
individual levels of intakes for a particular dietary pattern. Thus a high score meant high 
intakes whereas low scores meant lower intake for that dietary pattern (component).  
 
To enable the association between these dietary patterns and nutritional and disease state 
to be explored, Spearman Rank correlations between each of the dietary components and 
energy, some selected nutrients (protein, vitamins A, C, D, E, thiamine, riboflavin, folic 
acid,  iron,  calcium  and  zinc)  and  anthropometrics  (BMI,  lean  body  mass  and 
anthropometric score) were determined, controlling for age, gender and urbanisation level. 
Binary and multinomial logistic regression analyses were used to determine which of the 
four dietary patterns predicted a more optimal nutritional and disease status in the two HIV 
groups. 
5.2  Association between dietary patterns and intake of selected nutrients 
A summary of Spearman correlation coefficients and statistical significance is presented in 
Table 5.1 to show the relationship between the four different dietary patterns and intake of 
selected  nutrients  within  the  study  population  stratified  by  HIV  infection  status.  The 
correlation coefficients were controlled for age, sex and urbanisation level. 
5.2.1  Relationship between the predominantly animal based dietary pattern and 
nutrient intake 
In the HIV infected population, the animal based dietary pattern showed moderate positive 
correlations  for  protein,  iron,  zinc,  calcium,  vitamin  A  and  vitamin  C.  Weak  positive 
correlations were recorded for folic acid, energy, thiamine, riboflavin, vitamin D and vitamin 
E. These correlation coefficients were all positive and statistically significant (p<0.001). 
This implied that in the HIV infected population, subjects who followed this dietary pattern 
were likely to consume high levels of energy, protein and micronutrients. 
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Within the HIV uninfected population, the animal based dietary pattern recorded moderate 
positive correlations for nutrients such as protein, calcium, zinc, folic acid and vitamin C 
whereas  weak  positive correlations were  shown  for  energy,  iron,  vitamin  A,  riboflavin, 
vitamins D, E and thiamine. In statistical terms, the correlations recorded for nutrients and 
the animal based dietary pattern were significant (p<0.001), implying that HIV uninfected 
subjects who followed such a dietary pattern were likely to consume high levels of both 
energy and micronutrients just like the HIV infected population. Thus the animal based 
dietary pattern could be associated with increased macro and micronutrient intakes in both 
HIV infected and uninfected groups. 
5.2.2  Relationship  between the  ‘recommended’ or ‘healthy’  dietary pattern and 
nutrient intake 
In Chapter 4, the second dietary pattern was associated with a more varied or broad food 
intake with low fat and high fruits and vegetables and was shown to depict a ‘healthy’ or 
‘recommended’ dietary guideline. Within the HIV infected population this dietary pattern did 
not show strong positive correlations with any  of the dietary  nutrients including energy 
intake. Weak  positive correlations were however  recorded for all the nutrients  with the 
exception of vitamin D which showed a weak negative correlation with this type of diet. 
Statistically, most of the correlation coefficients were significant but the associations for 
vitamin D, protein, vitamin A, thiamine and riboflavin were not statistically significant. This 
observation implied that unlike the animal based dietary pattern, HIV infected subjects who 
followed  the  ‘recommended’  or  ‘healthy’  dietary  pattern  were  likely  to  consume  less  
nutrients in general but specifically for vitamin D, A, thiamine, riboflavin and protein intake. 
 
In  the  HIV  uninfected  population  however,  the  recommended  dietary  pattern  recorded 
weak positive associations with folic acid and vitamin C and weak positive correlation for 
the other nutrients, except vitamin D. It seemed that the correlation coefficients recorded 
within the HIV uninfected group for these dietary patterns were a little higher than in the 
HIV infected population. Also the p values for these associations were much lower than in 
the HIV infected population and statistically, more significant. This implied that compared 
with  the  HIV  infected  group,  this  dietary  pattern  was  associated  with  a  better  overall 
nutrient intake in the HIV uninfected. However compared with the animal based dietary 
pattern, the recommended dietary pattern was likely to be associated with lower overall 
nutrient intake in the HIV uninfected population just like the HIV infected sub-group. 
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5.2.3  Relationship  between  the  staple  based  1  (maize  meal  with  eggs  for  HIV 
infected, and maize meal with legumes and sugar for HIV uninfected) dietary 
pattern and nutrient intake 
The  third  dietary  pattern within the study  population was  described  as  a staple  based 
dietary pattern due to the positive factor loading recorded for maize meal.  
In the HIV infected group this dietary pattern recorded very weak associations for all the 
nutrients. With the exception of folic acid which showed a correlation coefficient of 0.3, the 
rest of the nutrients recorded 0.1 or less with some nutrients recording negative (vitamin D 
and C) or no (zinc, riboflavin and vitamin E) associations with this nutrient pattern. Thus 
HIV infected subjects who followed this dietary pattern were very likely to consume low 
levels of energy and micronutrients especially vitamin D, E, C, B2, and zinc and probably 
more energy. This dietary pattern was likely to be calorie based. 
 
In the HIV uninfected population this dietary pattern showed higher correlation coefficients 
which were statistically more significant compared with the HIV infected group. However, 
negative associations were recorded for vitamin C and vitamin A and no association was 
shown for vitamin D. Notably, this dietary pattern provided better nutrient intake for the HIV 
uninfected population than the  HIV infected although compared with the  animal  based 
dietary  pattern,  nutrients  intake  may  have  been  less  for  HIV  uninfected  subjects  who 
followed this dietary pattern. 
5.2.4   Relationship  between  the  fourth  dietary  pattern  (described  as  legumes, 
carbohydrates and vegetables based for HIV infected and staple based 2 - 
maize meal based without legumes for HIV uninfected) and nutrient intake 
In the HIV infected population the fourth dietary pattern (staple based 2) was moderately 
associated with energy, protein, thiamine, vitamin D, iron and vitamin E in the HIV infected 
population. Weak positive associations were recorded for vitamin C, A, riboflavin and there 
was no association for calcium. Thus this dietary pattern was likely to provide high energy, 
protein and intake of the above micronutrients in the HIV infected sub-group. In the HIV 
uninfected group the associations shown for this dietary pattern and nutrient intakes were 
similar but the correlation coefficients were a little lower. However, HIV uninfected subjects 
who followed this dietary pattern were also likely to consume high energy, protein and 
some micronutrients. 
5.2.5  Summary  of  relationship between  dietary patterns  and selected  nutrients 
intake 
Comparing the associations between the four dietary patterns and nutrients intake, the 
animal  based  diet  seemed  to  be  associated  with  better  nutrient  intake  for  individual 180 
 
nutrients in both HIV infected and uninfected populations compared with the other three 
dietary  patterns.  The  fourth  dietary  pattern  (staple  based  2  for  HIV  uninfected  and 
vegetables, carbohydrates and legumes for the HIV infected) was also strongly associated 
with  nutrients  intake  than  the  ‘recommended’ and  staple  based  1  dietary  pattern. The 
staple based 1 dietary showed the lowest association with the dietary nutrients.  However, 
the other  three  dietary  patterns were  associated with  better  nutrient  intake  in  the  HIV 
uninfected population than the infected. This implied that the animal based dietary pattern 
was  more  optimal  in  terms  of  nutrient  consumption  than  the  other  3  dietary  patterns, 
followed by the fourth dietary pattern 4 (depicting staple based 2 for HIV uninfected and 
carbohydrate, legumes and vegetables for HIV infected), then the recommended dietary 
pattern and then the staple based 1 (dietary pattern 3). 
5.3  Relationship between dietary patterns and nutrient patterns 
In Tables 5.2 and 5.3 respectively, the crude and adjusted Spearman correlations and 
statistical  significance  between  nutrient  patterns  and  dietary  patterns  have  been 
presented, stratified by HIV infection status.  The purpose of this analysis was to show 
how the different dietary patterns were associated with overall nutrient intake patterns (not 
individual nutrient intake) by HIV infection status. The associations were controlled for age, 
sex and urbanisation level (Table 5.3). The animal based dietary pattern recorded large or 
moderate  positive  correlations  with  the  first  nutrient  pattern  (high  macronutrients  and 
micronutrients) in both the HIV infected and uninfected populations for the crude (r=0.6, 
p=0.000) and adjusted (r=0.5, p=0.000) relationships. This implied that both HIV infected 
and uninfected subjects who followed the animal based dietary were likely to have high 
macro and micronutrient intake irrespective of gender, age, residency and year of study. 
 
The recommended dietary pattern was weakly (r=0.3, p<0.01) associated with the most 
optimal nutrient pattern in the HIV infected and uninfected populations. The staple based 1 
dietary pattern was weakly associated with the most optimal nutrient pattern in both the 
HIV infected and uninfected subgroups (r=0.1 and 0.2 for both HIV infected and uninfected 
groups). This  implied  that  this  dietary  pattern  was unlikely  to  be  associated with  high 
intakes of macro and micronutrients. The fourth dietary pattern (staple based 2 for HIV 
uninfected  and  carbohydrate,  vegetables  and  legumes  for  the  HIV  infected)  however 
showed moderate positive associations with the most optimal nutrient pattern in both the 
HIV infected (r=0.5) and uninfected (r=0.4) groups which were lower compared with the 
animal based dietary pattern.  181 
 
Table 5.1: Spearman correlations coefficients and statistical significance between the four component scores (dietary 
patterns) and individual nutrient intakes in HIV infected group  
 
 
 
R denotes correlation coefficient, p values denotes statistical significance for the association. N is sample size, partial correlations controlled for age, sex, year of study, 
smoking status and stratum (urbanisation level) 
 
 
 
     Total 
energy 
Total 
protein 
Calcium  Iron   Zinc  Vitamin A  Thiamine  Riboflavin  Folic acid  Vitamin D  Vitamin E  Vitamin  
C 
HIV 
infected 
Animal based 
diet 
  
0.3  0.6  0.5  0.5  0.6  0.5  0.3  0.3  0.4  0.2  0.2  0.5 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  P<0.001  p<0.001 
Recommended 
diet 
  
0.2  0.1  0.3  0.2  0.2  0.2  0.1  0.1  0.3  -0.1  0.2  0.3 
0.050  0.400  p<0.001  0.020  0.010  0.080  0.300  0.300  P<0.001  0.600  0.040  p<0.001 
Staple based 1 
  
0.1  0.1  0.1  0  0  0.03  0.1  0.0  0.3  -0.1  0  -0.1 
0.200  0.200  0.200  0.900  1.000  0.700  0.100  0.900  p<0.01  0.600  0.900  0.500 
Carbohydrate, 
legumes and 
vegetables 
0.6  0.5  0  0.5  0.4  0.1  0.6  0.3  0.4  0.5  0.5  0.2 
p<0.001  p<0.001  0.700  p<0.001  p<0.001  0.600  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  0.100 
HIV 
uninfecte
d 
Animal based 
diet 
  
0.4  0.6  0.5  0.4  0.5  0.4  0.3  0.4  0.5  0.2  0.3  0.5 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001 
Recommended 
diet 
  
0.3  0.2  0.2  0.2  0.2  0.3  0.2  0.2  0.4  -0.1  0.2  0.4 
p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  0.004  p<0.001  p<0.001 
Staple based 1 
  
0.3  0.2  0.2  0.1  0.1  -0.1  0.2  0.1  0.3  0.0  0.2  -0.1 
p<0.01  p<0.01  p<0.010  p<0.010  0  0.100  p<0.010  0.060  P<0.010  0.300  P<0.01  0.005 
Staple based 2 
  
0.5  0.4  0  0.4  0.3  0.04  0.5  0.2  0.3  0.4  0.4  -0.01 
p<0.001  p<0.001  0.910  p<0.001  p<0.001  0.300  p<0.001  p<0.001  p<0.001  p<0.001  p<0.001  0.7 182 
 
Table  5.2:  Spearman  crude  correlation  coefficient  and  statistical  significance  for 
associations between dietary patterns and patterns of nutrient intake within 
study population stratified by HIV infection status 
 
R denotes Spearman correlation coefficient, p value <0.01 denotes statistical significance with 99% confidence. Dietary 
pattern four is staple based 2 for HIV uninfected and carbohydrate, vegetables and legumes for HIV infected. 
 
 
Table  5.3:  Spearman  partial  correlation  coefficient  and  statistical  significance  to 
show     association between dietary patterns and patterns of nutrient intake 
within study population stratified by HIV infection status 
  nutrient pattern 1  nutrient pattern 2  nutrient pattern 3 
 
  HIV infected  HIV 
uninfected 
HIV 
infected 
HIV 
uninfected 
HIV 
infected 
HIV 
uninfected 
Animal based diet    0.5  0.5  0.2  -0.2  0.2  0.3 
p<0.01  p<0.01  0.030  p<0.01  0.020  p<0.01 
  
Recommended diet  
  
0.3  0.3  0.2  -0.3  0.2  0.2 
0.004  p<0.01  0.100  p<0.01  0.060  p<0.01 
  
Staple based 1  
  
0.1  0.2  0.01  0.1  -0.2  -0.1 
0.300  p<0.01  0.900  0.100  0.060  0.100 
  
Dietary pattern 4  
  
0.5  0.4  -0.6  0.4  0.2  0.2 
p<0.01  p<0.01  p<0.01  p<0.01  0.040  p<0.01 
R denotes Spearman correlation coefficient, p value <0.05 denotes statistical significance. Spearman correlation was 
adjusted for age, sex and year of study, stratum (urbanisation level). Dietary pattern 4 was denoted staple based 2 for HIV 
uninfected and carbohydrate, vegetables and legumes based for HIV infected. 
 
The animal based dietary pattern was also weakly but positively associated with second 
and third nutrient patterns in the HIV infected group but within the HIV uninfected group 
this dietary pattern was negatively but weakly associated with the second nutrient pattern. 
The recommended dietary pattern recorded weak associations with both the second and 
third nutrient patterns in both HIV infected and infected subpopulations but the association 
    Nutrient pattern 1  Nutrient pattern 2  Nutrient pattern 3 
 
     HIV infected  HIV 
uninfected 
HIV 
infected 
HIV 
uninfected 
HIV 
infected 
HIV 
uninfected 
Animal based 
diet 
  
  
R  0.6  0.6  0.3  -0.3  0.3  0.3 
P 
value 
p<0.01  p<0.01  p<0.01  p<0.01  p<0.01  p<0.01 
N  128  874  128  874  128  874 
Recommended 
diet 
  
  
R  0.3  0.4  0.1  -0.3  0.2  0.2 
P 
value 
p<0.01  p<0.01  0.200  p<0.01  p<0.01  p<0.01 
N  128  874  128  874  128  874 
Staple based 1 
  
  
R  0.1  0.1  -0.2  0.2  -0.2  -0.2 
P 
value 
0.400  p<0.01  0 p<0.01  p<0.01  0.100  p<0.01 
N  128  874  128  874  128  874 
Dietary pattern 
4 
  
  
R  0.5  0.4  -0.4  0.3  -0.1  -0.2 
P 
value 
p<0.01  p<0.01  p<0.01  p<0.01  0.3  p<0.01 
N  128  874  128  874  128  874 183 
 
with the nutrient pattern in the HIV uninfected subgroup was negative (Table 6.3). In the 
HIV uninfected subgroup the staple based 1 recorded the weakest association with the 
most optimal nutrient profile. Within the HIV infected group also the staple based 1 dietary 
pattern showed the weakest association with the most optimal nutrient profile. Thus this 
dietary pattern might be associated with the least overall nutrient intake within both HIV 
infected and uninfected subjects. 
5.3.1  Summary of associations between dietary patterns and nutrient patterns 
With regards to overall nutrient patterns, the animal based dietary pattern showed stronger 
association with better overall nutrient intake followed by dietary pattern 4 (staple based 2 
for HIV uninfected and carbohydrate, vegetables and legumes for HIV infected), followed 
by  the  recommended  dietary  pattern  in  both  HIV  infected and  uninfected  groups. The 
staple based 1 (dietary pattern 3) showed the least association with the ‘optimal’ nutrient 
intake  pattern.  However  in  the  HIV  uninfected  group  all  four  dietary  patterns  showed 
statistically significant positive correlation with the most optimal nutrient intake pattern. 
5.4       The relationship between different dietary patterns and anthropometrics 
(lean body mass, BMI, anthropometric score) 
In  the  unadjusted  analysis  (Table  5.4),  the  animal  based  diet  showed  weak  positive 
correlations with BMI (r=0.1), Lean Body Mass (r=0.2), and anthropometric score (r=0.2) 
variables  in the  HIV  infected  population.  Statistically,  none  of  these  associations were 
significant. When these associations were controlled for age, gender, and residency type, 
the correlations were still positive but weak and statistically not significant. However, the 
animal  based  dietary  pattern  in  the  HIV  infected  population  seemed  to  show  positive 
associations with anthropometric indicators. The ‘recommended’ or ‘healthy’ diet on the 
other  hand  showed  very  weak  negative  associations  with  BMI,  lean  body  mass  and 
anthropometric score in both the crude and adjusted correlation coefficients for the HIV 
infected group. Statistically, these associations were not significant, but the finding implied 
that there was a trend of decreasing lean body mass, BMI and anthropometric score in 
subjects who followed the ‘recommended’ or ‘healthy’ dietary pattern. In the PLWH, the 
staple based 1 dietary pattern also showed very weak and negative associations with BMI, 
lean body mass and anthropometric score which were statistically not significant whereas 
the fourth dietary pattern (carbohydrate, legumes and vegetables) showed weak positive 
associations with BMI, lean body mass and anthropometric score. Thus between the four 
dietary patterns, the animal based and the carbohydrate, legumes and vegetables based 
dietary patterns were positively associated with BMI, lean body mass and anthropometric 184 
 
score (general anthropometric profile), whereas the ‘recommended’ and staple based 1 
dietary patterns were negatively associated with anthropometrics in PLWH. 
 
In the HIV uninfected population, the crude associations between the four different dietary 
patterns and nutritional anthropometrics were all smaller (although positive) than in the 
HIV  infected  and  statistically  insignificant.  Thus  compared  to  the  HIV  uninfected,  the 
animal based diet was better associated with BMI, lean body mass and anthropometric 
score  in the HIV infected population. This also implied  that HIV  infected subjects who 
followed  this  dietary  pattern  had  better  BMI  and  lean  body  mass  compared  with  HIV 
uninfected subjects who followed this dietary pattern. 
  
Table  5.4:  Spearman  crude  and  adjusted  correlation  coefficient  and  statistical 
significance between dietary patterns and anthropometrics (BMI and lean body 
mass and anthropometric score) by HIV infection status  
 
Partial Correlations were adjusted for age, gender and residency (urbanisation level) 
 
In the HIV uninfected group, the animal based diet maintained weak positive associations 
with  the  anthropometric  variables when  controlled  for  gender,  residency  and age. The 
associations were all statistically insignificant and the correlation coefficients were all 0.1 
signifying very weak associations. However, compared to the other three dietary patterns, 
the  animal  based  dietary  pattern  was  more  strongly  associated  with  anthropometrics 
HIV infected     Anthropometric 
score 
BMI 
 
LBM 
    crude  Adjusted  crude  adjusted  Crude  adjusted 
Animal based diet  Correlation  0.2  0.2  0.1  0.2  0.2  0.2 
   P value  0.050  0.050  0.200  0.080  0.070  0.060 
Recommended diet  Correlation  -0.1  -0.1  -0.2  -0.1  0  -0.1 
   P value  0.700  0.400  0.080  0.300  0.900  0.300 
Staple based 1 (maize 
meal) 
Correlation  0  -0.1  0  -0.1  0.02  -0.1 
   P value  0.900  0.300  0.900  0.200  0.900  0.500 
Carbohydrate, legume 
and vegetables 
Correlation  0.2  0.1  0.1  0.2  0.3  0.3 
   P value  0.060  0.200  0.500  0.100  0.020  0.030 
HIV uninfected               
Animal based diet  Correlation  0.1  0.1  0.1  0.1  0.1  0.1 
   P value  0.300  0.100  0.070  0.200  0.200  0.070 
Recommended diet  Correlation  0  0  0  0  -0.01  -0.03 
   P value  0.900  0.400  0.500  0.600  0.900  0.600 
Staple based 1  Correlation  -0.01  -0.1  -0.1  -0.1  0.02  0.01 
   P value  0.899  0.200  0.200  0.300  0.632  0.900 
Staple based 2  Correlation  -0  -0.1  -0.1  -0.1  -0.01  -0.05 
   P value  0.400  0.100  0.100  0.200  0.800  0.300 185 
 
implying that this dietary pattern was likely to be better associated with BMI, lean body 
mass and anthropometric score. Between the HIV uninfected and PLWH however, the 
animal  based  dietary  pattern  was  better  associated  with  anthropometrics  in  the  HIV 
infected group.  
5.4.1  Summary of associations between dietary patterns and anthropometrics 
In summary, the Spearman correlation between dietary patterns and BMI, lean body mass 
and anthropometric score controlled for age, gender and urbanisation level showed that 
the animal based and carbohydrate, legumes and vegetable based dietary patterns in the 
HIV infected group showed weak but positive associations with BMI, lean body mass and 
anthropometric  score  whereas  the  recommended  dietary  pattern  showed  negative 
associations with anthropometric markers within the HIV infected population. Statistically, 
the correlation recorded between the carbohydrate, legumes and vegetable based pattern 
and  lean  body  mass  (r=0.3,  p=0.030)  was  significant  but  the  rest  did  not  show  any 
statistical  significance.  Similar  associations  were  observed  in  the  HIV  uninfected 
population. However the animal based pattern seemed to be better associated with BMI, 
LBM and anthropometric score in the HIV uninfected whereas in the infected group the 
carbohydrate, legumes and vegetables dietary pattern was better associated with BMI and 
LBM. 
5.5   Regression analysis to show how the different dietary patterns predicted 
anthropometric status (BMI, lean body mass and anthropometric score) 
5.5.1   Multinomial regression analysis to determine predictors of high Body Mass 
Index in HIV infected population compared with the uninfected 
In Table 5.5, a summary of associations between different dietary patterns and BMI status 
in the HIV infected and uninfected subgroups have been presented. This was necessary to 
find if any of the dietary patterns predicted BMI status and to show if differences existed in 
these  associations  comparing  HIV  infected  and  uninfected.  For  continuous  variables, 
parameters with significant  positive coefficients increase the likelihood of  the response 
category whereas parameters with significant negative coefficients decrease the likelihood 
of that event with respect to the reference category.  
 
From Table 5.5, HIV infected subjects with higher animal based score were more likely to 
have normal (coefficient, β =0.7, OR= 1.9, p=0.1) BMI and BMI above 25 kg/m
2 (coefficient 
β = 0.8, OR=2.2, p=0.07) than the other dietary patterns. On the other hand, HIV infected 
subjects  with  high  score  for  the  recommended  diet  were  likely  to  have  lower  BMI 
(coefficient β = -0.3, OR=0.8, for normal BMI and -0.5, OR=0.2, for BMI≥25.0 kg/m
2). This 186 
 
implied that in the HIV infected subjects, the higher the intake of the animal based diet and 
the lower the intake of the recommended diet, the higher the likelihood of a BMI in the 
normal or above 25.0 kg/m
2 category. Statistically, these associations were not significant 
because  the  p  values  for  the  coefficients  were  above  0.05  and  the  95%  confidence 
intervals overlapped. 
 
Table 5.5: Multinomial logistic regression (odds ratio with 95% confidence interval 
and  p  value)  to  identify  which  dietary  patterns  were  associated  with  BMI, 
comparing the HIV infected and the uninfected sub-groups 
 
In the HIV uninfected population, the coefficients recorded for the animal based diet (β 
=0.3, OR=1.3, p=0.04) and the recommended diet (β  =0.1, OR=1.1, p=0.7) were  both 
positive. This implied that in this group increased score for the animal and ‘recommended’ 
dietary patterns were both associated with increased likelihood for higher BMI. Thus unlike 
the HIV infected group, increased intake of both animal based diet and recommended diet 
in the HIV uninfected group was associated with increased BMI. In statistical terms, the 
associations observed were significant for the animal based dietary pattern implying that 
this dietary pattern rather than the other three was likely to be associated with higher BMI 
in the HIV uninfected group. 
 
    Coefficient 
 
P 
values 
Odds 
ratio 
95% confidence 
interval 
HIV infected        Lower 
limit 
Upper 
limit 
Normal BMI  Animal based diet score  0.7  0.100  1.9  0.9  4.3 
Recommended diet score  -0.3  0.500  0.8  0.3  1.7 
Staple based 1 score  -0.2  0.400  0.8  0.5  1.3 
Carbohydrate, legumes and 
vegetables 
0.2  0.400  1.3  0.7  2.3 
Overweight 
/obese 
  
  
  
  
Animal based diet score  0.8  0.070  2.2  0.9  5.0 
Recommended diet score  -0.5  0.200  0.6  0.3  1.4 
Staple based 1 score  0.1  0.800  1.1  0.7  1.7 
Carbohydrate, legumes and 
vegetables 
0.2  0.500  1.3  0.7  2.4 
HIV uninfected           
Normal BMI  Animal based diet score  0.3  0.040  1.3  1.1  1.7 
Recommended diet score  0.1  0.700  1.1  0.8  1.4 
Staple based 1 score  -0.2  0.200  0.9  0.7  1.1 
Staple based 2 score  0.1  0.300  1.1  0.9  1.4 
Overweight 
/obese 
  
  
  
  
Animal based diet score  0.4  0.003  1.5  1.1  1.9 
Recommended diet score  0  1.000  1.0  0.8  1.3 
Staple based 1 score  -0.2  0.100  0.8  0.7  1.0 
Staple based 2 score  -0.1  0.500  0.9  0.7  1.2 187 
 
5.5.2  Multinomial regression analysis to determine predictors of high lean body    
mass in HIV infected population compared with the uninfected 
In Table 5.6, summary of association between the four different dietary patterns and lean 
body  mass  in  the  HIV  infected  and  uninfected  subgroups  identified  by  multinomial 
regression modelling have been  presented.  In  the  HIV  infected  population,  the animal 
based  dietary  pattern,  recommended  diet  and  carbohydrate,  legumes  and  vegetable 
based dietary patterns were positively associated with middle thirds for lean body mass 
because of the positive coefficients recorded for these dietary patterns. This implied that 
increased score for these dietary patterns were associated with increased likelihood for a 
higher lean body mass. However the staple based dietary pattern recorded a negative 
association with lean body mass.  
 
Table 5.6: Multinomial logistic regression (odds ratio with 95% confidence interval 
and  p value) to identify which dietary  patterns were associated with higher 
lean body mass, comparing the HIV infected and the uninfected sub-groups 
 
Lean body 
mass 
categories 
covariates  Coefficient  Statistical 
significance 
Odds 
ratio 
95% confidence 
interval 
HIV infected        Lower 
limit 
Upper 
limit 
Upper third  Animal based diet score  0.9  0.080  2.5  0.9  6.8 
Recommended diet 
score 
0.2  0.600  1.2  0.6  2.7 
Staple based 1 score  -0.1  0.800  0.9  0.4  1.8 
Carbohydrate, legumes 
and vegetables 
0.8  0.040  2.2  1.0  4.7 
Middle third 
  
  
  
  
Animal based diet score  1.3  0.020  3.6  1.3  10.4 
Recommended diet 
score 
0.6  0.200  1.7  0.8  4.0 
Staple based 1 score  -0.1  0.800  0.9  0.5  1.9 
Carbohydrate, legumes 
and vegetables 
0.5  0.200  1.7  0.8  3.6 
HIV uninfected           
Upper third  Animal based diet score  0.2  0.300  1.2  0.9  1.7 
Recommended diet 
score 
-0.1  0.600  0.9  0.7  1.3 
Staple based 1 score  0.0  0.800  1.0  0.8  1.4 
Staple based 2 score  -0.3  0.030  0.8  0.6  0.9 
Middle third 
  
  
  
  
Animal based diet score  0.2  0.300  1.2  0.9  1.7 
Recommended diet 
score 
0.1  0.600  1.1  0.8  1.5 
Staple based 1 score  0.1  0.500  1.1  0.8  1.5 
Staple based 2 score  -0.0  0.900  1.0  0.8  1.2 
 
However,  comparing  the  four  dietary  patterns  showed  that  the  animal  based  dietary 
pattern recorded the highest positive coefficient (β=1.3, p=0.02) and predicted higher lean 
body  mass  (OR=3.6,  95%  CI=1.3-10.4),  followed  by  ‘recommended’  dietary  pattern 188 
 
(OR=1.7,  95%  CI=0.8-4.0)  and  then  the carbohydrate,  legumes  and vegetables  based 
dietary pattern (OR=1.8, 95% CI=0.8-3.6). This implied that though these three dietary 
patterns  were  positively  associated  with  lean  body  mass  in  the  HIV  infected,  the 
association with the animal based dietary pattern was statistically significant. The staple 
based  1  dietary  pattern  was  the  only  diet  among  the  four  dietary  patterns  that  was 
negatively  associated  with  lean  body  mass.  Statistically,  these  associations  were 
significant for only the animal based dietary pattern. 
  
In the HIV uninfected group, the animal based dietary pattern and staple based 1 dietary 
patterns recorded positive coefficients for the upper thirds of lean body mass. This implied 
that  higher  scores  or  consumption  of  these  diets  were  likely  to  be  associated  with 
increased likelihoods for higher lean body mass. However, the coefficients (β=0.2, p=0.2) 
recorded for the association with the animal based dietary pattern, and the staple based 1 
dietary pattern (β=0.1, p=0.8, OR=1.1, 95% CI=0.8-1.5) were not statistically significant. 
The staple based 2 dietary pattern (β=-0.3, p=0.03, OR=0.8, 95% CI=0.6-0.9) was on the 
other hand significantly associated with lower lean body mass. 
5.5.3  Multinomial  regression  analysis  to  determine  predictors  of  high 
anthropometric  score  in  HIV  infected  population  compared  with  the 
uninfected 
Table 5.7 presents the predictive effect of the different dietary patterns on anthropometric 
score, comparing the HIV infected and uninfected groups. In the HIV infected population 
the first two dietary patterns all recorded negative coefficients and lower odds ratios for the 
upper third category of anthropometric score. This implied that for the animal based and 
the ‘recommended’ dietary patterns,  increased scores were associated with decreased 
likelihoods for high anthropometric score. This could also be interpreted that HIV infected 
who  followed  an  animal  based  dietary  pattern  or  a  pattern  that  corresponded  with  a 
recommended dietary guidelines were more likely to have lower overall anthropometric 
score.  Statistically,  the  staple  based  (β  =0.7,  OR=2.1,  95%  CI=1.0-4.3,  p=0.040)  and 
carbohydrate, legumes and vegetables based (β =0.9, OR=2.4 95% CI=1.2-5.2, p=0.020) 
dietary patterns both recorded significant positive associations with overall anthropometric 
score  in  PLWH whereas  the  associations  recorded  for  the  ‘recommended’  and animal 
based dietary patterns were not significant.   
 
In  the  HIV infected the carbohydrate,  legumes and vegetables (OR=2.4,  p=0.020) and 
staple  based  dietary  patterns  (OR=2.1,  p=0.040)  were  the  only  diets  associated  with 189 
 
increased odds for anthropometric score and in the HIV uninfected group the two staple 
based dietary patterns both showed increased odds for anthropometric score (OR=1.8, 
p<0.001) for staple based 1 and (OR=1.1, p=0.400) for staple based 2.  It did seem that 
although the animal based dietary pattern was associated with higher lean body mass and 
BMI in the HIV infected, it was likely to be associated with lower overall anthropometric 
score. 
 
Table 5.7: Multinomial logistic regression (odds ratio with 95% confidence interval 
and p value) to identify the dietary patterns that predicted high anthropometric 
score comparing HIV infected and uninfected sub-groups 
 
 
 
5.5.4  Summary  of  findings  for  multinomial  regression  analysis  between  dietary 
patterns and anthropometrics 
 
In  summary,  multinomial  regression  modelling  revealed  that  among  the  four  dietary 
patterns, increased score for the animal and carbohydrate, legumes and vegetables based 
dietary patterns were likely to be associated with higher BMI whereas the ‘recommended’ 
and staple based dietary patterns were likely to be associated with lower BMI in the HIV 
infected  population.  The  animal  based  diet  however  predicted  higher  BMI  (OR=2.2, 
p=0.070)  than  the  rest  of  the  patterns.  In  the  HIV  uninfected  population  however,  the 
  Dietary pattern score  Coefficient  Statistical 
significance 
Odds 
ratio 
95% confidence 
interval 
HIV infected        Lower 
limit 
Upper 
limit 
Middle 
third 
  
  
  
  
Animal based diet score  -0.6  0.200  0.5  0.2  1.3 
Recommended diet score  -0.5  0.100  0.6  0.3  1.2 
Staple based 1 score  -0.1  0.800  0.9  0.4  2.0 
Carbohydrate, legumes 
and vegetables 
0.3  0.400  1.4  0.6  3.0 
Upper 
third 
  
  
  
Animal based diet score  -0.9  0.100  0.4  0.2  1.1 
Recommended diet score  -0.1  0.800  1.0  0.4  1.9 
Staple based 1 score  0.7  0.040  2.1  1.0  4.3 
Carbohydrate, legumes 
and vegetables 
0.9  0.020  2.4  1.2  5.2 
HIV uninfected           
Middle 
third 
Animal based diet score  -0.1  0.700  0.9  0.7  1.3 
Recommended diet score  .01  0.900  1.0  0.8  1.4 
Staple based 1 score  0.3  0.100  1.3  1.0  1.7 
Staple based 2 score  0.1  0.300  1.1  0.9  1.4 
Upper 
third 
  
  
  
  
Animal based diet score  -0.4  0.030  0.7  0.5  1.0 
Recommended diet score  -0.1  0.700  0.9  0.7  1.3 
Staple based 1 score  0.6  0.000  1.8  1.3  2.4 
Staple based 2 score  0.1  0.400  1.1  0.9  1.4 190 
 
animal based and  ‘recommended’ dietary  patterns were positively  associated with  BMI 
whereas the staple based patterns showed negative associations.  
 
For  lean  body  mass,  multinomial  regression  modelling  showed  that  among  the  HIV 
infected group, an animal based (OR=3.6, 95% CI=1.3-10.4) dietary pattern followed by 
the  ‘recommended’  (OR=1.7,  95%  CI=0.8-4.0),  and  carbohydrate,  legumes  and 
vegetables based (OR=1.7, 95% CI=0.8-3.6) dietary patterns were likely to predict higher 
lean body mass in that order. The only statistically significant association was however for 
the  animal  based  dietary  pattern  (p=0.020).  In  the  HIV  uninfected,  the  animal  based 
(OR=1.2,  95%  CI=0.9-1.7),  ‘recommended’  (OR=1.1,  0.8-1.5)  and  staple  based  1 
(OR=1.1, 95% CI=0.8-1.5) dietary patterns were associated with increased odds for lean 
body mass, but not statistically significant. The staple based 2 dietary pattern  (β=-0.3, 
p=0.030) was on the other hand significantly associated with lower lean body mass. 
 
In  terms  of  an  overall  anthropometric  score  multinomial  logistic  regression  analysis 
showed  that  in both  HIV  infected  and  uninfected  populations  increased scores  for  the 
animal  based  and  recommended  dietary  patterns  were  associated  with  decreased 
likelihood for a high anthropometric score whereas increased scores for the staple based 1 
and dietary pattern 4 for both HIV infected and uninfected showed increased likelihoods for 
higher anthropometric scores. 
5.6   Binary  regression  analysis  to  model  the  association  between  dietary 
patterns and liver enzymes (markers of inflammation and liver damage) 
A summary of the regression of dietary patterns on serum overall liver enzyme score and 
also for individual liver enzymes in the HIV infected subjects have been presented in Table 
5.8. An overall liver enzyme score was derived from the first principal component of liver 
enzymes (AST, ALT, ALP and GGT), which recorded large positive factor loadings for all 
the liver enzymes. A high score thus depicted high serum liver enzyme status and low 
score depicted low serum liver enzymes status. The goodness of fit statistic was generally 
above  0.05  for  almost  all  the  analyses  which  implied  that  these  models  adequately 
described the population. The R square statistics ranged between 0 to 10% and this meant 
that these models generally explained between 0 to 10% of the observed variability within 
the population. 
 
Among the four dietary patterns, the animal based, ‘recommended’ and staple based 1 
dietary patterns recorded negative coefficients with overall liver enzyme score whereas 191 
 
dietary  pattern  4  (staple  based  2  in  HIV  uninfected  and  carbohydrate,  legumes  and 
vegetables) recorded positive coefficients with overall liver enzyme score. This implied that 
for the first three dietary patterns, increased score (increased intakes) were associated 
with decreased likelihoods for high serum liver enzyme status. It also implied that for the 
fourth dietary pattern, increased score was associated with an increased likelihood for a 
high liver enzyme status. 
 
However comparing the values for the coefficients, the animal based and ‘recommended’ 
dietary patterns both recorded β=-0.4 whereas the staple based 1 diet recorded β=-0.1. 
The odds ratios and 95% confidence intervals for the odds ratios were only significant for 
the recommended dietary pattern but were not significant for the other 3 diets implying that 
the association for recommended diet was significant and the rest were not likely to be 
significant. Also in the backward stepwise analysis the recommended dietary pattern was 
the only dietary pattern which remained in the final model implying that this dietary pattern 
was likely to be the most important predictor of an overall lower serum liver enzyme status 
   
For  serum  AST,  negative  coefficients  were  recorded  for  the  animal  based  and  the 
recommended dietary patterns and positive values were shown for the third and fourth 
dietary  patterns.  However  the  odds  ratios  and  95%  confidence  intervals  were  only 
significant for the association between the animal based dietary pattern and serum AST (p 
=0.008), (OR) = 0.5 (95% CI 0.3 to 0.8). This implied that among the four dietary patterns, 
high score (intakes) for the animal based dietary pattern was significantly associated with 
lowered  serum  AST. The  backward  stepwise analysis confirmed this  fact because  the 
animal based dietary pattern was the only one that remained in the final model of the 
backward regression analysis. This implied that among the four dietary patterns the animal 
based  dietary  pattern  was  an  independent  predictor  of  lower  serum  AST  in  the  HIV 
infected population. 
 
Likewise  for  serum  ALT,  negative  coefficients  were  recorded  for  animal  based, 
‘recommended’ and dietary pattern 4, implying that for these dietary patterns higher scores 
or intakes were likely to be associated with lower serum ALT. However the animal based 
dietary pattern alone recorded statistically significant p value (0.04) and odds ratio (OR = 
0.6, 95% CI 0.5 to 0.9) and was the only dietary pattern that remained in the final model of 
the backward elimination analysis.  
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Table  5.8:  Binary  logistic  regression  (odds  ratio  with  95%  confidence  interval, 
significance  of  Wald  statistics)  to  identify  which  dietary  patterns  predicted 
high serum liver enzymes in the HIV infected population 
 
Dietary pattern 4 in the HIV infected is predominantly carbohydrate, legumes and vegetables based. Last step refers to final 
step of backward elimination. 
 
This implied that among the four dietary patterns the animal based dietary pattern was an 
independent predictor of lowered serum ALT status in PLWH. Also for serum ALP and 
GGT, the animal based and recommended dietary patterns recorded negative coefficients 
whereas the staple dietary  patterns  recorded positive coefficients,  indicating again that 
higher scores for the first two dietary patterns were likely to be associated with lowered 
serum  ALT  and  GGT  levels.  With  regard  to  serum  total  bilirubin,  the  ‘recommended’ 
HIV infected  N  Dietary patterns  Coefficient  P 
value 
Odds 
ratio 
Lower 
limit 
Upper 
limit 
R
2/goodn-
ess of fit 
Liver enzyme 
score 
125  Animal based diet  -0.4  0.001  0.7  0.4  1.1  8%, 0.8 
     Recommended diet  -0.4  0.040  0.7  0.4  1.0   
     Staple based 1  -0.1  0.500  0.9  0.6  1.2   
     Dietary pattern 4  0.1  0.500  1.1  0.8  1.6   
Last step  125  Recommended diet  -0.4  0.040  0.7  0.4  0.9  5%, 0.5 
AST  125  Animal based diet  -0.7  0.008  0.5  0.3  0.8  10% , 0.6 
    Recommended diet  -0.2  0.300  0.8  0.6  1.2   
    Staple based 1  0.1  0.600  1.1  0.8  1.5   
    Dietary pattern 4  0.0  0.900  1.0  0.7  1.5   
Last step  125  Animal based diet  -0.7  0.007  0.5  0.3  0.8   
ALT  125  Animal based diet  -0.5  0.040  0.6  0.4  0.9  7%, 0.2 
    Recommended diet  -0.2  0.300  0.8  0.6  1.2   
    Staple based 1  0.1  0.500  1.0  0.8  1.6   
    Dietary pattern 4  -0.1  0.500  0.9  0.6  1.3   
Last step  125  Animal based diet  -0.5  0.040  0.6  0.4  0.9  5%, 0.5 
GGT  125  Animal based diet  -0.4  0.100  0.7  0.4  1.1  6%, 0.3 
    Recommended diet  -0.1  0.500  0.9  0.6  1.3   
    Staple based 1  -0.0  0.800  1.0  0.7  1.3   
    dietary pattern 4  0.3  0.100  1.4  0.9  2.0   
Last step  125  No variable remained             
ALP  125  Animal based diet  -0.1  0.600  0.9  0.6  1.4  5%, 0.8 
    Recommended diet  -0.2  0.200  0.8  0.5  1.1   
    Staple based 1  0.0  0.900  1.0  0.7  1.4   
    Dietary pattern 4  0.3  0.100  1.3  0.9  2.0   
Last step    No variable remained             
Total bilirubin  125  Animal based diet  0.2  0.400  1.2  0.8  1.9  7%, 0.2 
    Recommended diet  -0.4  0.060  0.7  0.5  1.0   
    Staple based 1  -0.2  0.300  0.8  0.5  1.2   
    Dietary pattern 4  -0.2  0.400  0.8  0.6  1.2   
Last step  125  No variable remained             193 
 
dietary pattern was a predictor of lower status in PLWH compared with the other three 
dietary patterns but none of the patterns remained in the final backward regression model. 
 
Table  5.9:  Odds  ratio  with  95%  confidence  interval  and  p  value  showing  dietary 
patterns  which  predicted  high  serum  liver  enzymes  in  the  HIV  uninfected 
population 
 
 
HIV uninfected  N  Dietary patterns  Coefficient  P 
value 
Odds 
ratio 
95% CI  R
2/goodn-
ess of fit 
Lower 
limit 
Upper 
limit 
Overall liver 
enzyme score 
  
  
  
821  Animal based diet  -0.3  0.001  0.8  0.7  0.9  4, 0.1 
  Recommended diet  0.1  0.300  1.1  0.9  1.3   
  Staple based 1  0.2  0.010  1.2  1.0  1.4   
    Staple based 2  0.1  0.060  1.1  1.0  1.3   
Last step     Animal based diet  -0.3  0.001  0.8  0.7  0.9  4%, 0.5 
   Staple based 1  0.2  0.010  1.2  1.0  1.4   
AST  823  Animal based diet  -0.3  0.001  0.8  0.7  0.9  4%, 0.05 
  Recommended diet  0.1  0.100  1.1  1.0  1.3   
  Staple based 1  0.2  0.008  1.2  1.1  1.4   
  Staple based 2  0.1  0.400  1.1  0.9  1.2   
Last step  823  Animal based diet  -0.3  0.001  0.8  0.7  0.9  4%, 0.1 
    Staple based 1  0.2  0.005  1.2  1.2  1.4   
ALT  823  Animal based diet  -0.2  0.005  0.8  0.7  0.9  3%, 0.3 
  Recommended diet  0  0.600  1.0  0.9  1.2   
  Staple based 1  0.2  0.030  1.2  1.0  1.3   
  Staple based 2  0.1  0.080  1.1  1.0  1.3   
Last step   823  Animal based diet  -0.2  0.005  0.8  0.7  0.9  3%, 0.4 
  Staple based 1  0.2  0.030  1.2  1.0  1.3   
GGT  823  Animal based diet  0  0.500  1.0  0.8  1.1  0.4%, 0.8 
  Recommended diet  0  0.500  1.0  0.8  1.1   
  Staple based 1  0  0.800  1.0  0.9  1.1   
  Staple based 2  0.1  0.200  1.1  1.0  1.3   
Last step    No variable              
ALP  823  Animal based diet  -0.3  0.000  0.8  0.7  0.9  7%, 0.03 
  Recommended diet  0  0.900  1.0  0.9  1.1   
  Staple based 1  0.4  0.000  1.5  1.3  1.7   
  Staple based 2  0.1  0.050  1.2  1.0  1.3   
Last step   823  Animal based diet  -0.3  0.000  0.8  0.7  0.9   
  Staple based 1  0.4  0.000  1.5  1.3  1.7  7%, 0.02 
Total bilirubin  801  Animal based diet  0.5  0.000  1.6  1.3  1.8  8%, 0.6 
  Recommended diet  0.1  0.060  1.1  1.0  1.3   
  Staple based 1  -0.3  0.000  0.8  0.7  0.9   
  Staple based 2  0.1  0.500  1.1  0.9  1.2   
Last step   801  Animal based diet  0.4  0.000  1.6  1.3  1.8  8%, 0.4 
  Staple based 1  -0.3  0.000  0.8  0.7  0.9   194 
 
 
In  the  HIV uninfected population, the animal  based dietary  pattern (Table 5.9) was an 
independent predictor of lower overall serum liver enzyme score and for the specific liver 
enzymes (AST, ALT, and ALP).  The staple based 1 dietary pattern was an independent 
predictor  of  higher  serum  overall  liver  enzyme  status,  AST,  ALT  and  ALP.    The 
‘recommended’ dietary pattern was not associated with any of the serum liver enzymes in 
the HIV uninfected group. This implied that in the HIV uninfected population subjects who 
consumed the animal based dietary patterns were likely to have lower liver enzyme status 
compared to those who followed the other dietary patterns. Also within the animal based 
diet group, higher scores were likely to  be  associated with lower  levels of serum  liver 
enzymes status. However with regards to bilirubin, the animal based dietary pattern was 
an independent predictor of higher serum total bilirubin in the HIV uninfected whereas the 
staple based pattern predicted lower total bilirubin. 
 
Comparing the HIV infected and the uninfected groups, it could be shown that in the HIV 
infected  subjects both  the animal based  dietary  pattern and  the  recommended dietary 
patterns  were  associated  with  lower  serum  liver  enzymes;  but  significant  associations 
were between the animal based dietary pattern and serum AST and ALT, and between the 
recommended dietary pattern and an overall liver enzyme score.  In the uninfected group 
however, the animal based dietary pattern alone was associated with lower overall liver 
enzyme and individual enzymes. This meant that in the HIV infected population the animal 
based  and  recommended  dietary  pattern  were both  likely  to  be  associated with  lower 
serum liver enzymes but in the HIV uninfected the animal based dietary pattern alone was 
associated with lower liver enzymes. 
5.6.1  Summary of dietary patterns predictors of liver enzymes and bilirubin 
Binary regression analysis showed that comparing the four different dietary patterns in the 
HIV infected population; a predominantly animal based dietary pattern was an independent 
predictor  of  lower  serum  AST  and  ALT.  The  ‘recommended’  dietary  pattern  was  an 
independent  predictor  of  lower  overall  liver  enzyme  score  whereas  the  carbohydrate, 
legumes and vegetables based predicted higher serum ALP. In the HIV uninfected the 
animal based dietary pattern independently predicted lower serum overall liver enzymes 
status, AST, ALT and ALP and the staple based dietary patterns independently predicted 
higher serum  liver  enzymes status. The  ‘recommended’  dietary  pattern  did not  predict 
status of any of the liver enzymes. 195 
 
5.7    Binary  regression  analysis  to  model  the  association  between  dietary 
patterns and  serum proteins  status  (protein  metabolism,  inflammation  or 
disease progression) 
Summary  of  the  regression  of  dietary  patterns  on  serum  proteins  in  the  HIV  infected 
population have been presented in Table 5.10. A high serum protein score from PCA in 
the HIV infected depicted high serum globulin and low serum albumin whereas a high 
score in HIV uninfected depicted subjects with high serum globulin and albumin. In the HIV 
infected population the association between serum proteins and dietary patterns models 
explained  between  1  to  9%  of  variability  within  the  population  whereas  in  the  HIV 
uninfected subgroup the R square statistics was between 0.3 to 4%. This indicated that the 
regression  models  for  the  association  between  serum  proteins  and  dietary  patterns 
explained lower variability within the HIV uninfected population. Moreover the goodness of 
fit statistics were both above 0.05 for the various models, both in the HIV infected and 
uninfected  subgroups.  This  implied  that  these  models  adequately  described  the 
population. 
 
For serum albumin,  the  animal based diet  recorded a positive coefficient whereas the 
other three dietary patterns recorded negative coefficients in the HIV infected population. 
This implied that increased score for the animal based diet was likely to be associated with 
higher serum albumin levels whereas increased score for the other three dietary patterns 
were  likely  to  be  associated  with  decreased  serum  albumin  status.  Statistically,  the  p 
values were above 0.05 for the coefficients and the odds ratios also had overlapping 95% 
confidence  intervals  implying  that  these  associations  were  not  statistically  significant 
despite the observed trend. None of the dietary patterns independently predicted serum 
albumin using backward elimination analysis. Within the HIV uninfected population (Table 
5.11), positive coefficient were  recorded for the association between the animal based 
dietary  pattern  and  serum  albumin  (β=0.3,  p=<0.001,  OR=1.4,  95%  CI=1.2-1.6)  and 
negative coefficients were observed for the other three dietary patterns. This implied that 
just like the HIV infected population, increased intake for the animal diet increased the 
likelihood for a high serum albumin status whereas increased score (intakes) for the other 
dietary patterns increased the likelihood for a lower serum albumin status.  
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Table  5.10:  Binary  logistic  regression  (odds  ratio  with  95%  confidence  interval, 
significance of Wald statistics) showing dietary patterns which predicted high 
serum proteins in the HIV infected population 
Last step refers to variable that remained in the final step of backward regression analysis 
 
For serum globulin and total protein, none of the dietary patterns predicted serum status in 
the HIV infected populations. However, the animal based and  recommended  diet  showed 
a negative coefficient whiles the other two dietary patterns showed positive coefficient in 
the HIV infected group. This implied that in the HIV infected group increased scores for the 
animal and  recommended dietary patterns were  likely to  be  associated with  increased 
likelihood for lower serum globulin. In the HIV uninfected group on the other hand all four 
dietary patterns recorded negative coefficients with serum globulin implying that increased 
scores for these dietary patterns increased the likelihood for a low serum globulin status. 
None  of  these  association  were  statistically  significant,  signified  by  overlapping  95% 
confidence intervals for the odds ratios. 
 
With regards to total serum proteins, the animal based dietary pattern showed a negative 
association  in the  HIV infected group and a positive association in  the  HIV uninfected 
group. This meant that this dietary pattern was associated with decreased  total serum 
proteins  in  the  HIV  infected  and  increased  total  serum  proteins  uninfected  subjects 
  N  Coefficient  Significance  Odds 
ratio 
95% confidence 
interval 
R square, 
goodness 
of fit 
Serum protein score          Lower 
limit 
Upper 
limit 
 
Animal based diet  125  -0.2  0.300  0.8  1.2  0.5  9.0%, 0.1 
Recommended diet    0.1  0.700  1.1  1.5  0.7   
Staple based 1    0.1  0.600  1.1  1.5  0.8   
Carbohydrate, legumes 
and vegetables 
  0.1  0.700  1.1  1.5  0.8   
Last step  125  No variable remained 
  
 
Serum albumin  125            9.0%, 0.1 
Animal based diet    0.4  0.100  1.5  0.9  2.4   
Recommended diet    -0.1  0.500  0.9  0.6  1.3   
Staple based 1    -0.4  0.100  0.7  0.4  1.0   
Carbohydrate, legumes 
and vegetables 
  -0.1  0.600  0.9  0.6  1.3   
Serum globulin               
Animal based diet  125  -0.0  0.900  1.0  0.6  1.5  1.0%,  0.1 
Recommended diet    -0.1  0.700  0.9  0.6  1.4   
Staple based 1    0.1  0.500  1.1  0.8  1.6   
Carbohydrate, legumes 
and vegetables 
  0.0  0.800  1.0  0.7  1.5   
Last step  125  No variable remained   197 
 
respectively.  The  recommended  and  staple  based  dietary  patterns  recorded  negative 
coefficients with serum total protein in the HIV uninfected and positive coefficients in the 
HIV infected group implying the different dietary patterns were associated with serum total 
protein  status  differently  between  the  HIV  infected  and  uninfected  populations.  Again, 
these associations observed for serum total proteins were not statistically significant for 
both PLWH and the uninfected 
 
Table  5.11:  Binary  logistic  regression  (odds  ratio  with  95%  confidence  interval, 
significance of Wald statistics) showing dietary patterns which predicted high 
serum proteins in the HIV uninfected population 
 
Serum total protein 
score 
N  Coefficient  Significance 
(p value) 
Odds 
ratio 
95% confidence 
interval 
R square, 
goodness of fit 
          Lower 
limit 
Upper 
limit 
 
Animal based diet  823  0.1  0.090  1.1  1.0  1.3  1.3, 0.8 
Recommended diet    -0.1  0.500  0.9  0.8  1.1   
Staple based 1    -0.1  0.300  0.9  0.8  1.1   
Staple based 2    -0.1  0.060  0.9  0.8  1.0   
Last step    No variable remained 
Serum albumin               
Animal based diet  824  0.3  0.000  1.4  1.2  1.6  4.0%, 0.4 
Recommended diet    -0.0  0.900  1.0  0.9  1.2   
Staple based 1    -0.1  0.400  0.9  0.8  1.1   
Staple based 2    -0.1  0.100  0.9  0.8  1.0   
Last step               
Animal based   824  0.3  0.000  1.4  1.2  1.6   
Serum globulin              1.0, 0.9 
Animal based diet  824  -0.1  0.300  0.9  0.8  1.1   
Recommended diet    -0.0  0.500  1.0  0.8  1.1   
Staple based 1    -0.0  1.000  1.0  0.9  1.1   
Staple based 2    -0.1 
 
0.060  0.8  0.8  1.0   
Last step    No variable remained         
 
5.7.1    Summary of dietary pattern predictors of serum proteins 
Binary regression analysis to model the associations between the four different dietary 
patterns and serum albumin, globulin and total protein status, comparing HIV infected and 
uninfected groups have shown that in both HIV infected (β=0.4, p=0.1) and uninfected 
(β=0.3, p<0.001) populations the animal based dietary pattern was associated with higher 
serum albumin whereas the staple based 1 and dietary pattern were associated with lower 
albumin in both PLWH and the uninfected. In both groups however, none of the dietary 
patterns significantly predicted serum globulin or total protein.  198 
 
5.8   Binary  regression  analysis  to  model  the  association  between  dietary 
patterns and serum lipid status (lipid metabolism or altered metabolism) 
A summary of the regression of dietary patterns on serum overall lipid score and also for 
HDL, LDL and HDL:LDL in HIV infected and uninfected subjects have been presented in 
Table 5.12 and Table 5.13 respectively. The overall serum lipid score was derived from the 
first principal component for serum HDL, LDL, total cholesterol, triglyceride and HDL: LDL 
ratio, which recorded large positive factor loadings for LDL, cholesterol, triglyceride and 
HDL/LDL ratio. Thus the first principal component for serum lipids described the variability 
between subjects with high serum LDL but low HDL status. A high score thus depicted 
high serum LDL and low HDL and low score depicted low serum LDL but high HDL. 
 
Table 5.12 Odds ratio with 95% confidence interval and p values showing dietary 
patterns which predicted high serum lipids in the HIV infected population 
 
  N  Coefficient  significance  Odds 
ratio 
95% confidence 
interval 
 R square, 
goodness 
of fit 
Over all lipid score          Lower 
limit 
Upper 
limit 
 
Animal based diet  93  0.1  0.100  1.1  1.0  1.3  6.5%, 0.8 
Recommended diet    -0.1  0.500  1.0  0.8  1.1   
Staple based 1    -0.1  0.300  0.9  0.8  1.1   
Staple based 2    -0.1  0.060  0.9  0.8  1.0   
Last step  93  No variable remained         
Serum HDL  124             
Animal based diet    0.3  0.300  1.3  0.8  2.1  3.3%, 0.2 
Recommended diet    0.2  0.300  1.2  0.8  1.9   
Staple based 1    0.1  0.600  1.1  0.8  1.5   
Staple based 2    -0.1  0.600  0.9  0.6  1.4   
Final step  124  No variable remained   
Serum LDL               
Animal based diet  122  0.1  0.800  1.1  0.7  1.7  8.0%, 0.3 
Recommended diet    -0.1  0.700  0.9  0.6  1.4   
Staple based 1    -0.5  0.020  0.6  0.4  0.9   
Staple based 2    -0.2  0.200  0.8  0.5  1.2   
Last step  122             
Staple based 1    -0.5  0.020  0.6  0.4  0.9  7.0%, 0.3 
HDL/LDL ratio               
Animal based diet  97  0.1  0.800  1.1  0.4  3.5  12.4%, 0.4 
Recommended diet    0.2  0.600  1.2  0.6  2.5   
Staple based 1    0.2  0.700  1.2  0.5  3.0   
Staple based 2    -0.6  0.030  0.5  0.3  0.9   
Last step               
Carbohydrate, legumes 
and vegetables 
97  -0.6  0.030  0.5  0.3  0.9  11.4, 0.4 
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In the HIV infected group, between 3.3 to 12.4% of the variability within the population was 
explained by modelling the association between serum lipids and dietary patterns whereas 
in the  HIV uninfected subjects the variability  explained  ranged between 1 to 2%. This 
implied that the association between serum lipids and dietary patterns was better modelled 
in the HIV infected population. With regards to goodness of fit test, all the models recorded 
goodness  of  fit  statistics  about  0.05  indicating  that  these  models  were  appropriate  to 
describe the two populations. 
 
For total lipid score, the animal based dietary pattern recorded a positive coefficient and 
increased odds ratio (OR=1.1, 95% CI=1.0-1.3) whereas the other three dietary patterns 
showed negative coefficient in both HIV infected and uninfected groups. This implied that 
high  scores  for  the  animal  based  dietary  pattern  was  associated  with  an  increased 
likelihood for a high serum lipid score (high LDL, cholesterol, triglyceride and HDL: LDL 
ratio and low HDL) in both HIV infected and uninfected populations. However none of the 
coefficients were statistically significant signified by high p values (p>0.05) and overlapping 
confidence intervals. 
 
For serum HDL, in the HIV infected group, increased intakes of the animal based diet was 
associated  with  increased  odds  for  higher  HDL  (OR=1.3,  95%  CI=0.8-2.1.  Positive 
coefficients  were  recorded  between  the  first  three  dietary  patterns  (animal  based, 
recommended and staple based dietary patterns) and HDL whereas negative coefficient 
was shown for the carbohydrate, legumes and vegetables based pattern. This implied that 
the first three dietary patterns were likely to be associated with higher HDL whereas the 
fourth dietary pattern (carbohydrate, legumes and vegetables) was likely to be associated 
with  lower  HDL.  However the magnitude  of  the  coefficient  was  highest  for  the animal 
based  dietary  pattern  compared  with  the  recommended  and  staple  based  1  dietary 
patterns  implying  that  the  animal  based  dietary  pattern  showed  a  stronger  positive 
association with HDL but none of these associations reached statistical significance. 
 
In  the  HIV  uninfected  group,  a  positive  coefficient was  recorded  for  the  animal  based 
dietary pattern alone and the rest recorded negative coefficients for HDL but no variables 
remained in the final backward regression model. This implied that in the HIV infected 
group  increasing score for the  first three  dietary patterns could  be associated with  an 
increasing likelihood for a high serum HDL status whereas in the HIV uninfected group this 
association was likely to exist for the animal based dietary pattern only.  200 
 
Table 5.13 Odds ratio with 95% confidence interval and p values showing dietary 
patterns which predicted high serum lipids in the HIV uninfected population 
 
 
Regarding  serum  LDL,  in  both  HIV  infected  and  uninfected  groups,  the  staple  based 
dietary  patterns significantly  predicted  lowered  LDL  and  for  serum  HDL:LDL  ratio,  the 
fourth dietary pattern (carbohydrate, legumes and vegetables) in the HIV infected group 
significantly predicted lowered ratio (β=-0.6, p=0.03) whereas in the HIV uninfected none 
of the dietary patterns predicted HDL:LDL ratio. 
5.8.1    Summary of dietary pattern predictors of serum lipids 
For serum lipids binary regression analyses revealed that in the HIV infected population 
the staple based dietary pattern was associated with lowered serum LDL (OR=0.6, 95% 
CI=0.4-0.9), whereas the carbohydrate, legume and vegetables dietary pattern significantly 
predicted  lowered serum  HDL:LDL  ratio  (OR=0.5,  95%  CI=0.3-0.9).  These  two  dietary 
patterns were independent predictors of LDL and HDL:LDL respectively. The animal based 
Lipids score  N  Coefficient  Significance  Odds 
ratio 
95% confidence 
interval 
R square, 
goodness 
of fit 
          Lower 
limit 
Upper 
limit 
 
Animal based diet  844  0.1  1.000  1.1  1.0  1.3  1.3, 0.8 
Recommended diet    -0.1  0.500  0.9  0.8  1.1   
Staple based 1    -0.1  0.300  0.9  0.8  1.1   
Staple based 2    -0.1  0.100  0.9  0.8  1.0   
Last step    No variable remained         
Serum HDL               
Animal based diet  844  0.0  0.800  1.0  0.9  1.2  1.0%, 0.3 
Recommended diet    -0.0  0.800  1.0  0.9  1.1   
Staple based 1    -0.1  0.100  0.9  0.8  1.0   
Staple based 2    -0.1  0.300  0.9  0.8  11   
Last step    No variable remained    
Serum LDL               
Animal based diet  817  -0.1  0.500  0.9  0.8  1.1  2.0%, 0.8 
Recommended diet    -0.1  0.100  0.9  0.8  1.0   
Staple based 1    -0.0  0.700  1.0  0.8  1.1   
Staple based 2    -0.2  0.005  0.8  0.7  0.9   
Last step               
Staple based 2  817  -0.2  0.005  0.8  0.7  0.9  2.0%, 0.8 
HDL/LDL ratio               
Animal based diet  510  -0.0  1.000  1.0  0.7  1.5  1.3%, 0.3 
Recommended diet    -0.2  0.200  0.8  0.5  1.2   
Staple based 1    0.1  0.700  1.1  0.8  1.5   
Staple based 2    -0.1  0.200  0.9  0.7  1.1   
Last step    No variable remained    201 
 
diet on the other hand predicted higher HDL (OR=1.3, 95% CI=0.8-2.1). Within the HIV 
uninfected populations, the staple based 2 dietary pattern predicted lowered serum LDL 
but none  of the dietary  patterns significantly  predicted serum HDL,  total  lipid score or 
HDL:LDL. 
5.9  Chapter Summary 
Comparing the associations between the four dietary patterns and nutrients intake, the 
predominantly animal based dietary pattern seemed to be associated with better nutrient 
intake for individual nutrients in both HIV infected and uninfected populations compared 
with the other three dietary patterns. The fourth dietary pattern (staple based 2 for HIV 
uninfected and vegetables, carbohydrates and  legumes  for  the HIV  infected) was also 
strongly  associated  with  nutrients  intake  than  the  ‘recommended’  and  staple  based  1 
dietary pattern. The staple based 1 dietary showed the lowest association with the dietary 
nutrients.  However, the other three dietary patterns were associated with better nutrient 
intake in the HIV uninfected and seemed to be more desirable in the HIV uninfected. For 
overall nutrient intake profile, the animal based dietary pattern again showed a stronger 
association with high nutrient intake pattern followed by dietary pattern 4 (staple based 2 
for HIV uninfected and carbohydrate, vegetables and legumes for HIV infected), followed 
by the recommended dietary pattern regardless of HIV status. The staple based 1 (dietary 
pattern 3) showed the least association with the ‘optimal’ nutrient intake pattern. However 
in the HIV uninfected group all four dietary patterns showed statistically significant positive 
correlation with the most optimal nutrient intake pattern. 
 
Spearman  correlation  between  dietary  patterns  and  BMI,  lean  body  mass  and 
anthropometric score controlled for age, gender and urbanisation level showed that the 
animal based and carbohydrate, legumes and vegetable based dietary patterns in the HIV 
infected  group  showed  weak  but  positive  associations with  BMI,  lean body  mass  and 
anthropometric  score  whereas  the  recommended  dietary  pattern  showed  negative 
associations with anthropometric markers within the HIV infected population. Statistically, 
the correlation recorded between the carbohydrate, legumes and vegetable based pattern 
and lean body mass was significant but the rest did not show any statistical significance. 
Similar associations were observed in the HIV uninfected population. However the animal 
based pattern seemed to be better associated with BMI, LBM and anthropometric score in 
the  HIV  uninfected  whereas  in  the  infected  group  the  carbohydrate,  legumes  and 
vegetables dietary pattern was better associated with BMI and LBM. 
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In  summary,  multinomial  regression  modelling  revealed  that  among  the  four  dietary 
patterns, increased score for the animal and carbohydrate, legumes and vegetables based 
dietary patterns were likely to be associated with higher BMI whereas the ‘recommended’ 
and staple based dietary patterns were likely to be associated with lower BMI in the HIV 
infected  population.  The  animal  based  diet  however  predicted  higher  BMI  (OR=2.2, 
p=0.070)  than  the  rest  of  the  patterns.  In  the  HIV  uninfected  population  however,  the 
animal based and  ‘recommended’ dietary  patterns were positively  associated with  BMI 
whereas the staple based patterns showed negative associations.  
 
For  lean  body  mass,  multinomial  regression  modelling  showed  that  among  the  HIV 
infected group, an animal based (OR=3.6, 95% CI=1.3-10.4) dietary pattern followed by 
the  ‘recommended’  (OR=1.7,  95%  CI=0.8-4.0),  and  carbohydrate,  legumes  and 
vegetables based (OR=1.7, 95% CI=0.8-3.6) dietary patterns were likely to predict higher 
lean body mass in that order. The only statistically significant association was however for 
the  animal  based  dietary  pattern  (p=0.020).  In  the  HIV  uninfected,  the  animal  based 
(OR=1.2,  95%  CI=0.9-1.7),  ‘recommended’  (OR=1.1,  0.8-1.5)  and  staple  based  1 
(OR=1.1, 95% CI=0.8-1.5) dietary patterns were associated with increased odds for lean 
body mass, but not statistically significant. The staple based 2 dietary pattern  (β=-0.3, 
p=0.030) was on the other hand significantly associated with lower lean body mass. 
 
In  terms  of  an  overall  anthropometric  score  multinomial  logistic  regression  analysis 
showed  that  in both  HIV  infected  and  uninfected  populations  increased scores  for  the 
animal  based  and  recommended  dietary  patterns  were  associated  with  decreased 
likelihood for a high anthropometric score whereas increased scores for the staple based 1 
and dietary pattern 4 for both HIV infected and uninfected showed increased likelihoods for 
higher anthropometric scores. 
 
Binary regression analysis showed that comparing the four different dietary patterns in the 
HIV  infected  population;  a  predominantly  animal  based  dietary  pattern  was  the  only 
independent predictor of lower serum AST (OR=0.5, 95% CI=0.3-0.8) and ALT (OR=0.6, 
95% CI=0.4-4.9) compared with  the  other dietary patterns. The ‘recommended’ dietary 
pattern was an independent predictor of lower overall liver enzyme score (OR=0.7, 95% 
CI=0.4-0.9) whereas the carbohydrate, legumes and vegetables based predicted higher 
serum ALP (OR=1.3, 95% CI=0.9-2.0). In the HIV uninfected the animal based dietary 
pattern independently predicted lower serum overall liver enzymes status, AST, ALT and 203 
 
ALP  and  the  staple  based  dietary  patterns  independently  predicted  higher  serum  liver 
enzymes status. The ‘recommended’ dietary pattern did not predict status of any of the 
liver enzymes. 
 
Binary regression analysis to model the associations between the four different dietary 
patterns and serum albumin, globulin and total protein status, comparing HIV infected and 
uninfected groups have shown that in both HIV infected (β=0.4, p=0.1) and uninfected 
(β=0.3, p=0.000) populations the animal based dietary pattern was associated with higher 
serum albumin whereas the staple based 1 and dietary pattern were associated with lower 
albumin in both PLWH and the uninfected. In both groups however, none of the dietary 
patterns significantly predicted serum globulin or total protein. 
 
For serum lipids binary regression analyses revealed that in the HIV infected population 
the staple based dietary pattern was associated with lowered serum LDL (OR=0.6, 95% 
CI=0.4-0.9), whereas the carbohydrate, legume and vegetables dietary pattern significantly 
predicted  lowered serum  HDL:LDL  ratio  (OR=0.5,  95%  CI=0.3-0.9).  These  two  dietary 
patterns were independent predictors of LDL and HDL:LDL respectively. The animal based 
diet on the other hand predicted higher HDL (OR=1.3, 95% CI=0.8-2.1). Within the HIV 
uninfected populations, the staple based 2 dietary pattern predicted lowered serum LDL 
but none  of the dietary  patterns significantly  predicted serum HDL,  total  lipid score or 
HDL:LDL. 
 
Thus regression analysis showed that dietary patterns were associated with the markers of 
lipid  and  protein  metabolism  and  liver  damage,  inflammatory  markers  and  markers  of 
malnutrition, body composition and probably disease progression in the HIV infected and 
similar associations in the HIV uninfected although differences existed between the HIV 
infected and uninfected subgroups.  
5.10      Chapter Discussion 
5.10.1   Introduction 
Four different dietary patterns generated by principal component analysis were described 
in Chapter Four and these were the animal based, ‘recommended’, staple based 1 and 
dietary pattern 4 (carbohydrate, legumes and vegetables based in HIV infected and staple 
based  2  in  the  HIV  uninfected).  The  objective  of  this  chapter  was  to  explore  the 
relationship  between  the  four  different  dietary  patterns  and  markers  of  nutritional, 
metabolic and disease state in the HIV infected population, compared with the uninfected 204 
 
population in order to identify which of the dietary patterns were associated with more 
desirable  status  for  these  markers  (outcomes).  The  parameters  used  to  represent 
nutritional status, metabolic integrity and disease progression were nutrient intake (specific 
nutrients and nutrient patterns generated by PCA), anthropometrics (BMI, lean body mass 
and anthropometric score generated from nine anthropometric variables), serum proteins 
(especially  albumin),  lipids  (serum  HDL,  LDL,  cholesterol  and  triglycerides)  and  liver 
enzymes (serum AST, ALT, ALP and GGT) and serum bilirubin. 
 
Spearman crude and adjusted (age, sex and urbanisation level) correlations and statistical 
significance were determined between the different dietary patterns and dietary nutrient 
intake  (individual  nutrients  and  nutrient  patterns  from  PCA)  and  anthropometrics  (lean 
body  mass,  BMI  and  anthropometric  score  derived  from  PCA  of  nine  anthropometric 
variables), Multinomial and binary regression analyses were performed to determine how 
different dietary patterns (exposures) predicted nutritional, metabolic status and disease 
progression  indicators in PLWH compared with the uninfected population. 
5.10.2    Dietary patterns and nutrient intake 
Adequate dietary intake or nutrition security is required to supply (meet the demands) the 
body with the required energy and nutrients needed to prevent infections as well as to fight 
infections. In HIV infection there is an increased nutrients requirement due to increased 
nutrient losses caused directly and indirectly by the virus through diarrhoea, inflammatory 
response,  increased  metabolism  and  redistribution  of  nutrients  (Calder  and  Jackson, 
2000).  The  need  for  certain  dietary  patterns  (foods)  to  meet  this  increased  nutrient 
requirement and hence delay disease progression and promote adequate quality of life in 
the midst of the infection is imperative. Thus one of the objectives of this thesis was to 
explore  the  relationship  between  the  four  different  dietary  patterns  generated  from 
principal component analysis and selected nutrients intake as well as an overall nutrient 
pattern, in order to show which of the dietary patterns were associated with better nutrient 
intake.  
 
In both the HIV infected and uninfected populations, a predominantly animal based dietary 
pattern and dietary pattern 4 (carbohydrate, legumes and vegetable dietary pattern) were 
associated with better nutrient intake for individual nutrients than the staple based and the 
‘recommended’  dietary  patterns.  These  associations  were  similar  in  the  uninfected 
population but slight differences existed. In the HIV uninfected group only, all four dietary 
patterns were associated with desirable nutrient intake but in the HIV infected, it was the 205 
 
animal based and  fourth dietary  pattern which were associated with higher macro and 
micronutrient intake. 
 
Regarding  patterns  of  nutrient  intake,  the  animal  based  dietary  pattern  again  showed 
stronger  association  with  a  more  desirable  nutrient  intake  pattern  followed  by  dietary 
pattern  4,  followed  by  the  recommended  dietary  pattern  in  both  HIV  infected  and 
uninfected  groups.  The  staple  based  1  showed  the  least  association  with  the  more 
‘optimal’  nutrient  intake  pattern.  These  findings  probably  suggest  that  in  HIV  infection 
certain dietary patterns could be associated with better nutrient intake than others whereas 
in the HIV uninfected, although an animal based dietary pattern was likely to be associated 
with  better  nutrient  intake  and  pattern,  the  other  three  dietary  patterns  were  also 
associated with desirable nutrient intake as well.  
 
Micronutrients  in  general  play  very  important  roles  in  prevention  of  infection  and  in 
activating immune response to infections. Vitamin A is an essential nutrient and necessary 
for regulation and gene expression and therefore performs an important role in white blood 
cell differentiation and development (Semba 1998). It also maintains integrity and function 
of the skin and mucosal cells to serve as barriers against invading pathogens (McCullough 
et al., 1999). Zinc is an essential nutrient which stimulates enzymatic reactions to enable 
biochemical  reactions  that  promote  growth,  development  and  immune  response 
(Stanstead  1994).  Selenium  is  important  because  of  its  antioxidant  function  and  its 
influential role in the reduction of gluthathione peroxidase (Stephensen et al., 2006).  
 
Available literature explains the importance of energy and certain micronutrients in HIV 
infection. Associations between these nutrients and markers of disease progression (viral 
load, CD4 cell count, wasting and AIDS defining illnesses)  in HIV infection have been 
shown to some extent (Kupka et al., 2008; Baum and Shor Posner, 1998; Bodgen et al., 
2000; Jiamton et al., 2003; Wellinghausen et al., 1999). In the systematic review presented 
in Chapter two, supplementation with these nutrients in some cases were associated with 
improvement  of  markers  of  disease  progression  or  a  decrease  in  the  rate  of  disease 
progression. For instance, supplementation was shown to improve plasma micronutrient 
status and CD4 cell count (Coodley et al., 1993; Shor Posner et al., 2003; Semba et al., 
1998), and progression to AIDS was reduced in subjects whose intakes of zinc, vitamins 
B1 and B12, C and niacin were high (Baum, 2003; Baum et al., 1995; Kupka et al., 2004 
and 2007). In some other studies, high selenium, zinc, vitamins B12, vitamin A, and multiple 206 
 
micronutrients status or supplementation individually lowered mortality or risk of dying in 
HIV  infected  subjects  (Jiamton  et  al.,  2003;  Austin  et  al.,  2006).  At  the  same  time, 
excessive intakes of vitamins A and zinc were associated with rapid disease progression 
(Tang et al., 1993). 
 
The demand for nutrients in HIV infected needs to be met in order to maintain the plasma 
status necessary for essential metabolic functions and ultimately fight the HIV infection 
especially in the chronic inflammatory state. A dietary pattern/s that is able to meet these 
needs could be an answer to maintaining a good quality of life by preventing death and 
enabling  HIV  infected  persons  to  live  with  the  virus  like  any  chronic  disease.  This  is 
extremely  important  due  to  growing  levels  of  HIV  wasting  in  the  HAART era which  is 
associated with hyper-metabolic state caused by the chronic inflammatory process (Harris, 
2008). Among the dietary patterns described within this study population, the animal based 
dietary pattern seemed to be the most optimal diet to meet these needs in HIV infection 
because it showed stronger positive associations with energy and micronutrients as well 
as with an overall nutrient pattern/profile.  
 
The findings did not indicate if the animal based dietary pattern actually met the nutrient 
needs of the HIV infected because these needs are not clearly outlined and the nutrient 
requirements of the present study were not explored. However it has been shown that this 
dietary pattern compared with the dietary pattern that is closest to current recommended 
dietary guidelines was associated with more  a desirable nutrient intake  and an overall 
nutrient pattern. This may suggest that the animal based dietary pattern was more likely to 
meet the nutrient needs in HIV infection than the other dietary patterns. Also, the fact that 
the findings with regards to the HIV uninfected was quite different in that all four dietary 
patterns showed better association with dietary nutrient intake confirmed that the animal 
based dietary pattern was probably preferred or might be more beneficial to the PLWH.  
5.10.3   Dietary patterns and anthropometrics 
In  summary,  the  Spearman  correlation  between  dietary  patterns  and  anthropometrics 
(BMI,  lean  body  mass  and  anthropometric  score)  controlled  for  gender,  age  and 
urbanisation level showed that the animal based diet was weakly but positively associated 
with BMI, lean body mass and anthropometric score whereas the recommended dietary 
pattern showed negative associations with anthropometric markers within the HIV infected 
population. The carbohydrate, legumes and vegetables based dietary pattern also showed 
similar  associations  with  these  markers  observed  in  the  animal  based  dietary  pattern 207 
 
group.  In  the  HIV  uninfected  group  however,  the  animal  based  diet  maintained  weak 
positive associations with the anthropometric variables whereas the recommended dietary 
patterns recorded negative  associations with  BMI,  lean  body  mass and  anthropometric 
score.  The  associations were all  statistically  insignificant  (except  for  the  carbohydrate, 
vegetable  and  legume  based)  and  the  correlation  coefficients  were  all  less  than  1 
signifying very weak associations indeed. However a clear contrast was observed between 
the animal  based dietary  pattern  and  recommended dietary  pattern  in  that the  animal 
based dietary pattern recorded positive associations whereas the latter recorded negative 
associations.  
This implied that the consumption of the animal based dietary pattern was likely to be 
associated with higher BMI, lean body mass and overall anthropometric score in both HIV 
infected  and  uninfected  study  subjects  whether  they  lived  in  urban,  rural  or  informal 
settlement areas and irrespective of their gender and age. Between the HIV infected and 
uninfected  groups  however,  the  animal  based  dietary  pattern  showed  more  positive 
association with anthropometric indicators in the HIV infected sub-population.   
5.10.3.1   Dietary patterns which predicted BMI status 
Multinomial regression analysis showed that among the four dietary patterns increased 
score for the animal based dietary pattern was likely to be associated with higher BMI 
whereas the recommended dietary pattern was likely to be associated with lower BMI in 
the HIV  infected population. This implied  that in  the HIV  infected population  increased 
intake  (score)  for  the  animal  based  dietary  pattern  was  associated  with  an  increased 
likelihood  for  higher  BMI (25  kg/m
2 and above) whereas  increased score for a dietary 
pattern  closest  to  the  recommended  guidelines  was  associated  with  an  increased 
likelihood for a lower BMI. In the HIV uninfected population however both dietary patterns 
were associated with higher BMI.  
 
The  implication  of  these  findings  is  that  body  mass  index  could  be  improved  in  HIV 
infected subjects whose consumption of animal based diets including red meat, chicken, 
and fish, with high fat intake was high. Body mass index or Quatelet index is a statistical 
measure of an individual’s body weight which has been scaled according to the height and 
was  invented  between  1830  and  1850  by  the  Belgian  polymath  Adolphe  Quatelet 
(Eknoyan, 2008). BMI is most appropriate for population use to classify individuals into 
underweight  (BMI  lower  than  18.5  kg/m2),  normal  weight  (BMI  between  18.5  to  25.0 208 
 
kg/m2),  overweight  (BMI  above  25  kg/m2)  and  obesity  (BMI  above  30  kg/m2)  (WHO 
Technical Report Series 854).  
 
Malnutrition and wasting are complications of HIV and studies have shown that among HIV 
infected hospitalised patients about 60% or more are underweight or have lost more than 
10%  of  usual  body  weight  (Rabeneck  et  al.,  1996).  Weight  loss  in  HIV  infection  is 
associated with reduction in BMI (Luder et al., 1995) hence weight loss could also imply 
reduction in BMI. Even with the progression of HIV/AIDS treatment due to antiretroviral 
drugs (Rousseau et al., 2000), leading to a decline in HIV related morbidity and mortality 
(Patela,  1998),  wasting  syndrome  and  diarrhoea  remain major  manifestations  of  AIDS 
(Drain et al., 2007; Mitsuyasu, 2000) and this has been shown to be associated with the 
chronic inflammatory process associated with HIV infection. HIV infected subjects whose 
dietary intake was better were associated with higher survival (Paton et al., 2006).  
 
Studies have shown significant reduction in body weight, BMI, fat mass, fat free mass in 
HIV infection and these were shown to be associated with AIDS defining illness (Malvy et 
al., 2001; Sharpstone et al., 1999).  Van Lettow et al., (1998) found that close to 60% of 
the HIV infected subjects studied had BMI <18.5 kg/m2 indicating underweight and 17% of 
these  subjects  were  severely  wasted  (BMI  <16  kg/m2).  A  study  among  HIV  infected 
subjects also revealed that weight loss greater than 10% in HIV infected tripled the risk of 
disease progression to clinical AIDS and BMI <16.0 kg/m2, increased the relative risk of 
progression to AIDS to about 4.7 (Malvy et al., 2001). This implied that weight loss and low 
BMI are actually markers of HIV disease progression. Dietary intake therefore must be 
adequate  to meet  the metabolic  needs  and consequently  promote weight  gain  in  HIV 
infection.  
 
Weight loss is among the clinical conditions associated with disease progression in HIV 
infected persons (Wheeler, 1999; Grinspoon and Mulligan, 2003), even in those receiving 
antiretroviral therapy (Grinspoon and Mulligan, 2003). Karmon et al., (2005) reported that 
HIV/AIDS individuals on HAART treatment experienced weight loss and lipodystrophy and 
these were associated with lower CD4 cell count or rapid disease progression. Chlebowski 
et  al.,  (1995)  reported  that  clinical  outcome  and  survival  of  HIV/AIDS  persons  was 
associated with weight loss among other markers of disease progression and usual body 
weight  of  HIV  infected  persons were  independent  predictors  of  event  free  survival.  In 
patients infected with human immunodeficiency virus (HIV), wasting, particularly loss of 209 
 
metabolically active lean tissue, has been associated with increased mortality, accelerated 
disease  progression,  loss  of  muscle  protein  mass,  and  impairment  of  strength  and 
functional status (Grinspoon and Mulligan, 2003). This implied that body weight and BMI of 
persons before HIV infection as well as wasting during HIV infection is associated with 
disease progression.  
 
Inadequate  dietary  intake  has proved  to be  the  most  important  causes of  weight  loss 
though there are many other causes of weight loss in HIV/AIDS (Macallan et al., 1995) 
such  as  repeated  infections,  increased  needs  for  nutrients  caused  by  the  virus, 
medication,  anxiety  and  loss  of  appetite  (Grunfeld  et  al.,  1989;  Ott  et  al.,  1993  and 
Grunfeld  et  al.,  1992).  Among  the  reviewed  studies  which  involved  oral  dietary 
supplementation  of  HIV  infected  subjects,  notable  improvements  in  body  weight  were 
observed in many studies (Schwenk et al., 1999; Charlin et al., 2002; Clark et al., 2000; 
Topping et al.,; 1995; Shabert et al., 1999; De Luis et al., 2003 and Suttmann et al., 1996). 
Moreover  studies  which  involved  enteral  and  parenteral  nutritional  supplementation 
reported gains in body weight. Thus dietary intake has the potential to improve nutrient 
consumption and body weight or BMI in HIV infection.  
 
A dietary pattern which followed higher intakes of animal foods (red meat, chicken, fish, fat 
with fruits and vegetables) was shown to be more likely to provide such improvements in 
the present HIV infected population compared to a diet which followed the recommended 
dietary guidelines (low in fat and animal foods, high in fruits and vegetables, and generally 
more  varied).  This  dietary  pattern  was  likely  to  be  associated  with  increased  energy, 
protein, fat (probably saturated fat) and micronutrients intake as was shown in the earlier 
section,  which  may  not  be  recommended  in  normal  populations  in  order  to  prevent 
overweight  and  obesity  and  other  diet  related  chronic  diseases.  In  HIV  infected 
populations however, especially in poor resource countries burdened with malnutrition and 
endemic  infectious  diseases  such  as  observed  in  sub-Saharan  Africa  (Morgan  et  al., 
2002), this dietary pattern might be more optimal from the findings of this study. 
 
The  South  African  Nutritional  guidelines  for  HIV  infection  recommends  HIV  infected 
persons to make starchy foods the basis for each meal, eat lots of fruits and vegetables, 
meat and dairy foods may be eaten daily and dried beans, peas, lentils, peanuts or soya 
should be eaten regularly. Further, the guidelines suggest the need to include sugars, fats 
and oils, and eat salt sparingly. These guidelines seem to be similar to the recommended 210 
 
dietary  guidelines  for  normal  healthy  populations  to  ensure  a  general  maintenance  of 
health  and  prevention  of  obesity  and  other  cardiovascular  risk  factors  in  normal 
populations.  It  encourages  higher  intakes  of  starchy  foods  (staples)  and  advises  that 
animal  foods  may  be  eaten daily.  Thus  if  the  associations  between  the  animal  based 
dietary pattern and BMI observed were true, then the current dietary guidelines for PLWH 
may be less desirable  especially in this asymptomatic HIV infected group.   
 
Using regression analysis it was showed that in the HIV uninfected group higher intakes 
for both animal based and ‘recommended’ dietary patterns were associated with higher 
BMI  (>25  kg/m2),  although  statistical  significance  was  observed  for  the  animal  based 
dietary pattern only. This was in contrast to the findings among the HIV infected group in 
which the recommended dietary guideline showed a negative association with the higher 
BMI category whereas the animal based diet showed a positive association. In the HIV 
uninfected population, the findings of this study might suggest that both the animal based 
and recommended based dietary patterns were associated with better BMI.  
 
It was also worth noting that since the study population was quite healthy and the HIV 
infected  persons were asymptomatic, a positive association between the animal  based 
dietary  pattern  and  BMI  >25  kg/m2  might  have  seemed  disadvantageous  since  that 
denoted overweight. However, considering the fact that rapid and uncontrollable wasting 
and weight loss are major manifestations of symptomatic HIV infection as well as disease 
progression, high body weight or overweight in the early stages of the infection might be 
necessary and advantageous to the HIV infected person since such individual might be 
able to maintain higher body weight in the symptomatic stages of the infection than those 
who starts being underweight especially in resource poor countries. Hence, animal based 
dietary pattern might probably be more optimal in HIV infection as a way of preparing for 
symptomatic HIV infection. 
 
However, these associations did not imply causality because both dietary intake and BMI 
were assessed at the same time (cross sectional design) and there was no indication of 
which came first. Also, at this point, comparison was made between the dietary patterns 
and BMI not considering other factors that might have influenced the BMI levels, especially 
the socio-demographic factors.  
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5.10.3.2     Dietary patterns which predicted Lean Body Mass status 
The lean body mass refers to the sum of the weight of the bones, muscles and organs 
without fat. It simply refers to the mass of the body minus the fat. Lean body mass (LBM) 
can be determined with different methods including underwater weighing, BOD POD (a 
computerized  chamber),  DEXA  (dual-energy  X-ray  absorptiometry),  skin  callipers  and 
Bioelectric Impedance (BIA). 
 
There are insufficient data regarding lean body mass changes during the course of HIV 
infection. However there is enough evidence to show that changes in body composition 
and loss of lean body mass have become more common in HIV infected persons with the 
advent of highly active antiretroviral therapy (Grinspoon and Mulligan, 2003). Even though 
severe  weight  (wasting  syndrome)  loss  in  HIV  infection    appears  to  be  less  common 
especially in more affluent countries, erosion of lean body mass (LBM) – primarily from 
skeletal muscle) is still evident in many patients with HIV infection when body composition 
was measured (Earthman et al., 2000; Wanke et al., 2000).  
 
In AIDS wasting, Grinspoon and colleagues demonstrated that low serum testosterone is 
an important determinant of LBM loss (Grinspoon et al., 1996 and 1997) in HIV infection. 
Because muscle mass is the predominant determinant of strength, loss of LBM can lead to 
loss of functional capacity and independence, and the resulting reduced protein stores 
diminish the ability to withstand an acute infection (Grinspoon et al., 1999). Even though 
weight  loss  was  rare  in  the  cohort  of  patients  treated  with  highly  active  antiretroviral 
therapy, loss of LBM was common, and was driven by catabolic cytokines and not by 
inadequate dietary intake or hypogonadism (Roubenoff et al., 2002). Hence, there is some 
evidence  suggesting  loss  of  lean  body  mass  (LBM)  in  HIV  infection  was  not  due  to 
inadequate dietary intake.  
 
Interestingly, these findings may not be consistent with other literature regarding nutritional 
support and lean body mass in PLWH. From the studies reviewed, several subjects who 
received dietary supplementation, either orally, enterally or parenterally gained lean body 
mass and in some cases these gains were statistically significant. Among three out of 19 
studies which assessed the impact of oral macronutrient or diet supplementation on lean 
body mass, all three studies reported significant increase of lean body mass in subjects 
receiving supplementation (Clark et al., 2000; Berneis et al., 1997;). In another four studies 
which assessed changes in lean body mass after HIV infected subjects received enteral 212 
 
and parenteral nutritional supplementation, all four studies reported increase in lean body 
mass following supplementation (Ireton-Jones et al., 1998; De Luis et al., 2001; Hoh et al., 
1998) although these gains were statistically significant in one study only (Melchior et al., 
1996). Clearly, these findings are inconsistent with the studies that showed that lean body 
mass  gains  or  losses  were  not  associated  with  inadequate  dietary  or  nutrient  intake. 
Moreover if loss of lean body mass associated with the chronic inflammatory state, with 
resulting increase in cytokines as observed by Roubenoff and colleagues then adequate 
dietary intake is even more essential in order to restore LBM. 
 
Multinomial regression analysis in this study showed that among PLWH, an animal based 
dietary pattern was predicted higher lean body mass (OR=2.2, 9% CI=0.9-5.0), whereas 
the ‘recommended’ dietary pattern predicted lower lean body mass (OR=0.6, 95% CI=0.3-
1.4), similar to the findings regarding BMI. This probably implied that the quality of animal 
based dietary patterns in providing adequate nutrients (especially proteins) to meet the 
demands for nutrients needed for repletion of lean body mass in HIV infection was better 
than the other dietary patterns. Studies have also shown that severe weight loss in HIV 
infection is predominantly due to loss of lean body mass even though body fat remains 
unchanged  or  is  redistributed.  There  are  insufficient  data  regarding  lean  body  mass 
changes during the course of HIV infection. However there is enough evidence to show 
that  changes  in  body  composition  and  loss  of  lean  body  mass  have  become  more 
common in  HIV infected persons with the advent  of highly  active antiretroviral therapy 
(Grinspoon and Mulligan, 2003).  
 
Weight loss and muscle wasting remain significant clinical problems, even in the era of 
potent antiretroviral therapy. In patients infected with human immunodeficiency virus (HIV), 
wasting, particularly  loss of metabolically  active  lean  tissue,  has  been  associated  with 
increased mortality, accelerated disease progression, loss of muscle protein mass, and 
impairment  of  strength  and  functional  status.  Factors  that  may  contribute  to  wasting 
include inadequate intake, malabsorptive disorders, metabolic alterations, hypogonadism, 
and excessive cytokine production (Grinspoon et al., 2003). Since, the lean body mass is 
the  metabolically  active  tissue  of  the  body,  loss  of  it  in  HIV  infection  would  influence 
metabolic activities in PLWH. Thus the fact that an animal based dietary pattern predicted 
higher lean body mass in the population studied implies that subjects who followed this 
dietary pattern were likely to have a better metabolic integrity compared to those following 
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5.10.3.3    Dietary patterns which predicted an overall anthropometric status 
An overall anthropometric score was derived from the first principal component of nine 
anthropometric  variables  namely  body  weight,  height,  BMI,  triceps  skinfold,  waist 
circumference, and waist hip ratio. The rest were body fat, lean body mass, fat percent. 
This anthropometric profile was similar between the HIV infected and uninfected subjects 
because ANOVA between the score for the HIV infected and uninfected did not show any 
statistical significance and this implied that majority of the HIV infected and uninfected 
subjects had similar anthropometric profile.  
 
The first principal component for the nine anthropometric variables showed positive factor 
loadings for seven of the variables (body weight, BMI, lean body mass, fat percent, body 
fat,  triceps  skinfold  and  waist  circumference)  and  negative  factor  loadings  for  two 
anthropometric variables (stature and waist to hip ratio). This component thus described 
the variation between subjects who were likely to have higher BMI, LBM, triceps skinfold, 
waist circumference, lean body mass, body fat and fat percent with low waist-to-hip ratio 
and  height with subjects with high WHR and height but low  levels of the other  seven 
anthropometric variables. 
 
The summary of  multinomial  logistic regression analysis used  to identify  which dietary 
patterns were predictors of high or low anthropometric score in the HIV infected population 
comparing it with the HIV uninfected group revealed that in both populations increased 
score  for  animal  based  and  ‘recommended  dietary  patterns  were  associated  with 
decreased likelihood for a high anthropometric score. Also, increased scores for the staple 
based  dietary  patterns  were  associated  with  an  increased  likelihood  for  high 
anthropometric scores. This observation meant that irrespective of the HIV infection status, 
subjects  whose  dietary  patterns  followed  the  animal  based  or  ’recommended’  dietary 
patterns were likely to have lowered anthropometric score compared with subjects whose 
dietary patterns followed that of the staple based dietary patterns. 
 
Since  a  high  anthropometric score described subjects with  high  levels  of a mixture of 
anthropometric parameters some of which higher levels were considered desirable as well 
as some which were considered undesirable, it was difficult to decide whether a high score 
for the anthropometric profile was desirable or undesirable. For instance, high scores for 
body weight, BMI, lean body mass might be acceptable due to issues of wasting, rapid 
weight loss and cachexia discussed in the earlier sections (Rabeneck et al., 1996; Luder et 214 
 
al., 1995). However high body fat, fat percent and triceps skinfold thickness were likely to 
be  undesirable  in  these  subjects  due  to  the  effects  of  excess  fat  and  obesity  on 
cardiovascular diseases and metabolic syndrome as well as issues of fat redistribution in 
HIV infection. Thus the anthropometric score generated by PCA were difficult to interpret 
in this particular group studied. 
 
These  observations  might  also  be  suggestive  that  probably,  the  appropriate  way  of 
exploring the relationship between the four dietary patterns and nutritional anthropometrics 
may  be  to  consider  individual  anthropometric  variables  rather  than  an  overall 
anthropometric status. 
5.10.4    Dietary patterns as predictors of biochemical and metabolic state 
5.10.4.1 Dietary patterns which predicted serum liver enzymes status (markers of      
inflammation or liver damage) 
In  summary,  binary  logistic  regression  analysis  was  used  to  model  the  associations 
between different dietary patterns and serum liver enzymes and revealed that in both HIV 
infected and uninfected populations, the animal based pattern was associated with lower 
levels of liver enzymes (AST and ALT in the HIV infected and AST, ALT and ALP in the 
HIV  uninfected  group).  This  meant  that  HIV  infected  subjects  whose  consumption  of 
animal based dietary patterns were high were more likely to have lowered serum AST and 
ALT whereas in the HIV uninfected subjects increased intake of this diet was associated 
with lower AST, ALT and ALP. The ‘recommended’ diet was associated with an overall 
lower  liver  enzyme  status  whereas  the  staple  based  diets  were  more  likely  to  be 
associated  with  high  liver  enzymes.  Thus  a  clear  contrast  was  observed  for  the 
associations between the different dietary patterns and liver enzymes. 
 
Findings  presented  in  the  earlier  section  showed  that  the  HIV  infected  subjects  had 
relatively  higher  serum  liver  enzymes  compared  with  the  HIV  uninfected  but  further 
analysis using binary regression have shown that in both populations,  high consumption 
of  an  animal  based  dietary  pattern  could  be  associated  with  lowered  levels  of  these 
enzymes. The difference between the HIV infected and uninfected populations was that in 
the  HIV  infected  person  the  animal  based  dietary  pattern  and  a  dietary  pattern  that 
followed the recommended guidelines were both associated with lowered liver enzymes. 
The  association  with  the  animal  based  dietary  pattern  was  stronger  than  for  the 
‘recommended’  dietary  guideline  which  implied  that  though  both  dietary  patterns  were 
likely to be associated with lowered liver enzymes, the likelihood for the animal based 215 
 
dietary pattern was greater. In the HIV uninfected population, on the other hand the animal 
based dietary pattern was associated with lowered liver enzymes but the ‘recommended’ 
was likely to be associated with higher liver enzymes. The staple based dietary patterns 
were likely to be associated with higher liver enzymes. Thus comparing the four dietary 
patterns, the animal based and recommended diets were likely to be associated with lower 
liver  enzymes  in  the  HIV  infected  which  was  interesting  because  the  latter  showed 
negative association with BMI. 
 
Many studies have documented elevated liver enzyme levels in HIV infected populations 
(Sterling et al., 2008; Livry et al., 2003; Rathi et al., 1997; Ejilemele et al., 2007; Ofotokun 
et al., 2007; Torti et al., 2005; Livry et al., 2003) and these have been associated with anti-
retroviral therapy in some cases (Stapleton et al., 2007). High serum liver enzymes, low 
serum  albumin  and  high  serum  direct  bilirubin  in  general  are  indicative  of  metabolic 
abnormalities,  chronic  inflammation  and  liver  damage  (Kumar  and  Clark,  1999)  which 
could result from the liver’s response to chronic inflammation and other stresses in HIV 
infection. Very few studies have shown an association between dietary intake and liver 
enzymes in HIV infection (Vorster et al., 2004). Vorster et al., showed that red meat with 
fruit and vegetables consumption was associated with lower levels of liver enzymes in 
asymptomatic  HIV  infected  individuals  whereas  increased  maize  meal  intake  was 
associated  with  higher  liver  enzyme  status.  This  study  showed  that  an  animal  based 
dietary pattern in general and probably not red meat alone was likely to be associated with 
lowered  serum  liver  enzymes,  particularly  ALT and  AST  in  both the  HIV  infected  and 
uninfected populations. Since the study design was however cross-sectional, these might 
be solely associations. It is essential though to explore what might be the reasons for such 
associations. 
 
In the present population studied, inflammation was likely to be common irrespective of 
HIV status. This could be attributed to other threats from infectious diseases which are 
more common in less privileged populations (Morgan et al., 2002). However the higher 
levels of the enzymes in the infected group were suggestive of the increased burden and 
stress  caused  by  HIV  infection  such  as  increased  inflammation  and  its  associated 
metabolic  disturbances.  HIV  infection  is  now  regarded  by  Scientists  as  a  chronic 
inflammatory  process that affects the body’s organs and tissues causing  damage  long 
before  CD4  cell  counts  drop  to  levels  where  a  person  is  at  risk  of  AIDS  related 
opportunistic  infections  and  cancer  (Harris,  2008).  Findings  from  the  SMART  study 216 
 
showed  that  HIV  related  chronic  inflammation  can  lead  to  multiple  non-AIDS  defining 
diseases such as liver, kidney and heart diseases as well as non-AIDS cancers like lung, 
head, anal and neck cancers (Harris, 2008).Thus the relatively higher liver enzymes in the 
HIV  infected  group  could  be  indicative  of  the  chronic  inflammatory  process  and  the 
response of the liver to this inflammation and probably liver damage. Chronic inflammation 
is a condition caused by the body’s response to an invader such as bacteria or virus which 
leads to the release of high amounts of cytokines or signalling proteins causing increased 
immune response and this can lead to damage to tissues and organs.  
 
Following the initiation of the inflammatory stimulus, an acute phase response is invoked 
by the body which leads to the release of inflammatory cytokines such as interleukin-1 (IL-
1), tissue necrotic factor-alpha (TNF-α), interleukin-6 (IL-6) and some interferons (IFNs) to 
direct  the  inflammatory  response.  Additionally,  the  inflammatory  or  immune  response 
process, which is vital in the defence of the body’s integrity, also requires the expenditure 
of a large amount of energy and nutrients, which may culminate in nutrient and energy 
imbalances. Thus, the body’s requirements for nutrients in chronic inflammation such as 
observed  in  HIV  infection  are expected  to  increase  to meet  the  heightened  metabolic 
activities (Calder and Jackson, 2000; Piwoz and Preble, 2000).  
 
The  findings  of  this  study  thus  implied  that  a  predominantly  animal  based  diet  may 
enhance nutrient intakes and serum nutrients status crucial in the chronic inflammatory 
status PLWH are in and this probably explained why this dietary pattern seemed to be 
associated with lower liver enzyme levels.  It was however notable that the broad based 
dietary  pattern  described  as  ‘recommended’  was  associated  with  lower  overall  liver 
enzymes status in the HIV infected but higher status in the uninfected implying that this 
dietary pattern could be beneficial regarding the association with liver enzymes. The staple 
(maize  meal)  based  was  however  seemed  to  be  associated  with  higher  serum  liver 
enzymes  in  both  populations  though  statistical  significance  was  observed  in  the  HIV 
uninfected group only.  Thus comparing the four dietary patterns and associations with the 
liver enzymes, it did seem that marked differences existed and certain dietary patterns 
were likely to be more beneficial than others. 
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5.10.4.2  Dietary  patterns  which  predicted  serum  proteins  status  (protein 
metabolism, inflammation and malnutrition) 
 
In  both  HIV infected and uninfected populations, the animal based dietary  pattern and 
staple  based  1  (maize meal  based) were  important predictors  of  high  and  low  serum 
albumin status respectively although the association between the animal based diet and 
albumin was not statistically significant. In the HIV infected group there were no important 
dietary pattern predictors  of serum globulin  and total protein but in the  HIV uninfected 
group  the  staple  based  2  dietary  pattern  was  associated  with  lower  serum  albumin, 
globulins and total protein status.  
Low serum albumin levels as mentioned earlier could be indicative of liver disease, chronic 
inflammation,  nephrotic  syndrome,  burns,  protein-losing  enteropathy,  malabsorption, 
malnutrition, late pregnancy, artefact, posture, genetic variations and malignancy and quite 
common in HIV infection  (Mehta et al., 2006; Graham et al., 2007; Feldman et al., 2000; 
Feldman et al., 1998; Ramakrishnan et al., 2008 and Carter, 2006). In PLWH however 
lower serum albumin is more likely to be caused by the state of chronic inflammation. Low 
albumin  levels  have  been associated with HIV disease  progression and higher rate of 
mortality in a number of different populations with a variety of acute and chronic conditions 
(Mehta et al., 2006; Graham et al., 2007; Feldman et al., 2000; Feldman et al., 1998; 
Ramakrishnan et al., 2008 and Carter, 2006). Albumin levels have been associated with 
CD4 cell count in HIV infection (Graham et al., 2007). 
The explanation given for the association between the animal based dietary pattern and 
liver enzymes were likely to be similar to that of albumin. Chronic inflammation in HIV 
infection could  lead  to  diminished  albumin  and increased globulins  in  response  to  the 
inflammation (Jackson, 2007), thus explaining the higher globulins levels and diminishing 
albumin  status  observed  in  the  HIV  infected  population.  Moreover,  oxidative  stress 
observed  in  HIV  infection  and  populations  with  high  infectious  diseases  such  as  was 
studied could deplete proteins and antioxidants levels (Schwarz et al., 1996).  The animal 
based dietary pattern may be more likely to meet nutritional needs in this state of depleting 
proteins and antioxidants which are direct results of HIV infection. Although serum albumin 
was  significantly  lower  in  the  HIV  infected,  the  mean  levels  between PLWH and  their 
uninfected counterparts were both normal implying that the chronic inflammatory process 
in HIV infection might have contributed to the decline. The findings of the associations 218 
 
between albumin and the different dietary patterns could imply that certain dietary patterns 
were more desirable in the PLWH. 
5.10.4.3    Dietary  patterns predictors  of  serum  lipids  profile  (lipid metabolism  or      
altered metabolic state) 
Studies on lipids in PLWH in the pre-HAART era showed that altered lipids levels were 
associated with HIV infection and lipid profiles of HIV infected populations were different 
from  those  infected  (Baza  Caraciolo  et  al.,  2007;  Grunfield  et  al.,  1989  and  1992; 
Constans et al.,1994; Kotler et al., 1985). Lower cholesterol, HDL, and ApoA1 and higher 
triglycerides were associated with higher rates of cardiovascular diseases in HIV infection 
(Baza Caraciolo et al., 2007; Grunfield et al., 1989 and 1992; Constans et al.,1994; Kotler 
et al., 1985). In the HAART era, studies have shown that HAART treatment among HIV 
infected  persons  was  associated  with  high  serum  lipid  levels  and  increased  risk  for 
cardiovascular diseases (Koppel et al., 2000). A significant number of the HAART patients 
had very high levels
 of Lipoproteins and various combinations of increased lipid values
 
associated  with  considerably  increased  risk  for  CHD  (Koppel  et  al.,  2000).  Increase 
prevalence  of  heart  diseases  in  HIV  infection  could  be  associated  with  the  chronic 
inflammatory process observed in PLWH and many scientists think that HIV infection itself 
should be considered a risk factor for early cardiovascular diseases (Harris, 2008). 
Sadir and colleagues showed that PLWH with less advanced HIV disease, i.e. higher CD4 
lymphocyte count and lower HIV RNA, were more likely to have higher HDL cholesterol 
concentration (El-Sadir et al., 2005). They also demonstrated that low CD4 lymphocyte 
count,  high  HIV RNA  level and a history  of AIDS-defining events,  all markers of more 
advanced HIV disease, were all associated with higher concentrations of VLDL cholesterol 
and  triglycerides  (El-Sadir  et  al.,  2005).  These  studies  suggest  that  HIV  infection  is 
associated  with  altered  lipid  metabolism  and  this  could  be  associated  with  disease 
progression and predispose to long-term cardio-vascular disease risk. In light of this study, 
the findings did not just confirm this state of altered lipid metabolism but also showed that 
dietary patterns are associated with these changes. 
For instance, this study showed that the staple or maize meal based dietary pattern was 
significantly associated with lowered overall serum lipid score, LDL and HDL: LDL ratio in 
the HIV infected group but no dietary pattern remained in the final model for HDL. In the 
HIV uninfected group the most important predictor of lowered overall serum lipid score and 
LDL was the staple based 2 dietary pattern. None of the dietary patterns were significant 
predictors of HDL or HDL/LDL ratio status in the HIV uninfected group. Thus in terms of 219 
 
the dietary patterns, this study revealed that high intakes of the staple based 1 and 2 
dietary patterns were likely to be associated with lower serum LDL and HDL:LDL score but 
none of  the  dietary  patterns  predicted  HDL status. This  implied  that  the  staple  based 
dietary patterns were probably better in terms of maintaining lower lipid levels than the 
other dietary  patterns. This could be explained since  the  animal based dietary pattern 
showed  high  positive  factor  loadings  for  dietary  fat  intake  suggesting  that  this  dietary 
pattern could be associated with higher serum lipid levels. 
5.10.4.4    Summary of discussion 
In  summary,  although  these  findings were  not  conclusive  (bearing  the  cross sectional 
study design in mind), it was very interesting because it did reveal that the animal based 
pattern was likely to be more desirable for PLWH in terms of improving energy and nutrient 
intakes, BMI and lean body mass and markers of altered metabolism (serum albumin and 
liver  enzymes).  This  dietary  pattern  may  be  more  beneficial  especially  due  to  the 
increased requirement for nutrients in the chronic inflammatory state PLWH are likely to be 
in. 
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CHAPTER SIX: RESULTS 
CHAPTER SIX: EXPLORING THE ANALYTICAL FRAMEWORK OR PATHWYAS 
BETWEEN DIFFERENT DIETARY PATTERNS AND MARKERS OF 
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CHAIN MODELLING APPROACH 
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6.4  Direct determinants of outcome variables 
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6.6  Chapter Summary 
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6.0  The analytical framework between dietary patterns and outcomes 
6.1  Introduction 
In chapter four baseline descriptive characteristics of the study population and how these 
factors predicted HIV infection was explored. The findings of this chapter suggested that 
the HIV infected and uninfected were different in terms of the biochemical and metabolic 
parameters which could be attributed to HIV infection. Further analyses to show whether 
the different dietary patterns   were associated with any of the differences observed and 
any  of  the outcomes for  this study  were  carried  out  in  Chapter  Five. These analyses 
showed that within the HIV infected population an animal based dietary pattern was better 
associated with dietary nutrient intakes than a dietary pattern which followed a ‘healthy’ or 
recommended diet or  a staple  based diet.  The animal based dietary  pattern was  also 
better  associated  with  BMI,  LBM,  serum  albumin  and  liver  enzymes  than  the 
recommended or healthy dietary pattern. Some differences were also observed between 
the  HIV  infected  and  uninfected  populations  comparing  the  association  between  the 
different dietary patterns and outcomes variables. 
 
However there was no understanding of the existence of pathways of interrelationships 
between the levels of exposures and the outcomes in a hierarchical fashion from the first 
two results chapters, which formed part of the conceptual framework for this study. This 
was very crucial in order to show the pathway of interrelationships between dietary intake, 
nutritional status and metabolic integrity. One of the objectives of this study was to show if 
certain dietary patterns were  associated with optimal nutrient intake which  in turn was 
associated  with  better  serum  nutrients  status,  which  in  turn  predicted  better  body 
composition  and  metabolic  integrity.  Thus  in  the  final  results  chapter  (Chapter  Six), 
graphical chain modelling approach was used  to explore the pathways of associations 
between the different dietary patterns identified by PCA and markers of nutritional and 
metabolic status.  
6.2  The  conceptual  framework  (determining  the  blocks  for  graphical  chain 
modelling) 
Five different blocks of variables were identified for the graphical chain modelling outlining 
the framework  within which nutritional  status, metabolic and  immune integrity and HIV 
infection  are  expected  to  be  interrelated.  The  effects  of  malnutrition  and  infection  on 
immune  status  have  been  well  established  in  literature  and  in  HIV  infection  similar 
associations  have  been  postulated.  This  was  the  basis  for  selecting  the  blocks  and 
variables within these blocks (Scrimshaw et al., 1961; Scrimshaw et al., 1957; Solomon et 222 
 
al.,  1966;  Scrimshaw  and  SanGiovanni,  1997).  In  summary,  infection  can  lead  to 
unbalanced nutrient losses (e.g. zinc, vitamin A, vitamin B12 and folate losses as a result 
of diarrhoea and vomiting), which leads to the deficiencies of these specific nutrients. The 
specific  nutrient deficiencies can  influence appetite and consequently  lead  to low  food 
intake. Inadequate food intake, due to either a poor appetite or limited availability of food, 
leads to wasting syndrome, best captured as a relative loss of weight and associated with 
a range of complex adaptive changes in all tissues and organs.  
 
Hence for this thesis it was postulated that certain dietary pattern(s) was/were associated 
with better (quantity and quality) nutrient intake which in turn was associated with a more 
optimal serum nutrient status, consequently influencing nutritional anthropometrics, and 
metabolic  integrity  in  HIV  infection.  However  certain  socio-demographic  characteristics 
were likely to influence these interrelationships for instance income could influence food 
availability  and  choice  and  thus  reduce  dietary  intake.  Variables  in  one  block  were 
potential causes of the variables in the next block or potential consequences of variables 
in the preceding block. This formed the basis for the blocks of interrelations outlined in 
Figure 6.1. 223 
 
Table 6.1 and Figure 6.1: Outline of main blocks of variables showing framework used for graphical chain modelling 
(left) derived from synergistic interaction between malnutrition and HIV infection, Figure 6.1 (right) presented 
earlier in Chapter 1 as Figure 1.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Socio-demographic influences 
    Block 1: socio -  demographic status, age, gender, rural urban 
status, education, marital  and  smoking     status
   
 
Main exposures 
  Block 2: dietary patterns 
(animal based, recommended, 
staple based 1 and 2    
 
intermediate exposures 
  Nutrient intake score 
 
 
Intermediate exposures 
  Block 4: serum vitamins A, E and1
st PCA for 
serum proteins, lipids 
 
Main  outcomes variables 
              
  B  lock 5: BMI, lean body mass, 
Serum albumin, serum AST and serum 
Total bilirubin     
       
 
  
                HIV infection  
Socio-
demographic 
status 
Reduced/altered 
dietary intake 
Reduced /altered 
nutrient intake 
Reduced/altered 
serum nutrient status 
Altered body composition and 
metabolic integrity 
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6.3  Modelling the interrelationships within blocks of exposures 
The first phase of the graphical chain modelling was to model the interrelationships within 
the blocks. There was the need to establish whether variables in the same block were 
related  and  to  show  the  direction  of such  associations.  Thus  interactions  of  the  main 
response  variables,  main  exposures  and  intermediate  exposures  were  determined  by 
performing  series  of  binary  logistic  regression  and  using  the  different  variables  as 
dependent variables one at a time. This was done separately for both HIV infected and 
uninfected populations to show if differences existed by HIV infection status. 
6.3.1  Modelling the interrelationships between the main response variables 
The main response variables for the graphical chain modelling were BMI, lean body mass, 
serum AST, serum albumin and total bilirubin. Outlines for the interrelationships between 
the main response variables for the HIV infected and uninfected populations are presented 
in Figure 6.2a and 6.2b respectively. Backward regression models were used to determine 
these associations presented in Table 6.2. 
 
In the HIV infected population: 
•  High lean body mass was associated with high BMI and vice versa 
•  High serum AST was associated with low lean body mass but high albumin 
•  High serum total bilirubin was associated with high albumin and vice versa 
•  Thus HIV infected subjects with high BMI were likely to have high lean body mass, 
lower AST, low albumin and high bilirubin 
 
Within the HIV uninfected populations: 
•  High lean body mass was associated with high BMI 
•  High AST was associated with low BMI but high albumin 
•  High albumin was associated with high total bilirubin 
•  Thus, HIV uninfected subjects with high BMI were likely to have high lean body 
mass, high albumin and total bilirubin but low AST 
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Table 6.2 Coefficient, odds ratio, and statistical significance for determinants of the 
main outcomes within the outcome variables 
 
 
Figure 6.2a Modelling the associations within the main response variables in the HIV 
infected population 
 
                                    BMI ●                                ● Lean Body Mass                             
 
                                                                                                     
                                                                                                        ●Total Bilirubin   
                                       
 
 
                                    AST●                             ●Albumin                                                     
 
 
 
Figure 6.2b: Modelling the associations within the main response variables in the 
HIV uninfected population 
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Coefficient 
Statistical 
significance  Odds ratio 
95% Confidence 
Interval 
Predictors of BMI        Lower  Upper 
HIV infected  Lean Body Mass 0.290  0.000  1.336  1.201  1.485 
HIV uninfected  Bilirubin  -0.121  0.003  0.886  0.819  0.959 
  Lean Body Mass 0.254  0.000  1.290  1.236  1.345 
Predictors of LBM             
HIV infected  BMI  0.714  0.000  2.042  1.584  2.633 
HIV uninfected  BMI  0.587  0.000  1.798  1.630  1.984 
  Bilirubin  0.052  0.073  1.054  0.995  1.116 
Predictors of albumin             
HIV infected  Bilirubin  0.148  0.010  1.159  1.036  1.296 
HIV uninfected  Bilirubin  0.126  0.000  1.134  1.071  1.201 
Predictors of bilirubin             
HIV infected  Albumin  0.142  0.002  1.153  1.056  1.259 
HIV uninfected  Albumin  0.083  0.000  1.087  1.043  1.133 
Predictors of AST             
HIV infected  Albumin  0.091  0.045  1.095  1.002  1.197 
  Lean Body Mass -0.047  0.035  0.954  0.913  0.997 
HIV uninfected  BMI  -0.084  0.000  0.919  0.881  0.959 
  Albumin  0.092  0.000  1.096  1.052  1.143 226 
 
6.3.2    Modelling  the  interactions  within  the  intermediate  exposure  variables 
(nutritional biochemistry)  
Summaries of the interrelationships between the serum markers are presented in Figures 
6.3a (for HIV infected) and 6.3b (for the uninfected group). The regression models from 
which  these  graphs  were  derived  are  presented  in  Appendix  II.  The  interrelationships 
within the main exposure variables for the HIV infected were different from the uninfected 
group.  In  the  HIV  infected  population,  higher  protein  score  (lower  albumin  and  higher 
globulin) was associated with lower serum vitamin A and higher lipid score (high LDL, 
cholesterol, triglyceride and low HDL) was associated with higher serum vitamin E.  
 
In the HIV uninfected population, on the other hand higher serum protein (low albumin with 
high globulin) score was associated with higher serum vitamin A unlike the HIV infected 
group. High serum vitamin E was associated with higher serum lipid profile and serum 
vitamin A and high serum protein score was associated with higher serum lipid score and 
vitamin  A  status. Thus  in  the  HIV  uninfected  population  all  four variables  in  the main 
exposures block were  interrelated  in the same direction such that subjects with higher 
serum vitamin A were likely to have higher serum vitamin E, lipid score and protein score 
unlike  the  HIV  infected  group  within  which  higher  protein  score  (low  albumin)  was 
associated with lower vitamin A. 
 
 
Figure  6.3a:  Modelling  the  interrelationship  within  the  main  exposure  variables 
(nutritional biochemistry) in the HIV infected population 
                               Serum Vitamin  A      ●                           ● Serum Vitamin  E                    
 
                                      
 
                   Serum Protein score ●                            ●Serum Lipid score                 
 
 
 
 
Figure 6.3b: Modelling the interrelationships within the main variables in the HIV 
uninfected population 
                                                                        
 
                               Serum Vitamin A      ●                           ● Serum Vitamin E                     
 
                                      
 
                  Serum Protein score  ●                           ●Serum Lipid  score                 
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6.3.3    Modelling the interrelationships between the socio-demographic exposure 
variables 
The interrelationships within the various demographic variables are presented in Figures 
6.4a and 6.4b for the HIV infected and uninfected groups respectively and the regression 
models from which these graphs were derived are presented in Appendix III. In the HIV 
infected  subgroup,  urbanisation  level  was  not  associated  with  any  of  the  socio-
demographic  variables.  However,  low  education  was  associated  with  low  income  and 
female gender in the HIV infected persons. HIV infected subjects with lower age (up to 40 
years old) were likely to be more educated compared with older HIV subjects. Moreover 
younger (below 40 years) HIV infected subjects were less likely to married but were more 
likely  to  have  higher  education  compared  with  older  HIV  infected  subjects.  Also  HIV 
infected subjects who smoked were more likely to be males compared to those who did 
not smoke. In summary Figure 6.4a has shown that HIV infected subjects with low income 
were less educated and more likely to be females. HIV infected subjects who were never 
married were younger.   
 
Figure 6.4a: Modelling the interrelationships within the socio-demographic variables 
in the HIV infected population 
Gender              ●                                ●Education       
Smoking status ●                                 ●Income 
Age                    ●                         ●Urbanisation level 
                                              ●Marital status 
 
Figure 6.4b: Modelling the interrelationships within the socio-demographic variables 
in the HIV uninfected population 
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In the HIV uninfected population, the interrelationships were similar to the HIV infected in 
that the observed associations in the HIV infected group also existed in the uninfected 
population but more complex interrelationships were observed.   In contrast to  the HIV 
infected  group,  residential  status  was  associated  with  some  socio-demographic 
characteristics in the HIV uninfected group. HIV uninfected subjects were more likely to 
have lower income and education but were less likely to smoke. Low education in the HIV 
uninfected group was associated with older subjects (above 40 years old), low income, 
female subjects and  rural dwellers and  living in rural  areas was associated with being 
single. Thus, HIV uninfected subjects who were younger were likely to be unmarried with 
lower education, non smokers females.  
6.4        Direct determinants of Outcome markers (BMI, lean body mass, serum AST, 
albumin and total bilirubin) 
The  direct  determinants  (predictors)  of  the  outcome  variables  were  determined  by 
backward regression models and have been presented in Appendix I. 
6.4.1  Direct determinants of BMI 
The direct determinants of high BMI in the HIV infected population were high lean body 
mass, serum vitamin A and male gender. The direct determinants of high BMI in the HIV 
uninfected population were female gender, low staple based 2 dietary pattern, low serum 
AST, high lean body mass and high serum lipid score. 
6.42  Direct determinants of lean body mass 
With regards to lean body mass, the direct predictors were the same for both HIV infected 
and uninfected population. Gender and BMI were the significant direct predictors of lean 
body mass in both groups. Males respondents were more likely to have high lean body 
mass compared to the females and subjects with lower BMI were more likely to have lower 
high lean body mass in both HIV infected and uninfected populations. 
6.4.3  Direct determinants of serum albumin 
In the HIV infected population the direct predictors of higher serum albumin were urban 
dwellers with more education, high serum lipid score and low serum total protein score. In 
the uninfected  population  however  the direct  predictors  of  higher  serum  albumin were 
higher education, serum vitamin A, total protein score, AST and staple based 1 dietary 
pattern. Thus compared to the HIV infected, the predictors of high serum albumin were 
more in the HIV uninfected population. In both populations education and serum protein 
score  predicted serum albumin but serum AST,  vitamin A  and staple based 1 dietary 
pattern were associated with serum albumin  in the HIV uninfected and not in  the HIV 229 
 
infected whereas urbanisation level was associated with serum albumin status in the HIV 
infected but not in the uninfected population 
6.4.4  Direct determinants of serum AST 
In the HIV infected population the direct predictors of high serum AST were high serum 
total protein (that is high globulins but low albumin), total bilirubin, and low education. This 
implied that in the HIV infected group, low serum albumin, high globulin and total bilirubin 
and low education were likely to be associated with high serum AST. In the uninfected 
population on the other hand, direct predictors of higher serum AST were high serum total 
protein score (that is low albumin), high dietary nutrient score, male gender; and lower 
BMI, serum vitamin  E, and education. This implied that in the  HIV uninfected subjects 
female subjects, high education, high BMI and high serum vitamin E were likely to be 
associated with lower  serum  AST  whilst high serum protein score and dietary nutrient 
score were likely to be associated with higher serum AST.   
6.4.5  Direct determinants of serum total bilirubin 
For serum total bilirubin status, the direct determinants of high serum status in the HIV 
infected population were low serum protein score and albumin status and the determinants 
of low serum bilirubin were likely to be low education and serum AST. This implied that 
within the HIV infected group, low serum protein score, low albumin status, high education 
and/or high serum AST were likely to be associated with high serum total bilirubin status. 
In the HIV uninfected population, the direct determinants of serum total bilirubin status 
were smoking status, education, serum vitamin E, albumin and lean body mass. Subjects 
with low education, lean body mass and albumin were associated with lower serum total 
bilirubin whereas respondents with low serum vitamin E and smoked were associated with 
higher total serum bilirubin.  
6.4.6  Summary of direct determinants of outcomes  
•  The direct predictors of high BMI in the HIV infected group were high lean body mass, 
vitamin A and female gender whereas in the HIV uninfected group high BMI likely to be 
predicted by female gender, high lean body mass, high serum lipid score, low staple 
based 2 dietary pattern and low AST 
•  The direct predictors of high lean body mass in both HIV infected and uninfected group 
were high BMI and male gender 
•  The direct predictors of high serum albumin were likely to be high education, urban 
dwelling, high serum lipid score and low serum protein score in the HIV infected group 230 
 
and that for the uninfected group were likely to be high education, high staple based 1 
dietary pattern, high serum vitamin A, protein score and AST. 
•  The direct predictors of high serum AST in the HIV infected population were likely to be 
high serum protein score, bilirubin and albumin status and low education and for the 
HIV uninfected the likely predictors were high serum protein score, high dietary nutrient 
score and low education, serum vitamin E, BMI and male gender. 
•  The direct predictors of high serum total bilirubin were low serum protein score and 
albumin status and high serum AST and education for the HIV infected and for the 
uninfected the predictors of high serum total bilirubin were smoking, more education, 
high lean body mass, serum vitamin E and albumin. 
6.5  Modelling the pathway between exposure variables and outcome variables: 
graphical chain analysis 
The  chain graphs  modelling  the  interrelationships  observed  are  presented  for  the  HIV 
infected and uninfected populations by Figures 6.5a and 6.5b respectively. These figures 
were derived from the regression models presented in Appendix I (direct determinants of 
the  outcomes)  and  V  (direct  determinants  of  the  exposures  or  indirect  predictors  of 
outcomes). Apart from deriving the direct predictors of the outcome variables, analysis was 
done for each  of the other  variables in  the intermediate,  main and socio-demographic 
levels/blocks to determine the direct predictors of variables in these blocks. It was based 
on these models that the indirect predictors of the outcome variables were teased out and 
presented  in  the  graphical  chains.  Separate  analysis  were  done  for  PLWH  and  the 
uninfected group, hence separate graphs were drawn. 
 
A close look at the overall models (Figures 6.5a and 6.5b) showing the interrelationships 
between and within the various levels of exposures and the main outcomes (response 
variables)  revealed  that  the  interrelationships  of  the  variables  in  the  HIV  infected 
population were simpler and less complex compared with the HIV uninfected. Some of the 
variables were directly linked with the response variables whereas some were associated 
with the outcomes through other variables. Hence these variables were described as the 
indirect determinants of the outcomes. Other variables were however both directly and 
indirectly associated with  the  outcomes. For each of the  outcome variables (BMI,  lean 
body mass, serum albumin, total bilirubin and AST), separate pathways of interactions with 
exposures were generated from the main chains (Figures 6.5a and 6.5b) in order to show 
the  specific  pathways  for  these  outcomes.  The  next  sections  thus  describe  these 
pathways. 231 
 
 
Figure 6.5a: A graph of the whole framework between socio-demographic factors, 
dietary  patterns,  nutrient  intake,  serum  nutrient  status  and  markers  of 
nutritional and metabolic integrity for HIV infected 
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Figure 6.5b: A graph of the whole framework between socio-demographic factors, 
dietary  patterns,  nutrient  intake,  serum  nutrient  status  and  markers  of 
nutritional and metabolic integrity for HIV uninfected  
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6.5.1  Characteristics of the HIV infected subjects with high BMI and LBM 
•  In the HIV infected people, high lean body mass was associated with high BMI. 
Hence HIV infected people with higher lean body mass were likely to have higher 
BMI. 
•  From  Figure 6.5a,  the  following characteristics  can be derived  for  HIV  infected 
people with higher BMI and lean body mass: 
•  HIV infected with higher lean body mass and BMI were male subjects with higher 
income, lower age (up to 40 years old); subjects with higher animal based and 
higher carbohydrate, legumes and vegetable based pattern consumption; subjects 
with lower staple based 1 dietary intake; subjects with higher nutrient intake score; 
subjects with higher serum vitamin E and vitamin A status and lower serum lipid 
score. 
•  This implies that in PLWH, subjects who were males, younger (up to 40 years old) 
and with higher income, were more likely to consume higher animal based and 
carbohydrate, legumes and vegetables based dietary patterns  but lower staple 
based 1 (maize meal) diets. These were likely to consume higher dietary nutrients 
and therefore have better serum vitamins A and E and lipids status.  
6.5.2  Characteristics  of  HIV  uninfected  subjects  with  high  BMI  and  lean  body 
mass  
In the HIV uninfected group (Figure 6.5b), subjects with high BMI and lean body mass 
were 
•  Female subjects, above 40 years olds, urban dwellers; subjects with lower staple 
based 2 dietary intake and subjects with higher serum lipid score. 
6.5.3  Characteristics of HIV infected subjects with higher serum albumin 
The characteristics of HIV infected population with higher serum albumin from the chain 
graph (Figure 6.5a) are: 
•  Subjects  with  higher  income,  younger  (up  to  40  years  old)  and  lived  in  rural 
dwelling 
•  Subjects with higher animal based dietary intake, higher carbohydrate, vegetable 
and legume based dietary intake and lower staple based dietary intake 
•  Subjects  with  higher  dietary  nutrient  intake  score,  higher  serum  vitamin  E  and 
serum lipids score  
•  This implied that HIV infected subjects with higher income, younger (up to 40 years 
old)  and  lived  in  rural  dwellings  who  consumed  higher  animal  based  and 
carbohydrate, vegetable and legume based dietary patterns but lower staple based 234 
 
dietary pattern had higher overall dietary nutrient score, higher serum lipids and 
vitamin E status and higher serum albumin status.  
6.5.4  Characteristics of HIV uninfected subjects with higher serum albumin  
In the HIV uninfected population the characteristics of subjects with higher serum albumin 
from Figure 6.5b were: 
•  Subjects  who  were  non  smokers,  with  higher  education  and  lived  in  urban 
residencies 
•  Subjects with higher serum vitamin E and vitamin A status. 
•  Thus in  HIV uninfected  group,  non smokers, living in  urban  dwellings and with 
higher education were likely to have higher serum vitamins A and E and higher 
serum albumin  
•  None of the dietary patterns were in the chain of associations for albumin in the 
HIV uninfected population. 
6.5.5  Characteristics of HIV infected subjects with higher serum AST  
In the HIV infected population there were no direct pathway for AST that involved any of 
the dietary patterns  
•  However  lower  education  and  higher  total  bilirubin were associated  with  higher 
AST  
6.5.6  Characteristics of HIV uninfected subjects with higher serum AST  
In  the  HIV  uninfected  population  on  the  contrary,  more  complex  interactions  existed 
between  the  various  levels  of  exposures  and  serum  AST.  The  characteristics  of  the 
uninfected population with higher serum AST from Figure 6.5b were: 
•  Subjects with higher income, education, males and  lived  in urban dwellers and 
were non smokers 
•  Subjects with higher intake for all four dietary patterns 
•  Subjects with higher dietary nutrient intake score 
•  Subjects with higher serum vitamin E status 
•  This implied that in the HIV uninfected population, increased food intake in general 
was  associated with  higher  dietary  nutrient  intake, serum vitamin  E and  higher 
serum AST irrespective of the dietary pattern.  
•  With regards to the influences of the socio-demographic characteristics within the 
HIV uninfected population, higher animal based dietary score was associated with 
higher income, education and/or rural dwelling. Urban dwelling was associated with 235 
 
higher  staple  based  1  dietary  pattern,  and  staple  based  2  dietary  pattern  was 
associated with males, rural dwelling and/or younger respondents.  
6.5.7  Characteristics of HIV infected subjects with higher serum total bilirubin  
For serum total bilirubin there were no pathways of interactions through the various levels 
of exposures for the HIV infected population. However, the characteristics of HIV infected 
subjects with higher total bilirubin were: 
•  Subjects with higher education, high AST and lower albumin 
•  Lower total protein score (that is higher serum globulins) 
6.5.8  Characteristics of HIV uninfected subjects with higher serum total bilirubin  
In the HIV uninfected, subjects with higher total serum bilirubin were: 
•  Subjects who smoked, lived in urban dwellers, were males and were younger (up 
to 40 years old), with lower education and unmarried 
•  Subjects with lower serum vitamin E and A and lower lipid score 
•  This implied that in the HIV uninfected population, subjects with lower education, 
unmarried, who smoked and lived in urban dwellers and were 40 years and below 
were more likely to have lower serum vitamin A and E and lipid score and this was 
associated with higher serum total bilirubin. 
6.6  Chapter Summary 
The  aim  of  this  chapter  was  to  describe  the  hierarchical  order  between  the  levels  of 
exposures starting  from  dietary  patterns  through  nutrient  intake,  serum  nutrient status, 
anthropometrics and markers of metabolic integrity using graphical chain modelling. Many 
interactions were observed at different levels of the exposures and outcomes but the main 
interactions showed that: 
 
For BMI and lean body mass: 
•  In the HIV infected group, subjects who were males, younger (up to 40 years old) 
and with higher income, were more likely to consume higher animal based and 
carbohydrate, legumes and vegetables based dietary patterns  but lower staple 
based 1 (maize meal) diets. These were likely to consume higher dietary nutrients, 
have better serum vitamins A and E and lipids status, associated with higher BMI 
and lean body mass  
•  In  the  uninfected  population,  females  subjects,  above  40  years  olds,  urban 
dwellers; subjects with lower staple based 2 dietary intake; subjects with higher 
serum lipid score had higher BMI and lean body mass. 236 
 
For serum albumin  
•  Within  the  HIV  infected  group,  subjects with  higher  income,  younger  (up to  40 
years old) and lived in rural dwellings who consumed higher animal based and 
carbohydrate, vegetable and legume based dietary patterns but lower staple based 
dietary pattern had higher overall dietary nutrient score, higher serum lipids and 
vitamin E status and higher serum albumin status.  
•  In the HIV uninfected group, non smokers, living in urban dwellings and with higher 
education were likely to have higher serum vitamins A and E and higher serum 
albumin. 
For serum AST 
•  In the HIV infected, lower education and higher total bilirubin were associated with 
higher AST  
•  In the HIV uninfected population, increased food intake in general was associated 
with  higher  dietary  nutrient  intake,  serum  vitamin  E  and  higher  serum  AST 
irrespective  of  the  dietary  pattern.  Intakes  of  the  four  dietary  patterns  were 
associated with residency, age, gender, income, education and smoking status. 
For serum total bilirubin, 
•  The  characteristics  of  HIV  infected  subjects  with  higher  total  bilirubin  were: 
Subjects with higher education, high AST and  lower total protein score (that is 
higher serum globulins and lower albumin). 
•  In the HIV uninfected population, subjects with lower education, unmarried, who 
smoked and lived in urban dwellers and were 40 years and below were more likely 
to have lower serum vitamin A and E and lipid score and this was associated with 
higher serum total bilirubin. 
6.7  Chapter Discussion   
The  objective  of  this  section  was  to  show  by  graphical  chain  modelling  the 
interrelationships  between dietary  patterns,  nutrient  intake,  nutritional  biochemistry  and 
markers  of  metabolic  integrity  in  the  HIV  infected  population  and  to  show  if  these 
interrelationships  were  different  in  the  HIV  uninfected  or  general  population.  Available 
evidence suggests that dietary intake influences nutrient intake which could affect serum 
nutrient  status,  anthropometrics,  metabolic  integrity  and  possibly  markers  of  disease 
progression in HIV infection (Calder and Jackson, 2000; Semba and Tang, 1999; Piwoz 
and Preble, 2000). This formed the basis for the analytical framework described in Table 
6.1 and Figure 6.1. In developing the graphical chain, five main outcome variables were 
chosen as the final level depicting nutritional, metabolic and disease state in the study 237 
 
population.  The  intermediate  exposures  in  this case were serum nutrients  and  dietary 
nutrient  score.  The  main  exposures  were  the  four  different  dietary  patterns.  Socio-
demographic status was thought to influence some of the variables at the various levels 
and  thus  the  socio-demographic  parameters  were  placed  at  the  first  level  of  the 
framework.  
6.7.1    The pathway between exposures and BMI/LBM - anthropometric markers of 
nutritional status and metabolic integrity in PLWH 
Modelling the interactions within the outcome variables showed that BMI was positively 
associated with lean body mass in both HIV infected and uninfected population. Thus the 
pathway of interactions between BMI and the levels of exposures was similar to that of 
lean  body  mass.  Wasting  and  loss  of  lean  body  mass  as  discussed  previously  are 
common in HIV infection and associated with increased mortality, disease progression and 
reduced  quality  of  life  (Mulligan  et  al.,  2005;  Heckman  et  al.,  2004;  Grinspoon  and 
Mulligan, 2003; Salomon et al., 2002).  Loss of body weight (BMI) in PLWH is usually 
associated with loss of lean body mass (the metabolically active tissue) and some studies 
have even suggested that wasting and weight loss in HIV infection was due primarily to 
loss of lean body mass (Grinspoon and Mulligan, 2003; Salomon et al., 2002). Loss of BMI 
and lean body mass could therefore be appropriate markers of disease progression in 
PLWH. 
 
Using  graphical  chain  modelling  approach,  it  was  shown  that  in  the  HIV  infected 
population, younger respondents (subjects up to 40 years old) and/or higher income were 
associated with higher dietary pattern 1 (animal based) dietary pattern 4 (carbohydrate, 
legume  and  vegetable)  and  low  staple  based  dietary  pattern.  These  were  in  turn 
associated with higher serum vitamin E and A status; which were in turn associated with 
higher BMI and LBM. This implied that HIV infected subjects who consumed more animal 
based and carbohydrate, legume and vegetable based dietary patterns were more likely to 
have high dietary nutrient score (high intake of energy and micronutrients) compared to 
subjects  whose  dietary  patterns  followed  the  recommended  or  staple  base  1  dietary 
pattern. Furthermore, high dietary nutrient score was associated with high serum vitamin A 
and E status in the HIV infected group as could be expected and consequently high BMI 
and  lean body  mass.  It may  be  that subjects whose dietary  intake followed  these two 
dietary patterns (animal based  and carbohydrate, legume and vegetable based dietary 
patterns) consumed more energy and nutrients and therefore had more optimal nutrient 
intake compared to the other two dietary patterns.  238 
 
 
The findings were also suggestive that in PLWH, high consumption of animal based and 
carbohydrate, legume and vegetable based dietary patterns were associated with more 
optimal  and  probably  adequate  dietary  nutrient  intake  necessary  for  improved  serum 
vitamin A and E status and consequently high BMI and lean body mass. From the earlier 
discussions, it was established that declining body weight, BMI and lean body mass were 
all indicative of wasting and weight loss and signs of disease progression in HIV infection 
(Salomon  et al.,  2002).  Studies have  also shown  that wasting and weight  loss  in HIV 
infection is  due to hyper-metabolism associated  with the chronic inflammatory  process 
(Harris, 2008). Thus changes in lean body mass mark a state of altered metabolism in 
PLWH. Furthermore available literature has shown that  low serum micronutrient status 
including vitamin A, the B vitamins, zinc and selenium were common in HIV infection and 
were predictors of rapid disease progression, secondary infections, and mortality in HIV 
infection (Baum et al., 1995 and 2003; Kupka et al., 2007; Jiamton et al., 2003 and Austin 
et al., 2006) due to the many important enzymatic, structural, catalytic and functional roles 
played by micronutrients in general (Kotler and Grunfield 1995; Liang et al., 1996; Beisel 
1982 and Kupka, 2004).  
 
Hence, a dietary pattern associated with improved nutrient intake which promotes a more 
optimal serum nutrient status in HIV infection is recommended for HIV infection and could 
lead to delayed of disease progression. Such dietary pattern may also maintain body mass 
and promote metabolic integrity, ultimately maintaining good quality of life in HIV infection. 
An animal based and carbohydrate, vegetable and legumes based dietary patterns rather 
than dietary patterns which followed the recommended and staple based patterns were 
more likely to meet the quality and quantity of nutrients required to meet the increasing 
demands  observed  in  HIV  infection  and  these  might  explain  the  desirable  outcomes 
observed for these two dietary patterns. 
 
Apart from the associations between animal based dietary pattern, serum micronutrients 
and BMI and lean body mass, another chain of interactions revealed that high serum lipids 
score  (that  is  high  cholesterol,  triglyceride  and  LDL)  was  associated  with  high  serum 
vitamin E and A which was associated with high BMI and lean body mass. This implied 
that high serum lipids were associated with better BMI and lean body mass. This particular 
chain  of  interactions  showed  that  subjects  who  consumed  low  staple  based  1  dietary 
pattern (that is those who consumed less maize meal) were likely to have higher serum 239 
 
lipids (cholesterol, LDL and triglyceride) status and high serum lipid score was associated 
with higher BMI and LBM. The association between serum lipids and BMI/lean body mass 
implied  that  high  serum  lipids  was  more  desirable  in  this  particular  study  population 
contrary  to  what  would  normally  be  expected  and  the  evidence  from  literature.  In  the 
earlier results chapters high serum lipids such as cholesterol, triglycerides and LDL were 
reported  in  the  HIV  infected  subjects  and  were  indicative  of  altered  metabolism  and 
associated with disease progression and increased risk for cardiovascular diseases (El-
Sadir et al., 2005; Riddler et al., 2003). It was not clear why high serum LDL, triglycerides 
and cholesterol was associated with better outcomes in this population. It might be due to 
interplay of other factors outside the scope of this study.  
 
In the HIV uninfected population, female subjects, older subjects and/or urban dwellers 
were associated with lower staple based 2 dietary pattern and high serum lipids score 
which was associated with higher BMI and LBM. Thus in the HIV uninfected population, 
low staple based dietary pattern was also associated with high BMI and lean body mass 
just as was observed in the HIV infected population. The difference however between the 
HIV  infected and uninfected groups was that in  the  HIV infected population  an animal 
based dietary pattern was associated with high nutrient intake, serum nutrients and high 
BMI and lean body mass whereas in the HIV uninfected the animal based was not directly 
linked with BMI. The association between low staple based dietary pattern and high BMI 
however,  indirectly  implied that high consumption of the other  dietary patterns (animal 
based and recommended dietary guidelines) were more desirable in the HIV uninfected 
population. However, clear differences existed for the pathways between the HIV infected 
and their uninfected counterparts. 
 
The observed interactions in the HIV infected and uninfected populations as shown by the 
graphical chain analyses suggested that the determinants of BMI and lean body mass in 
the HIV infected population were likely to be different from the uninfected. It was also likely 
that in HIV infection, particular dietary patterns (especially diets of animal origin) could be 
more beneficial than others due to increased demand for nutrients caused by nutrients 
losses, altered  and  hyper metabolic state due  to chronic  inflammation  and the  body’s 
response  to  inflammation  observed  in  HIV  infection. This may  be  different  in  the  HIV 
uninfected population within which different dietary patterns may be as important.  
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However the findings with regards to BMI and LBM were quite striking especially since the 
present study population were asymptomatic and ‘healthy’ and also due to the different 
pathways observed for the uninfected group. In spite of methodological limitations of this 
study the observed findings was probably indicative  of different pathways between the 
dietary patterns and markers of structural and functional integrity for PLWH, compared 
with uninfected groups especially in the population studied. 
6.7.2  The pathway between exposures and serum albumin - biochemical marker 
of nutritional status, liver damage and chronic inflammation  
The  observed  framework  for  albumin  suggested  that  subjects  whose  dietary  patterns 
followed lower staple (maize  meal) food intake were more  likely  to have higher serum 
lipids and this group of subjects were more likely to have higher serum albumin status. The 
other pathways observed suggested that HIV infected individuals with higher animal based 
and  carbohydrate,  legumes  and  vegetables  dietary  patterns  were  more  likely  to  be 
associated with higher serum albumin in the pathway of interrelationships. This could also 
imply that subjects with lower staple dietary pattern consumption were likely to have higher 
intake of the other dietary patterns. 
 
However among the socio-demographic parameters, income, smoking, age and gender 
were associated with dietary intake. Marital status, education and urbanisation levels were 
not  directly  associated  with  any  dietary  patterns.  Interestingly,  high  income  was  not 
associated with a high consumption of animal based or ‘recommended’ dietary patterns 
which was expected considering the fact that high consumption of animal based and the 
‘recommended’  dietary  patterns  (which  was  more  varied)  might  be  common  in  higher 
income groups due to high cost of these foods in poorer and less affluent countries (Wiig 
and Smith, 2007). However in the population studied this was unlikely since consumption 
of animal based foods is common in rural and low income people. 
From literature low serum albumin levels have been reported commonly in PLWH and 
could  be  indicative  of  disease  progression  (Mehta  et  al.,  2006;  Graham  et  al.,  2007; 
Feldman et al., 2000; Feldman et al., 1998; Ramakrishnan et al., 2008; Drain et al., 2006 
and  Carter,  2006)  which  may  depict  nutritional  factors  and  the  state  of  chronic 
inflammation observed in PLWH (Ramakrishnan et al., 2008; Drain et al., 2006). Among 
453 HIV-infected individuals, albumin <35 g/l was associated with faster progression to 
AIDS, AIDS mortality and all-cause mortality (Mehta et al., 2006). In Graham et al., (2007) 
study, each 1g/l decrease in albumin with HIV-1 acquisition was associated with a 13% 241 
 
increase in the risk of progression to a CD4 count <200 cells/ l and a decrease in albumin 
over 10% was associated with a 3.5 fold increase in the risk of progression to a CD4 count 
<200 cells/  l. Serum albumin status significantly and positively correlated with CD4 cell 
count and some investigators believe that testing serum albumin could be a particularly 
useful  means of monitoring HIV  disease progression,  and the success of antiretroviral 
therapy, in poorer countries where many patients with access to HIV drugs cannot afford 
CD4 cell counts or viral load tests (Carter, 2006). 
As  mentioned  previously,  the  lower  serum  albumin  status  observed  in  HIV  infected 
subjects depicts a state of chronic inflammation observed in HIV infected population. In the 
population studied, the level of inflammation and other metabolic threats were likely to be 
more severe considering threats from other infectious diseases such as, tuberculosis as 
well as higher prevalence of malnutrition  (Morgan et al.,. 2002). Thus a predominantly 
animal based diet may provide better nutrient quality in terms of macro and micronutrients 
and higher protein necessary for enhanced synthesis of albumin. This could explain the 
supposed  beneficial  effect of  the animal based  dietary  pattern.  Moreover  the  pathway 
observed confirmed the association between this dietary pattern and albumin showed in 
Chapter Five and could be revealing a causal relationship between this dietary pattern and 
albumin although such conclusions could not be drawn. 
For  this  particular  study,  the  HIV  infected  subjects  were  asymptomatic,  similar  to  the 
normal population, and were unaware of being infected. Moreover, the same inclusion and 
exclusion criteria were used to select all the subjects. Despite this fact, the HIV infected 
subjects had significantly lower serum albumin (although levels were not in the normal 
ranges for population) which confirmed the state of altered metabolism and also suggested 
that the HIV infected group were progressing to AIDS although asymptomatic. This final 
Chapter  of  the  results  has  however  showed  that  perhaps  a  low  staple  based  dietary 
pattern but high animal based foods, promoted better dietary nutrient intake in order to 
replete loss of proteins and micronutrients and thus maintain optimal metabolic integrity.  
It was notable that within the HIV infected population, high and low serum albumin was 
relative.  The  HIV  infected  population  generally  recorded  lower  serum  albumin  status 
compared with  the  general  population though both groups  had  normal  serum  albumin 
ranges. Thus, high serum albumin in the HIV infected population referred to those in the 
upper half for serum albumin which was still low compared with the HIV uninfected group. 
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HIV  infection  was  associated  with  low  serum  albumin  for  various  reasons,  those  with 
particular dietary patterns (high staple dietary patterns) were associated with even lower 
serum albumin status. 
No study as at date have explored how different dietary patterns and the various levels of 
exposures were associated with serum albumin in a conceptual framework as have been 
shown in this study and thus it was difficult to relate these findings with other studies. 
However  this  study  did  confirm  that  the  HIV  infected  population  had  lower  albumin 
compared  to  the  uninfected,  which  could  be  attributable  to  chronic  inflammation  and 
altered metabolic integrity just as some  other studies showed  and the different dietary 
patterns observed in the HIV infected influenced differently albumin status.  
6.7.3  The pathway between exposures and serum AST - biochemical marker of 
liver damage and altered metabolism  
Comparison  of  the  HIV  infected  and  uninfected  population  in  Chapter  Four  revealed 
relatively higher serum liver enzymes such as AST, ALT and GGT and ALP in the HIV 
infected compared with the uninfected. However, further analysis using backward binary 
logistic  regression  showed  serum  AST  as  the  only  liver  enzyme  which  significantly 
predicted HIV infection. In Chapter Five multinomial logistic regression models showed 
that  in  both  HIV  infected  and  uninfected  subjects  an  animal  based  dietary  pattern 
compared  with  the  other  3  dietary  patterns  was  associated  with  lowered  serum  liver 
enzymes status especially serum AST and ALT in the HIV infected and serum AST, ALT, 
GGT and ALP in the HIV uninfected group. This meant that although these liver enzymes 
were  higher  in  the  HIV  infected  population  compared  with  the  uninfected,  following  a 
predominant  animal  based  dietary  pattern  was  associated  with  lowered  liver  enzymes 
(serum AST and ALT) in the PLWH and lowered liver enzymes (serum AST, ALT, GGT 
and ALP) in the HIV uninfected group. The carbohydrate, legume and vegetable based 
pattern was likely to be associated with higher liver enzymes whereas the ‘recommended’ 
pattern was associated with lowered overall liver enzyme status. 
  
In  this chapter  serum  AST  alone was used to determine the  pathway  of  relationships 
because that was the only enzyme which showed the greatest difference between the HIV 
infected and uninfected populations and independently predicted HIV infection status. The 
findings of the graphical chain modelling for the HIV infected group revealed that there was 
no  pathway  of  interrelationships  involving  the  dietary  patterns  for  serum  AST.  Lower 243 
 
education (up to standard six), higher serum total bilirubin and/or high serum protein score 
(higher globulin and lower albumin) were all directly associated with a higher serum AST.  
 
This observation might be suggesting that there was no conceptual framework to capture 
the effects of exposures (dietary patterns) on serum liver enzymes. Also noticeable was 
the fact that in the graphical chain modelling, none of the dietary patterns remained directly 
associated with serum AST unlike the earlier chapters where the animal based dietary 
pattern remained significant predictor of serum AST when the dietary patterns alone were 
modelled. The implication of these findings could be that when other variables such as 
serum nutrients, dietary nutrient intake, socio-demographic and other outcome variables 
(albumin, bilirubin, lean body mass and BMI) parameters were considered, none of the 
dietary patterns were significant predictors of serum AST status. This finding could also be 
suggesting interplay  of factors influencing metabolic and inflammatory  response  in HIV 
infection implying that  raised  liver enzymes may  not be influenced by dietary patterns. 
However  since  serum  AST  was  the  only  liver  enzyme  used  for  the  graphical  chain 
modelling, it was possible that the influence of the different dietary patterns on an overall 
liver enzyme status was not captured.  
 
In the HIV uninfected population however, there was some form of pathway between some 
of the levels of exposures with serum AST. However, higher score for all the four dietary 
patterns were associated with higher dietary nutrients score which in turn was associated 
with high serum AST. This suggested that higher intake of food in general was associated 
with higher nutrient intake which was associated with higher serum AST. Thus comparing 
the  HIV  infected  and  uninfected  population  in  terms of  findings  of the  graphical chain 
modelling showed that in the HIV infected no pathway seemed to exist in contrast with the 
HIV  uninfected  population  which  showed  that  increased  food  intake  in  general  was 
associated with higher serum AST irrespective of the dietary pattern.  
 
 Available evidence with regards to the influences of diet on serum liver enzymes in HIV 
infection  was  the  associations  found  between  high  red  meat  intake,  with  fruits  and 
vegetables and lowered liver enzymes shown from the earlier analysis of the THUSA data 
(Vorster  et  al.,  2004).  However,  no  study  has  shown  in  a  graphical  chain  modelling 
approach the framework within which all these exposures are associated with serum AST 
in PLWH. Elevated liver enzymes are indicative of liver damage and liver’s response to 244 
 
inflammation  and  thus  raised  liver  enzymes  in  the  current  HIV  infected  population 
confirmed the chronic inflammatory process and possible liver damage.  
 
Evidence of the present analysis did not suggest a pathway or framework within which 
dietary patterns, nutrient intake, nutritional biochemistry, and serum AST were interrelated 
in PLWH although increased animal based dietary pattern was associated with lowered 
liver  enzymes in  the earlier Chapters. It seemed that  the conceptual  framework within 
which the serum liver enzymes and exposures were related could involve other factors 
which were beyond the study’s objectives. 
6.7.4 The path between exposures and serum total bilirubin  
For serum total bilirubin findings from the graphical chain modelling within the HIV infected 
group did not reveal any pathway between the levels of exposures.  Lower serum albumin 
was however associated with higher bilirubin and higher serum AST was associated with 
higher  serum  total  bilirubin.  This  is  however  expected  in  HIV  infection  due  to  the 
inflammatory process associated with increased bilirubin and liver enzymes with a fall in 
serum albumin. Also higher education (above standard six) compared with less than or 
standard six educational attainment was associated with higher serum total bilirubin. In the 
uninfected  group  likewise,  there  were  no  direct  pathways  involving  any  of  the  dietary 
patterns but findings within this group suggested that low serum nutrients (indicative of 
malnutrition or altered metabolism) especially vitamin E was associated with high serum 
total bilirubin.   
 
Increase serum bilirubin in HIV infection could be associated with red cell breakdown, liver 
damage, inflammation and altered metabolism among other reasons. Hence this marker 
was used as one of the proxy outcome measures of metabolic and immune integrity in the 
PLWH. In the earlier results Chapter higher serum total bilirubin was found in the HIV 
infected population compared with the uninfected. However, among the dietary patterns 
the animal based showed a positive relationship with serum total bilirubin whereas the 
other three dietary patterns were inversely related. However further regression analysis 
suggested that none of the dietary patterns were important predictors of bilirubin status 
and graphical chain modelling did not reveal otherwise. Therefore this study did not reveal 
any pathway of interrelationships between dietary patterns, nutrient intake, serum nutrient 
status and anthropometrics. 
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CHAPTER SEVEN: GENERAL DISCUSSION 
This chapter gives an overview of the aims, hypothesis, objectives and framework of the 
research, key findings, general discussion, implications of the findings, limitations of the 
study and suggestions for future studies. 
7.1  The study hypothesis, aim and objectives are restated below 
7.1.1  Hypothesis  
HIV infected people who followed the current South African dietary guidelines for PLWH 
would have more optimal serum nutrient intake, nutrient status, metabolic integrity and 
body composition than those who do not follow these guidelines. 
7.1.2  Study Aim 
The study aim was to examine the impact of different dietary patterns on dietary nutrient 
intake, serum nutrient status (serum vitamins A, E, lipids and proteins), body composition 
(BMI and lean body mass) and markers of altered metabolism and disease progression in 
PLWH compared to an uninfected population. 
7.1.3  Specific Objectives 
1.  To describe the characteristics of the diet of the study population. 
2.  To describe the associations between different dietary patterns and dietary nutrient 
intake.  
3.  To determine the association between different dietary patterns and serum nutrient 
status. 
4.  To  identify  the  associations  between  different  dietary  patterns  and  markers  of 
disease progression and metabolic integrity (serum albumin, AST, total bilirubin, lean 
body mass and BMI). 
5.  To  determine  the  pathway  of  interrelationships  between  dietary  patterns,  dietary 
nutrients  intake,  serum  nutrient  status,  and  markers  of  metabolic  integrity  and 
disease progression using graphical chain modelling approach. 
7.1.4   The  conceptual  framework  for  the  thesis:  the  causal  pathway  of  dietary 
patterns, nutritional status and disease progression 
 
The synergistic association between nutritional status and HIV infection, the basis for the 
conceptual framework for this thesis have been described extensively in section 1.6 on 
pages  9-11  of  this  document.  It  was  implied  from  this  interrelationship  that  in  PLWH, 
dietary  intake  or  different  dietary  patterns  would  influence  the  quality  and  quantity  of 
nutrients in the diet and this could influence serum status of nutrients and metabolites, 246 
 
impacting on the body mass, metabolic integrity and ultimately disease progression. This 
also  implies  that  a  desirable  diet  should  improve  nutrient  intake  leading  to  improved 
nutritional biochemistry or serum nutrient status and ultimately better body composition, 
metabolic integrity and slower disease progression.  This was the basis for this study and 
has been simplified into Figure 2.1. This study however did not assess the direct markers 
of disease progression in the population studied. 
 
Figure  7.1:  Causal  pathway  of  dietary  pattern,  nutritional  status  and  disease 
progression in HIV infection 
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7.2    Key findings 
1.  Though  asymptomatic,  marked  biochemical  differences  depicting  altered 
metabolism and inflammation were observed in PLWH compared to the uninfected.  
2.  PLWH  also  showed  an  anthropometric  profile  that  depicted  altered  body 
composition and abnormal fat distribution. HIV infection was associated with higher 
body fat and lower lean body mass.  
3.  Among the four dietary patterns the animal based and carbohydrate, vegetables 
and legumes based were associated with better energy and micronutrients that the 
recommended and staple diets. 
4.  In PLWH, the animal based diet predicted higher lean body mass (OR=3.6, 95% 
CI=1.3-10.4),  serum  albumin  (OR=1.5,  95%  CI=0.9-2.4),  HDL  (OR=1.4,  95% 
CI=0.8-2.1), BMI (OR=2.2, 95% CI=0.9-5.0), and lower serum AST (OR=0.7, 95% 
CI=0.4-0.9),  ALT  (OR=0.6,  95%  CI=0.4-0.9)  and  overall  liver  enzyme  score 
(OR=0.7, 95% CI=0.4-1.1) compared to the other dietary patterns. 
 
Using graphical chain modelling approach, it was shown that:  
For BMI and lean body mass: 
•  In the HIV infected group, subjects who were males, younger (up to 40 years old) 
and with higher income, were more likely to consume higher animal based and 
carbohydrate,  legumes  and  vegetables  based  dietary  patterns  but  lower  staple 
based  1  (maize meal)  diets.  This  was  associated with  higher  dietary  nutrients, 
better serum vitamins A and E and lipids status and ultimately higher BMI and lean 
body mass. 
•  In  the  uninfected group, female subjects,  above  40  years olds,  urban dwellers; 
subjects with lower staple based 2 dietary intake had higher serum lipid score and 
higher BMI and lean body mass. 
 
For serum albumin  
•  In the HIV infected group, subjects with higher income, younger (up to 40 years 
old)  and  lived  in  rural  dwellings  who  consumed  higher  animal  based  and 
carbohydrate, vegetable and legume based dietary patterns but lower staple based 
dietary pattern had higher overall dietary nutrient score, higher serum lipids and 
vitamin E status and ultimately higher serum albumin status.  248 
 
•  In the HIV uninfected group, non smokers, living in urban dwellings and with higher 
education were likely to have higher serum vitamins A and E and higher serum 
albumin. 
 
For serum AST 
•  In the HIV infected, lower education and higher total bilirubin were associated with 
higher AST  
•  In the HIV uninfected population, increased food intake in general was associated 
with  higher  dietary  nutrient  intake,  serum  vitamin  E  and  higher  serum  AST 
irrespective  of  the  dietary  pattern.  Intakes  of  the  four  dietary  patterns  were 
associated with residency, age, gender, income, education and smoking status. 
 
For serum total bilirubin, 
•  The  characteristics  of  HIV  infected  subjects  with  higher  total  bilirubin  were: 
Subjects with higher education, high AST and  lower total protein score (that is 
higher serum globulins and lower albumin). 
•  In the HIV uninfected population, subjects with lower education, unmarried, who 
smoked and lived in urban dwellers and were 40 years and below were more likely 
to have lower serum vitamin A and E and lipid score and this was associated with 
higher serum total bilirubin. 
7.3  General discussion and implications of the findings 
Infection and malnutrition complement and worsen each other synergistically, leading to 
poor immune integrity (Scrimshaw, 2003; Jackson and Calder, 2000). The human body 
comes  into  contact  with  infection  causing  agents  all  the  time.  These  microbes  cause 
diseases which can lead to death. In healthy people however, the immune system protects 
the individual and prevents damage by these microbes. However with HIV people, this 
immune system is compromised and so is the body’s ability to fight infections.  
 
Nutrition is a critical determinant of immune response and malnutrition the most common 
cause  of  immuno-deficiency  worldwide  (Chandra,  2003).  Protein-energy  malnutrition  is 
associated with a significant impairment of cell-mediated immunity, phagocytic function, 
secretory  immunoglobulin  A  antibody  concentrations  and  cytokine  production.  Also, 
deficiency  of  single  nutrients  could  result  in  altered  immune  response  (Cunningham-
Rundles  et  al.,  2005).  Chronic  undernutrition  and  micronutrient  deficiency  compromise 
cytokine  response  and  affect  immune  cell  trafficking.  The  combination  of  chronic 249 
 
undernutrition  and  infection  further  weakens  the  immune  response,  leading  to  altered 
immune  cell  populations  and  a  generalized  increase  in  inflammatory  mediators 
(Cunningham-Rundles et al., 2005). Other researches have documented the relationship 
between nutrition, infection and immune function (Scrimshaw et al., 1968; Scrimshaw and 
SanGiovanni, 1997; Chandra, 1976 and Kantona and Kantona, 2008; Calder and Jackson, 
2000;  Jackson,  2007)  which  was  described  extensively  earlier.  Thus,  the  synergistic 
relationship  between  infection,  malnutrition  and  immune  function  has  been  well 
established. 
 
The Human Immunodeficiency Virus being an infectious agent is no different from other 
infectious agents in that it has similar impact on malnutrition and immune integrity (Piwoz 
and Preble 2000; Semba and Tang, 1999; Jackson and Calder, 2000). The relationship 
between  HIV  and  nutrition  however  may  be  more  complicated  than  the  relationship 
between nutrition and other infections because the virus directly attacks and destroys the 
cells of the immune system (Piwoz and Preble 2000). Moreover, the effects of malnutrition 
on  immune  function  in  HIV  infection  may  influence  viral  replication,  thus  influencing 
disease progression and mortality. These include oxidative stress for example which could 
hasten HIV replication (Semba and Tang, 1999), and the production of hormones such as 
glucagon,  insulin,  epinephrine,  and  cortisol.  These  are  involved  in  the  metabolism  of 
carbohydrates, proteins and fats  and increased levels of these hormones contribute to 
weight loss and the wasting syndrome seen in most adults AIDS patients.       
 
Nutrition is a demand led process and thus an optimal nutritional status is achieved when 
the demands of the body are met. The demands of the human body are dependent on its 
physiological state; for instance whether there is an infection or not or levels of physical 
activity. Infections increase the demand for nutrients because of increased utilization and 
excretion of protein and micronutrients as the body mounts its acute phase response to 
invading pathogens and reduce the intake of food and nutrient availability due to anorexia 
and malabsorption (Piwoz and Pebble 2000). Infections also can result in the release of 
pro-oxidant  cytokines  and  other  reactive  oxygen  species  leading  to  the  increased 
utilization of antioxidants vitamins (such as vitamin E, C and beta-carotene) as well as the 
sequestration of several minerals (e.g., iron, zinc, selenium, manganese and copper) that 
are used to form antioxidant enzymes (Friis and Michaelson, 1998).  
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Whenever  there  is an  imbalance between  the  pro-oxidants  and  antioxidants,  oxidative 
stress occurs and this leads to further damage to cells, protein and enzymes (Schwarz, 
1996). Thus HIV infection does not only compromise the immune system but increases the 
nutrient  needs  of  the  body  to  restore  losses,  enhance  immune  response,  respond  to 
inflammation and oxidative stress and maintain metabolic integrity. In light of these issues, 
improving nutritional status should be a key consideration in promoting health and well 
being and delaying disease progression and mortality in HIV infection. 
 
Highly Active Anti-Retroviral Therapy (HAART) and treatment of HIV/AIDS has progressed 
significantly over the years and has led to a decline in HIV related morbidity and mortality 
(Rousseau et al., 2000). Recent studies indicate that  the availability of  these effective 
drugs  to  control  HIV/AIDS  has  tended  to  downplay  the  potential  benefits  that  may 
accompany  appropriate  supportive  measures,  designed  to  complement  or  precede 
pharmacotherapy, to arrest progression from infection to disease, or to delay the rate of 
progression of the earlier phases of the illness, before specific medicinal interventions are 
indicated and nutritional support is one such potentially valuable measure (ASSAF, 2007). 
HAART may not be enough in the management of HIV infection because HIV infected 
persons who begin antiretroviral therapy without adequate nutrition have lower survival 
rates and patients starting antiretroviral therapy without adequate nutrition were shown to 
be six times more likely to die (Paton et al., 2006). There are also issues with adherence, 
side effects, immune deficiencies and wasting and even sustaining anti-retroviral treatment 
which makes nutritional implications imperative in the management of HIV/AIDS (UNAIDS, 
2008; Paton et al., 2006; Hardon et al., 2007; Drain et al., 2007; Mitsuyasu, 2000).  
 
However, what  is adequate nutritional status  or to ask  in a different way what sort of 
nutritional status promotes health in HIV infection and specifically which dietary patterns 
ensure adequate nutritional status have been asked by researchers (Vorster et al., 2004; 
Wiig  and  Smith,  2007).  This  study  therefore  sought  to  assess  the  impact  of  different 
dietary  patterns  on  nutritional  status,  metabolic  integrity  and  disease  state  in  an  HIV 
infection  population.  The  focus  of  this  study  was  on  dietary  patterns  and  not  specific 
nutrient intake mainly because the evidence from specific nutrient studies were mixed and 
a great knowledge gap  existed regarding the influence of dietary patterns on nutritional 
and disease stage in HIV infection. Dietary guidelines are also better ways of providing 
nutritional support for the prevention of disease because they may be more beneficial, 
feasible, practical and sustainable  in resource  poor settings.  Moreover,  people tend to 251 
 
consume patterns of food rather than nutrients (Williams et al., 2000). Foods are usually 
consumed in a number of combinations providing a range of nutrients that interact with 
each other in a complex manner (Wirfaelt 2000) and these interactions could be lost when 
individual  nutrients  are  consumed.  These  reasons  supported  the  need  to  study  the 
influence  of  dietary  patterns  rather  than  nutrients  on  nutritional  and  metabolic  status, 
immune integrity and disease progression in PLWH. 
 
There are National and International dietary and nutritional guidelines for PLWH providing 
recommendations  for  foods and  nutrients  in  HIV  infection.  Review  of  these  guidelines 
showed some inconsistencies, lack of exactness, and the fact that these recommendations 
did not seem different from dietary guidelines for HIV uninfected populations. No study had 
however assessed if these recommended dietary guidelines were ‘healthy’ for PLWH or if 
following  these  guidelines  would  be  associated  with  better  disease  outcomes  in  HIV 
infected people. This study therefore did not only assess the effects of different dietary 
patterns on nutritional and metabolic state but also asked whether following the dietary 
guidelines closest to the current South African guidelines for PLWH was associated with 
better nourishment, and more desirable metabolic and immune integrity. 
 
Initial analysis of the data used for the study showed that the HIV infected population (who 
were  asymptomatic  and  apparently  healthy)  were  similar  to  the  general  uninfected 
population in  terms of BMI, lean body mass, and  other body composition  parameters, 
patterns of dietary and nutrient intakes, and many socio-demographic factors except for 
age and residential dwelling. Means for these markers were not different between the HIV 
infected and uninfected populations and this probably confirmed the asymptomatic status 
of this group. However mean levels of majority of the biochemical markers (haematocrit, 
albumin,  globulins,  LDL,  total  cholesterol,  HDL  and  liver  enzymes)  were  significantly 
different between the HIV infected and uninfected populations suggesting a state of altered 
metabolism, inflammation, malnutrition and probably disease progression in the infected 
and confirming findings from other studies (El-Sadir et al., 2005; Baza Caraciolo et al., 
2007; Graham et al., 2007; Mehta et al., 2006; Sterling et al., 2008 and Ejilemele et al., 
2007).  
 
Whilst there were no differences in the means for BMI and lean body mass between the 
HIV  infected and uninfected populations, regression  analysis showed  the  HIV  infection 
was associated with increased odds for high fat mass and decreased odds for lower lean 252 
 
body mass. This observation implied that HIV infection was associated with lower lean 
body mass and higher fat mass, depictive of loss of metabolically active tissue (Grinspoon 
and  Mulligan,  2003;  Earthman  et  al.,  2000)  and  possible  abnormal  fat  distribution  or 
lipodystrophy  (Shlay  et al., 2004; McDermott  et al., 2005; Guaraldi et al., 2008). Thus 
although the  study  population were  asymptomatic  and probably  in  early  stages  of  the 
infection, marked changes in  body composition and  biochemical  markers suggesting a 
state of altered metabolism and declining nutritional status were manifested.  
 
The four main dietary patterns determined by PCA were similar between the HIV infected 
and the general population suggesting that dietary intake was probably not a consequence 
of HIV infection. These dietary patterns were described as predominantly animal based, 
‘recommended’ or ‘healthy’, staple based and carbohydrate, legume and vegetable based. 
Comparing  the  four  dietary  patterns  however,  the  second  dietary  pattern  was  more 
associated with the current South Africa dietary guidelines for PLWH than the other three 
patterns and that was the basis for describing this pattern as ‘recommended’ or ‘healthy’. 
Within the HIV infected population, these different dietary patterns were associated with 
some  selected  outcome variables  (nutrient  intake  and  pattern, anthropometrics,  serum 
nutrient  status  and  markers  of  metabolic  integrity)  in  a  unique  and  different  manner 
suggesting  that  dietary  patterns  could  have  important  influences  on  nutritional  status, 
structural and functional integrity in PLWH.  
 
Exploring how these dietary patterns were associated with the selected outcome variables 
using correlations and regression analyses in Chapter Five, showed that in both the HIV 
infected  and  uninfected  the  animal  based  dietary  pattern  was  associated  with  better 
energy  and  micronutrient  intakes,  anthropometric  indicators,  serum  albumin  and  liver 
enzymes  than  the  ‘recommended’  or  staple  based  dietary  patterns  though  these 
associations were not statistically significant in some cases. The carbohydrate, vegetables 
and legumes based pattern was also associated with higher nutrient intake and lean body 
mass but showed positive associations with the liver enzymes. This implied that the animal 
based  dietary  pattern  was more  likely  to  improve  the  quality  of  the diet  by  enhancing 
energy and nutrient intakes, which ultimately influenced anthropometric status (BMI and 
lean body mass) and markers of metabolic integrity and probably disease progression. 
However  this  implication  was  only  suggestive  at  this  stage  because  graphical  chain 
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These necessitated a more detailed examination of the analytical framework or pathway 
within  which  the  different  dietary  patterns  were  associated  with  the  outcomes  in  a 
hierarchical  order  using  graphical  chain  modelling  approach.  The  pathways  observed 
suggested that  food  intake  in general was  in the pathway  of interrelationship between 
nutritional status and disease progression. Comparing the four dietary patterns observed 
within the study population, a predominantly animal based and a carbohydrate, legumes 
and vegetable based dietary patterns were associated with better indicators of the function 
(metabolic integrity, serum nutrients, and probably disease outcome) and structure (BMI 
and LBM) in HIV infection within the framework. On the other hand, the dietary pattern that 
depicted  the  current  recommended  guidelines  for  PLWH  in  South  Africa  and  staple 
(maize-meal) based dietary patterns was least desirable in the framework or pathway of 
interrelationships. 
Evidence  from  literature  suggests  that  micronutrients  and  minerals  status  and 
supplementation  in  HIV  infected  populations  were  more  likely  to  improve  immune  and 
metabolic  function  (Bodgen et al., 2000; Jiamton et al., 2003;  Baum et al., 2003; Van 
Lettow  et  al.,  2004;  Austin  et  al.,  2006;  Kupka  et  al.,  2004).  The  studies  involving 
macronutrients on the other hand were more associated with repletion of body weight, 
body cell mass and lean body mass (Rathmacher et al., 2004; Berneis et al., 1995; Clark 
et al., 2000; Schwenk et al., 1999; Topping et al., 1995). The fact that findings of the 
review following nutrient supplementation were not as expected  in some studies could 
have  been  due  to  the  fact  that  the  combination  of  nutrients  as  well  as  their  complex 
interactions that occur when eaten as a diet were lacking. Issues like low sample, different 
stages of HIV infection of study subjects, combining both subjects on HAART and those 
not on treatment in the analysis could have influenced the findings. However the review 
implied that a healthy diet for people with HIV infection should be that which provides 
adequate macro and micronutrients as well as the complex interactions of these that occur 
when eaten as whole diet. Comparing the four dietary patterns observed within the study 
population, the animal based dietary pattern was better associated with nutrient intakes 
and could provide the quality and quantity of nutrients necessary to maintain and promote 
structural and functional integrity in the PLWH. 
There is however the need to consider the population within which this study was done 
with the study population for the reviewed literature. For instance, majority of the studies 
reviewed was carried out in developed countries and within affluent participants who were 
likely  to  be  well  nourished  with  very  little  risk  from  threats  like  malaria,  tuberculosis, 254 
 
poverty,  malnutrition  and  environmental  issues  that  increase  diseases  (Morgan  et  al., 
2002). This may imply that the impact of nutritional intake on disease progression in PLWH 
could be underestimated by these studies. However, if within these populations increased 
macro  and  micronutrient  intake  improved  disease  outcomes,  and  delayed  disease 
progression and mortality, then the findings of this study confirm the literature but more so 
suggest that an animal based dietary pattern could be even more significant in resource 
lacking and poor settings such as the current study population.  
 
Infections, stress and  trauma  lead  to  specific  nutrient  losses such as  zinc, vitamin  A, 
vitamin B12, and folate increasing the likelihood of deficiencies, cellular damage and tissue 
malfunction (Jackson, 2007). The problems faced in HIV infected individuals as described 
earlier  are  loss  of  nutrients  and  increased  nutrient  utilization  which  could  result  from 
oxidative  stress  or  decreased  anti-oxidant  protection,  inflammation,  malabsorption  and 
increased  metabolic  activities.  Studies  have  also  shown  that  inadequate  food  intake, 
anorexia,  dysphagia,  diarrhoea,  malabsorption,  opportunistic  infection  and  immulogical 
and  metabolic changes  are  the  main  disorders  associated  with  the  wasting  syndrome 
(Kotler et al., 1991; Kotler et al., 1992; Raiten, 1991). Loss of body cell mass and low 
serum albumin characterizes the clinical picture of protein-energy malnutrition in AIDS and 
is predictive of the mortality in advanced disease (Chlebowski et al., 1989; Kotler et al., 
1989; Suttmann et al., 1995). Chronic inflammation could lead to increased liver enzymes 
and lowering of albumin as the body mounts an acute phase response and this leads to 
increased  use  and excretion  of  proteins  and  micronutrients  (Piwoz and  Preble,  2000). 
Moreover, oxidative stress could lead to damage to cells and proteins, increasing the need 
for these nutrients (Schwarz, 1996).  
 
The  inflammatory  response  to  infections  such  as  HIV  is  marked  by  fever  and  with  a 
widespread reordering of metabolic function, including sequestration of iron and zinc in the 
liver and an increase in circulating acute phase proteins such as the copper-containing 
protein,  ceruloplasmin  (Jackson,  2007; Golden  et  al.,  1987).  This  marks  a shift  in  the 
pattern of proteins being synthesised and secreted by the liver and enhances formation of 
acute phase proteins at the expense of the formation of nutrient transport proteins such as 
transferrin, retinol-binding protein and albumin (Jackson, 2007). The diminishing levels of 
some  acute  phase  proteins  such  as  albumin  have  also  been  shown  to  be  due  to 
intercapillary leakages associated with the inflammatory process. Thus ensuring adequate 
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of the individual, ensuring body weight and body mass are maintained. Energy, proteins 
and micronutrients intake must be optimal to restore losses from excretion and increased 
utilization, to  repair cellular  damage, maintain tissue malfunction and  promote  immune 
integrity.    The  predominantly  animal  based  diet  was  associated  with  better  levels  of 
nutrients  including  proteins,  which  could  enhance  serum  proteins  including  albumin 
(reduced due to chronic inflammation  in HIV  infection) and this could explain why this 
dietary pattern was associated with better serum albumin status. 
 
To show whether the animal based dietary pattern was that important in the HIV infected 
population, the findings were compared with the HIV uninfected group and these were 
confirmed because although the animal based dietary pattern was associated with better 
outcomes in the HIV uninfected group as well, the other dietary patterns were also likely to 
be  associated with better  outcomes  as  well.  This  probably  meant  that  specific dietary 
pattern may not be as important in the HIV uninfected as was shown in the infected. It 
could also mean that in HIV infection the increased nutritional needs resulting from the 
infection was better provided by the animal based dietary pattern. 
Another difference between the evidence from literature and the findings of this study was 
that more direct outcome markers such as CD4 cell count, viral load, AIDS mortality and 
hospitalisations from secondary infections were used in the available literature. For this 
study however, proxy markers (serum albumin, AST, BMI and lean body mass) of disease 
progression were used because the more direct ones were not assessed. However these 
proxy  markers  are  indicative  of  altered  metabolic  function,  inflammatory  stress  and 
changes in body composition and several authors have shown that BMI, LBM and serum 
albumin could be used as markers of disease progression in PLWH (Mehta et al., 2006; 
Feldman et al., 2000; Goldwasser et al., 1997; Justice et al., 1989; Villarmor et al., 2005; 
Steinhart, 2001; Graham et al., 2007).  
Some other difference between this study and the reviewed literature was that the current 
study population was asymptomatic and apparently ‘healthy’, and subjects were unaware 
of  the  HIV  infection  status.  Subjects  with  symptoms  of  disease  including  fever  were 
excluded from the study. The reviewed studies on the other hand included populations 
which suffered from AIDS (Winkler et al., 2004; Jiamton et al., 2003; Baum et al., 2003; 
Cappell and Godil, 2003; Charlin et al., 2002 and Kupka et al., 2004) as well as subjects 
who  were  terminally  ill  implying  that  the  findings  of  this  study  did  not  represent 
symptomatic HIV infected subjects. In spite of these issues, dietary patterns seemed to 256 
 
have  a  significant  influence  on  markers  of  metabolic  and  structural  integrity  assessed 
suggesting  that  even  in  the  supposed  asymptomatic  stage  of  the  PLWH  nutritional 
considerations are needed.  
The current study population came from a resource poor country in sub-Saharan African 
where  malnutrition prevalence and threats from other  infectious diseases  are generally 
higher  compared  to  rich  developed  countries.  Majority  of  the  studies  in  HIV  infected 
populations reviewed came from more affluent countries especially the United States. This 
could mean that the findings for this study may not be applicable to more affluent and well 
nourished  populations  such  as  that  of the  reviewed studies.  Bearing  the study  design 
(cross sectional) and other limitations (measurement error) related to dietary assessment 
in general and the specific method used in the study, these findings might just be showing 
associations and may not be causal. However if these findings are anything to consider, 
then there are considerable implications for nutritional and dietary support, further studies, 
the role of nutrition in the triple disease burden in Africa and other developing countries 
and for policy. 
Literature  regarding  the  influence  of  dietary  patterns  on  disease  progression  in  HIV 
infected populations is scanty. Wiig and Smith (2007) showed that HIV infected subjects 
recruited from an out-patient Hospital in Ghana, consumed very little vegetables and fruits 
and energy intake was mainly from staples. It was however not shown whether dietary 
intake was associated with markers of disease progression. Vorster et al., (2004) showed 
that  in  asymptomatic  HIV  infected  population  in  North West  Province of  South  Africa, 
increased  red  meat  with  fruit  and  vegetable  intake  was  associated  with  lower  liver 
enzymes compared with subjects who consumed more staples (maize meal). Smit and 
colleagues also reported low intake of fruits and vegetables, milk and milk products in HIV 
infected people but did not show if this had any bearing on disease progression (Smit et 
al., 1996). 
Moreover  McDermott and colleagues described a customized nutrition intervention that 
produces changes in energy intake, maintenance of appropriate protein intake, and the 
reversal  of  unintentional  weight  loss  over  5  to  15  months.  Sustained  improvements 
occurred across a socioeconomically diverse population, despite persistent disease- and 
medication-associated  side  effects  (McDermott  et  al.,  2003).  For  this  study,  the 
intervention  was  a  dietary  supplement  which  was  aimed  to  surpass  daily  energy 
requirement by 500 kcal and protein intake by 0.2g/kg body weight per day. The findings of 257 
 
this study again suggested that dietary intervention could be effective in managing HIV 
infection.  No  study  has  explored  the  framework  or  pathway  of  relationships  between 
dietary  patterns  and  nutrition  status,  immune  function,  metabolic  integrity  and  disease 
progression in HIV infected people using graphical chain analysis. Thus it was difficult to 
compare  the  findings  of  this  study  with similar  studies.  However several  studies  have 
shown  that  dietary  patterns  could  influence  disease  outcomes  such  as  some  cancers 
(Schatzkin et al., 2007; Wirfalt  et al., 2008; Park et al., 2007  and Flood et al.,  2007), 
cardiovascular diseases (Hung et al., 2004; Joshipura et al., 1999; Swain et al., 2008 and 
Keogh et al., 2007), body weight or obesity (Liu et al., 2003 and Schaefer et al., 1995) 
blood lipid and cholesterol levels (Luscombe-Marsh et al., 2005 and Gardner et al., 2005) 
and diabetes (de Munter et al., 2007). The findings of this study thus explain the impact of 
different dietary patterns on nutritional and metabolic integrity in HIV infection. 
From  literature,  there  is  just  one  very  recent  study  which  assessed  the  association 
between  different  dietary  patterns  and  nutritional  status  and  HIV  related  outcomes 
(Hendricks  et al.,  2008).  Hendricks and  colleagues  assessed  the  association between 
dietary patterns identified by cluster analysis and changes in body mass index, CD4 count, 
and viral load (VL) among 348 HIV-positive adult male subjects who were evaluated by 
biochemical, body composition, and dietary data. Cluster analysis was performed on 41 
designated  food  groups  derived  from  3-day  food  records  and  dietary  clusters  were 
compared for socio-demographic, nutrient intake, and clinical outcomes using multivariate 
regression analysis.  
Three dietary patterns: juice and soda; fast food and fruit drinks; and fruit, vegetable, and 
low-fat dairy were observed and findings showed that subjects in the fast food and fruit 
drinks pattern had the lowest fibre intake, highest viral load, and lowest CD4 count and 
had  a  lower  income  than  did  subjects  in  the  other  2  clusters.  Subjects  in  the  fruit, 
vegetable, and low-fat dairy diet pattern on the other hand had higher intakes of protein, 
fibre, and micronutrients and the highest BMI and CD4 count whereas subjects in the juice 
and soda pattern had higher energy intakes and lowest BMI. Moreover, the fast food and 
fruit drinks cluster and fruit, vegetable, and low-fat dairy cluster gained 0.33 (p = 0.06) and 
0.42 (p = 0.02), respectively, more in BMI than the juice and soda cluster across the study 
interval in a multivariate model. The study concluded that in a cohort of HIV-positive men, 
each dietary pattern was associated with specific nutrition, demographic, and HIV-related 
variables (Hendricks et al., 2008). 258 
 
The differences between the study by Hendricks et al., (2008) and this study are that the 
designs, populations, settings and dietary analysis methods were all different. Also, some 
of the outcomes variables between the two studies varied. The findings of the two studies 
were also different in that a predominantly animal based dietary pattern associated with 
high fat intake was associated with more desirable outcomes for this study whereas a fruit 
and  vegetable  and low  fat  dietary  pattern was associated with better  outcomes  in the 
former. The reasons for the differences are not certain but the different findings could be 
pointing to the fact that the expected dietary quality for PLWH in poorer populations with 
other risks and threats (malnutrition  and infections) typical of this study population are 
likely to be different from populations which are more affluent, better nourished, with less 
threats from infectious agents such as in Hendricks et al., (2008) study. 
It  was  also  noted  that  certain  socio-demographic  indicators  were  associated  with  the 
different dietary patterns, suggesting that although dietary choice may not be associated 
with  HIV infection status especially in  the asymptomatic phase, the socio-demographic 
environment  influenced  dietary  intake.  It  was  showed  that  urbanisation  level,  income, 
gender,  age,  marital  status,  education  and  smoking  were  all  associated  with  the  four 
dietary patterns in one way of the other. In the HIV infected population higher household 
income,  rural  dwelling  and  younger  subjects  (up  to  40  years)  consumed more  animal 
based diet than older, lower income and urban dwellers. This implied that even if certain 
dietary patterns were more desirable in HIV infection, choices could be limited depending 
on the socio-demographic status of the individual or household and these issues have 
been  acknowledged  by  both  National  and  International  organisations  (UNAIDS,  2008; 
Gillespie and Kadiyala, 2005). This was also confirmed in the study by Hendricks et al., 
(2008) which showed that subjects who consumed more fast foods and fruit juices had the 
lowest income.  
Enwonwu  and  Warren  (1995)  also  found  that  although  a  typical  West  African  dietary 
staples (common elsewhere in Africa as well), including rice, yam, plantain, and cassava, 
generally  do  not  meet  the  recommended  dietary  allowances  for  macronutrients  and 
micronutrients,  yet  high-protein  and energy-rich foods such as beans, groundnuts, and 
tropical plant oils, in addition to vitamin and mineral rich green leafy vegetables and fruits 
available  throughout  the continent, may  be considered  more expensive  or  simply  less 
preferred  by  the  people.  Wiig  and  Smith  showed  a  low  consumption  of  fruits  and 
vegetables  but  high  consumption  of  staples  in  the  HIV  infected  population  studied  in 259 
 
Ghana, and the reasons could be attributed to socio-demographic factors such as was 
found by this study. 
Another significant finding of this study was shown during the post hoc power calculations 
which  revealed  that  the  lack  of  statistical  significance  for  some  of  the  observed 
associations and means could have been due to under powered study and for that matter 
lower sample. For instance the four dietary patterns generated by PCA were not different 
between the HIV infected and uninfected using ANOVA and most of the anthropometric 
variables were not different between the two groups. However post hoc power analysis 
showed that the study was under-powered to show significant differences for the observed 
effects. Moreover, within the HIV infected population the associations observed between 
the dietary patterns and BMI, LBM and albumin were not statistically significant. Yet, post 
hoc  power  analysis  showed  the  possibility  of  inadequate  power.  These  observations 
suggested that the findings of this study could have even been more profound if the study 
was adequately powered.  
However there is also the need to treat statistical significance with caution. This is because 
there may be instances where an observed statistical significance is not associated with 
biological significance. For instance although the difference between the HIV infected and 
uninfected  population  for  mean  serum  albumin  was  1.6  g/l  and  this  was  statistically 
significant  (p=0.001),  it  is  important  to  ask  if  this  difference  have  any  biologically 
implication  especially  when  the  mean  serum  albumin  for  both  the  HIV  infected  and 
uninfected group fell within normal ranges. Also, the mean BMI in the HIV uninfected was 
higher  by  0.8  kg/m
2  than  the  infected  group  and  this  difference  was  not  statistically 
significant. Moreover the means for the two groups were within normal ranges for BMI. 
Graham et al., (2007), found that each 1g/l decrease in albumin with HIV-1 acquisition was 
associated with a 13% increase in the risk of progression to a CD4 count <200 cells/ l and 
a decrease in albumin over 10% was associated with a 3.5 fold increase in the risk of 
progression to a CD4 count <200 cells/ l. Serum albumin was shown to significantly and 
positively  correlate  with  CD4  cell  count  and  body  weight  both  before  and  after  anti-
retroviral treatment of HIV infected subjects (Carter, 2006). The findings of the study by 
Graham  and  colleagues  implied  that  a  1g/l  decrease  in  serum  albumin  is  biologically 
significant  because  it  hastens  HIV  disease  progression.  Thus  the  1.6g/l  difference 
observed  between  the  HIV  infected  and  uninfected  population  for  this  though  was 
statistically significant also showed a biologically significance.  Even if this difference had 260 
 
not reached a statistical significance, it would have still been appropriate to describe its 
biological implications.  
In  summary  the  study  showed  that  within  the  asymptomatic  HIV  infected  population 
studied, comparing all the four dietary patterns observed, the predominantly animal based 
dietary pattern enhanced macronutrient, micronutrient and mineral intake, promoting better 
dietary quality, serum nutrient status, BMI, LBM and markers of metabolic integrity within a 
framework of associations. Hence this dietary pattern could be more desirable compared 
with the other dietary patterns observed. The least associations were shown for the staple 
based dietary pattern. The animal based dietary pattern may not necessarily be desirable 
in a normal or HIV uninfected population where the dietary goals could be to reduce fat 
intake and prevent overweight and obesity and associated risks or even in an HIV infected 
population  in  more  affluent  populations  where  HIV  infected  persons  might  be  well 
nourished and even overweight. Also, whereas this dietary pattern may be beneficial in the 
short term, there is the need to consider the long term implications for instance of high fat 
intake associated with this pattern on risks or threats such as overweight, obesity and 
cardiovascular diseases and their complications. However in the current PLWH, faced with 
increased threats of disease progression, malnutrition and rapid unintentional weight loss 
as symptoms of AIDS begin, such dietary pattern might be ‘recommended’ and considered 
‘healthy’.  The  implications  of  the  findings  of  this  study  are  discussed  in  the  following 
sections. 
7.4  Implications  of  findings  for  public  health,  current  dietary  guidelines  and 
future nutritional support for PLWH 
HIV infection remains a major threat to the health and economic development globally but 
more importantly in sub-Saharan Africa, threatening the very fabric of the society. Many 
young and productive  in communities are die each year living orphaned children. This 
makes  the  issue  a  very  big  one  indeed.  Knowledge  of  the  interrelationship  between 
nutrition and infection suggest that malnutrition can predispose people to infection and 
infection cause  malnutrition. Therefore  it  is  important  to ask  if  certain  dietary  patterns 
reduce susceptibility to HIV infection, prevent or delay disease progression and reduce 
mortality from AIDS. There have been no answers  to these  questions:  partly because 
characterising the diet is difficult and that is why most studies on nutrition and HIV infection 
have focussed  on specific nutrients. This study is  therefore unique  and moreover, the 
findings are extremely important.  
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The most recent UNAIDS policy brief on HIV food security and nutrition made it clear that 
food and nutrition security are often neglected but are critical for individuals, household 
and  communities  affected  by  HIV  (UNAIDS,  2008).  Inadequate  food  availability  and 
access, and poor nutrition could hasten disease progression to AIDS defining illness in 
PLWH, undermine  adherence to  anti-retroviral  therapy  and  exacerbate  socio-economic 
impact of the virus. Meanwhile HIV infection itself reduces work capacity and productivity 
and jeopardises household livelihoods and thereby undermining food security and nutrition 
(Edstrom  and Samuels,  2007;  Gillespie  and  Kadiyala,  2005;  Paton  et al.,  2006; WHO 
2005).  
 
Member states of the United Nations resolved to address food security and nutrition in all 
settings since these are vital to the achievement of universal access to HIV prevention, 
treatment, care and support by 2010 as contained in both 2001 and 2006 United Nations 
General Assembly Special Session Declaration of Commitment on HIV/AIDS and the 2006 
Political Declaration on HIV/AIDS. Members of the United Nations have also committed 
themselves to integrate food and nutritional support in the response to HIV with the goal 
that all people at all times will have access to sufficient, safe and nutritious food to meet 
their nutritional needs and dietary preferences for an active and healthy life as part of a 
comprehensive response to HIV/AIDS (UNAIDS, 2008).  
 
The  issue of whether  nutrition  is important  in HIV infection is  therefore not a  problem 
because  there  is  unanimous  agreement  to  that  effect.  The  issue  however  is  how  to 
maintain  an optimal  nutritional  status  in order  to  ensure  an  active and  healthy  life  for 
PLWH.  This  would  ensure  comprehensive  but  very  clear  and  tailor-made  dietary 
guidelines for HIV infected populations based on strong evidence of what is optimal in HIV 
infection. Little information is available on the effectiveness of current dietary guidelines in 
maintaining  and promoting  health of  PLWH.  However,  the  dietary  pattern  found  to  be 
associated with better outcomes within the HIV infected population for the current study 
was a predominantly animal based dietary pattern.  
 
The first implication for this finding is that the dietary guidelines recommended for normal 
healthy people may not necessarily be ‘healthy’ for PLWH. A review of the current South 
African dietary guidelines and four other national dietary guidelines for PLWH showed that 
the  recommendations  were  not  really  different  from  recommendations  for  the  general 
population. There is  a dire  need for a closer look at  nutrition  and HIV  in general and 262 
 
nutritional guidelines for this special group. It is not enough for countries to commit to 
addressing food security and nutrition in HIV infection in United Nations meeting without 
knowing clearly what the  requirements are and which diet  to recommend which would 
meet these requirements. Policies are not enough though they could be starting points but 
there may be several of these policies and declarations already.  
 
It is also suggested from the findings of this study for nutritional guidelines to focus on 
foods rather than nutrients. Food based approach for promoting adequate nutrient intake 
in PLWH  may be the best way forward due to practicality, feasibility and sustainability 
issues especially in sub-Saharan Africa and other poor regions. The issues surrounding 
the combinations and complex interactions of nutrients when eaten as a whole diet support 
the dietary based approach as well (Williams 2000; Wirfaelt, 2000). Some of the more 
general public health issues raised by the Association of Science Report, South Africa 
report on HIV/AIDS, TB and malnutrition were to direct resources to ensure food security 
based on locally available, affordable and traditional foods to vulnerable populations also 
implied from the findings of the study.  
 
ASSAF also recommended that the nutritional care for PLWH should focus on diversified 
diets  including  locally  available,  affordable  and  traditional  foods,  and  should  be 
complemented by appropriate, locally acceptable macronutrient supplements. The dietary 
recommendations did not place any emphasis on animal based diets unlike the findings of 
this study. Nevertheless it stresses the need to do everything possible to promote and 
support adequate dietary intake of micronutrients, while recognising that this may not be 
sufficient to correct nutritional deficiencies in all HIV infected individuals (ASSAF, 2007). 
However,  from  the  findings  of  this  study  there  is  the  need  for  dietary  guidelines  to 
recommend locally available, affordable predominantly animal based foods.  
 
The following public health messages can be drawn from the findings of this study: 
•  Dietary intake matter immensely in HIV infection and different dietary patterns can 
influence nutritional status and metabolic integrity differently in HIV infection. 
•  Even  in  asymptomatic  stage  of  HIV  infection  with  no  obvious  observable 
differences  between  HIV  infected and  non-infected people, marked  biochemical 
changes depicting altered metabolism and inflammation, altered body composition 
and abnormal fat distribution are likely to be prevalent and this calls for nutritional 
support and counselling very early in HIV infection.  263 
 
•  Within different HIV infected populations, in terms of stages of the infection as well 
as countries from which subjects are drawn, nutritional requirements are likely to 
be different and therefore the pattern of diet to meet these requirements is very 
likely to be different. Comparing our findings and the study by Hendricks et al., 
2008 supports this observation. 
•  The current dietary guidelines for HIV infected population for South Africans which 
focuses on a broad based dietary intake and does not emphasise animal based 
dietary intake may not be appropriate for PLWH. In fact these guidelines are not 
different for the normal population suggesting that HIV infection does not influence 
dietary requirement. There is the need for additional studies to access the impact 
of  current  dietary  guidelines  on  disease  progression  so  that  the  recommended 
guidelines would be more specific to the needs of PLWH. This is currently not the 
case.  
•  However, formulation of dietary guidelines for PLWH should take into consideration 
the  impact  of  other  disease  burdens  (communicable  and  non-communicable 
diseases) and imperatively weigh the risks from the other disease burdens both 
within the HIV infected and the general population. This is crucial for public health.  
•  If  the  findings  of  this  study  are  true,  then  the  public  health  message  should 
encourage asymptomatic PLWH to consume predominantly animal based foods in 
order  to  ensure  adequate  nutrients  and  promote  better  nutritional  status  and 
metabolic integrity.   
•  The findings call for governments and bilateral organisations to formulate policies 
and implement nutritional programmes to support PLWH in order to improve dietary 
intake and promote nutritional and metabolic status necessary for improved quality 
of life and slower disease progression. 
•  Moreover,  governments  and  all  agencies  offering  nutritional  support  for  PLWH 
should  formulate  policies  to  intervene  in  the  asymptomatic  stage since marked 
biochemical  and  body  composition  changes  are  already  manifested  in  the 
supposedly early stages. It is also likely that intervening at this stage may be more 
beneficial, feasible and cost-effective especially in areas with limited resources. 
7.5  Implications  of  findings  for  the  triple  burden  of  disease  in  low-income 
countries, especially in sub-Saharan African  
A review of 57 studies from more than 20 African countries commissioned by the WHO 
found that chronic diseases like heart disease and diabetes were on the rise (English, 
2006, WHO 2005). The review revealed that across Africa, hypertension existed at levels 264 
 
from 3 percent in rural areas to more than 30 percent in some urban settings and most 
people were not aware they had hypertension (English, 2006).  As many as 20 percent of 
Africans suffer from diabetes and again the highest illness rates were found among people 
living in urban settings according to the review. Moreover, over 80% of the diabetic were 
type II, the form of the illness linked to obesity and inactivity, implying that overnutrition is a 
major problem in many African countries. Trends in chronic diseases from the WHO data 
in the Global burden of disease and risk factors report projects increases in deaths due to 
illness from chronic diseases in low and middle income countries up to 2030 (Nugent, 
2008).   
 
The estimated number of chronic disease-related deaths such as cardiovascular diseases, 
cancers and diabetes in the WHO African Region in 2005 was 2,446,000 (WHO, 2005 and 
2007). WHO also projects that 28 million people in  the African Region will die from a 
chronic  disease  over  the  next  10  years.  The  rate  of  increase  of  deaths  from  chronic 
diseases will outstrip that from infectious diseases, maternal and perinatal conditions and 
nutritional deficiencies more than four-fold in the next 10 years (WHO 2005 and 2008).  
However, WHO estimates that 36 million lives could be saved between 2005 and 2015 by 
deploying some simple, tested chronic disease prevention strategies (English, 2006) and 
this  gives  an  indication  of  the  cost  of  high  chronic  diseases  burden  on  the  African 
continent. 
 
On the other  extreme of the spectrum lies  undernutrition and communicable  diseases, 
which remain major problems in many African countries in spite of growing trends in non 
communicable  diseases.  Sixty  percent  of  the  10.9  million  deaths  each  year  among 
children below five years in the developing world are associated with undernutrition (WHO, 
2002). Current estimates by WHO suggests that about 1 million children die every year 
from severe acute malnutrition and severely malnourished children comprise a significant 
proportion  of  paediatrics  deaths  in sub-Saharan  Africa  (WHO,  2008).  More  than  2000 
million people have iron deficiency and iodine deficiency is the greatest single preventable 
cause of brain damage and mental retardation worldwide (WHO/NHD, 2001 and 1999). 
Vitamin A deficiency remains highly prevalent and is responsible for childhood blindness 
and  increased  risk  of  childhood  mortality  (WHO/NUT,  1995)  and  Chronic  and  acute 
malnutrition are still endemic. 
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The double burden of disease could be caused by many factors. Progress in improving 
water and sanitation systems and development of sound public health systems has been 
slow,  thwarting  efforts  to  reduce  undernutrition.  At  the  same  time,  changing  dietary 
patterns and lifestyles, spurred by urbanisation, the liberalisation of markets, demographic 
shifts and declining levels of physical activity have contributed to overweight and chronic 
diseases (Nugent,  2008).  A special  report by the  Food  and  Agricultural Organisation’s 
Nutrition and Consumer protection Division (AGN) in six case study countries in Egypt, 
India, Mexico, the Philippines and South Africa found a marked shift over the past 20 years 
to diets high in saturated fat, sugar and refined foods. Although, transition from cereal or 
staple based dietary patterns to an animal based foods could have positive impact on 
intakes of protein and several micronutrients and thus reduce child undernutrition, these 
changing dietary  and lifestyles have  resulted  in overnutrition  in adults resulting in high 
prevalence  of  both  adult  overnutrition  and  underweight  and  stunting  in  children  (FAO, 
2006). 
 
The malnutrition problem is aggravated by HIV/AIDS and other humanitarian emergencies 
and rising trends in tuberculosis. HIV currently affects over 33 million people globally, and 
about two thirds of these are from sub-Saharan Africa. Thus, Africa and most developing 
countries are faced with a double burden of disease due to the high prevalence of both 
communicable and chronic diseases. The double disease burden coupled with the effects 
of the HIV pandemic is responsible for what is called the triple burden of disease currently 
experienced in sub-Saharan Africa. 
 
South Africa is a typical country undergoing nutritional transition and faced with the triple 
disease burden. The prevalence of overweight and obesity in South Africa was  about 42% 
for overweight, 22% pre-obese and 19.8% obese (Motala et al., 2007; Pouane et al., 2002) 
and the complications of overnutrition are enormous. Overweight and obesity prevalence 
in other countries undergoing nutrition transition is equally high (Uauy et al., 2001; Wang 
et  al.,  2002;  Rivera  et  al.,  2002)  On  the  other  hand  there  are  still  high  levels  of 
undernutrition in many developing countries, including South Africa (Samba et al., 2006; 
Nube and van den Boom, 2003). HIV infection prevalence is high not only in South Africa 
but  in  the  whole  Southern  African  sub-region  (WHO,  2008;  UNAIDS,  2008).  Many 
households  are  affected  by  HIV  infection  and  the  influence  of  this  on  household  food 
security and nutrition, work capacity and development is enormous (UNAIDS, 2008). 
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Thus none of these three burdens is less important and each requires close attention, and 
though the answers might not be straight forward, there is still need for policy formulators 
and governments to strategise very well in order to tackle each of these problems in the 
most effective manner without neglecting any. For instance, dietary recommendations to 
reduce  overweight,  obesity,  cardiovascular  diseases  and  cancers,  and  other  diseases 
related  to  overnutrition  might  be  to  reduce  intake  of  fat  and  energy  which  are  most 
predominant  in  animal  foods.  However  to  overcome  undernutrition,  a  different  dietary 
guideline  is  required  and  this  should  be  a  diet  that  is  adequate  in  macro  and 
micronutrients,  enhancing  both  quantity  and  quality  of  dietary  intake.  With  regards  to 
PLWH, findings of this study have shown that separate dietary considerations are needed, 
which might be different recommendations for normal healthy populations.  
 
The way forward is to address the needs of the different populations within Africa and 
other  populations  with  high  HIV  prevalence  separately  but  still  ensure  that  the  other 
disease  burdens  are  tackled.  Implementing  policies  to  reduce  communicable diseases 
without taking into consideration the effects of non-communicable diseases would not be 
adequate  and  at  the  same  time  addressing  HIV  infection  without  considering 
communicable disease may not be wholistic. A balance is imperatively required. There 
may  also  be  the  need  to  consider  cost-benefit  analysis  in  order  to  strategise  and 
implement interventions  effectively. The need for cost-benefit considerations  is brought 
about by the  limited resources  available to most developing countries where the triple 
burden of disease is currently taking place. There is no one solution and this is why trained 
public  health  practitioners  able  to  disentangle  the  complexities  and  provide  adequate 
recommendations  are  in  dire  need.  A  concerted  effort  is  also  required  involving  all 
stakeholders, networking and in partnership so that nutrition could have a single agenda 
and  one  voice  as  this  is  needed  to  ensure  that  these  important  areas,  which  require 
nutritional expertise are addressed in an appropriate manner. Nutrition capacity building 
for countries faced with the triple disease burden needs to be strengthened at all levels 
and settings and the right structures should be in place to ensure effective function. 
 
The other aspect of the triple burden of disease is that everything is interrelated and HIV 
infected people are not only bedevilled by the demands of the infection but also the risks of 
the  other  burdens.  For  instance,  PLWH  are  exposed  to  undernutrition  and  other 
communicable diseases such as Tuberculosis and malaria in many countries experiencing 
the  HIV  pandemic.  The  threats  of  the  non-communicable  diseases  such  as  diabetes, 267 
 
cardiovascular diseases and cancers are also very pronounced. Morphological changes 
related  to  altered  distribution  of  regional  adipose  tissue  are  well  characterized  as  a 
potential complication of antiretroviral treatment regimens that can be physically disfiguring 
and negatively affect the quality of life (Wohl et al., 2008; Guaraldi et al., 2008) A recent 
review undertaken by Wohl and colleagues reported that there could be potential  increase 
in risk of cardiovascular disease  associated with metabolic  disturbances caused  by  fat 
redistribution  and  anti-retroviral  (Wohl  et  al.,  2008).  This  goes  to support  the fact  that 
dietary  counselling  offered  to  HIV  infected  people  should  consider  the  implications  of 
having high intakes of fat associated with animal foods which could predispose PLWH to 
obesity  and  CVDs.  This  implies  that  overweight  as  well  as  underweight  should  be 
addressed in the HIV infected and for that reason nutritional support for this population 
should be addressed, giving due consideration to the other burdens of disease within the 
HIV  infected  group  as  well  as  the    general  population.  The  solution  indeed  is  not 
straightforward.  
7.6   Implication of the findings for future study 
This study provides several opportunities for more formal studies on this topic. First of all, 
more  studies  are  needed  to  investigate  the  impact  of  dietary  patterns  on  disease 
progression in a longitudinal manner so that causal relationships could be established, 
although ethical issues may make such studies very hard to do. Graphical chain analysis 
approach is one of the best ways of establishing causal pathways between exposures and 
outcomes but rely mainly on longitudinal studies and future work using this approach is 
strongly  recommended.  If  the need for cross sectional studies arises, probably due to 
limited resources and time, then more direct outcome indicators of disease progression 
should  be  used  and  stronger  dietary  assessment  methods  with  fewer  disadvantages 
should  be  employed.  The  need  to  address  other  populations  within  Africa  and  other 
developing countries and possibly developed countries to enhance comparisons between 
different populations would be very relevant. 
 
One  major  observation  from  the  systematic  review  of  evidence  regarding  nutritional 
support  and  disease  progression  in  PLWH  was  the  fact  that  few  of  the  studies  were 
conducted  in  Africa  where  HIV  burden  is  greatest.  Apart  from  the  Micronutrient  study 
category which had substantial work from Africa, the other study categories such as oral 
macro  and  micronutrient  and  dietary  supplementation,  enteral  and  parenteral 
supplementation were poorly represented. In fact none of the studies in the enteral and 
parenteral nutritional support category  was conducted  in Africa. Moreover, most  of the 268 
 
studies in the category were done in AIDS patients and this implied that AIDS subjects in 
Africa  are  probably  not  giving  this  type  of  nutritional  support  at  all.  The  findings  may 
therefore  be  irrelevant  to  HIV  infected  malnourished  poor  peasant  farmers  in  remote 
villages in Africa because such a population is definitely different from a well nourished 
and  probably  over  fed  gay  men  in  the  USA  with  access  to  adequate  health  care, 
supplements,  anti-retroviral  therapy,  a  better  environment  and  the  list  goes  on.  Thus 
studies on the effectiveness of enteral and parenteral nutritional support are needed in 
Africa  in  order  to  understand  the  impact  of  this  type  of  nutritional  support  within  this 
context.  
 
The authors of the scientific enquiry into the nutritional influences of human immunity with 
special  reference  to  HIV  infection  and  active  TB  in  South  Africa  recommended  well-
designed and informative clinical and epidemiological studies urgently needed to generate 
and test hypotheses in relation to nutritional support for HIV infected subjects (both those 
who are not being treated with antiretrovirals, and those who are), and patients exposed 
to,  or  suffering  from,  active  tuberculosis  (ASSAF,  2007).  Pragmatic,  high-powered 
approaches should be developed in which explanatory designs are embedded as far as is 
possible. The studies should include adults and children, pregnant women, infants and 
children  (ASSAF,  2007).  These  observations  were  also  realized  from  the  systematic 
review  of  literature  presented  in  Chapter  Two  of  this  study  and  hence  ASSAF’s 
recommendations are very vital. 
7.7  Limitations of the study 
The main aim of the study was to show how different dietary patterns influenced disease 
progression  in  HIV  infection.  The  above  framework  required  a  longitudinal/progressive 
study design because causal relationships can only be explored with progressive study 
designs. However, data for this thesis was a secondary data from a cross sectional study. 
This meant that causal relationship between these variables could not be concluded in 
spite of the observed associations and pathways (Margetts and Nelson, 1997). There was 
also no way of knowing whether HIV infection was a consequence of changed dietary 
intake  and  for  that  matter  the  dietary  patterns  observed.  This  was  however  unlikely 
because the dietary patterns within the HIV infected were not different from the uninfected 
population. Also, the uninfected participants were apparently healthy and asymptomatic 
and were unlikely to have altered their dietary intake. The pathway of interrelationships 
observed for the graphical chain analyses models were only associations and therefore 
not  conclusive  because  of  the  study  design.  There  was  also  the  possibility  of 269 
 
underrepresentation of the HIV infected since this study was not set out to address this 
population which could have impacted on the lack of statistical significance observed for 
some of the comparisons and this was showed by post hoc power calculations.  
 
Another  limitation  of  a  cross  sectional  design  is  that  confounders  (age,  gender  and 
ethnicity) might not have been equally distributed between the groups being compared and 
this could lead to bias and subsequent misinterpretation. To remove the impact of the 
confounders,  adjustment  and  controls  were  made  for  the  possible  confounders  at  the 
analysis stage. 
 
Dietary  assessment  for  this  study  was  done  using  a  Quantitative  Food  Frequency 
Questionnaire developed and tested for validity in the study population. The advantages of 
retrospective tools for dietary assessment are that they are cheap, quick, requiring low 
subject motivation and lower literacy and numeracy skills, good cooperation and can be 
posted.  Generally,  retrospective  dietary  assessment  tools  rely  on  memory  and  needs 
conceptualisation skills to describe accurately frequency of consumption and food portion 
sizes. Usually observer bias could occur and reported diet may be a distortion of usual 
diets. These tools also require regular eating habits and may lack the measure of day-to-
day variation in diet (Margetts and Nelson, 1997). QFFQ are thus more imprecise in the 
estimation of usual food consumption or nutrient intake and could be a major limitation.  
 
Generally dietary assessments are associated with high measurement errors which may 
be due to specific individual errors rather than a systematic rendering biased information 
from all  individuals. Errors also may arise from the use of food  tables, assessment of 
frequency, failure to report usual diet either due to changes in habits during the study or 
misreporting. Measurement error in dietary assessment is about 50% for foods and 20% 
for nutrients probably due to cancelation of errors from food tables for nutrient assessment 
(Margetts  and  Nelson,  1997).  Apart  from  the  fact  that  assessment of dietary  intake  is 
associated with errors, dietary intake itself is inherently variable and therefore even one 
may be able to measure precisely the intake at a given occasion, this intake may not be 
habitual.  However  the asymptomatic state  of  the  HIV  infected  and  the  fact that  those 
infected did not know their state could have been beneficial for the dietary assessment 
because  the  subjects  were  unlikely  to  introduce  errors  and  bias  during  the  dietary 
assessment.  
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However, the QFFQ used for dietary assessment was developed specifically for the study 
and was rigorously pre-tested to ensure that the meanings of the food names and the 
portion  size  descriptors  were  clear  to  the  subjects  and  that  the  method  for  recording 
responses was not ambiguous. The questionnaire was also validated against a reference 
measure and although the validity study showed some concerns, the two methods agreed 
quite well for estimating foods and food groups than nutrient (Maclintyre et al., 2000) which 
made it more suitable for this particular study because food intake data were the main 
variables used. The limitations are however acknowledged and could have influenced the 
findings in either direction. 
 
Data on the main markers of disease progression in HIV infection, that is, CD4 cell count, 
viral load and opportunistic infections were not available. This was mainly because the 
study  was  not  designed  to  address  the  current  objective.  Thus,  markers  used  in  the 
present analysis to depict disease progression (BMI, lean body mass, serum albumin, AST 
and total bilirubin)  were  more of proxy markers of disease progression. Furthermore, 
since the study was not designed to address HIV infection, subjects who were ill were 
excluded and this could have influenced the findings. For instance the more healthy HIV 
infected participants were more likely to be similar to the uninfected populations in terms of 
anthropometrics  since  those  who  were  likely  to  be  different  were  likely  to  have  been 
excluded and this might explain the similarities between the two groups anthropometric-
wise.   
 
The effect of HIV infection on food intake could be influenced by the stage of the HIV 
disease. This is because in the asymptomatic phase of the infection, factors that influence 
appetite  and  problems  such  as  unbalanced  nutrient  losses  which  could  be  due  to 
diarrhoea  may  not  be  a  problem  at  this  stage  (Calder  and  Jackson,  2000).  Reduced 
dietary intake in  HIV infection could also  be due to  low physical activity and reductive 
adaptation which together could reduce Basic Metabolic Rate and consequently energy 
expenditure (Jackson, 2007). This study did not assess the influences of different levels of 
physical  activity,  BMR  and  assumed  that  the  effects  of  these  variables  were  similar 
between subjects and  between  the  HIV  infected  and  uninfected  populations. Thus  the 
findings of this study could have been influenced by other factors beyond the scope of this 
study such as BMR, physical activity, stage of HIV infection and subjects on nutritional 
supplements thus limiting the interpretation of findings. 
 271 
 
It was assumed that low dietary intake and for that matter reduced nutrient intake would 
lead to weight loss and reduction of lean body mass of the study participants. Again, low 
dietary intake, if it is associated with low physical activity and reduced BMR or reductive 
adaptation might mean a balance between energy and nutrient intake and requirements. If 
this balance exists, there is likely to be no change in body weight or lean body mass. 
 
Another limitation of this study could be associated with under power and for that matter 
lower sample size  for  the HIV  infected  populations. Since this study was a secondary 
analysis of data, post hoc power analysis was carried out to determine if the findings that 
were  not  statistically  significant  were  associated  with  the  study  power  (see  detailed 
calculations in Appendix V). The findings showed that for all the differences that were not 
significant, the study was under-powered (below 50%). Further calculations showed that 
larger sample sizes were needed to observe significance for the differences observed. 
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CHAPTER EIGHT CONCLUSION 
The  study  explored  the  interrelationships  between  different  dietary  patterns,  dietary 
nutrient  intake,  serum  nutrient  status  (serum  vitamins  A,  E,  lipids  and  proteins),  body 
composition (BMI and lean body mass) and metabolic markers (serum albumin and liver 
enzymes, bilirubin) in an asymptomatic and ‘healthy’ HIV infected population in the North-
West Province of South Africa. The hypothesis for this study was that “HIV infected people 
who  followed  the current  South African  dietary guidelines for PLWH would have more 
optimal nutrient intake, serum nutrient status, metabolic integrity and body composition 
than those who do not follow these guidelines”. 
 
Though  asymptomatic,  marked  differences  in  biochemical  markers  such  as  serum 
albumin, liver enzymes, and lipids were observed between PLWH and the uninfected. This 
was suggestive of chronic inflammation and a possible metabolic shift in PLWH. It was 
also notable that HIV infection was associated with lower lean body mass, higher body fat 
and changes in certain skinfold parameters, which probably depicted loss of metabolically 
active tissue  and possible abnormal  fat  distribution at a supposedly early stage  of the 
infection. Among the four main dietary patterns shown by principal component analysis, 
the  animal  based  dietary  pattern  showed  a  more  desirable  associations  with  nutrient 
intakes,  body  composition,  serum  lipids,  albumin  and  liver  enzymes.  This  implied  that 
dietary  intake  influenced  markers  of  nutritional  and  metabolic  status  in  the  study 
population.    
 
From graphical chain modelling, the pathway of interrelationships between the four dietary 
patterns  observed  within  the  study  population  and  outcome  markers  showed  that  a 
predominantly animal based dietary pattern was associated with higher intakes for dietary 
nutrients which was in turn associated with higher serum vitamin A, E and lipids and which 
were  associated  with  higher  BMI  and  lean  body  mass.  In  another  pathway  of 
interrelationships, this dietary pattern was associated with higher serum albumin. There 
was no pathway of interrelationships for AST. However, this dietary pattern was directly 
associated with lower AST and ALT. A dietary pattern depicting carbohydrate, legumes 
and vegetables showed similar associations observed for the animal based dietary pattern 
in terms of its association with nutrient intake and anthropometric parameter.  This dietary 
pattern  however  showed  positive  association  with  the  liver  enzymes.  Subjects  who 
followed  dietary  patterns  which  were  more  associated  with  the  current  South  African 
dietary guidelines for PLWH depicted as ‘recommended’ or ‘healthy’ dietary pattern and 273 
 
subjects whose dietary consumption were predominantly staple (maize meal) based were 
least desirable in terms of associations with the outcome markers observed for the animal 
based dietary pattern.  
 
Similar observations were shown in the HIV uninfected population but it seemed that within 
this  population  intake  of  all  four  dietary  patterns  was  more  desirable  though  the 
predominantly animal based dietary pattern was again more superior to the other dietary 
patterns.  Thus  testing  the  hypothesis  showed  that  the  most  optimal  dietary  in  the 
population  studied  comparing  the  four  dietary  patterns  observed  was  a  predominantly 
animal based dietary pattern.  
 
Nutrition  is  a  critical  determinant  of  immune  response  and  malnutrition  is  one  of  the 
commonest causes of immuno-deficiency worldwide. Deficiency of single nutrients could 
also result in altered immune response. Malnutrition (characterised by low serum nutrients 
status,  weight  loss  and  wasting),  chronic  inflammation,  altered  metabolism,  oxidative 
stress  and  immune  suppression  are  common  in  HIV  infected  individuals,  and  these 
increase  disease  progression  and  morbidity  leading  eventually  to  death.  Inflammation 
could cause a shift in the pattern of proteins being synthesised and secreted by the liver, 
enhancing formation of positive acute phase proteins at the expense of the formation of 
nutrient transport proteins such as transferring, retinol-binding protein and albumin. Loss of 
lean body mass and lipodystrophy depict a state of altered metabolism in HIV infection. 
Thus the positive associations between the predominantly animal based dietary pattern 
and lean body mass, BMI and albumin, and negative association with the liver enzymes 
implied that this dietary pattern is associated with better nutritional status and metabolic 
integrity and therefore recommended for this population. 
 
Despite  some methodological weaknesses  discussed  earlier,  the findings  of  this cross 
sectional study are significant and unique since there are no studies of this sort in PLWH 
in Africa. It is possible that in HIV infection people in general, some dietary patterns may 
be more optimal in terms of maintaining the structure (body shape and composition) and 
function (immune response, and metabolic integrity) than other dietary patterns, ultimately 
leading to delayed disease progression and better quality of life. The HIV infected subjects 
were asymptomatic and apparently healthy and were unlikely to suffer any symptoms of 
AIDS  but  this  finding  showed  that  even  in  early  stages  of  HIV  infection  dietary  and 
nutritional considerations are essential and the impact of dietary intake on nutritional and 274 
 
metabolic integrity is remarkable. It is however worth noting that the findings of the study 
may be different in a symptomatic HIV infected persons or subjects from more affluent 
populations  with  lower  malnutrition  and  threats from  other  infectious and  inflammatory 
diseases  typical  of  the  current  study  population  and  HIV  infected  populations  in  sub-
Saharan Africa in general. 
 
A review of studies involving HIV infected populations showed that increased micronutrient 
intakes were  associated with  better  metabolic  and  immune markers such as  CD4 cell 
count, lower viral load and fewer hospitalisations which could together be classified as 
improving  functional  capability.  On  the  other  hand,  studies  involving  macronutrient 
supplementation were mainly aimed at improving body weight, body cell mass and lean 
body  mass;  also  categorized  as  improving  the  structure  of  the  system.  The  fact  that 
findings of the review following nutrient supplementation were not as expected in many 
studies could have been due to the fact that the combination of nutrients as well as their 
complex interactions that occur when eaten as a diet were lacking. The findings of the 
reviewed studies however implied that a healthy diet for people with HIV infection should 
be  that  which  provides  adequate  macro  and  micronutrients  as  well  as  the  complex 
interactions  of  these  that  occur  when  eaten  as  whole  diet.  It  is  possible  that  a 
predominantly animal based dietary pattern provides the needed dietary quality, enhancing 
energy,  vitamins  and  mineral  intakes  necessary  to  maintain  structural  and  metabolic 
integrity in HIV infection. 
 
The  findings  for  this study  raise  the need  to have another  look  at  the current  dietary 
guidelines  and  nutritional  support  for  PLWH  since  these  guidelines  do  not  emphasise 
animal based diets and may as well not be ‘the recommended or healthy guidelines’ for 
this population. However considerations for nutritional support for PLWH need to address 
the nutritional requirements for the HIV infected in light of risks which are associated with 
the  triple  burden  of  diseases  and  chronic  inflammation  observed  in  recent  studies. 
Secondly, governments and stakeholders are required to have policies to address all three 
burden of disease in the population. There may not be a single answer but the burden of 
undernutrition  and  infectious  diseases,  non-communicable  diseases  related  to 
overnutrition, and HIV/AIDS are real and neither should be neglected. However with the 
limited resources available to tackle nutritional issues as well as the needs of other aspect 
of society, cost-effective analysis may be needed in order to give the required attention 275 
 
and resources to the various issues. Integration, partnership, collaboration and capacity 
building are areas which require adequate attention.  
 
To date too little research on nutrition and HIV has been undertaken in countries with the 
triple burden  of  disease but  the  triple burden offers massive challenges  for  the  public 
health systems in resource poor countries. Whereas a predominantly animal based dietary 
pattern may be beneficial in the short term especially in resource poor countries (it may not 
be adequate in more affluent populations), there is the need to consider the longer term 
implications, for instance of high fat intake associated with animal based dietary patterns 
on associated risks or threats such as communicable diseases in general and specifically 
overweight,  obesity  and  cardiovascular  diseases  within  HIV  infected  populations, 
especially those on anti-retroviral therapy. Moreover the findings also pose a challenge to 
imperatively weigh up the longer term risk analysis of the overall population profile which is 
crucial for public health and health promotion.  
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APPENDIX I-V: Summaries of backward regression analyses which were used to 
outline the graphical chains 
 
Appendix I: Direct determinants (coefficients, odds ratio, statistical significance and 
95% confidence intervals) of outcomes (BMI, LBM, AST, albumin and total 
bilirubin) 
 
 
 
  N  Factors  Coefficient 
 
P  value  Odds 
ratio 
Lower 
limit 
Upper 
limit 
Direct determinants of high lean body mass           
 HIV infected  63  Low BMI  -3.8  0.001  0.0  0.0  0.2 
     Male  2.2  0.044  8.9  1.1  75.0 
HIV uninfected   335             
     Low BMI  -4.1  0.000  0.0  0.0  0.0 
 
  
  Male  1.3  0.002  3.5  1.6  7.7 
Direct determinants of high BMI           
HIV infected  63  Low serum vitamin A  -2.3  0.029  0.1  0.0  0.8 
    Male  -4.7  0.001  0.0  0.0  0.1 
    Low lean body mass  -4.0  0.001  0.0  0.0  0.0 
 HIV uninfected  335  Male  -2.2  0.000  0.1  0.1  0.3 
     Low lean body mass  -4.2  0.000  0.0  0.0  0.0 
     Low staple based 2 diet  1.1  0.003  2.9  1.5  5.9 
     Low serum lipids score  -1.9  0.000  0.2  0.1  0.3 
     Low serum AST  1.3  0.001  3.6  1.7  7.6 
 Direct determinant s of high serum AST 
 HIV infected  63  Low serum protein score  -3.6  0.001  0.0  0.0  0.2 
     Low serum albumin  -3.8  0.002  0.0  0.0  0.3 
     Low serum total bilirubin  -3.7  0.001  0.0  0.0  0.2 
     Low education  2.8  0.005  17.2  2.3  127.1 
HIV uninfected  335  Low serum protein score  -0.6  0.029  0.5  0.3  0.9 
     Low education  0.8  0.003  2.2  1.3  3.7 
     Low serum vitamin E  0.6  0.017  1.9  1.1  3.1 
     Male  1.1  0.000  3.0  1.8  5.0 
     Low dietary nutrient score  -0.5  0.037  0.6  0.3  0.9 
     Low BMI  0.9  0.001  2.4  1.4  4.1 
 Direct determinants of high serum total bilirubin 
 HIV infected  63  Low serum protein score  2.5  0.006  12.7  2.1  77.5 
     Low education  -1.8  0.011  0.2  0.0  0.7 
     Low serum AST  -3.1  0.001  0.0  0.0  0.3 
     Low serum albumin  2.2  0.030  9.1  1.2  67.0 
 HIV uninfected  335  Smoking  0.4  0.086  1.5  0.9  2.5 
     Low education  -0.5  0.031  0.6  0.4  0.9 
     Low serum albumin  -0.8  0.001  0.5  0.3  0.7 
     Low serum vitamin E  0.7  0.004  2.0  1.3  3.3 
     Low lean body mass  -0.5  0.038  0.6  0.4  0.9 
 Direct determinants of high serum albumin 
 HIV infected  63  Low serum lipids score  -2.1  0.048  0.1  0.0  0.1 
     Low serum protein score  5.8  0.000  331.1  15.0  7266.8 
     Low education  -2.7  0.025  0.1  0.0  0.7 
     Rural dwellers  -2.4  0.033  0.1  0.0  0.8 
 HIV uninfected  335  Low staple based 1 dietary 
pattern  -0.5  0.043  0.6  0.3  0.9 
     Low serum vitamin A  -0.75  0.010  0.5  0.3  0.8 
     Low serum protein score  -2.0  0.000  0.1  0.0  0.2 
     Low education  -0.7  0.043  0.5  0.3  0.9 
     Low serum AST  -0.6  0.036  0.6  0.3  0.9 277 
 
APPENDIX II 
 Interrelationships (coefficients, odds ratio, statistical significance and 95% 
confidence intervals) within the intermediate exposures (serum nutrient 
status) determined by backward stepwise regression analysis 
 
  N   
Coefficient 
P  
value 
Odds 
ratio 
Lower 
limit 
Upper 
limit 
Serum vitamin A               
HIV infected  129  Low albumin high globulin 
score  -0.6  0.009  0.6  0.4  0.8 
HIV uninfected  695  Low albumin high globulin 
score  0.3  0.000  1.3  1.1  1.5 
    Serum vitamin E  0.2  0.000  1.2  1.1  1.2 
Vitamin E               
HIV infected  129  Low HDL, high LDL, 
cholesterol, triglycerides,   1.0  0.001  2.7  1.5  4.8 
 HIV uninfected  695  Low HDL, high LDL, 
cholesterol, triglycerides,   1.1  0.000  3.1  2.4  3.9 
    Serum Vitamin A  0.0  0.006  1.0  1.0  1.0 
Serum lipid score               
HIV infected  129  Serum vitamin E  0.4  0.000  1.4  1.2  1.7 
 HIV uninfected  695  Low albumin high globulin 
score  0.2  0.020  1.2  1.0  1.4 
    Serum vitamin E  0.4  0.000  1.6  1.4  1.6 
Serum proteins 
score 
             
HIV infected  129  Vitamin A  -0.0  0.022  0.9  0.9  0.9 
 HIV uninfected  695  Serum vitamin A  0.0  0.003  1.0  1.0  1.0 
    Low HDL, high LDL, 
cholesterol, triglycerides,   0.4  0.000  1.5  1.3  1.8 
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APPENDIX III 
Interrelationships (coefficients, odds ratio, statistical significance and 95% 
confidence intervals) within the socio-demographic variables determined by 
backward stepwise regression analysis 
 
Predictors of gender 
(female) 
Variable  Coefficient  P  value  Odds 
ratio 
Lower 
limit 
Upper 
limit 
  HIV infected  Low education  1.1  .033  2.8  1.1  7.5 
     smokers  -2.450  0.000  0.1  0.0  0.2 
  HIV uninfected  Low income  0.949  0.000  2.6  1.5  4.2 
     Low education  0.5  0.010  1.7  1.1  2.5 
     Smokers  -2.4  0.000  0.1  0.1  0.1 
Predictors of low income 
  HIV infected  Low education  1.2  0.028  3.4  1.1  9.9 
  HIV uninfected  Low education  1.5  0.000  4.7  3.0  7.3 
    Rural dwellers  0.7  0.057  2.1  1.0  4.4 
    Male subjects  -0.9  0.000  0.4  0.2  0.6 
Predictors of low education 
  HIV infected  ≤ 40 years  -2.4  0.000  0.1  0.0  0.3 
    Low income  1.3  0.032  4.2  1.1  14.4 
  HIV uninfected  ≤ 40 years  -1.9  0.000  0.1  0.1  0.2 
    Low income  1.5  0.000  4.8  2.9  7.8 
    Never married  -0.4  0.064  0.67  0.4  1.0 
    Rural dwellers  0.8  0.008  2.2  1.2  4.1 
Predictors of age (≤ 40 years) 
  HIV infected  Never married  1.5  0.002  4.6  1.7  12.5 
    Smokers  -.9  0.070  0.4  0.1  1.1 
    Low education  -2.3  0.000  0.1  0.0  0.3 
  HIV uninfected  Never married  1.6  0.000  5.3  3.6  7.6 
     Smokers  -0.5 
 
0.027  0.6  0.4  0.9 
     Low education  -2.0  0.000  0.1  0.1  0.2 
 Predictors of marital status (never married) 
  HIV infected  ≤ 40 years  1.5  0.000  4.8  2.0  11.2 
   HIV uninfected  ≤ 40 years  1.6  0.000  5.3  3.6  7.7 
     Rural dwellers  0.6  0.008  1.8  1.1  2.9 
     Low education  -0.4  0.076  0.6  0.4  1.0 
 Predictors of rural residency 
   HIV infected  No variable remained       
   HIV uninfected  Low income  0.6  0.066  2.0  .9  4.2 
     Low education  0.9  0.001  2.5  1.4  4.4 
     Never married  0.5  0.021  1.6  1.1  2.5 
 Predictors of smoking status (smokers) 
   HIV infected  Male  2.2  .000  9.8  3.8  25.1 
     ≤ 40 years  -0.8  .082  0.4  0.1  1.1 
   HIV uninfected  Male  2.3  .000  10.8  7.2  16.4 
     ≤ 40 years  -0.5  .004  0.6  0.4  0.8 
No of respondents in adjusted model was 105 and 638 for HIV infected and uninfected populations respectively 
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APPENDIX IV 
Regression  analysis  showing  direct  determinants  (coefficients,  odds  ratio, 
statistical  significance and  95%  confidence  intervals)  of  exposure  variables 
determined from backward regression analysis and used to draw chain graphs 
 
HIV status  N  variables  Coefficient 
 
P value  Odds 
ratio 
95% confidence 
interval 
            Lower 
limit 
Upper 
limit 
Predictors of high serum vitamin A 
HIV 
infected  
56  Male  1.3  0.011  3.9  1.3  11.6 
     ≤ 40years old  -1.6  0.006  0.1  0.0  0.6 
     Rural dwelling  1.3  0.014  3.9  1.3  12.0 
    Low serum vitamin E  -1.8  0.010  0.2  0.0  0.7 
HIV 
uninfected 
326  Low serum vitamin E  -1.1  0.000  0.3  0.1  0.5 
    Smokers  0.6  0.017  1.8  1.1  3.1 
    Low education  -0.5  0.042  0.5  0.3  0.9 
    Low serum protein 
score 
-0.4  0.039  0.6  0.3  0.9 
    Never married  -0.6  0.015  0.5  0.3  0.9 
Predictors of high serum vitamin E 
HIV 
infected 
85  Low serum lipid score  -1.1  0.023  0.3  0.1  0.8 
    Male  -1.0  0.054  0.3  0.1  1.0 
    Low dietary nutrient 
score 
-0.8  0.009  0.4  0.1  0.9 
    Low serum vitamin A  -1.0  0.057  0.3  0.1  1.0 
HIV 
uninfected 
445  Low serum lipid score  -1.5  0.000  0.2  0.1  0.3 
    Low serum vitamin A  -0.8  0.000  0.4  0.2  0.7 
    Animal based dietary 
pattern 
-0.4  0.064  0.6  0.4  1.0 
    Smokers  -0.5  0.022  0.5  0.3  0.9 
    Rural dwellers  0.4  0.044  1.2  1.0  2.6 
Predictors of high serum lipid score 
HIV 
infected 
85  Low staple based 1 
dietary pattern 
1.0  0.035  2.8  1.1  7.6 
    Smokers)  -1.8  0.002  0.1  0.1  0.4 
    ≤ 40 years old  -1.5  0.008  0.2  0.1  0.6 
HIV 
uninfected 
445  Low serum protein 
score 
-0.6  0.007  0.5  0.3  0.8 
    ≤ 40 years old  -0.9  0.000  0.3  0.2  0.5 
    Low serum vitamin E  1.5  0.000  4.8  3.0  7.5 
    Male  -0.5  0.011  0.5  0.3  0.8 
    Rural dwellers  -0.9  0.000  0.3  0.2  0.6 
Predictors of high serum protein score 
HIV 
infected 
85  No variable remained           
HIV 
uninfected 
445  Low serum lipid score  -0.5  0.011  0.6  0.4  0.8 
    Low serum vitamin A  -0.5  0.008  0.5  0.4  0.8 
Predictors of high dietary overall nutrient score 
HIV 
infected 
97  Lower half animal based 
dietary pattern  
-2.2  0.001  0.1  0.0  0.4 
    Low carbohydrate, 
legumes and vegetables 
based 
-3.5  0.000  0.0  0.0  0.1 
HIV 
uninfected 
515  Low animal based 
dietary pattern  
-1.5  0.000  0.2  0.1  0.3 
    Low staple based 1 
dietary pattern 
-0.7  0.000  0.4  0.3  0.7 
    Low staple based 2 
dietary pattern 
-1.6  0.000  0.2  0.1  0.3 
    Smokers  0.7  0.001  2.1  1.4  3.4 
    Low education  -0.4  0.047  0.6  0.4  0.9 
    Low recommended  -1.3  0.000  0.2  0.2  0.4 280 
 
dietary pattern 
Predictors of high dietary pattern 1 
HIV 
infected 
97  Low recommended 
dietary pattern score 
-0.7  0.086  0.4  .193  1.1 
    ≤ 40 years old  1.1  0.033  3.1  1.1  9.1 
    Low income  -0.9  0.051  0.4  0.1  1.0 
HIV 
uninfected 
515  Low recommended 
dietary pattern score 
-0.7  0.001  0.5  0.3  0.7 
    Low income  -0.5  0.047  0.6  0.4  1.0 
    Low education  -0.6  0.003  0.5  0.4  0.8 
    Rural dwellers  0.1  0.000  2.5  1.7  3.9 
Predictors of high dietary pattern 2 
HIV 
infected 
97  Low staple based 1 
dietary pattern 
-1.2  0.008  0.3  0.1  0.7 
    Smokers  -1.6  0.017  0.2  0.0  0.7 
    Male  1.7  0.011  5.6  1.5  21.6 
    urbanstatus3(1)  0.9  0.051  2.5  1.0  6.7 
HIV 
uninfected 
515  Low staple based 1 
dietary pattern 
-0.7  0.000  0.5  0.3  0.6 
    Low staple based 2 
dietary pattern 
0.6  0.003  1.7  1.2  2.5 
    Low income  -0.4  0.049  0.7  0.4  1.0 
    Low animal based 
dietary pattern 
-0.7  0.000  0.5  0.3  0.7 
Predictors of high dietary pattern 3 
HIV 
infected 
97  Low income  0.9  0.059  2.6  0.9  7.5 
    Rural dwellers  -0.8  0.102  0.5  0.2  1.2 
    Low recommended 
dietary pattern score 
-1.4  0.004  0.3  0.1  0.6 
HIV 
uninfected 
515  Rural dwellers  -0.5  0.013  0.6  0.4  0.9 
    Low recommended 
dietary pattern score 
0.8  0.000  0.5  0.3  0.7 
    Males  0.4  0.023  1.5  1.1  2.2 
Predictors of high dietary pattern 4 
HIV 
infected 
97  Low income  -1.4  0.007  0.2  0.1  0.7 
HIV 
uninfected 
515  Males  0.5  0.006  1.6  1.1  2.4 
    ≤ 40 years old  0.8  0.000  2.2  1.5  3.3 
    Rural dwellers  0.5  0.014  1.6  1.1  2.5 
    Low recommended 
dietary pattern score 
0.7  0.000  1.9  1.3 
 
2.8 
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APPENDIX V: Post hoc power calculations for means which were not significantly 
different between HIV infected and uninfected  
Although several of the descriptive variables were not different between by HIV infection 
status, post hoc power calculation have been made for only variables which were among 
the response variables used in subsequent analysis in Chapter Five. Thus post hoc power 
calculation have been made for the dietary patterns, BMI, LBM, first principal component 
of nutrient pattern (nutrient score), serum ALP and GGT. Since the values compared were 
the means, the equation for power calculation used would be:  
  
z1-β   =  f
           n
                
-
   
Z1-α/2
  
       
      
2 
 
Appendix Vb: Derivation of values in the power calculation formula for variables 
  DP 1  DP2  DP3  DP 4 
Sample size  n 
 
128  128  128  128 
Mean for HIV infected 
 
-0.05  -0.09  0.09  0.09 
Mean for HIV uninfected 
 
0.007  0.01  -0.01  -0.01 
Difference between mean detected d*  0.057  0.1  -0.1  -0.1 
Standard deviation of overall men σ 
 
1.0  1.0  1.0  1.0 
f=d*/ σ 
 
0.057  0.01  -0.1  -0.1 
Conversion value for level of significance Z 1-α/2    1.96  1.96  1.96  1.96 
Z 1- β  -1.50  -1.88  -2.76  -2.76 
 
Power 1-β 
 
44.0  42.4  39.0  39.0 
DP1 to 4 refers to the first four dietary patterns generated by principal component analysis. 
Appendix Va: Derivation of values in the power calculation formula for variables 
  BMI  LBM  Anthropometric 
 score 
Serum ALP  Serum GGT 
Sample size  n 
 
214  119  118  209  209 
Mean for HIV infected 
 
23.79  58.68  0.06  80.49  44.04 
Mean for HIV uninfected 
 
24.53  57.76  -0.008  77.25  41.44 
Difference between mean detected d*  0.74  -1.12  -1.18  -3.24  -2.6 
Standard deviation of overall mean σ 
 
6.46  10.3  1.0  37.6  104.6 
f=d*/ σ 
 
0.11  -0.12  -1.18  0.09  -0.02 
Conversion value for level of 
significance Z 1-α/2   
1.96  1.96  1.96  1.96  1.96 
Conversion value for power Z 1- β  -0.82  -2.89  -11.02  -1.04  -2.16 
Power 1-β 
 
46.8  38.6  <50  46.0  41.2 282 
 
Conclusion 
The power calculated for the descriptive variables which were not different between HIV 
infected and uninfected differences were all less than 50%. This implies that the study was 
underpowered and thus the lack of statistical significance between these variables could 
be due to lack of adequate power and possibly fewer samples.  
 
Post hoc power calculations for hypotheses in Chapter Five 
Power calculation was done for the following hypotheses which could be derived from the 
main hypothesis, analysed in Chapter 5: 
 
Power calculation for association between the first two dietary patterns and BMI and 
LBM 
For animal based 
H1:  HIV  infected  population  who  followed  the  ‘animal  based’  dietary  pattern  would  be 
associated with higher BMI, than those who consumed the animal based dietary pattern. 
 
H0: There is no difference in associations between the animal based and ‘recommended’ 
dietary patterns and BMI 
The correlation between animal based dietary pattern and BMI d* = 0.2 
n = 125. The equation for power calculation was derived from:  
 
Z1-β=   d*
2 (n - 5)
        - zα/2 
                   
1-d*
2         
 
Z1-β=   0.2
2 (125 - 5)
        - 1.96 
                   
1-0.2
2         
 
Z1-β=   
        4.8                - 1.96 
                   
   0.96      
 
Z 1-β = 2.236-1.96 
 
Z 1-β = 0.28 283 
 
 
Using the normal distribution tables, Table B.2 (Zar, 1996), 0.2760 corresponds to  
β = 0.3897 
 
Therefore 1-β = 1-0.3897= 61% 
 
The power of the analysis is 60%, which gives a confidence that the study was under 
powered to observe a significant difference for the association between the animal based 
dietary pattern and BMI. To observe a statistical significance for the correlation observed 
with at least 80% power, the number of subjects required for the study could be worked as: 
n=
    
 (Z1-α/2  + Z1-β)
2      
+5 
              d*
2/(1-d*
2)         
n =
          7.8                 
+5 
           (0.04/0.96)  
n = 200 
 
Thus  the  sample size  (subjects with data)  required  to have enough power  to  reach  a 
statistical significance for a correlation of 0.2 is 200. The sample size used for this study 
was 125. It is therefore possible that the lack of statistical significance for the association 
between the animal. Since the correlation obtained for the association between LBM and 
animal based dietary pattern was 02, with sample size n = 125, just as for BMI, then the 
study power would be 60%. So the same conclusion could be drawn for LBM that the 
study was underpowered to find statistical significance for the association observed and  a 
larger sample (200) was needed to find a difference (that is to reject the null hypothesis).  
 
 
For the ‘recommended’ diet 
The association between the ‘recommended’ dietary pattern and BMI and lean body mass 
were both -1 and not statistically significant. Thus just as the animal based dietary patter, 
post hoc power calculation has been determined to show if the study was well powered. 
The correlation between ‘recommended’ dietary pattern and BMI d* = -0.1, n = 125 
 
Z 1-β = √ [-0.1
2 (125 - 5) / {1 – (-0.1)
2 }] – 1.96 
 Z 1-β = √ [0.01(120)/ (1-0.01)} – 1.96 284 
 
Z 1-β = √ (1.2/0.99) – 1.96 
 Z 1-β = 1.10 – 1.96 
Z 1-β = - 0.86 
                    
This corresponds to 19.5% on the normal distribution table. This implied that the study was 
underpowered to detect a significance of association between the ‘recommended dietary 
pattern and BMI for the available sample size and correlation coefficient observed. 
 
Calculation  of the  required  sample  to  detect  a statistical  significance  for  the observed 
correlation with 80% power was done from: 
n =
          7.8                 
+5 
           0.01/0.99 
n = 793       
 
The  sample size for this  analysis  was 125  but the  calculation  showed  that about 793 
subjects were needed to detect a significance difference for the correlation observed which 
could be concluded that if there were enough subjects we could be able to show that 
increasing  consumption  of  the  ‘recommended’  dietary  pattern  were  associated  with 
decreased BMI. The correlation observed between this dietary pattern and LBM was also -
0.1 just as for BMI, thus the above conclusion could be drawn for LBM as well.                                               
 
Conclusion 
The above analyses for the association between the first two dietary patterns and BMI and 
LBM have shown that the lack of statistical significance for the association between these 
dietary patterns and anthropometric indicators was due to inadequate power and larger 
samples  were  needed  to  detect  statistical  significance  for  the  correlation  coefficients 
observed. 
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Appendix VI 
Appendix VIa: Foods and food groups which predicted high animal based dietary 
pattern from binary regression analysis 
 
  Odds ratio  P value  95.0% C.I. for odds ratio 
         Lower  Upper 
Red meat  Lower third  1.0   0.000       
   Middle third  2.5  0.004  1.4  4.8 
   Upper third  15.6  0.000  7.7  31.4 
 Chicken  Lower third  1.0   0.000       
   Middle third  2.5  0.010  1.2  5.2 
   Upper third  8.1  0.000  3.8  17.2 
 Eggs  Lower third  1.0   0.009       
   Middle third  1.9  0.036  1.0  3.4 
   Upper third  2.7  0.002  1.4  5.1 
 Potato  Lower third  1.0   0.000       
   Middle third  1.2  0.549  0.6  2.4 
   Upper third  6.4  0.000  3.2  12.4 
 Maize meal  Lower third  1.0   0.000       
   Middle third  1.9  0.802  0.5  1.7 
   Upper third  0.3  0.000  0.1  0.5 
 Rice  Lower third  1.0   0.000       
   Middle third  1.6  0.120  0. 9  3.0 
   Upper third  5.9  0.000  3.0  11.3 
 cereal  Lower third  1.0   0.006       
   Middle third  1.0  0.893  0.5  1.8 
   Upper third  2.3  0.012  1.2  4.7 
 Fat  Lower third  1.0   0.000       
   Middle third  1.8  0.057  0.9  3.1 
   Upper third  31.9  0.000  15.7  65.1 
   Constant  .004  0.000       
Odds ratios, statistical significance, and 95% confidence intervals for foods that predicted the animal based dietary pattern 
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Appendix VIb: Foods and food groups which predicted high ‘healthy’ dietary pattern 
from binary regression analysis 
 
  Odds ratio  P value  95.0% C.I. for odds ratio 
         Lower  Upper 
Chicken  Lower third  1.0   0.000       
   Middle third  2.4  0.002  1.4  4.1 
   Upper third  5.1  0.000  2.7  9.4 
 Legumes  Lower third  1.0   0.000       
   Middle third  1.2  0.559  0.7  2.1 
   Upper third  3.0  0.001  1.6  5.6 
 Potato  Lower third  1.0   0.000       
   Middle third  1.9  0.013  1.1  3.2 
   Upper third  7.8  0.000  4.3  13.9 
 Maize meal  Lower third  1.0   0.000       
   Middle third  0.5  0.022  0.3  0.9 
   Upper third  0.1  0.000  0.1  0.2 
 Rice  Lower third   1.0  0.000       
   Middle third  2.1  0.004  1.3  3.6 
   Upper third  6.8  0.000  3.8  12.3 
 Sugar  Lower third  1.0   0.001  1.0     
   Middle third  1.0  0.917  0.6  1.7 
   Upper third  2.5  0.002  1.4  4.5 
 Bread  Lower third  1.0   0.000  1.0     
   Middle third  2.1  0.009  1.2  3.6 
   Upper third  10.5  0.000  5.8  19.0 
 Cereal  Lower third  1.0   0.000  1.0     
   Middle third  2.0  0.014  1.1  3.4 
   Upper third  6.5  0.000  3.7  11.4 
 Fat  Lower third  1.0  0.000       
   Middle third  0.4  0.000  0.2  0.6 
   Upper third  0.0  0.000  0.0  0.0 
   Constant  .048  0.000       
Odds ratios, statistical significance, and 95% confidence intervals for foods that predicted the animal based dietary pattern 
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Appendix VII: Summary of design, interventions and main findings for studies involving micronutrients obtained from the 
systematic review 
 
Authors  Study Design  Sample 
Size 
Stage of 
HIV 
Country  ART   Intervention/Exposures  Findings 
 
Experimental Studies 
Shabert  et al., 
1999  
A randomised 
double blind 
controlled trial 
21  AIDS 
patients 
USA,     Treatment group received 
glutamine 40g/d along with 
antioxidant (ascorbic acid, beta 
carotene, tocopherol, selenium, 
n acetyl cysteine)  
Body weight increased by 2.2 kg over 3 months (3.2%) 
in treatment group and 0.3 kg in controls (p=.04). 
 
treatment group gain  BCM in 1.8kg over 3 months and 
.4kg in controls (p=.007) 
 
Kelly et al., 1999  Randomised 
placebo controlled 
trial 
141, 106 
completed 
Subjects 
had 
persistent 
diarrhoea 
Zambia,     Patients randomly allocated to 
albendazole plus placebo or 
micronutrient supplement 
(vitamin A 10500u, vitamin C 
300mg, E 300mg, selenium 150 
mg,  zinc 200mg)  for 14 days, 
Diarrhoea incidences was not statistically different at 4 
(p=0.4) or 12 week (p=0.97).  
Mortality rate did not differ (RR 1.06, P=0.87) between 
treatment and control groups. 
 
Serum vitamin  A increased slightly in treatment group 
but differences not statistically different from the 
placebo group (p=.52) 
 
CD4+ cell count did not change 
Jiamton et al., 
2003 
Randomised 
placebo controlled 
trial 
481  Different 
stages 
Thailand,   No  Multiple micronutrients 
comprising both vitamins and 
minerals  
Mortality rate was significantly lower in supplemented 
group whose CD4 levels were either <200 or <100 
x10
6/l. 
 
No sig diff for CD4 count greater than 200 
Impact of CD4 count on plasma viral overload did not 
differ  
Shor-Posner et 
al., 2003 
Randomised double 
blind placebo 
controlled study 
115   Different 
stages 
USA 
 
  Selenium 200ug/day or placebo 
of the same colour 
Results showed that vitamin A level of treatment group  
remained stable during follow-up visits whereas that of 
the placebo reduced 
 
there was no difference in CD4 count between 
treatment and placebo groups at baseline (p=.10) 
second (p=.76) or 3
rd visits (p=.17) 288 
 
Semba et al., 
1998 
Randomised double 
masked placebo 
controlled trial 
120    USA  Yes  Vitamin A  Selenium status rose after 12 months in treatment 
group compared to placebos (p=0.002). 
No significant change recorded in CD4 cell count 
between the two groups 
Viral load remained similar after supplementation. 
 
Austin  et al., 
2006 
Prospective RCT 
double-blinded and 
multi centre 
(331 adults) 
165 T , 166 
C 
Advanced  
AIDS 
England,     Treatment group also received 
1200000 IU (72mg) beta-
carotene in the form of natural 
mixed carotenoids.  Everybody 
received Vitamin A and trace 
elements  
Subjects were followed-up for 13 months. 
Subjects with higher baseline serum carotene 
concentrations (p<0.04) and higher CD4 cell count 
(p=0.005) had higher survival.  
Adjusted mortality increased significantly in those who 
did not receive carotenoids treatment compared with 
those who did (HR time to death 3.15 95% CI 1.10-
8.98, P=0.03) 
Fawzi et al., 2007  Intervention, double-
blinded placebo CT 
1078     Tanzania,   No  Vitamin A and beta-carotene, 
multivitamins B C and E 
supplementation, iron as part of 
antenatal care 
Mean age and gestational age of enrolled women were 
4.7±4.8 y and 20.3±3.4 wk and treatment groups did 
not differ from placebo on baseline characteristics. 
 
Women who received multivitamins had higher 
haemoglobin (0.33g/dl higher) through out the study 
(P=0.07) compared with the other 3 groups. 
Fawzi et al., 2004  Intervention, double-
blinded placebo CT 
1078     Tanzania,     Daily supplements of vitamin A, 
multivitamins  or both 
67 of 271 women receiving supplements progressed to 
AIDS and died. 83 of placebo progressed and died 
from AIDS (p=0.04) 
Relative risk of death reduced significantly in women 
receiving supplements (0.73 95% CI 0.72-0.9, P=0.02). 
Also progression to WHO stage 4 AIDS was reduced. 
Multivitamins also resulted in higher CD4+ and CD8+ 
and lower viral load 
Coodley et al., 
1993 
A double blind 
placebo controlled 
trial 
21    USA    180mg of beta-carotene a day or 
placebo 
Beta-carotene use was associated with a 
statistically significant increase in 
total WBC count ( p = 0.01), percent change in 
CD4 count (p = 0.02) and percent 
change in CD4KD8 ratio ( p = 0.01) compared to 
placebo 
Coodley et al., 
1996 
Prospective double 
blind study 
72    USA    60 mg beta-carotene orally three 
times daily or a matched 
placebo 
Except for serum beta-carotene concentration, there 
were no statistically significant differences (P < 0.05) 
between the treatment (60 mg beta-carotene three 289 
 
times daily and multivitamins) and placebo (placebo 
and multivitamins) groups at baseline or after either 1 
or 3 months of treatment. 
Observational studies (Longitudinal and Cross-Sectional) 
 
Baum et al., 2003  Observational, 
prospective 
118    USA  Few  Assessment of zinc intake and 
plasma zinc levels 
Zinc deficiency was prevalent in the population (about 
56% had plasma levels ≤75 g/mL). Subjects with 
higher dietary zinc intake had significantly higher 
plasma zinc status (p<0.0001) 
 
Plasma zinc were positively associated with CD4 cell 
count (β=0.679, P=0.005) and total lymphocyte count 
(β=0.351, P=0.011). 
 
Zinc deficiency was significantly associated with 
advance HIV-1 disease, i.e. CDE cell count <200 
cells/mm3 (OR, 1.72; P=0.027). 
The risk of dying from HIV-1 related disease decreased 
by 33% for every 1mg/day increase of dietary zinc 
intake. 
Baum and Shor-
Posner, 1997 
Observational, 
longitudinal 
125 HIV 1 
men and 
women 
  USA    Biochemical assessment of 
immune and nutritional 
parameters 
 
 
The following nutrient deficiencies were shown to be 
associated with HIV-1 related mortality independent of 
CD4 cell count <200/mm
3 at base line: 
Prealbumin (RR =4.01, P<0.009) 
Vitamin A (RR =3.23, P<0.03) 
Vitamin B12 (RR =8.33 P<0.009) 
Zinc (RR =2.29, p<0.04) 
Selenium (RR =19.9, P<0.0001). 
When all factors that could affect survival were 
considered jointly, only CD4 cell count over time (RR 
=0.69, P<0.04) and selenium deficiency (RR =10.08, 
P<0.002) were significantly associated with mortality. 
Baum and Shor-
Posner, 1995 
Observational, 
Longitudinal study, 
    USA    Biochemical assessment of 
plasma levels of nutrients and 
CD4 cell counts 
Development of deficiency of vitamin A or vitamin B12 
was associated with a decline in CD4 cell count 
(p=0.025 and p=0.037 respectively). 
Normalising vitamin A, B12 and zinc was associated 
with higher CD4 cell counts (p=0.0492, 0.0061 and 
0.0112, respectively) irrespective of zidovudine use. 
Low baseline vitamin B12 significantly predicted 
accelerated HIV-1 disease progression determined by 
CD4 cell count (p=0.041) and AIDS index (p=0.005)  
Baum and Shor-
Posner, 1997 
Observational  125   AIDS 
patients 
USA    Immune and nutritional 
measurements were obtained 
Nutritional deficiencies were widespread with up to 
86% of the drug users exhibiting at least one nutritional 
alteration. 290 
 
Immune parameters were similar between HIV-1 
infected men and women but women were of 
significantly poorer overall nutritional status measured 
by plasma proteins which are considered to be 
sensitive markers of malnutrition. 
In individuals with advanced disease (CD4 <200 
cells/mm3) plasma levels were lower in women than in 
men for prealbumin (p<0.01), selenium (p<0.05), and 
greater deficiencies of vitamin A (p<0.01) and E 
(p<.05) existed in the women 
Beach and 
Mantero-Atienza, 
19092 
Longitudinal,   100   Asymptomat
ic 
USA    Assessment of biochemical 
nutrient levels, dietary history, 
anthropometrics and clinical 
examination of signs of 
nutritional deficiency 
Prevalence of specific nutrient abnormalities was 
widespread among HIV-1 infected subjects. 
Overtly or marginally low blood levels of vitamins A, E, 
riboflavin, B6, and B12 together with copper and zinc 
were documented in the HIV infected population 
De Luis et al., 
2002 
Observational, cross 
sectional 
119    Spain    Assessment of anthropometric 
and biochemical parameters of 
nutritional status 
 
Kruzich et a., 
2004l 
Cross-sectional  264 HIV+ 
and 127 
HIV- 
  USA, 2004  Half  Dietary data collected by block 
FFQ, biochemical data available 
Lowered intake of iron was significantly associated with 
HIV infected participants who had CD4 cell count ≥500 
cells/ l (p<0.05) compared with those whose CD4 were 
between 200 to 499 cell/ l.   
Kupka et al., 2007  Observational 
Longitudinal 
584     Tanzania, 
2007 
No  Evaluation of Hb, serum ferritin, 
CRP and transferring receptor 
Anaemia prevalence was 48.3%.  Prevalence 
estimates for low SF and elevated sTfR were 5 and 
4.3% respectively. Prevalence of ID and IDA were 39.7 
and 23.6%. 
 
SF>150.0 g/l compared with <1.0  g/l was marginally 
associated with progression to stage 4 (p=0.08) and 
associated with composite end point AIDS-related 
death or progression to stage 4 (p=0.01) 
Kupka et al., 2004  Micronutrient, 
prospectively 
observational 
949  Different 
stages 
Tanzania, 
004 
No  Examine the association 
between plasma selenium levels 
and survival and CD4 cell count 
306 out of 949 died over 5-7 year follow-up time. 
Lower plasma selenium levels were associated with an 
increased risk of mortality (p=0.01).  
Plasma selenium level was weakly positively 
associated with CD4 count but not associated with time 
to progression. 
 
Stambullian et al., 
2007 
Observational, cross 
sectional 
43   Both HIV 
and AIDS 
groups 
2007  35 
subjects 
Assessment of plasma zinc, 
copper and selenium levels 
No differences were observed in between HIV and 
AIDS subjects in BMI, serum total protein 
concentration, albumin, transthyretin RBP. 
No significant differences were observed for serum 
mineral status such as Zinc and Selenium 
About 70% of subjects had plasma Se concentrations 
below 60 g/l 
Stephensen et al.,  Cross sectional  365     2007  Some  Assessment of plasma selenium  Selenium status was adequate in both HIV positive and 291 
 
2007  , whole blood glutathione and 
GPX, immune activation and 
oxidative damage 
negative subjects. 
 
GPX activity was significantly higher in HIV positive 
than negative subjects. GPX was not associated with 
CD4 cell count. The use of ART was increased even 
further the activity of GPX. 
 
Providing selenium supplements increased GPX 
activity but this increase diminished in subjects with 
initial low serum selenium concentrations 
Tang et al., 1993  Observational, 
longitudinal 
281   AIDS and 
none AIDS 
USA  Yes  Assessment of dietary intake by 
semi quantitative FFQ 
High levels of vitamin C, B1 and niacin were 
associated with significantly decreased disease 
progression (RH are 0.55 for vitamin C, 0.52 for niacin 
and 0.6 for vitamin B1). 
 
Relationship between vitamin A intake and disease 
progression was u-shaped. Very low and very high 
intakes enhanced disease progression (RH 0.55 95% 
CI 1.16-3.64). 
 
Different levels of zinc intake were all associated with 
increased risk of disease progression 
Tang et al., 1996  Observational 
longitudinal 
281   Different 
stages 
USA, 1996    Assessment of dietary intake   The  highest intake  of vitamins B1, B2, B6  and  niacin 
were independently associated with increased survival. 
Intakes of more than twice the RDA for B6 (0.6 95% CI 
0.39-0.93) was associated with improved survival, and 
intakes of more than 5 times of RDA for B1 (0.61 95% 
CI 0.38-0.98) and B2 (RH 0.6 95% CI 0.37-0.97) were 
both associated with improved survival.  
 
Any  intake  of  zinc  supplements  was  associated  with 
poorer survival (RH 1.49, 95% CI 1.02-2.18) 
van Staden et al., 
1998 
Observational, cross 
sectional 
90   Different 
stages 
South 
Africa, 
1998 
  Assessment of nutrient intake 
and serum micronutrient and 
macronutrients 
Abnormal values for several parameters, including 
plasma-retinol and serum-protein were found, but no 
correlation between more advanced disease and 
micronutrient deficiencies could be demonstrated 
van Lettow et al., 
2004 
Cross sectional 
study 
601   Not 
mentioned 
Malawi, 
2004 
No  Assessment of anthropometrics, 
plasma HIV load, and 
micronutrients 
Majority of the subjects (59%) were wasted (BMI<18.5 
kg/m
2) and 17% were severely wasted (BMI<16 kg/m
2). 
 
BMI (p<0.0001), plasma retinol (p<0.001), carotenoids 
(p<0.0001) and selenium (p<0.0001) concentrations 
significantly decreased with increased plasma HIV 
load. The odds ratio for independent association 
between wasting and vitamin A deficiency was 
2.86(95% CI 2.11-3.89) and that for selenium 
deficiency was 1.59 (95% CI 1.04-2.43) 292 
 
Bodgen et al., 
2000 
Cross sectional 
study 
135  Different 
stages 
USA, 2000    A questionnaire to assess 
nutritional and health status  
HIV infected males and females had similar BMI and 
BMI did not differ with HIV infection status or stage 
(p>0.05). Five of the 8 biochemical variables studied 
differed significantly with stage of infection 
 
Statistically significant univariate associations were 
found between CD4 cell count and haematocrit, 
plasma magnesium and, zinc concentrations. 
Haematocrit, plasma free choline and, zinc were joint 
independent predictors of  CD4 cell count in a multiple 
regression analysis 
Woods et al., 
2003 
Observational 
prospective 
412   Different 
stages but 
AIDS 
patients 
were 
excluded 
USA, 2003  Yes  Dietary intake, blood was 
collected and stored for 
immunological. Biochemical and 
nutritional testing 
Serum values for vitamin B12 was significantly higher 
in supplement users than non-supplement users 
(p=0.0001). 
However, during intervals with PI use increase in 
vitamin B12 intake was associated with lower increase 
in serum B12 compared with periods of non PI use. 
 
Campa and Shor-
Posner, 1999 
observational, 
longitudinal 
24  symptomatic  USA, 1999    Assessment of CD4 cell count 
and serum albumin and plasma 
trace elements such as iron, 
zinc, selenium,  
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Appendix VIII: Summary of design, interventions and main findings for studies involving enteral/parenteral nutritional 
supplementation obtained from the systematic review 
Authors  Study Design  Sample 
Size 
Stage of 
infection 
 
Country  ART   Form of Intervention  Main findings 
Singer et al, 1994  Prospective 
randomized, 
controlled study 
59  AIDS 
patients 
USA  Not 
mentione
d 
910 kcal of parenteral 
supplementation including 
20% lipid emulsion (group 1) 
or a new 2% lipid emulsion 
with a high 
phospholipids/triglyceride ratio 
(1:1.7) 
Weight increased was not significant (from 61.3±2.1 in 
group 1 and 59.7±2.4kg in gp2).  
CD4 cells expressed in absolute numbers were very 
low in the two groups, showing the severity of the 
infections, CD3 cells increased in absolute numbers in 
group 2 and reduced in group 1 
Singer et al 
(Parenteral lipids) 
Age matched 
controlled trial 
8  AID patients  USA,   Not 
mentione
d 
 
Home parenteral nutrition 
period for 2 months 
•  CD4 cell count reduced markedly and CD8 
increased but not statistically significant. 
•  Weight gain of 11lb, ±4.2lb SD over two months 
 
Singer et al., 1997  Randomized 
controlled trial 
50  AIDS 
patients 
USA    Comparing two a standard 
parenteral formula to a 
phospholipid enriched formula 
All patients gained weight and improved their activity 
levels. 
Those receiving the high phospholipids composition 
showed increased serum cholesterol concentrations 
(p<0.01) but no increase was seen in the number of 
CD4 cells or improvement in immune function 
Melchior et al., 
1996  
Prospective 
randomised 
controlled 
multicentre  trial 
 
31 (15 
controls and 
16 study 
group). 
 
AIDS 
patients 
France  Not 
mentione
d 
Home TPN for two months or 
counselling 
Body weight increased by 8kg in study group and 
reduced by 3kg in control group (P<0.0006). Lean 
body mass increased by 9kg in supplemented group 
and reduced by 5 kg in controls (p<0.004). 
However no difference in survival rate was recorded 
between the two groups 
Bouletreau et al., 
1995 
Retrospective 
study 
25  AIDS 
patients 
France  No  All in one nutritional formula 
which provided electrolytes, 
vitamins and trace elements 
with a mean energy intake of 
2150 kcal for 180 days 
19 patients died during PN, 4 showed a temporary 
stabilization and 3 others were still under parenteral 
support.  
There were frequent episodes of hospitalization for the 
whole group 
21 patients gained weight and 4 either maintained a 
stable weight or lost weight. The mean weight gain 
was 7 kg (1-17 kg) 
Craig et al., 1997  Double blind 
randomised 
balance study 
(control group 
included) 
24    USA    Intervention group received 
MCT enriched or control group 
LCT formula 
24 completed the study 
no significant changes and differences within or 
between groups were observed for body weight 
Chlebowski et al., 
1993 
Prospective 
randomised trial 
80  Patients 
were largely 
asymptomati
USA   
Yes 
New enteral formula versus 
Standard formula 
 
56 out of 80 evaluable for all secondary end points. 
Patients with New enteral formula (NEF) maintained 294 
 
c  (about 
60% of 
subjects) 
weight than those with the standard enteral formula 
(SEF). NEF group gained 1.8 kg and SEF gained 0.7 
kg (P<.04). 
NEF group had significantly more stable triceps skin-
fold (p=0.03) and reduced hospitalizations (p=0.02) 
compared to the SEF group 
Ireton-Jones et 
al., 1998 
Controlled trials 
but not 
randomised 
22  Not 
mentioned 
USA   Not 
mentione
d 
HTPN for 73 days and controls 
received oral diet for 155 days, 
both received counselling 
HTPN group gained 5.5kg BW and 3kg LBM and 
controls loss 5kg BW and 3kg LBM, but differences not 
statistically significant. 
 
Progression to AIDS diagnosis reduced slightly in 
intervention group 
 
HTPN groups received 52% and more calories and 
twice as much protein than the non-HTPN group 
 
Kotler et al., 1991  Prospective study  8   AIDS 
patients 
 USA  Not 
mentione
d 
Nutritional support 
administered through a 
percutaneously placed 
endoscopically directed 
gastrosnomy tube 
 
Enteral feeding associated with 3kg weight gain 
(p>0.05). 
Feeding was shown to be associated with an increase 
in TBK, an index of body cell mass,  
Serum immunoglobulin concentrations did not change 
after feeding. 
Increased in total lymphocytes in peripheral blood 
(p<.0001) 
CD4 cell count did not change. 
 
Kotler et al., 1990  Prospective 
longitudinal study 
12  AIDS 
patients 
 USA  Not 
mentione
d 
TPN received at home  Average increased in weight of 3kg. Body fat also 
increased. Body cell mass estimated as total body 
potassium content was unchanged. However subjects 
who with altered intake or absorption had significant 
repletion of body cell mass compared to those with 
systemic infections 
De Luis et al.,  
2001 
Randomized trial  74   AIDS 
patients 
Spain  Yes 
 
Enteral formula against 
enterotropic peptide based 
enteral formula with n-3 fatty 
acids 
Supplementation led to sustained increased in body 
weight of 3.2% in group 1and 3.1% in group 2 (p<.05). 
BMI, fat mass and tricipital skinfold were all 
significantly increased in both groups (p<0.05). 
Fat free mass, MUAC and total body water changes 
were not statistically significant. 
CD4 was stable in group one but in group 2 (enriched 
supplement group) significant increase occurred 
(p<.05) at 3 months. 
Hospitalisations were fewer in group 2 than group 
1(p>0.05) 
Salomon et al., 
1999 
prospective 
intervention, not 
randomised nor 
23, were 
recruited by 
11 
  USA  Not 
mentione
d 
Full enteral feeding of a 
nutritionally complete oral, 
elemental diet containing 
Out of the 11 participants, 6 gained weight 
 
Slight increase in energy intake occurred that is from 295 
 
controlled  completed 
the study  
hydrolysed whey protein and 
medium chain triglycerides 
2107kcal to 109kcal. Mean fat intake increased from 
78g/day to 8g/day 
 
Significant reduction in number of stools per day 
(p<0.01) and faecal fat concentration (p<0.003) 
resulted. 
Hoh et al., 1998  Randomised 
double-blind trial 
49 subjects 
but 39 
completed 
AIDS 
patients with 
weight loss 
USA  No   Subjects received either a 
whole-protein-based or a 
peptide-based formula and 
were followed for 6 weeks 
No changes were observed between the two 
supplemental groups for any outcome measure. 
 
Protein and energy intakes were significantly increase 
in both supplemental groups and higher than that for 
the controls. 
 
Body weight and fat free mass were not changed 
significantly in either group. 
Grovenor et al  Prospective trial  80  Largely 
asymptomati
c 
    Participants received 2-3 8 oz 
cans of either the NEF or SEF 
supplement 
Patients with New enteral formula (NEF) maintained 
weight than those with the standard enteral formula 
(SEF) (P<.04). 
NEF group had significantly more stable triceps skin-
fold (p=0.03), lower blood urea nitrogen (p=0.04) and 
reduced hospitalizations (p=0.02) compared to the 
SEF group 
Brantsma et al., 
1991 
Prospective trial  14  AIDS 
patients 
    Percutaneous Endoscopic 
Gastrostomy (PEG) feeding 
was used in the management 
of malnutrition AIDS patients 
 
Cappell and 
Godil, 2003  
A multicenter 
case-controlled 
study 
14  AIDS 
patients 
  No  Risk of PEG feeding analysed 
in these patients 
Mean weight of the HIV patients increased by 7.4%, 3-
8 weeks after PEG. 
Serum biochemical nutritional parameters remained 
stable after PEG despite advanced HIV infection 
Crotty et al., 1998  Retrospective data 
analysis 
71  AIDS 
patients 
Australia 
 
  PEG feeding was offered to all 
HIV/AIDS patients attending 
the clinic for a median of 161 
days 
Fifty one (72%) patients gained 5.8 ±4.4 kg. Nine 
gained 10 kg or more. 
Weight gainers had longer median survival but this 
difference was not significant (p=0.07). 
The only predictor of weight gain was a CD4 count 
>100/ l 
Ockenga and 
Suttman et al, 
1996 
  47  AIDS 
patients 
Germany    PEG feeding  PEG feeding was safe. 
Significant increase of body weight (3.3 kg, p<0.001), 
serum albumin (4.5 g/l, p<0.005) and TIBC (9.5 
mmol/l, p<0.001) 
Suttman et al. 
1993 
Prospective 
intervention 
14  AIDS 
patients 
Germany    Home parenteral nutrition  Enteral formula resulted in significant increase in body 
weight (p<0.005), body cell mass (p<0.05), total body 
fat (p<0.005), serum albumin (p<0.05), and serum 
TIBC (p<0.01). 
Edwards et al. 
1997 
Case control study  80  AIDS 
patients 
USA    Medical record  TPN group gained significantly higher weight 2.2kg 
compared with an average loss of 1.4 kg in the control 296 
 
 
 
 
 
 
 
 
 
 
 
 
 
group (p<0.05). Quality of life indicators and length of 
stay in the facility was similar between supplemented 
group and controls 
Guriano et al., 
2002 
Observational, 
questionnaire 
62,   Full blown 
AIDS 
    TPN and enteral nutrition (46 
for TPN, 16 for enteral 
nutrition) 
Significant increase in CD4 cell count, xylose levels 
and body weight were observed following EN. Similar 
pattern was observed after TPN, 27 and 3 children 
who received TPN and EN respectively died eventually 
Henderson et al., 
1994 
Prospective, 
intervention 
18 children        Tube feeding  Tube feeding increased weight significantly (p=0.04), 
weight for height (p=0.004), arm fat area (p=0.01) 
Miller et al., 1995  Observational  
longitudinal 
23 children  Full blown 
AIDS  
    Enteral supplementation  Weight and weight for height z-scores and calorie 
intake increased. No improvements in CD4, AMC, TSF 
and hospital days. Weight increased was associated 
with lower (2.8 fold reduction, p=0.005) risk of dying in 
children 297 
 
Appendix IX: Summary of design, interventions and main findings for studies involving oral macronutrients supplement or 
formula obtained from the systematic review 
AUTHORS  STUDY 
DESIGN 
SAMPLE size  Stage of 
infection 
Country  Intervention/Exposures  ART  Main findings 
Fogaca et 
al., 2000 
Cohort studies  1  12 patients with 
AIDS defined by 
CDC*3 were (8 
male 4 female) 
AIDS patients  Brazil  A peptide-based formula containing 
omega 3 fatty acids for 6 ,wks, daily 
intake include 909kcal, 42.66g protein, 
16.2g fat, 153.4 g carbohydrate, 1.29 o-3,   
Yes 
 
 
No incidences of opportunistic infections 
during the study period.  
 
Weight gain was 0.9kg mean and was not 
significant (p>0.05),  
 
Peripheral blood T-lymphocytes count and 
serum albumin and transferring didn’t change 
much and not significant 
Schwenk et 
al., 1999 
Randomised 
non blinded 
controlled trial 
50 completed the 
study 
Not mentioned  Germany  Nutritional counselling for both groups, 
intervention group received list of 
household measures to increase their 
food intake whiles group 2 received 
fortified oral supplement. 
Yes 
 
Total energy intake increased in both the 
counselling only group (p=0.006) and the 
counselling and supplement group (p<0.0004) 
compared to baseline. 
 
The two groups did not differ in main outcome, 
that is, BCM. 
 
Body weight, fat free mass, or body fat not 
differ between groups but increased significant 
in each groups 
Charlin et 
al., 2002 
Prospective 
randomised 
cross over 
study 
46 started 
35 completed, 11 
died from 
opportunistic 
infections 
Different 
stages 
Chile  Patients given two types of dietary 
supplements consisting of a regular food 
or polymeric diet.  
Yes 
(some of 
the 
subjects) 
35 completed the study. 11 died from 
opportunistic infections. There was no immune 
or nutritional difference between survivors and 
those who died. 
 
Weight and FFM (4.8/2.6 and 6.8/3.1 kg in the 
PD and PD with zidovudine subgroup 
respectively), energy balance and nitrogen 
balance increased significantly after Polymeric 
diet.  
 
Winkler et 
al., 2004 
Randomised 
prospective 
pilot 
intervention 
study 
23 positive served 
as treatment group 
and 18 HIV 
negative served as 
controls 
From 
asymptomatic 
to AIDS 
subjects 
Germany  Either 1 litre of a fruit juice or 30 ml of a 
fruit vegetable concentrate. Subjects 
chose from five sort of commercially 
available juices, and they were allowed to 
combine these juices 
Yes, 
80% of 
subjects 
Supplementation with fruit juices increased 
lymphocyte proliferation in both HIV+ (p0.004) 
and HIV- controls (p=0.016). Apoptosis did not 
increase in HIV+ but did increase in the HIV- 
controls 
 
Ingestion of concentrate did not alter 
proliferation and apoptosis in both HIV+ and 
HIV- subjects. 298 
 
Pichard et 
al., 1997 
A randomised 
double blind 
controlled 
study 
64    Switzerland  An oral supp enriched with vitamins, 
trace elements and minerals given as two 
daily servings either enriched with 7.4g 
arginine and 1.7 g or omega FA or not 
enriched. 
  Protein and energy intake increased by 20% 
with oral supplementation 
 
patients in standard and arginine 
supplemented groups gained 1.9 and 2.2 kg 
respectively compared 0.5kg loss in control 
groups, weight gain was statistically significant 
 
There was no significant difference in 
lymphocytes CD4 and CD8 cells between the 
groups 
Changes in quality of life not significant 
 
Arendt et 
al., 2001 
Randomised 
clinical trial 
41 (23 infected and 
18 HIV uninfected) 
  Germany  Either 11 of fruit juice or 30 ml of a fruit 
vegetable concentration for 16 weeks in 
addition to usual western diet 
  Plasma antioxidant capacity at baseline not 
different between groups. 
 
 
Gibert et 
al., 1999 
A three arm 
randomised 
controlled trial 
684  AIDS patients  USA  One group received calorie supp drink 
containing peptides and multivitamins 
plus multivitamin and nine supp 
Second group received calorie supp 
containing whole protein plus supp 
3
rd containing con only supplements 
Yes 
 
Mean weight changes were not statistically 
significant (p=0.74) 
 
Mean BCM change were also not significant 
(p=0.63) 
Pulse and 
Uhlig., 1990 
Prospective 
intervention 
31(29 completed)  Not mentioned  USA  Patients took nutritional  supplement: 
essential fatty acid capsules, aloe Vera 
juice and a scoop of nut supplementation 
powder and continue with normal diets 
15 (51 
%) 
subjects 
had 
AIDS 
29 patients improved on Karnofsky quality of 
life assessment at 90 days, two remained the 
same. All improved at 180 days. 
 
AIDS diagnosis determined by a modified 
Walter Reed Clinical evaluation was reduced 
significantly at 90 days (p<0.0001) and at 180 
days (p<0.0001). 
Bell et al., 
1996 
Randomised 
prospective 
double blind 
study  
19 completed, 2 
dropped out,  
Different 
states based 
on CD4+ 
levels 
USA  Patients were given wrapped bars 
labelled with numbers corresponding to 
Fish Oil or safflower oil (SO) 
No  19 completed study, 2 dropped out. There was 
significant increase in IL-6 (p=0.01) in the FO 
group compared with the SO group. 
 
 
CD4 cell count levels were not significantly 
changed in either groups 
Swanson et 
al.,  2000 
 
Randomised 
double-blind 
placebo 
controlled pilot 
study 
11  Not 
mentioned, 
they were all 
clinically 
stable though 
USA  Participants were randomly assigned to 
consume 19.6 g or arginine in capsule 
form or an equivalent number of placebo 
capsules.  
Yes 
 
Groups did not differ in age, sex, plasma HIV 
RNA cells, NK cell toxicity but differed in CD4+ 
cell count 
 
Mean plasma HIV RNA increased by 122 
copies in supplemented group and decreased 
by 34copies/ml in placebo (p=0.54). Mean NK 
cell  cytotoxicity was increase in the 299 
 
supplemental group but this was not significant 
(p=0.79) 
 
 
Berneis et 
al.,  
 
RCT 
treatment and 
control group 
 
18 but 15 did study 
 
Different 
stages 
 
Switzerland 
 
Liquid and palatably 2510 KJ/day 26g of 
whey protein, 88g carbohydrate, 17g fat 
as corn oil, electrolytes and daily regimen 
of trace elements and vitamins.  
 
Yes 
 
Body weight did not change significantly. An 
average gain of 1.3kg in supplemented group 
and 0.5kg loss in control group. 
Lean body mass expressed as percentage of 
body weight assessed by BIA increased in the 
supplemented group from 83.5±1.8 to 
86.2±1.7 (p<0.05) but did not change in the 
control group. Fat mass also decreased in the 
intervention group significantly from 16.5±1.78 
to 13.8±1.7 . 
CD4 cell count and other biochemical markers 
unchanged. Quality life did not change 
Clark et al., 
2000 
Randomised 
double blind 
placebo 
controlled 
study 
68 sub, 54 male 14 
female 
Different 
stages (all had 
≥5% weight 
loss in 
previous 3 
months) 
USA  Subjects consumed a placebo treatment 
containing maltodextrin or an amino acid 
mixture treatment (HMB, Arginine, 
Glutamine) 14:14:3 daily mixed in a fruit 
juice. Citric acid added to achieve final 
PH of 4.5.  
  Trends of higher protein, haemoglobin, 
triglyceride in amino acid group.  
 
Body weight increased by 3.0 kg in the 
supplemented group against 0.37kg gain in 
the placebos (p=0.009) and this was mostly 
lean body mass. 
Lean body mass also increased by 2.6kg in 
supplemented group compared with the 
placebo group which lost 0.7 kg (p=.003). 
viral load reduced significantly (p=.007), and 
increase in total circulating lymphocytes 
 
Stechmiller 
et al., 2001 
Experimental 
double blinded 
trial 
19 HIV patients  Subjects had 
> 200 
cells/mm
3 for 
CD4 count 
implying that 
none of the 
subjects had 
AIDS by CDC 
classification 
USA  Patients randomised to consume 20g 
10g or 0g of arginine per day for four 
weeks 
Yes   No significant changes in CD4, or viral load. 
 
Increase in BCM (1% and 0.5% from baseline 
to 4 weeks for subjects) in subjects receiving 
protease inhibitors and other antiretroviral 
drugs respectively though the increase was 
not statistically significant. 
 
No significant changes in weight, height and 
BMI. 
Rathmache
r et al., 
2004 
Randomised 
controlled trial 
68  Subjects had 
AIDS 
associated 
weight loss 
USA  A placebo or a mixture of 3g,14g,14g of 
HMB, arginine and glutamine 
respectively per day 
  Supplemented group gained a net of 3.25kg 
(p=.003) lean body mass 
 
Red blood cell and Hb increased by 3.2% and 
1.5% in supplemented group and controls 
respectively 
Micke et al., 
2001 
Prospective 
double blind 
30  All subjects 
had CD4 
Germany  Patient divided into two groups to receive 
45g of whey protein per day of 2 different 
Majority 
(90%) 
Plasma GSH levels increased in the 
Protectamin group by 44±56% (p=0.004) 300 
 
 
 
clinical trial  count <300 
cells/mm
3 
formulae, i.e. Protectamin or Immunocal  were on 
ART 
whereas the increase in the Immunocal group 
did not reach significance (p=0.43). 
CD4 count and CD4/CD8 ratio were 
unchanged during the study 
 
Concentrations of immunoglobulins A, E, G M 
were unchanged 
 
Topping et 
al., 1995 
Prospective 
intervention 
50  Not mentioned  USA  A two-meal per day plan modified to 
provide more than 2000kcal and 100g of 
protein with approximately 40% of the 
energy from fat for 7 days/week, weekly 
shelf-stable snack packs, medical 
nutritional supplement sampler pack and 
two home visits from dieticians 
Not 
mention
ed 
13 out of 35 patients gained weight (mean of 
2.7 kg). Decrease in number of participants 
who reported symptoms and eating difficulties. 
Clients also reported an improvement in their 
appetite and food intake at visit 2. 
Suttmann et 
al., 1996 
Controlled 
double blind 
cross phase 
trials 
10    Germany  Subjects randomly assigned to study 
formula containing protein casein, 
arginine, fat linoleic acid, carbohydrate 
lactose and ribonucleic acid, 
(carbohydrate 53%, 22% protein and fat 
25%) 
   
•  10 male out patients completed the study 
•  mean intake of formula 638±117 and 
695± 118kcal daily in intervention and 
control groups respectively 
•  energy intake increased after 2 months, 
but not for other nutrients 
•  CD4 cell count reduced in treatment 
group 
•  weight gained by intervention group was 
2.9 kg whiles controls lost  0.5 kg 
De Luis et 
al., 2003 
Randomized 
controlled trial 
70    Spain  Group 1 received formula and group 2 
were not supplemented 
  Treatment group gained 2.85% in body weight 
(p<0.05), which was due to fat mass (10.8%, 
p<0.05). Increase in tricipital skinfold was 
significant. Total body water and fat free-mass 
did not change and CD4 count and viral load 
remained stable 
Rabeneck 
et al., 1998 
Randomised 
controlled 
trials 
118, 59 each, 99 
completed 
All patients 
had CD4 
count <500 
cells/mm3.  
USA  Patients were assigned randomly to 
normal diet or a normal diet plus oral 
supplements, specialised medium chain 
triglyceride formula. Both groups 
received nutritional counselling 
Not 
mention
ed 
99 men completed the study and half of the 
subjects in each group achieved at least 80% 
of energy intake. 
No significant change occurred in 
haematologic parameters, including CD4+ cell 
count, or serum albumin. 
Changes in anthropometrics variables were 
not statistically significant 301 
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